"ID","URL","PDF","Country","Province","Date","Completion","Trial status","Design","Blinding","Arms","COVID-19 status","Patient setting","Outcome","Treatment","Size"
"IRCT20170731035423N2","http://en.irct.ir/trial/48049",NA,"Iran","Tehran","2020-Jun","2021-Mar","Recruiting","Randomised","Double",4,"Confirmed","Hospital","Radiographic Findings","Other",120
"IRCT20200428047228N2","http://en.irct.ir/trial/48096",NA,"Iran","Tehran","2020-Jun","2020-Jun","Completed","Randomised","Double",2,"Confirmed","ICU","Mortality","HCQ, HCQ + AZT",40
"IRCT20080901001165N60","http://en.irct.ir/trial/48102",NA,"Iran","Tehran","2020-May","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Hospitalization, Fever, C-Reactive Protein","Alternative therapy, SOC",30
"IRCT20151227025726N17","http://en.irct.ir/trial/48153",NA,"Iran","Tehran","2020-May","2020-May","Completed","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality","Dexamethasone + LPV/r, LPV/r",48
"IRCT20150107020592N23","http://en.irct.ir/trial/48185",NA,"Iran","Tehran","2020-May","2020-Jun","Completed","Single-Arm","Open-Label",1,"Confirmed","ICU","IL-6","Plasma based therapy",15
"IRCT20160809029275N1","http://en.irct.ir/trial/48187",NA,"Iran","Tehran","2020-May","2020-Oct","Recruiting","Randomised","Double",2,"Confirmed","Hospital",NA,"SOC, Stem cells",20
"IRCT20180608040007N2","http://en.irct.ir/trial/48218",NA,"Iran","Tehran","2020-Jun","2020-Jun","Completed","Randomised","Open-Label",2,"Suspected","Hospital","Anxiety","Alternative therapy, SOC",70
"IRCT20200517047485N1","http://en.irct.ir/trial/48226",NA,"Iran","Tehran","2020-May","2021-Apr","Recruiting","Non-Randomised","Double",2,"Confirmed","Hospital","Hospitalization, SpO2","HCQ + Atazanavir/ritonavir, HCQ + LPV/r",108
"IRCT20200519047510N1","http://en.irct.ir/trial/48292",NA,"Iran","Tehran","2020-May","2020-Jun","Completed","Non-Randomised","Open-Label",2,"Confirmed","Hospital",NA,"Alternative therapy, SOC",60
"IRCT20151227025726N18","http://en.irct.ir/trial/48312",NA,"Iran","Tehran","2020-Jun","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital",NA,"Igs, LPV/r",30
"IRCT20161206031256N3","http://en.irct.ir/trial/48329",NA,"Iran","Razavi Khorasan","2020-Jun","2020-Jul","Recruiting","Randomised","Triple",4,"Confirmed","Hospital","Hospital Discharge, Blood Gas","IFN, SOC",76
"IRCT20080901001165N58","http://en.irct.ir/trial/48394",NA,"Iran","Tehran","2020-May","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, SpO2, Shock, Hypoxemia","Plasma based therapy, SOC",100
"IRCT20160126026217N4","http://en.irct.ir/trial/48403",NA,"Iran","Tehran","2020-Jun","2020-Sep","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality","Positioning, SOC",74
"IRCT20200422047168N2","http://en.irct.ir/trial/48444",NA,"Iran","Khuzestan","2020-May","2020-Jul","Recruiting","Randomised","Single",2,"Confirmed","Hospital","Mortality, Hospital Discharge","HCQ + LPV/r, HCQ + LPV/r + Ivermectin",60
"IRCT20200525047562N1","http://en.irct.ir/trial/48493",NA,"Iran","Tehran","2020-Jun","2020-Jul","Recruiting","Non-Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","ICU Admission, Hospitalization, Hospital Discharge","Plasma based therapy, SOC",100
"IRCT20200523047550N1","http://en.irct.ir/trial/48495",NA,"Iran","Tehran","2020-Jun","2020-May","Completed","Non-Randomised","Open-Label",2,"Confirmed Or Suspected","Outpatient",NA,"HCQ, HCQ + Umifenovir",50
"IRCT20160118026097N3","http://en.irct.ir/trial/48517",NA,"Iran","Tehran","2020-May","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Organ Failure or Dysfunction (SOFA)","IFN, SOC",60
"IRCT20150107020592N24","http://en.irct.ir/trial/48534",NA,"Iran","Tehran","2020-Jun","2020-Jun","Completed","Single-Arm","Open-Label",1,"Confirmed","ICU","Hospitalization","Opiate analgesics",60
"IRCT20200504047298N1","http://en.irct.ir/trial/48640",NA,"Iran","Tehran","2020-Jun","2020-Jun","Completed","Randomised","Double",2,"Confirmed","Hospital","Hospitalization, C-Reactive Protein, Platelet Count, Erythrocyte Sedimentation Rate, Blood Pressure","Antiretrovirals, LPV/r",100
"IRCT20200518047497N2","http://en.irct.ir/trial/48644",NA,"Iran","East Azarbaijan","2020-Jun","2020-Aug","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Mortality","Alternative therapy, SOC",80
"IRCT20200607047675N1","http://en.irct.ir/trial/48700",NA,"Iran","Tehran","2020-Jun","2020-Sep","Recruiting","Randomised","Single",2,"Confirmed","Hospital","Lymphocyte Count, Platelet Count","Alternative therapy, SOC",100
"IRCT20120703010178N20","http://en.irct.ir/trial/48702",NA,"Iran","Tehran","2020-Jun","2020-Sep","Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Mortality, Hospitalization, IL-1","Anakinra, SOC",30
"IRCT20200412047042N1","http://en.irct.ir/trial/48749",NA,"Iran","East Azarbaijan","2020-Jun","2020-Aug","Recruiting","Randomised","Single",3,"Confirmed","Hospital","Organ Failure or Dysfunction (SOFA), Platelet Count, Coagulation Test, Bilirubin, PaO2-FiO2, Renal Outcome (Unspecified)","HCQ, HCQ + Raltagravir, HCQ + Raltagravir + IFN",60
"IRCT20150107020592N27","http://en.irct.ir/trial/48907",NA,"Iran","Tehran","2020-Jun","2020-Jun","Completed","Single-Arm","Open-Label",1,"Confirmed","ICU","Radiographic Findings","Igs",60
"NCT04399746","https://clinicaltrials.gov/show/NCT04399746",NA,"Mexico","Mexico","2020-May",NA,"Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Outpatient","Viral Load or Clearance","AZT + Ivermectin + Vitamins, SOC",30
"ACTRN12620000612910","https://anzctr.org.au/ACTRN12620000612910.aspx",NA,"Australia","Canberra","2020-May",NA,"Not Recruiting","Randomised","Open-Label",NA,"Confirmed Or Suspected","ICU","ICU Admission, Fever, Treatment-emergent Adverse Events, Blood Gas, PaO2-FiO2","SOC, Stem cells",24
"NCT04445311","https://clinicaltrials.gov/show/NCT04445311",NA,"Egypt","Cairo","2020-Jun",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient",NA,"Ivermectin, SOC",100
"NCT04445246","https://clinicaltrials.gov/show/NCT04445246",NA,"Qatar","Doha","2020-Sep",NA,"Recruiting","Single-Arm","Open-Label",1,"Suspected Or Confirmed","ICU",NA,"Vasodilators",40
"NCT04445337","https://clinicaltrials.gov/show/NCT04445337",NA,"United States","Nebraska","2020-Sep",NA,"Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","ICU","Pneumonia or ARDS","Other",10
"NCT04445389","https://clinicaltrials.gov/show/NCT04445389",NA,"South Korea","Seoul","2020-Jun",NA,"Recruiting","Randomised","Double",1,"Healthy","Healthy Unexposed","Serious Adverse Events","SOC, Vaccine",190
"NCT04445428","https://clinicaltrials.gov/show/NCT04445428",NA,"Guinea-Bissau","Bissau","2020-Jun",NA,"Not Recruiting","Randomised","Double",1,"Healthy","Healthy Unexposed","Mortality","SOC, Vaccine",3400
"NCT04445467","https://clinicaltrials.gov/show/NCT04445467",NA,"Australia","Victoria","2020-Jun",NA,"Not Recruiting","Randomised","Quadruple",2,"Confirmed","Outpatient, Hospital",NA,"FPV, SOC",190
"NCT04445623","https://clinicaltrials.gov/show/NCT04445623",NA,"Italy","Rome","2020-Apr",NA,"Not Recruiting","Randomised","Double",1,"Confirmed","Hospital","PaO2-FiO2","Antiplatelet, SOC",128
"NCT04447534","https://clinicaltrials.gov/show/NCT04447534",NA,"Egypt","Cairo","2020-Jun",NA,"Recruiting","Randomised","Double",1,"Confirmed","Unclear",NA,"HCQ, HCQ + Zinc",200
"ACTRN12620000707965","https://anzctr.org.au/ACTRN12620000707965.aspx",NA,"Australia","Canberra","2020-Jun",NA,"Not Recruiting","Randomised","Double",NA,"Healthy","Healthy Unexposed, Healthy Exposed, Healthcare Workers",NA,"SOC, Vaccine",3468
"ISRCTN15281137","http://isrctn.com/ISRCTN15281137",NA,"United Kingdom","London","2020-Jun",NA,"Recruiting","Randomised","Unspecified",NA,"Healthy","Healthy Unexposed","Serious Adverse Events","SOC, Vaccine",1112
"NL8633","https://trialregister.nl/trial/8633",NA,"Netherlands","Amsterdam","2020-May",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","Plasma based therapy, SOC",430
"EUCTR2020-001673-75-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001673-75",NA,"France","Paris","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Outpatient","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, SpO2","Other, SOC",1034
"EUCTR2020-001673-75-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001673-75",NA,"Spain","Madrid","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Outpatient","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, SpO2","Other, SOC",1034
"EUCTR2020-001673-75-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001673-75",NA,"Brazil","Brasilia","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Outpatient","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, SpO2","Other, SOC",1034
"EUCTR2020-001673-75-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001673-75",NA,"Belgium","Brussels","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Outpatient","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, SpO2","Other, SOC",1034
"EUCTR2020-001673-75-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001673-75",NA,"Netherlands","Amsterdam","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Outpatient","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, SpO2","Other, SOC",1034
"EUCTR2020-001673-75-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001673-75",NA,"Germany","Berlin","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Outpatient","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, SpO2","Other, SOC",1034
"EUCTR2020-001673-75-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001673-75",NA,"Italy","Rome","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Outpatient","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, SpO2","Other, SOC",1034
"EUCTR2020-001673-75-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001673-75",NA,"United Kingdom","London","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Outpatient","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, SpO2","Other, SOC",1034
"NCT04442958","https://clinicaltrials.gov/show/NCT04442958",NA,"Turkey","Ankara","2020-Jun",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","ICU","C-Reactive Protein, Ferritin, Lymphocyte Count, D-Dimer, Procalcitonin, Fibrinogen","Plasma based therapy, SOC",60
"NCT04451239","https://clinicaltrials.gov/show/NCT04451239",NA,"Kuwait","Kuwait City","2020-Jun",NA,"Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Outpatient",NA,"Cyclosporin + Steroids",12
"NCT04452097","https://clinicaltrials.gov/show/NCT04452097",NA,"United States","California","2020-Jun",NA,"Not Recruiting","Non-Randomised","Open-Label",2,"Confirmed","ICU","Treatment-emergent Adverse Events, Serious Adverse Events","Stem cells",9
"NCT04453371","https://clinicaltrials.gov/show/NCT04453371",NA,"Russia","Moscow","2020-Jun",NA,"Not Recruiting","Randomised","Double",1,"Confirmed","Hospital","Pneumonia or ARDS, PaO2-FiO2","Other, SOC",50
"NCT04453384","https://clinicaltrials.gov/show/NCT04453384",NA,"France","Paris","2020-Jun",NA,"Not Recruiting","Randomised","Quadruple",1,"Confirmed","Hospital","Non-invasive Ventilation, Adverse Events, Antibodies","other, SOC",368
"NCT04453488","https://clinicaltrials.gov/show/NCT04453488",NA,"Spain","Madrid","2020-Jun",NA,"Not Recruiting","Randomised","Quadruple",1,"Healthy","Healthcare Workers",NA,"SOC, Vaccine",315
"NCT04460443","https://clinicaltrials.gov/show/NCT04460443",NA,"Egypt","Cairo","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",1,"Confirmed","Unclear",NA,"DAA, DAA + Antiviral, SOC",60
"NCT04399252","https://clinicaltrials.gov/show/NCT04399252",NA,"United States","Washington, Dc","2020-May",NA,"Recruiting","Randomised","Triple",1,"Healthy","Healthy Exposed",NA,"Nutrition, SOC",1000
"ISRCTN99916292","http://isrctn.com/ISRCTN99916292",NA,"Cameroon","Yaounde","2020-May",NA,"Recruiting","Randomised","Unspecified",NA,"Healthy","Healthcare Workers","Cough, Fever, Dyspnea, Other Mild Symptoms","HCQ, SOC",30000
"ISRCTN99916292","http://isrctn.com/ISRCTN99916292",NA,"Canada","Ottawa","2020-May",NA,"Recruiting","Randomised","Unspecified",NA,"Healthy","Healthcare Workers","Cough, Fever, Dyspnea, Other Mild Symptoms","HCQ, SOC",30000
"ISRCTN99916292","http://isrctn.com/ISRCTN99916292",NA,"Ghana","Accra","2020-May",NA,"Recruiting","Randomised","Unspecified",NA,"Healthy","Healthcare Workers","Cough, Fever, Dyspnea, Other Mild Symptoms","HCQ, SOC",30000
"ISRCTN99916292","http://isrctn.com/ISRCTN99916292",NA,"Ireland","Dublin","2020-May",NA,"Recruiting","Randomised","Unspecified",NA,"Healthy","Healthcare Workers","Cough, Fever, Dyspnea, Other Mild Symptoms","HCQ, SOC",30000
"ISRCTN99916292","http://isrctn.com/ISRCTN99916292",NA,"Peru","Lima","2020-May",NA,"Recruiting","Randomised","Unspecified",NA,"Healthy","Healthcare Workers","Cough, Fever, Dyspnea, Other Mild Symptoms","HCQ, SOC",30000
"ISRCTN99916292","http://isrctn.com/ISRCTN99916292",NA,"South Africa","Pretoria","2020-May",NA,"Recruiting","Randomised","Unspecified",NA,"Healthy","Healthcare Workers","Cough, Fever, Dyspnea, Other Mild Symptoms","HCQ, SOC",30000
"ISRCTN99916292","http://isrctn.com/ISRCTN99916292",NA,"Uganda","Kampala","2020-May",NA,"Recruiting","Randomised","Unspecified",NA,"Healthy","Healthcare Workers","Cough, Fever, Dyspnea, Other Mild Symptoms","HCQ, SOC",30000
"ISRCTN99916292","http://isrctn.com/ISRCTN99916292",NA,"United Kingdom","London","2020-May",NA,"Recruiting","Randomised","Unspecified",NA,"Healthy","Healthcare Workers","Cough, Fever, Dyspnea, Other Mild Symptoms","HCQ, SOC",30000
"ISRCTN99916292","http://isrctn.com/ISRCTN99916292",NA,"United States","Washington, Dc","2020-May",NA,"Recruiting","Randomised","Unspecified",NA,"Healthy","Healthcare Workers","Cough, Fever, Dyspnea, Other Mild Symptoms","HCQ, SOC",30000
"ISRCTN99916292","http://isrctn.com/ISRCTN99916292",NA,"Zambia","Lusaka","2020-May",NA,"Recruiting","Randomised","Unspecified",NA,"Healthy","Healthcare Workers","Cough, Fever, Dyspnea, Other Mild Symptoms","HCQ, SOC",30000
"ISRCTN99916292","http://isrctn.com/ISRCTN99916292",NA,"Zimbabwe","Harare","2020-May",NA,"Recruiting","Randomised","Unspecified",NA,"Healthy","Healthcare Workers","Cough, Fever, Dyspnea, Other Mild Symptoms","HCQ, SOC",30000
"IRCT20200508047345N1","http://en.irct.ir/trial/47987",NA,"Iran","Tehran","2020-Jun","2020-Jun","Completed","Unspecified","Open-Label",2,"Confirmed","Outpatient","SpO2","Alternative therapy",100
"IRCT20200506047323N2","http://en.irct.ir/trial/47990",NA,"Iran","Tehran","2020-May","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Serious Adverse Events, SpO2","HCQ, HCQ + Alternative therapy",60
"IRCT20150716023235N15","http://en.irct.ir/trial/48019",NA,"Iran","Razavi Khorasan","2020-May","2020-Jul","Recruiting","Randomised","Single",2,"Confirmed","Hospital","IL-6","HCQ + AZT + NSAIDs, HCQ + AZT + NSAIDs + Hormone therapy",80
"IRCT20180923041093N6","http://en.irct.ir/trial/47974",NA,"Iran","Tehran","2020-Jun","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed","Hospital","Radiographic Findings","Alternative therapy, SOC",60
"IRCT20200209046427N1","http://en.irct.ir/trial/47504",NA,"Iran","Tehran","2020-Jun","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization, C-Reactive Protein","Alterantive therapy, SOC",60
"IRCT20200411047016N1","http://en.irct.ir/trial/47044",NA,"Iran","Tehran","2020-May","2020-Jun","Completed","Randomised","Double",2,"Confirmed","Hospital","Hospitalization, SpO2","Alternative therapy, SOC",150
"IRCT20080901001165N59","http://en.irct.ir/trial/47477",NA,"Iran","Tehran","2020-May","2020-Jul","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Fever","Hygiene, SOC",80
"IRCT20200314046774N1","http://en.irct.ir/trial/46519",NA,"Iran","Qom","2020-Jun","2020-Jun","Completed","Randomised","Triple",2,"Confirmed","Hospital","Radiographic Findings","SOC, Vitamins",94
"IRCT20200405046951N1","http://en.irct.ir/trial/47722",NA,"Iran","Tehran","2020-Jun","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","SpO2","SOC, Vitamins",120
"IRCT20081027001411N3","http://en.irct.ir/trial/46975",NA,"Iran","Tehran","2020-Jun","2020-Jun","Completed","Randomised","Single",2,"Confirmed","Hospital","Troponin","Corticosteroids, SOC",60
"IRCT20200504047298N2","http://en.irct.ir/trial/47675",NA,"Iran","Alborz","2020-Jun","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Cough, Fever, Dyspnea, Other Mild Symptoms","Alterantive therapy",48
"EUCTR2020-001411-25-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"United States","Washington, Dc","2020-Jun",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Spain","Madrid","2020-Jun",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Austria","Vienna","2020-Jun",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Israel","Jerusalem","2020-Jun",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"United Kingdom","London","2020-Jun",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Italy","Rome","2020-Jun",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"India","New Delhi","2020-Jun",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"France","Paris","2020-Jun",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Canada","Ottawa","2020-Jun",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Belgium","Brussels","2020-Jun",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Malaysia","Kuala Lumpur","2020-Jun",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Australia","Canberra","2020-Jun",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Germany","Berlin","2020-Jun",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"IRCT20150303021315N19","http://en.irct.ir/trial/47335",NA,"Iran","Tehran","2020-May","2020-Nov","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Dyspnea","mAb",62
"IRCT20150107020592N25","http://en.irct.ir/trial/47666",NA,"Iran","Tehran","2020-Jun","2020-May","Completed","Single-Arm","Open-Label",1,"Confirmed","ICU",NA,"Positioning",30
"IRCT20091201002804N12","http://en.irct.ir/trial/46983",NA,"Iran","Tehran","2020-Jun","2020-Jun","Completed","Randomised","Triple",2,"Confirmed","ICU","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","Other, SOC",60
"IRCT20190727044343N3","http://en.irct.ir/trial/47062",NA,"Iran","Tehran","2020-Jun","2020-Jun","Completed","Randomised","Double",2,"Confirmed","Unclear","C-Reactive Protein, IL-6, Radiographic Findings","Antivirals, Vitamins",60
"IRCT20200503047280N1","http://en.irct.ir/trial/47704",NA,"Iran","East Azarbaijan","2020-Jun","2020-Jul","Completed","Randomised","Triple",3,"Healthy","Healthy Exposed",NA,"Alterantive therapy, SOC",300
"CHICTR2000030937","http://www.chictr.org.cn/showproj.aspx?proj=51240",NA,"China","Guangdong","2020-Mar","2020-Aug","Recruiting","Randomised","Open-Label",2,"Resolved","Resolved Discharged","Other Mild Symptoms","SOC, TCM",144
"CHICTR2000030751","http://www.chictr.org.cn/showproj.aspx?proj=50941",NA,"China","Inner Mongol","2020-Mar","2020-Dec","Not Recruiting","Single-Arm","Unspecified",1,"Confirmed","Unclear","Viral Load or Clearance, White Blood Cell Count, Monocyte Count, Natural Killer Cell Count, Neutrophils, Creatinine Phosphokinase, CK-MB, eGFR, ALT, Albumin, Bilirubin, Urine Sample, Radiographic Findings","TCM",60
"NCT04433013","https://ClinicalTrials.gov/show/NCT04433013",NA,"Singapore","Singapore","2020-Jun","2020-Dec","Not Recruiting","Randomised","Triple",2,"Confirmed","Unclear","Other Mild Symptoms","SOC, TCM",300
"JPRN-JRCTS041190120","https://jrct.niph.go.jp/latest-detail/jRCTs041190120",NA,"Japan","Aichi","2020-Feb",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Viral Load or Clearance","FPV, SOC",86
"NCT04347226","https://ClinicalTrials.gov/show/NCT04347226",NA,"United States","New York","2020-Apr","2021-Sep","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Clinical Improvement Score (Any)","mAb, SOC",138
"RPCEC00000306","https://rpcec.sld.cu/en/trials/RPCEC00000306-En",NA,"Cuba","Havana","2020-Apr",NA,"Recruiting","Randomised","Unspecified",2,NA,"Healthy Exposed","Viral Load or Clearance, Adverse Events, Serious Adverse Events, C-Reactive Protein, IL-6, Tumor Necrosis Factor (Any), Interferon (Any), Prothrombin, Triglycerides, ALT, Albumin, Bilirubin, Glucose","SOC, Vaccine",80
"CHICTR2000029461","http://www.chictr.org.cn/showproj.aspx?proj=48927",NA,"China","Hubei","2020-Feb","2021-Dec","Not Recruiting","Randomised","Unspecified",2,"Confirmed","Outpatient","Viral Load or Clearance, Cough, Fever, Adverse Events, 6-Minute Walking Distance, Quality of Life","SOC, TCM",100
"CHICTR2000030043","http://www.chictr.org.cn/showproj.aspx?proj=49866",NA,"China","Beijing","2020-Feb","2020-Dec","Not Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","ICU Admission, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","SOC, TCM",300
"NCT04278963","https://clinicaltrials.gov/show/NCT04278963",NA,"China","Beijing","2020-Feb",NA,"Not Recruiting","Randomised","Double",3,"Confirmed","Hospital",NA,"TCM",300
"CHICTR2000029381","http://www.chictr.org.cn/showproj.aspx?proj=48768",NA,"China","Guangdong","2020-Jan",NA,"Not Recruiting","Non-Randomised","Unspecified",2,"Confirmed","Hospital","ICU Admission, Hospitalization, Viral Load or Clearance, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), C-Reactive Protein, White Blood Cell Count, Creatinine Phosphokinase, CK-MB, eGFR, Myoglobin, Troponin, ALT, Albumin, Bilirubin, IgG, IgM or IgA, PaO2-FiO2, Respiratory Rate, Radiographic Findings","SOC, TCM",400
"NCT04354831","https://ClinicalTrials.gov/show/NCT04354831",NA,"United States","Wisconsin","2020-Apr","2022-May","Recruiting","Non-Randomised","Open-Label",2,NA,"Hospital, ICU","Mortality, ICU Admission","Plasma based therapy",131
"IRCT20200417047113N1","http://en.irct.ir/trial/47264",NA,"Iran","Tehran","2020-Apr","2020-Dec","Recruiting","Randomised","Double",7,NA,"Hospital","Cough, Respiratory Rate, Lung Inflamation","Natural Killer Cells, SOC",70
"NCT04382625","https://ClinicalTrials.gov/show/NCT04382625",NA,"United States","Idaho","2020-May","2022-Jan","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Cardiac Outcome (Unspecified)","HCQ, SOC",120
"IRCT20200404046948N1","http://en.irct.ir/trial/46973",NA,"Iran","Tehran","2020-Apr","2020-Jun","Completed","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Fever, PaO2-FiO2, Respiratory Rate","Plasma based therapy, SOC",60
"CHICTR2000030165","http://www.chictr.org.cn/showproj.aspx?proj=49947",NA,"China","Tianjin","2020-Feb","2020-Dec","Recruiting","Randomised","Unspecified",3,"Confirmed","Outpatient, Hospital","Viral Load or Clearance, Radiographic Findings","Respiratory support, SOC",60
"NCT04328272","https://ClinicalTrials.gov/show/NCT04328272",NA,"Pakistan","Islamabad","2020-Mar","2020-May","Not Recruiting","Randomised","Single",3,"Confirmed","Hospital","Clinical Improvement Score (Any), C-Reactive Protein, D-Dimer","HCQ, HCQ + AZT, SOC",75
"CHICTR2000029621","http://www.chictr.org.cn/showproj.aspx?proj=49165",NA,"China","Shanghai","2020-Feb","2020-Dec","Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Mortality, Viral Load or Clearance, Fever","SOC, Umifenovir",380
"CHICTR2000029941","http://www.chictr.org.cn/showproj.aspx?proj=49596",NA,"China","Shanghai","2020-Feb","2020-Jun","Not Recruiting","Randomised","Unspecified",2,"Confirmed And Suspected","Outpatient, Hospital","Hospitalization, Viral Load or Clearance, Fever, Adverse Events, Serious Adverse Events, Radiographic Findings","SOC, TCM",200
"CHICTR2000031089","http://www.chictr.org.cn/showproj.aspx?proj=51136",NA,"China","Guangdong","2020-Mar","2020-Apr","Not Recruiting","Non-Randomised","Unspecified",2,"Confirmed","Unclear","Pneumonia or ARDS, Cough, Fever, Dyspnea, Other Mild Symptoms, White Blood Cell Count, Erythrocyte Sedimentation Rate, Creatinine Phosphokinase, CK-MB, eGFR, Myoglobin, Troponin, Procalcitonin, Prothrombin, Fibrinogen, Coagulation Test, ALT, Albumin, Bilirubin, Radiographic Findings","SOC, TCM",300
"CHICTR2000029550","http://www.chictr.org.cn/showproj.aspx?proj=48775",NA,"China","Sichuan","2020-Feb","2020-May","Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","C-Reactive Protein, White Blood Cell Count, Monocyte Count, Natural Killer Cell Count, Erythrocyte Sedimentation Rate, D-Dimer, Weight, Height or BMI, Creatinine Phosphokinase, Troponin, Procalcitonin, Radiographic Findings","TCM",300
"CHICTR2000030039","http://www.chictr.org.cn/showproj.aspx?proj=49544",NA,"China","Jiangsu","2020-Feb","2020-Feb","Recruiting","Non-Randomised","Unspecified",2,"Confirmed","Outpatient, Hospital","Viral Load or Clearance, C-Reactive Protein, IL-6, LDH, Respiratory Rate, Renal Outcome (Unspecified)","Plasma based therapy, SOC",90
"CHICTR2000030255","http://www.chictr.org.cn/showproj.aspx?proj=50089",NA,"China","Shanghai","2020-Feb","2020-Jul","Not Recruiting","Randomised","Unspecified",2,"Confirmed","Outpatient, Hospital","Clinical Improvement Score (Any), Viral Load or Clearance, Cough, Fever, Dyspnea, Other Mild Symptoms, Respiratory Rate, Radiographic Findings","SOC, TCM",300
"NCT04349592","https://ClinicalTrials.gov/show/NCT04349592",NA,"Qatar","Doha","2020-Apr","2020-May","Not Recruiting","Randomised","Quadruple",3,"Yes","Hospital","Viral Load or Clearance","HCQ, HCQ + AZT, SOC",456
"NCT04324021","https://clinicaltrials.gov/show/NCT04324021",NA,"Italy","Rome","2020-Mar",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Healthcare Workers, Unclear",NA,"Anakinra, mAb",54
"CHICTR2000030987","http://www.chictr.org.cn/showproj.aspx?proj=51329",NA,"China","Beijing","2020-Mar","2020-Jun","Recruiting","Randomised","Unspecified",3,"Resolved","Resolved Discharged","Viral Load or Clearance, Pneumonia or ARDS, Cough, Dyspnea","FPV, FPV + HCQ, SOC",150
"NCT04261270","https://clinicaltrials.gov/show/NCT04261270",NA,"China","Beijing","2020-Apr",NA,"Recruiting","Randomised","Single",3,"Confirmed","Hospital","ICU Admission, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms, Adverse Events, C-Reactive Protein, Erythrocyte Sedimentation Rate, Creatinine Phosphokinase, CK-MB, ALT, PaO2-FiO2, Respiratory Rate","Oseltamivir, Oseltamivir + Antivirals, Other + Oseltamivir",60
"EUCTR2020-001634-36-ES","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001634-36",NA,"Spain","Madrid","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever","Sarilumab, SOC",30
"NCT04326452","https://ClinicalTrials.gov/show/NCT04326452",NA,"United States","Arizona","2020-Mar","2020-May","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Blood Gas, Blood Pressure, Heart Rate, SpO2, Respiratory Rate","Non-invasive respiratory support",15
"NCT04326452","https://ClinicalTrials.gov/show/NCT04326452",NA,"United States","California","2020-Mar","2020-May","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Blood Gas, Blood Pressure, Heart Rate, SpO2, Respiratory Rate","Non-invasive respiratory support",15
"NCT04326452","https://ClinicalTrials.gov/show/NCT04326452",NA,"United States","Georgia","2020-Mar","2020-May","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Blood Gas, Blood Pressure, Heart Rate, SpO2, Respiratory Rate","Non-invasive respiratory support",15
"NCT04376034","https://ClinicalTrials.gov/show/NCT04376034",NA,"United States","West Virginia","2020-May","2021-Mar","Recruiting","Non-Randomised","Open-Label",3,"Confirmed","ICU",NA,"Plasma based therapy, SOC",240
"NCT04363034","https://ClinicalTrials.gov/show/NCT04363034",NA,"United States","Arkansas","2020-Apr",NA,"Recruiting","Unspecified","Unspecified",1,NA,"ICU",NA,"Plasma based therapy",NA
"NCT04268537","https://clinicaltrials.gov/show/NCT04268537",NA,"China","Beijing","2020-Aug",NA,"Not Recruiting","Randomised","Single",3,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), C-Reactive Protein, IL-6, Procalcitonin, Radiographic Findings","mAb, Other",120
"DRKS00021238","https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021238",NA,"Germany","Baden-Wurttemberg","2020-Apr",NA,"Recruiting","Randomised","Triple",2,NA,"ICU","Mortality, ICU Admission, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, PaO2-FiO2","SOC, TCZ",200
"NCT04366323","https://clinicaltrials.gov/show/NCT04366323",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,NA,"ICU","Adverse Events","SOC, Stem cells",26
"NCT04261426","https://clinicaltrials.gov/show/NCT04261426",NA,"China","Beijing","2020-Jun",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events","Igs, SOC",80
"CHICTR2000029580","http://www.chictr.org.cn/showproj.aspx?proj=49088",NA,"China","Hubei","2020-Feb","2020-Dec","Recruiting","Randomised","Single",2,"Confirmed","Hospital","Adverse Events","SOC, Stem cells",70
"NCT04332094","https://ClinicalTrials.gov/show/NCT04332094",NA,"Spain","Barcelona","2020-Apr","2020-Sep","Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO","HCQ + AZT, TCZ + AZT + HCQ",276
"CHICTR2000029638","http://www.chictr.org.cn/showproj.aspx?proj=49224",NA,"China","Sichuan","2020-Feb",NA,"Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","Cough, Fever, Dyspnea, Other Mild Symptoms, Treatment-emergent Adverse Events, C-Reactive Protein, IL-1, IL-2, IL-4, IL-6, IL-7, IL-8, IL-10, Tumor Necrosis Factor (Any), Granulocyte Stimulaiting Factor, White Blood Cell Count, Hemoglobin, Erythrocyte Sedimentation Rate, Creatinine Phosphokinase, CK-MB, Myoglobin, Troponin, Procalcitonin, Coagulation Test, Urine Sample, Blood Pressure, Heart Rate, Respiratory Rate, Radiographic Findings","IFN",100
"NCT04331899","https://ClinicalTrials.gov/show/NCT04331899",NA,"United States","California","2020-Apr","2021-May","Recruiting","Randomised","Single",2,"Confirmed","Outpatient","Viral Load or Clearance","IFN, SOC",120
"CHICTR2000029947","http://www.chictr.org.cn/showproj.aspx?proj=49599",NA,"China","Shanghai","2020-Feb","2020-Jun","Not Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Viral Load or Clearance, Serious or Seconday Infections, Adverse Events, Quality of Life","SOC, TCM",200
"CHICTR2000029960","http://www.chictr.org.cn/showproj.aspx?proj=49639",NA,"China","Hunan","2020-Feb","2020-May","Not Recruiting","Non-Randomised","Unspecified",2,"Confirmed Or Suspected","Unclear",NA,"SOC, TCM",100
"NCT04299724","https://ClinicalTrials.gov/show/NCT04299724",NA,"China","Guangdong","2020-Mar","2023-Jul","Recruiting","Single-Arm","Open-Label",1,"Confirmed And Healthy","Healthy Unexposed, Healthy Exposed, Outpatient","Mortality, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Treatment-emergent Adverse Events, C-Reactive Protein","Vaccine",100
"CHICTR2000030897","http://www.chictr.org.cn/showproj.aspx?proj=50462",NA,"China","Zhejiang","2020-Mar","2021-May","Recruiting","Randomised","Unspecified",2,"Resolved","Resolved Discharged","Hospitalization, Hospital Discharge, Viral Load or Clearance, Fever, C-Reactive Protein, IL-2, IL-4, IL-6, IL-8, IL-10, Tumor Necrosis Factor (Any), Interferon (Any), White Blood Cell Count, Monocyte Count, Weight, Height or BMI, Albumin, IgG, IgM or IgA, Antibodies, CD4, Radiographic Findings","Nutrition, SOC",20
"NCT04312997","https://ClinicalTrials.gov/show/NCT04312997",NA,"United States","California","2020-Mar","2020-Sep","Recruiting","Randomised","Quadruple",2,"Confirmed","Unclear","Mortality, ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation","Other, SOC",100
"NCT04312997","https://ClinicalTrials.gov/show/NCT04312997",NA,"United States","Florida","2020-Mar","2020-Sep","Recruiting","Randomised","Quadruple",2,"Confirmed","Unclear","Mortality, ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation","Other, SOC",100
"NCT04312997","https://ClinicalTrials.gov/show/NCT04312997",NA,"United States","Kentucky","2020-Mar","2020-Sep","Recruiting","Randomised","Quadruple",2,"Confirmed","Unclear","Mortality, ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation","Other, SOC",100
"NCT04312997","https://ClinicalTrials.gov/show/NCT04312997",NA,"United States","Oklahoma","2020-Mar","2020-Sep","Recruiting","Randomised","Quadruple",2,"Confirmed","Unclear","Mortality, ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation","Other, SOC",100
"NCT04312997","https://ClinicalTrials.gov/show/NCT04312997",NA,"United States","Texas","2020-Mar","2020-Sep","Recruiting","Randomised","Quadruple",2,"Confirmed","Unclear","Mortality, ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation","Other, SOC",100
"CHICTR2000029460","http://www.chictr.org.cn/showproj.aspx?proj=48930",NA,"China","Hubei","2020-Feb","2021-Dec","Not Recruiting","Randomised","Open-Label",2,"Resolved","Resolved Discharged","Adverse Events, 6-Minute Walking Distance, Quality of Life","Exercise, SOC",100
"NCT04315298","https://ClinicalTrials.gov/show/NCT04315298",NA,"United States","California","2020-Mar","2021-May","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia","Sarilumab, SOC",2500
"NCT04315298","https://ClinicalTrials.gov/show/NCT04315298",NA,"United States","Colorado","2020-Mar","2021-May","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia","Sarilumab, SOC",2500
"NCT04315298","https://ClinicalTrials.gov/show/NCT04315298",NA,"United States","Connecticut","2020-Mar","2021-May","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia","Sarilumab, SOC",2500
"NCT04315298","https://ClinicalTrials.gov/show/NCT04315298",NA,"United States","District Of Columbia","2020-Mar","2021-May","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia","Sarilumab, SOC",2500
"NCT04315298","https://ClinicalTrials.gov/show/NCT04315298",NA,"United States","Florida","2020-Mar","2021-May","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia","Sarilumab, SOC",2500
"NCT04315298","https://ClinicalTrials.gov/show/NCT04315298",NA,"United States","Georgia","2020-Mar","2021-May","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia","Sarilumab, SOC",2500
"NCT04315298","https://ClinicalTrials.gov/show/NCT04315298",NA,"United States","Illinois","2020-Mar","2021-May","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia","Sarilumab, SOC",2500
"NCT04315298","https://ClinicalTrials.gov/show/NCT04315298",NA,"United States","Louisiana","2020-Mar","2021-May","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia","Sarilumab, SOC",2500
"NCT04315298","https://ClinicalTrials.gov/show/NCT04315298",NA,"United States","Maryland","2020-Mar","2021-May","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia","Sarilumab, SOC",2500
"NCT04315298","https://ClinicalTrials.gov/show/NCT04315298",NA,"United States","Massachusetts","2020-Mar","2021-May","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia","Sarilumab, SOC",2500
"NCT04315298","https://ClinicalTrials.gov/show/NCT04315298",NA,"United States","Michigan","2020-Mar","2021-May","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia","Sarilumab, SOC",2500
"NCT04315298","https://ClinicalTrials.gov/show/NCT04315298",NA,"United States","Minnesota","2020-Mar","2021-May","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia","Sarilumab, SOC",2500
"NCT04315298","https://ClinicalTrials.gov/show/NCT04315298",NA,"United States","New Jersey","2020-Mar","2021-May","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia","Sarilumab, SOC",2500
"NCT04315298","https://ClinicalTrials.gov/show/NCT04315298",NA,"United States","New York","2020-Mar","2021-May","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia","Sarilumab, SOC",2500
"NCT04315298","https://ClinicalTrials.gov/show/NCT04315298",NA,"United States","Oklahoma","2020-Mar","2021-May","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia","Sarilumab, SOC",2500
"NCT04315298","https://ClinicalTrials.gov/show/NCT04315298",NA,"United States","Oregon","2020-Mar","2021-May","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia","Sarilumab, SOC",2500
"NCT04315298","https://ClinicalTrials.gov/show/NCT04315298",NA,"United States","Pennsylvania","2020-Mar","2021-May","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia","Sarilumab, SOC",2500
"NCT04315298","https://ClinicalTrials.gov/show/NCT04315298",NA,"United States","Texas","2020-Mar","2021-May","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia","Sarilumab, SOC",2500
"NCT04315298","https://ClinicalTrials.gov/show/NCT04315298",NA,"United States","Utah","2020-Mar","2021-May","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia","Sarilumab, SOC",2500
"NCT04315298","https://ClinicalTrials.gov/show/NCT04315298",NA,"United States","Virginia","2020-Mar","2021-May","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia","Sarilumab, SOC",2500
"NCT04315298","https://ClinicalTrials.gov/show/NCT04315298",NA,"United States","Washington","2020-Mar","2021-May","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia","Sarilumab, SOC",2500
"NCT04425252","https://ClinicalTrials.gov/show/NCT04425252",NA,"United States","Connecticut","2020-Jun","2020-Sep","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Viral Load or Clearance, Adverse Events","DHODH inhibitor, SOC",24
"NCT04425252","https://ClinicalTrials.gov/show/NCT04425252",NA,"United States","Florida","2020-Jun","2020-Sep","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Viral Load or Clearance, Adverse Events","DHODH inhibitor, SOC",24
"NCT04425252","https://ClinicalTrials.gov/show/NCT04425252",NA,"United States","Pennsylvania","2020-Jun","2020-Sep","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Viral Load or Clearance, Adverse Events","DHODH inhibitor, SOC",24
"NCT04385095","https://clinicaltrials.gov/show/NCT04385095",NA,"United Kingdom","London","2020-Apr",NA,"Recruiting","Randomised","Quadruple",2,"Confirmed Or Suspected","Outpatient, Hospital","Clinical Improvement Score (Any)","IFN, SOC",400
"NCT04393038","https://ClinicalTrials.gov/show/NCT04393038",NA,"Belgium","Brussels","2020-May","2020-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient, Hospital","Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, D-Dimer, Troponin","Other, SOC",1034
"NCT04393038","https://ClinicalTrials.gov/show/NCT04393038",NA,"Brazil","Amazonas","2020-May","2020-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient, Hospital","Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, D-Dimer, Troponin","Other, SOC",1034
"NCT04393038","https://ClinicalTrials.gov/show/NCT04393038",NA,"Brazil","Roraima","2020-May","2020-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient, Hospital","Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, D-Dimer, Troponin","Other, SOC",1034
"NCT04393038","https://ClinicalTrials.gov/show/NCT04393038",NA,"Brazil","Sao Paulo","2020-May","2020-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient, Hospital","Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, D-Dimer, Troponin","Other, SOC",1034
"NCT04393038","https://ClinicalTrials.gov/show/NCT04393038",NA,"Brazil","Rio De Janeiro","2020-May","2020-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient, Hospital","Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, D-Dimer, Troponin","Other, SOC",1034
"NCT04393038","https://ClinicalTrials.gov/show/NCT04393038",NA,"France","Nord","2020-May","2020-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient, Hospital","Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, D-Dimer, Troponin","Other, SOC",1034
"NCT04393038","https://ClinicalTrials.gov/show/NCT04393038",NA,"France","Paris","2020-May","2020-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient, Hospital","Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, D-Dimer, Troponin","Other, SOC",1034
"NCT04393038","https://ClinicalTrials.gov/show/NCT04393038",NA,"Germany","Berlin","2020-May","2020-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient, Hospital","Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, D-Dimer, Troponin","Other, SOC",1034
"NCT04393038","https://ClinicalTrials.gov/show/NCT04393038",NA,"Germany","Nordrhein-Westfalen","2020-May","2020-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient, Hospital","Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, D-Dimer, Troponin","Other, SOC",1034
"NCT04393038","https://ClinicalTrials.gov/show/NCT04393038",NA,"Germany","Hamburg","2020-May","2020-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient, Hospital","Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, D-Dimer, Troponin","Other, SOC",1034
"NCT04393038","https://ClinicalTrials.gov/show/NCT04393038",NA,"Italy","Milano","2020-May","2020-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient, Hospital","Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, D-Dimer, Troponin","Other, SOC",1034
"NCT04393038","https://ClinicalTrials.gov/show/NCT04393038",NA,"Spain","Barcelona","2020-May","2020-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient, Hospital","Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, D-Dimer, Troponin","Other, SOC",1034
"NCT04393038","https://ClinicalTrials.gov/show/NCT04393038",NA,"Spain","Alicante","2020-May","2020-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient, Hospital","Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, D-Dimer, Troponin","Other, SOC",1034
"NCT04393038","https://ClinicalTrials.gov/show/NCT04393038",NA,"Spain","Madrid","2020-May","2020-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient, Hospital","Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, D-Dimer, Troponin","Other, SOC",1034
"IRCT20140428017469N1","http://en.irct.ir/trial/47989",NA,"Iran","Fars","2020-May","2020-Jul","Completed","Single-Arm","Open-Label",1,"Healthy","Healthy Exposed",NA,"Vaccine",130000
"NCT04377334","https://ClinicalTrials.gov/show/NCT04377334",NA,"Germany","Berlin","2020-May","2021-Apr","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Lymphocyte Count, D-Dimer, Antibodies","SOC, Stem cells",40
"NCT04429867","https://ClinicalTrials.gov/show/NCT04429867",NA,"United States","Georgia","2020-Jun","2020-Dec","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization","HCQ, SOC",700
"NCT04377477","https://ClinicalTrials.gov/show/NCT04377477",NA,"Italy","Brescia","2020-May","2021-May","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Unclear","ICU Admission, Hospitalization, Adverse Events, Radiographic Findings","Radiation therapy",30
"NCT04392128","https://ClinicalTrials.gov/show/NCT04392128",NA,"France","Paris","2020-May","2020-Dec","Not Recruiting","Randomised","Quadruple",4,"Confirmed","Outpatient","Mortality, Viral Load or Clearance, Cough, Fever, Dyspnea, Anti SARS-COV-2 Titers","HCQ + AZT, SOC",114
"NCT04379518","https://ClinicalTrials.gov/show/NCT04379518",NA,"United States","New York","2020-May","2021-Apr","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Outpatient","Mortality, Hospitalization, Viral Load or Clearance, Pneumonia or ARDS, Adverse Events, Distress","IFN + Rintatolimod",80
"NCT04369365","https://ClinicalTrials.gov/show/NCT04369365",NA,"Austria","Vienna","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,NA,"Outpatient","Treatment-emergent Adverse Events","AZT, SOC",200
"NCT04381988","https://ClinicalTrials.gov/show/NCT04381988",NA,"United States","New Jersey","2020-May","2021-May","Recruiting","Randomised","Triple",3,"Healthy","Healthy Unexposed","Mortality","HCQ + Radiation therapy, Radiation therapy",132
"NCT04381988","https://ClinicalTrials.gov/show/NCT04381988",NA,"United States","New York","2020-May","2021-May","Recruiting","Randomised","Triple",3,"Healthy","Healthy Unexposed","Mortality","HCQ + Radiation therapy, Radiation therapy",132
"2020-001327-13","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001327-13/AT/",NA,"Austria","Vienna","2020-Mar",NA,"Recruiting","Randomised","Single",2,NA,"Healthy Unexposed","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance","AZT, SOC",NA
"2020-001257-51","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001257-51/DK/",NA,"Denmark","Copenhagen","2020-Mar",NA,"Suspended","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",NA
"ACTRN12620000457943","https://anzctr.org.au/ACTRN12620000457943.aspx",NA,"New Zealand","Wellington","2020-Aug",NA,"Not Recruiting","Randomised","Double",2,NA,"Outpatient","Mortality, Clinical Improvement Score (Any), Fever, Adverse Events","HCQ, SOC",70
"NCT04353674","https://ClinicalTrials.gov/show/NCT04353674",NA,"Canada","Ontario","2020-Apr","2020-Jul","Recruiting","Randomised","Open-Label",2,NA,"ICU","ICU Admission, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), White Blood Cell Count, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Dialysis, SOC",40
"CHICTR2000029989","http://www.chictr.org.cn/showproj.aspx?proj=49720",NA,"China","Beijing","2020-Feb","2020-May","Not Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Viral Load or Clearance, Cough, Fever, Dyspnea, Respiratory Rate, Radiographic Findings","IFN, SOC",300
"CTRI/2020/05/025178","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43557",NA,"India","Delhi","2020-May",NA,"Not Recruiting","Randomised","Open-Label",2,"Healthy","Healthy Exposed",NA,"Alternative therapy, SOC",140
"NCT04347239","https://ClinicalTrials.gov/show/NCT04347239",NA,"United States","California","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",2,NA,"Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","mAb, SOC",390
"NCT04347239","https://ClinicalTrials.gov/show/NCT04347239",NA,"United States","Connecticut","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",2,NA,"Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","mAb, SOC",390
"NCT04347239","https://ClinicalTrials.gov/show/NCT04347239",NA,"United States","Massachusetts","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",2,NA,"Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","mAb, SOC",390
"NCT04347239","https://ClinicalTrials.gov/show/NCT04347239",NA,"United States","New Jersey","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",2,NA,"Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","mAb, SOC",390
"NCT04347239","https://ClinicalTrials.gov/show/NCT04347239",NA,"United States","New York","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",2,NA,"Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","mAb, SOC",390
"NCT04347239","https://ClinicalTrials.gov/show/NCT04347239",NA,"United States","North Carolina","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",2,NA,"Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","mAb, SOC",390
"NCT04347239","https://ClinicalTrials.gov/show/NCT04347239",NA,"United States","Ohio","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",2,NA,"Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","mAb, SOC",390
"NCT04347239","https://ClinicalTrials.gov/show/NCT04347239",NA,"United States","Oregon","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",2,NA,"Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","mAb, SOC",390
"NCT04347239","https://ClinicalTrials.gov/show/NCT04347239",NA,"United States","Texas","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",2,NA,"Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","mAb, SOC",390
"NCT04394117","https://ClinicalTrials.gov/show/NCT04394117",NA,"Australia","New South Wales","2020-May","2021-Jan","Recruiting","Randomised","Single",2,"Confirmed","Outpatient, Hospital","Mortality, ICU Admission, Renal Outcome (Unspecified)","ARBs, SOC",605
"CHICTR2000030855","http://www.chictr.org.cn/showproj.aspx?proj=51090",NA,"China","Guizhou","2020-Mar","2020-May","Not Recruiting","Single-Arm","Unspecified",1,"Confirmed","Hospital","ICU Admission, PaO2-FiO2, Respiratory Rate","Respiratory support",200
"CHICTR2000030479","http://www.chictr.org.cn/showproj.aspx?proj=50450",NA,"China","Jiangsu","2020-Mar","2021-Feb","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Viral Load or Clearance, Pneumonia or ARDS, Fever, Dyspnea, Other Mild Symptoms, C-Reactive Protein, White Blood Cell Count, Erythrocyte Sedimentation Rate, Procalcitonin","SOC, TCM",100
"CHICTR2000029780","http://www.chictr.org.cn/showproj.aspx?proj=49220",NA,"China","Hubei","2020-Feb","2020-Jun","Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Viral Load or Clearance, Dyspnea, Other Mild Symptoms, Adverse Events, Serious Adverse Events","SOC, TCM",160
"CHICTR2000029742","http://www.chictr.org.cn/showproj.aspx?proj=49297",NA,"China","Hubei","2020-Feb","2020-Dec","Recruiting","Randomised","Unspecified",5,"Confirmed Or Suspected","Outpatient, Hospital","Viral Load or Clearance, Radiographic Findings","SOC, TCM",90
"PACTR202005599385499","https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10971",NA,"Egypt","Cairo","2020-Apr",NA,"Not Recruiting","Randomised","Unspecified",2,"Confirmed Or Healthy Or Suspected","Healthy Exposed, Healthcare Workers",NA,"Nutrition, SOC",60
"NCT04393792","https://ClinicalTrials.gov/show/NCT04393792",NA,"United Kingdom","Hampshire","2020-May","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed Or Healthy Or Suspected","Healthy Exposed, Healthcare Workers","Viral Load or Clearance","Hygiene, SOC",40
"NCT04323800","https://ClinicalTrials.gov/show/NCT04323800",NA,"United States","Alabama","2020-Mar","2022-Dec","Recruiting","Randomised","Triple",2,"Healthy (Exposed)","Healthy Exposed","Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea","Plasma based therapy, SOC",487
"NCT04323800","https://ClinicalTrials.gov/show/NCT04323800",NA,"United States","California","2020-Mar","2022-Dec","Recruiting","Randomised","Triple",2,"Healthy (Exposed)","Healthy Exposed","Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea","Plasma based therapy, SOC",487
"NCT04323800","https://ClinicalTrials.gov/show/NCT04323800",NA,"United States","District Of Columbia","2020-Mar","2022-Dec","Recruiting","Randomised","Triple",2,"Healthy (Exposed)","Healthy Exposed","Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea","Plasma based therapy, SOC",487
"NCT04323800","https://ClinicalTrials.gov/show/NCT04323800",NA,"United States","Florida","2020-Mar","2022-Dec","Recruiting","Randomised","Triple",2,"Healthy (Exposed)","Healthy Exposed","Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea","Plasma based therapy, SOC",487
"NCT04323800","https://ClinicalTrials.gov/show/NCT04323800",NA,"United States","Illinois","2020-Mar","2022-Dec","Recruiting","Randomised","Triple",2,"Healthy (Exposed)","Healthy Exposed","Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea","Plasma based therapy, SOC",487
"NCT04323800","https://ClinicalTrials.gov/show/NCT04323800",NA,"United States","Maryland","2020-Mar","2022-Dec","Recruiting","Randomised","Triple",2,"Healthy (Exposed)","Healthy Exposed","Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea","Plasma based therapy, SOC",487
"NCT04323800","https://ClinicalTrials.gov/show/NCT04323800",NA,"United States","Massachusetts","2020-Mar","2022-Dec","Recruiting","Randomised","Triple",2,"Healthy (Exposed)","Healthy Exposed","Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea","Plasma based therapy, SOC",487
"NCT04323800","https://ClinicalTrials.gov/show/NCT04323800",NA,"United States","New York","2020-Mar","2022-Dec","Recruiting","Randomised","Triple",2,"Healthy (Exposed)","Healthy Exposed","Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea","Plasma based therapy, SOC",487
"NCT04323800","https://ClinicalTrials.gov/show/NCT04323800",NA,"United States","Ohio","2020-Mar","2022-Dec","Recruiting","Randomised","Triple",2,"Healthy (Exposed)","Healthy Exposed","Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea","Plasma based therapy, SOC",487
"NCT04323800","https://ClinicalTrials.gov/show/NCT04323800",NA,"United States","Rhode Island","2020-Mar","2022-Dec","Recruiting","Randomised","Triple",2,"Healthy (Exposed)","Healthy Exposed","Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea","Plasma based therapy, SOC",487
"NCT04323800","https://ClinicalTrials.gov/show/NCT04323800",NA,"United States","Texas","2020-Mar","2022-Dec","Recruiting","Randomised","Triple",2,"Healthy (Exposed)","Healthy Exposed","Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea","Plasma based therapy, SOC",487
"NCT04397328","https://ClinicalTrials.gov/show/NCT04397328",NA,"Canada","Ontario","2020-May","2021-Apr","Not Recruiting","Randomised","Quadruple",2,"Healthy","Healthy Unexposed, Healthy Exposed, Hospital","Mortality, ICU Admission, Cough, Fever, Dyspnea","HCQ, SOC",336
"NCT04323527","https://ClinicalTrials.gov/show/NCT04323527",NA,"Brazil","Amazonas","2020-Mar","2020-May","Completed","Randomised","Quadruple",2,"Mixed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, Creatinine Phosphokinase, CK-MB, Troponin, AST, Renal Outcome (Unspecified)","HCQ",278
"NCT04322565","https://ClinicalTrials.gov/show/NCT04322565",NA,"Italy","Parma","2020-Mar","2020-Dec","Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Mortality, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Fever","Colchicine, SOC",310
"NCT04389359","https://ClinicalTrials.gov/show/NCT04389359",NA,"United Kingdom","Cambridgeshire","2020-May","2021-Aug","Not Recruiting","Randomised","Open-Label",2,"Healthy","Healthy Unexposed","Mortality","HCQ, SOC",1500
"IRCT20160313027033N2","http://en.irct.ir/trial/46762",NA,"Iran","Tehran","2020-Apr","2020-May","Completed","Randomised","Open-Label",2,NA,"Outpatient","Mortality, Hospitalization, Cough, Fever, Other Mild Symptoms, Respiratory Rate","Nutrition, SOC",120
"2020-001469-35","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001469-35/PL/",NA,"Poland","Warsaw","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,NA,"Outpatient","Mortality, Hospitalization, Fever, Dyspnea, Other Mild Symptoms, Adverse Events, Heart Rate","HCQ, SOC",400
"NCT04370834","https://ClinicalTrials.gov/show/NCT04370834",NA,"United States","Maryland","2020-May","2021-Nov","Recruiting","Single-Arm","Open-Label",1,NA,"Hospital",NA,"TCZ",217
"NCT04370834","https://ClinicalTrials.gov/show/NCT04370834",NA,"United States","Nevada","2020-May","2021-Nov","Recruiting","Single-Arm","Open-Label",1,NA,"Hospital",NA,"TCZ",217
"NCT04370834","https://ClinicalTrials.gov/show/NCT04370834",NA,"United States","Oklahoma","2020-May","2021-Nov","Recruiting","Single-Arm","Open-Label",1,NA,"Hospital",NA,"TCZ",217
"NCT04370834","https://ClinicalTrials.gov/show/NCT04370834",NA,"United States","Washington","2020-May","2021-Nov","Recruiting","Single-Arm","Open-Label",1,NA,"Hospital",NA,"TCZ",217
"IRCT20200317046797N5","http://en.irct.ir/trial/47015",NA,"Iran","East Azarbaijan","2020-Apr","2020-Jul","Recruiting","Single-Arm","Open-Label",1,NA,"ICU","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Radiographic Findings","Dialysis",10
"NCT04352985","https://ClinicalTrials.gov/show/NCT04352985",NA,"United States","District Of Columbia","2020-Apr",NA,"Recruiting","Unspecified","Unspecified",1,NA,"ICU",NA,"Antibiotics",NA
"NCT04352985","https://ClinicalTrials.gov/show/NCT04352985",NA,"United States","New York","2020-Apr",NA,"Recruiting","Unspecified","Unspecified",1,NA,"ICU",NA,"Antibiotics",NA
"NCT04276896","https://ClinicalTrials.gov/show/NCT04276896",NA,"China","Guangdong","2020-Feb","2023-Jul","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Radiographic Findings","Vaccine",100
"CHICTR2000030720","http://www.chictr.org.cn/showproj.aspx?proj=50793",NA,"China","Hubei","2020-Mar","2020-Aug","Recruiting","Randomised","Unspecified",2,"Recovering","Resolved Discharged","Clinical Improvement Score (Any), Fever, Antibodies, Radiographic Findings","SOC, TCM",120
"IRCT20160131026298N2","http://en.irct.ir/trial/46733",NA,"Iran","Tehran","2020-Apr","2020-Mar","Completed","Randomised","Open-Label",2,NA,"Hospital","Cough, Dyspnea, Radiographic Findings","Alternative therapy, SOC",64
"NCT04364802","https://ClinicalTrials.gov/show/NCT04364802",NA,"United States","Kentucky","2020-Apr","2021-May","Recruiting","Non-Randomised","Open-Label",4,NA,"Healthcare Workers, Hospital",NA,"Hygiene, SOC",250
"CHICTR2000029432","http://www.chictr.org.cn/showproj.aspx?proj=48881",NA,"China","Guangdong","2020-Feb","2020-Apr","Not Recruiting","Single-Arm","Unspecified",1,"Confirmed Or Suspected","Hospital","Fever, C-Reactive Protein, Creatinine Phosphokinase, CK-MB, eGFR, Myoglobin, Procalcitonin, ALT, Albumin, Bilirubin, Blood Gas, Radiographic Findings, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","TCM",72
"2020-002287-31","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-002287-31/ES/",NA,"Spain","Madrid","2020-May",NA,"Recruiting","Randomised","Unspecified",2,"Healthy","Healthy Unexposed","Mortality, Cough, Fever, Dyspnea, Other Mild Symptoms","HCQ, SOC",1930
"NCT04400019","https://ClinicalTrials.gov/show/NCT04400019",NA,"Spain","Malaga","2020-May","2020-Dec","Not Recruiting","Randomised","Double",2,"Healthy","Healthy Unexposed, Healthcare Workers","Mortality, Hospitalization, Adverse Events","HCQ, SOC",1930
"NCT04394169","https://ClinicalTrials.gov/show/NCT04394169",NA,"Spain","Barcelona","2020-May","2020-Sep","Not Recruiting","Randomised","Single",2,"Resolved","Resolved Discharged","Quality of Life, Depression, Anxiety","Rehabilitation, SOC",102
"NCT04375735","https://ClinicalTrials.gov/show/NCT04375735",NA,"Canada","Ontario","2020-May","2021-Jan","Not Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Adverse Events, IL-1, IL-4, IL-6, IL-10, Tumor Necrosis Factor (Any), Granulocyte Stimulaiting Factor, MCP-1","Other, SOC",20
"NCT04347941","https://clinicaltrials.gov/show/NCT04347941",NA,"Ireland","Dublin","2020-Aug",NA,"Not Recruiting","Randomised","Double",2,NA,"ICU","Invasive Mechanical Ventilation or ECMO, PaO2-FiO2, Respiratory Rate, Patient Positioning","Positioning, SOC",200
"NCT04343248","https://ClinicalTrials.gov/show/NCT04343248",NA,"United States","Florida","2020-Apr","2020-Aug","Recruiting","Randomised","Triple",3,"Not Specified","Hospital","Mortality, Clinical Improvement Score (Any), PaO2-FiO2","Antivirals, SOC",800
"NCT04343248","https://ClinicalTrials.gov/show/NCT04343248",NA,"United States","Georgia","2020-Apr","2020-Aug","Recruiting","Randomised","Triple",3,"Not Specified","Hospital","Mortality, Clinical Improvement Score (Any), PaO2-FiO2","Antivirals, SOC",800
"NCT04343248","https://ClinicalTrials.gov/show/NCT04343248",NA,"United States","Louisiana","2020-Apr","2020-Aug","Recruiting","Randomised","Triple",3,"Not Specified","Hospital","Mortality, Clinical Improvement Score (Any), PaO2-FiO2","Antivirals, SOC",800
"NCT04343248","https://ClinicalTrials.gov/show/NCT04343248",NA,"United States","Texas","2020-Apr","2020-Aug","Recruiting","Randomised","Triple",3,"Not Specified","Hospital","Mortality, Clinical Improvement Score (Any), PaO2-FiO2","Antivirals, SOC",800
"CHICTR2000029972","http://www.chictr.org.cn/showproj.aspx?proj=49664",NA,"China","Hubei","2020-Feb","2020-May","Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","Viral Load or Clearance","Other, SOC",40
"NCT04303507","https://ClinicalTrials.gov/show/NCT04303507",NA,"Thailand","Nan","2020-Mar","2021-Apr","Recruiting","Randomised","Double",2,"Healthy (Exposed)","Healthcare Workers","Viral Load or Clearance, Pneumonia or ARDS","HCQ, SOC",40000
"NCT04303507","https://ClinicalTrials.gov/show/NCT04303507",NA,"United Kingdom","London","2020-Mar","2021-Apr","Recruiting","Randomised","Double",2,"Healthy (Exposed)","Healthcare Workers","Viral Load or Clearance, Pneumonia or ARDS","HCQ, SOC",40000
"CHICTR2000029978","http://www.chictr.org.cn/showproj.aspx?proj=49702",NA,"China","Shanghai","2020-Feb","2020-Jul","Not Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Hospitalization, Cough, Fever, Dyspnea, PD-1, Weight, Height or BMI, Creatinine Phosphokinase, CK-MB, ALT, CD4, CD8, Respiratory Rate, Radiographic Findings, Depression, Anxiety, Distress","SOC, TCM",186
"EUCTR2020-001570-30-FR","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001570-30",NA,"France","Paris","2020-Jun",NA,"Not Recruiting","Randomised","Double",2,NA,"ICU","Mortality, Secondary CoViD-19 Re-infection, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, C-Reactive Protein, Lymphocyte Count, D-Dimer, Fibrinogen, CD4, CD8, Renal Outcome (Unspecified)","Other, SOC",126
"2020-001395-15","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001395-15/DK/",NA,"Denmark","Copenhagen","2020-Mar",NA,"Suspended","Randomised","Double",2,"Confirmed","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO, Shock, Quality of Life, Renal Outcome (Unspecified)","Corticosteroids, SOC",NA
"JPRN-UMIN000040602","https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046338",NA,"Brazil","Brasilia","2020-Jan",NA,"Not Recruiting","Randomised","Double",NA,"Confirmed","Outpatient",NA,"Alternative therapy, SOC",100
"NCT04275388","https://ClinicalTrials.gov/show/NCT04275388",NA,"China","Beijing","2020-Feb","2020-May","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, PaO2-FiO2, Respiratory Rate","LPV/r + IFN, LPV/r + IFN + TCM",348
"CHICTR2000030029","http://www.chictr.org.cn/showproj.aspx?proj=49824",NA,"China","Zhejiang","2020-Feb","2020-May","Not Recruiting","Single-Arm","Unspecified",1,"Confirmed","Unclear","Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO","Other",20
"CHICTR2000030259","http://www.chictr.org.cn/showproj.aspx?proj=49918",NA,"China","Shanghai","2020-Feb","2020-Apr","Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Viral Load or Clearance, PaO2-FiO2, Respiratory Rate","DAA, SOC",60
"2020-000936-23","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000936-23/AT/",NA,"Austria","Vienna","2020-May",NA,"Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, Electrolytes, INR, ALT, AST, Bilirubin, Glucose, Renal Outcome (Unspecified)","HCQ, LPV/r, Remdesivir",3100
"2020-001363-85","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001363-85/DK/",NA,"Denmark","Copenhagen","2020-Apr",NA,"Status Unclear","Randomised","Open-Label",2,NA,"Hospital","Mortality, Hospitalization, Visits or Returns to Emergency Department, Viral Load or Clearance","HCQ, SOC",NA
"2020-001765-37","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001765-37/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Single-Arm","Open-Label",1,NA,"Unclear","Clinical Improvement Score (Any), Cough, Fever, Dyspnea, Other Mild Symptoms, Serious or Seconday Infections, Adverse Events","HCQ",NA
"ACTRN12620000566932","https://anzctr.org.au/ACTRN12620000566932.aspx",NA,"Australia","Canberra","2020-May",NA,"Not Recruiting","Randomised","Unspecified",2,"Confirmed Or Suspected","Hospital","Mortality","HCQ, SOC",3000
"NCT04426201","https://ClinicalTrials.gov/show/NCT04426201",NA,"United States","Florida","2020-Jun","2020-Nov","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Serious or Seconday Infections, C-Reactive Protein, Ferritin, Lymphocyte Count, D-Dimer, CD4, CD8","Other, SOC",48
"NCT04428008","https://ClinicalTrials.gov/show/NCT04428008",NA,"United States","Virginia","2020-Jun","2021-Jan","Not Recruiting","Randomised","Open-Label",2,"Healthy","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Lymphocyte Count, CD4, CD8","Other, SOC",240
"CHICTR2000030170","http://www.chictr.org.cn/showproj.aspx?proj=50017",NA,"China","Shanghai","2020-Feb","2020-Jul","Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Clinical Improvement Score (Any)","JAKi",16
"NCT04324073","https://ClinicalTrials.gov/show/NCT04324073",NA,"France","Paris","2020-Mar","2021-Mar","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2, Blood pH","Sarilumab, SOC",239
"NCT04331808","https://ClinicalTrials.gov/show/NCT04331808",NA,"France","Paris","2020-Apr","2021-Mar","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, PaO2-FiO2, Radiographic Findings, Blood pH","SOC, TCZ",228
"NCT04331665","https://ClinicalTrials.gov/show/NCT04331665",NA,"Canada","Ontario","2020-Apr","2020-Oct","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events","JAKi",64
"NCT04374019","https://clinicaltrials.gov/show/NCT04374019",NA,"United States","Washington, Dc","2020-Jan",NA,"Recruiting","Randomised","Open-Label",4,"Confirmed","Unclear",NA,"HCQ, HCQ + AZT, HCQ + Ivermectin, Other",240
"NCT04333914","https://clinicaltrials.gov/show/NCT04333914",NA,"France","Paris","2020-Jan",NA,"Not Recruiting","Randomised","Open-Label",5,"Confirmed Or Suspected","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, IL-6, Neutrophils, Hemoglobin","HCQ, mAb, SOC, TCZ",384
"CTRI/2020/05/025068","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43449",NA,"India","New Delhi","2020-Jul",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Viral Load or Clearance","Ivermectin, SOC",50
"CHICTR2000030084","http://www.chictr.org.cn/showproj.aspx?proj=49952",NA,"China","Shanxi","2020-Feb","2022-Feb","Recruiting","Randomised","Unspecified",2,"Confirmed","Outpatient","Depression, Anxiety","Psychological therapy, SOC",180
"NCT04279197","https://clinicaltrials.gov/show/NCT04279197",NA,"China","Beijing","2020-Feb",NA,"Recruiting","Randomised","Double",2,"Negative(?)","Unclear","Pneumonia or ARDS, Dyspnea, 6-Minute Walking Distance, Radiographic Findings","SOC, TCM",136
"CHICTR2000030761","http://www.chictr.org.cn/showproj.aspx?proj=50956",NA,"China","Shanghai","2020-Mar","2020-Apr","Not Recruiting","Single-Arm","Unspecified",1,"Confirmed","ICU","C-Reactive Protein, IL-6, IL-8, Tumor Necrosis Factor (Any)","Other",20
"NCT04322773","https://ClinicalTrials.gov/show/NCT04322773",NA,"Denmark","Copenhagen","2020-Mar","2021-Jun","Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein","Sarilumab, SOC, TCZ",200
"CHICTR2000029814","http://www.chictr.org.cn/showproj.aspx?proj=49387",NA,"China","Shanghai","2020-Feb","2020-Dec","Recruiting","Non-Randomised","Unspecified",2,"Confirmed","Unclear","Viral Load or Clearance, Cough, Fever, Dyspnea","SOC, TCM",30
"CHICTR2000030314","http://www.chictr.org.cn/showproj.aspx?proj=50248",NA,"China","Hubei","2020-Feb","2020-Apr","Not Recruiting","Single-Arm","Unspecified",1,"Confirmed","Unclear","Cough, Fever, Dyspnea","TCM",40
"CHICTR2000030324","http://www.chictr.org.cn/showproj.aspx?proj=50231",NA,"China","Hubei","2020-Feb","2020-May","Not Recruiting","Single-Arm","Unspecified",2,"Confirmed","Outpatient","Cough, Fever, Dyspnea","SOC, TCM",40
"NCT04346667","https://ClinicalTrials.gov/show/NCT04346667",NA,"Pakistan","Punjab","2020-Apr","2020-May","Recruiting","Randomised","Double",4,NA,"Outpatient","Clinical Improvement Score (Any), Viral Load or Clearance, Cough, Fever, Dyspnea, Adverse Events","HCQ, SOC",400
"ISRCTN86534580","http://isrctn.com/ISRCTN86534580",NA,"United Kingdom","London","2020-Mar",NA,"Recruiting","Randomised","Unspecified",2,"Suspected","Outpatient","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",3000
"NCT04429529","https://ClinicalTrials.gov/show/NCT04429529",NA,"Singapore","Singapore","2020-Jun","2020-Oct","Recruiting","Randomised","Double",7,"Healthy","Healthy Unexposed","Adverse Events, Radiographic Findings","Other, SOC",25
"EUCTR2020-001448-24-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001448-24",NA,"Ghana","Accra","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",4,"Healthy, Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections, Serious Adverse Events, ALT","HCQ, LPV/r, SOC",6400
"EUCTR2020-001448-24-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001448-24",NA,"Nigeria","Niger","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",4,"Healthy, Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections, Serious Adverse Events, ALT","HCQ, LPV/r, SOC",6400
"EUCTR2020-001448-24-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001448-24",NA,"South Africa","Pretoria","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",4,"Healthy, Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections, Serious Adverse Events, ALT","HCQ, LPV/r, SOC",6400
"EUCTR2020-001448-24-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001448-24",NA,"United Kingdom","London","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",4,"Healthy, Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections, Serious Adverse Events, ALT","HCQ, LPV/r, SOC",6400
"EUCTR2020-001448-24-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001448-24",NA,"India","New Delhi","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",4,"Healthy, Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections, Serious Adverse Events, ALT","HCQ, LPV/r, SOC",6400
"NCT04333628","https://ClinicalTrials.gov/show/NCT04333628",NA,"Israel","Hazafon","2020-Apr","2021-Apr","Not Recruiting","Randomised","Open-Label",3,"Confirmed","Outpatient","Clinical Improvement Score (Any), Viral Load or Clearance","HCQ, SOC",210
"CTRI/2020/03/024402","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42638",NA,"India","New Delhi","2020-Mar",NA,"Not Recruiting","Randomised","Open-Label",2,NA,"Healthcare Workers","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Other Mild Symptoms","HCQ",500
"DRKS00021300","https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021300",NA,"Germany","Baden-Wurttemberg","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, IL-6","ECMO, ECMO + Cytokine removal",30
"NL8609","https://trialregister.nl/trial/8609",NA,"Netherlands","Amsterdam","2020-Nov",NA,"Not Recruiting","Randomised","Open-Label",5,"Healthy","Healthy Unexposed","Monocyte Count","SOC, Vaccine, Vaccine + Bisphosphonate, Vaccine + Vaccine",100
"CTRI/2020/04/024833","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43105",NA,"India","New Delhi","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Healthy (Exposed)","Healthcare Workers","Cough, Fever, Dyspnea, Antibodies, Distress","SOC, Vaccine",1826
"ISRCTN88057279","http://isrctn.com/ISRCTN88057279",NA,"United Kingdom","London","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Healthy","Hospital",NA,"HCQ, SOC",500
"CTRI/2020/05/025171","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43487",NA,"India","Delhi","2020-May",NA,"Not Recruiting","Randomised","Open-Label",2,"Healthy","Healthy Unexposed, Healthy Exposed",NA,"Alternative therapy, SOC",50000
"CTRI/2020/05/025069","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43522",NA,"India","New Delhi","2020-Jul",NA,"Not Recruiting","Single-Arm","Open-Label",1,"Healthy","Healthy Exposed",NA,"Alternative therapy",1324
"CTRI/2020/05/025088","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43555",NA,"India","New Delhi","2020-Sep",NA,"Not Recruiting","Randomised","Open-Label",2,"Healthy","Healthy Unexposed, Healthy Exposed",NA,"Alternative therapy, SOC",1200
"CTRI/2020/05/025093","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43539",NA,"India","New Delhi","2020-Nov",NA,"Not Recruiting","Randomised","Open-Label",2,"Healthy","Healthy Unexposed, Healthy Exposed",NA,"Alternative therapy, SOC",1200
"NCT04412356","https://ClinicalTrials.gov/show/NCT04412356",NA,"Sweden","Stockholm","2020-Jun","2020-Dec","Recruiting","Randomised","Single",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Adverse Events","Procedure",180
"CTRI/2020/05/025067","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43019",NA,"India","New Delhi","2020-Jun",NA,"Not Recruiting","Randomised","Open-Label",2,"Healthy (Exposed)","Healthcare Workers",NA,"HCQ, SOC",10990
"NCT04422275","https://ClinicalTrials.gov/show/NCT04422275",NA,"United States","Missouri","2020-Jun","2023-Jun","Not Recruiting","Randomised","Quadruple",4,"Resolved","Outpatient",NA,"Corticosteroids + Other, Other",200
"CHICTR2000029806","http://www.chictr.org.cn/showproj.aspx?proj=49161",NA,"China","Hubei","2020-Feb","2021-Jan","Recruiting","Randomised","Unspecified",3,"Confirmed","Hospital","Clinical Improvement Score (Any)","mAb, Other, SOC",120
"NCT04326075","https://clinicaltrials.gov/show/NCT04326075",NA,"Italy","Milan","2020-Mar",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","Non-invasive respiratory support, SOC",900
"NCT04264533","https://ClinicalTrials.gov/show/NCT04264533",NA,"China","Hubei","2020-Feb","2020-Sep","Recruiting","Randomised","Triple",2,"Confirmed","ICU","Mortality, ICU Admission, Clinical Improvement Score (Any), PaO2-FiO2, Respiratory Rate, Hypoxia, Hypoxemia","SOC, Vitamins",140
"NCT04347538","https://ClinicalTrials.gov/show/NCT04347538",NA,"United States","Tennessee","2020-Apr","2021-Jun","Recruiting","Randomised","Open-Label",3,NA,"Outpatient","Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Other Mild Symptoms","Hygiene, SOC",90
"NCT04269525","https://ClinicalTrials.gov/show/NCT04269525",NA,"China","Hubei","2020-Feb","2020-Dec","Recruiting","Single-Arm","Open-Label",1,"Confirmed","ICU","Mortality, Hospitalization, Viral Load or Clearance, Pneumonia or ARDS, IL-2, IL-4, IL-6, IL-7, IL-8, IL-10, Tumor Necrosis Factor (Any), White Blood Cell Count, Procalcitonin, PaO2-FiO2, Radiographic Findings","Stem cells",16
"CHICTR2000029992","http://www.chictr.org.cn/showproj.aspx?proj=49574",NA,"China","Fujian","2020-Feb","2020-May","Not Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Hospital Discharge, Viral Load or Clearance, Fever, Serious Adverse Events, Respiratory Rate","HCQ, SOC",100
"CHICTR2000029606","http://www.chictr.org.cn/showproj.aspx?proj=49146",NA,"China","Zhejiang","2020-Feb","2022-Dec","Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","SOC, TCM",63
"CHICTR2000029855","http://www.chictr.org.cn/showproj.aspx?proj=49543",NA,"China","Zhejiang","2020-Feb",NA,"Recruiting","Randomised","Unspecified",3,"Confirmed","Outpatient","Clinical Improvement Score (Any), Viral Load or Clearance, Fever","SOC, TCM",180
"NCT04286503","https://ClinicalTrials.gov/show/NCT04286503",NA,"China","Beijing","2020-Feb","2021-Feb","Not Recruiting","Randomised","Open-Label",3,"Confirmed","Outpatient, Hospital, ICU","Viral Load or Clearance, Fever, Radiographic Findings","Carrimycin, HCQ or LPV/r or Umifenovir",520
"CHICTR2000029867","http://www.chictr.org.cn/showproj.aspx?proj=49514",NA,"China","Beijing","2020-Feb","2021-Feb","Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient, Hospital, ICU","Viral Load or Clearance, Fever","Carrimycin, LPV/r",520
"NCT04323228","https://ClinicalTrials.gov/show/NCT04323228",NA,"Saudi Arabia","Riyadh","2020-Mar","2020-Oct","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Non-invasive Ventilation, Fever, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), MCP-1, White Blood Cell Count, Neutrophils, Weight, Height or BMI","Nutrition, SOC",30
"CTRI/2020/04/024749","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42972",NA,"India","New Delhi","2020-Apr",NA,"Recruiting","Randomised","Double",2,"Healthy","Healthy Unexposed, Healthy Exposed, Healthcare Workers",NA,"SOC, Vaccine",5946
"CTRI/2020/05/025166","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43553",NA,"India","New Delhi","2020-May",NA,"Not Recruiting","Randomised","Open-Label",2,"Healthy","Healthy Unexposed",NA,"Alternative therapy, SOC",1200
"PACTR202004893013257","https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10981",NA,"Ghana","Accra","2020-Apr",NA,"Not Recruiting","Randomised","Unspecified",4,"Healthy","Hospital","Mortality, Pneumonia or ARDS, Distress","HCQ, HCQ + LPV/r, LPV/r, SOC",6400
"NCT04326790","https://ClinicalTrials.gov/show/NCT04326790",NA,"Gibraltar","Gibraltar","2020-Mar","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Clinical Improvement Score (Any), C-Reactive Protein, Troponin","Colchicine, SOC",180
"NCT04425837","https://ClinicalTrials.gov/show/NCT04425837",NA,"Colombia","Cundinamarca","2020-Jun","2021-Feb","Not Recruiting","Randomised","Single",2,"Confirmed","Hospital, ICU","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, D-Dimer, Troponin, Procalcitonin, LDH, PaO2-FiO2","Plasma based therapy, SOC",236
"CHICTR2000030923","http://www.chictr.org.cn/showproj.aspx?proj=51139",NA,"China","Shaanxi","2020-Mar","2020-Apr","Recruiting","Randomised","Open-Label",4,"Confirmed Or Suspected","Unclear","Clinical Improvement Score (Any), Viral Load or Clearance","SOC, TCM",400
"NCT04313023","https://ClinicalTrials.gov/show/NCT04313023",NA,"United States","California","2020-Mar","2020-Sep","Recruiting","Randomised","Quadruple",2,"Healthy (Exposed)","Healthy Exposed","Mortality, ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation","Other, SOC",200
"NCT04313023","https://ClinicalTrials.gov/show/NCT04313023",NA,"United States","Florida","2020-Mar","2020-Sep","Recruiting","Randomised","Quadruple",2,"Healthy (Exposed)","Healthy Exposed","Mortality, ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation","Other, SOC",200
"NCT04313023","https://ClinicalTrials.gov/show/NCT04313023",NA,"United States","Georgia","2020-Mar","2020-Sep","Recruiting","Randomised","Quadruple",2,"Healthy (Exposed)","Healthy Exposed","Mortality, ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation","Other, SOC",200
"NCT04313023","https://ClinicalTrials.gov/show/NCT04313023",NA,"United States","Louisiana","2020-Mar","2020-Sep","Recruiting","Randomised","Quadruple",2,"Healthy (Exposed)","Healthy Exposed","Mortality, ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation","Other, SOC",200
"NCT04313023","https://ClinicalTrials.gov/show/NCT04313023",NA,"United States","New Jersey","2020-Mar","2020-Sep","Recruiting","Randomised","Quadruple",2,"Healthy (Exposed)","Healthy Exposed","Mortality, ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation","Other, SOC",200
"NCT04313023","https://ClinicalTrials.gov/show/NCT04313023",NA,"United States","Oklahoma","2020-Mar","2020-Sep","Recruiting","Randomised","Quadruple",2,"Healthy (Exposed)","Healthy Exposed","Mortality, ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation","Other, SOC",200
"NCT04313023","https://ClinicalTrials.gov/show/NCT04313023",NA,"United States","Texas","2020-Mar","2020-Sep","Recruiting","Randomised","Quadruple",2,"Healthy (Exposed)","Healthy Exposed","Mortality, ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation","Other, SOC",200
"NCT04438850","https://ClinicalTrials.gov/show/NCT04438850",NA,"Italy","Verona","2020-Jun","2020-Aug","Not Recruiting","Randomised","Quadruple",3,"Confirmed","Healthcare Workers, Outpatient, Unclear","Hospitalization, Viral Load or Clearance","Ivermectin, SOC",102
"NCT04438850","https://ClinicalTrials.gov/show/NCT04438850",NA,"Italy","Bologna","2020-Jun","2020-Aug","Not Recruiting","Randomised","Quadruple",3,"Confirmed","Healthcare Workers, Outpatient, Unclear","Hospitalization, Viral Load or Clearance","Ivermectin, SOC",102
"NCT04438850","https://ClinicalTrials.gov/show/NCT04438850",NA,"Italy","Rome","2020-Jun","2020-Aug","Not Recruiting","Randomised","Quadruple",3,"Confirmed","Healthcare Workers, Outpatient, Unclear","Hospitalization, Viral Load or Clearance","Ivermectin, SOC",102
"NCT04438850","https://ClinicalTrials.gov/show/NCT04438850",NA,"Italy","Turin","2020-Jun","2020-Aug","Not Recruiting","Randomised","Quadruple",3,"Confirmed","Healthcare Workers, Outpatient, Unclear","Hospitalization, Viral Load or Clearance","Ivermectin, SOC",102
"NCT04438850","https://ClinicalTrials.gov/show/NCT04438850",NA,"Spain","Barcelona","2020-Jun","2020-Aug","Not Recruiting","Randomised","Quadruple",3,"Confirmed","Healthcare Workers, Outpatient, Unclear","Hospitalization, Viral Load or Clearance","Ivermectin, SOC",102
"NCT04438850","https://ClinicalTrials.gov/show/NCT04438850",NA,"Spain","Madrid","2020-Jun","2020-Aug","Not Recruiting","Randomised","Quadruple",3,"Confirmed","Healthcare Workers, Outpatient, Unclear","Hospitalization, Viral Load or Clearance","Ivermectin, SOC",102
"NCT04392453","https://clinicaltrials.gov/show/NCT04392453",NA,"Italy","Milano","2020-May",NA,"Not Recruiting","Single-Arm","Open-Label",1,"Healthy","Hospital",NA,"Device",40
"IRCT20200418047121N2","http://en.irct.ir/trial/47275",NA,"Iran","Tehran","2020-May","2020-Sep","Recruiting","Non-Randomised","Double",2,"Confirmed","Hospital, Unclear","Radiographic Findings","SOC, Stem cells",6
"NCT04333550","https://ClinicalTrials.gov/show/NCT04333550",NA,"Iran","Kermanshah","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital, Unclear","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), C-Reactive Protein, PaO2-FiO2","Other, SOC",50
"NCT04359862","https://ClinicalTrials.gov/show/NCT04359862",NA,"Spain","Madrid","2020-Apr","2020-Aug","Recruiting","Randomised","Open-Label",2,NA,"Hospital, Unclear","Mortality, IL-1, IL-6, IL-8, Tumor Necrosis Factor (Any), PaO2-FiO2","Anesthetic",50
"NCT04359862","https://ClinicalTrials.gov/show/NCT04359862",NA,"Spain","Valencia","2020-Apr","2020-Aug","Recruiting","Randomised","Open-Label",2,NA,"Hospital, Unclear","Mortality, IL-1, IL-6, IL-8, Tumor Necrosis Factor (Any), PaO2-FiO2","Anesthetic",50
"NCT04341935","https://ClinicalTrials.gov/show/NCT04341935",NA,"United States","Florida","2020-Apr","2020-Dec","Not Recruiting","Randomised","Open-Label",2,NA,"Outpatient, Unclear","IL-6, Glucose, SpO2","DPP-4i, SOC",20
"NCT04377672","https://ClinicalTrials.gov/show/NCT04377672",NA,"United States","Maryland","2020-May","2021-May","Recruiting","Single-Arm","Open-Label",1,"Confirmed Or Healthy","Healthy Exposed, Unclear","Adverse Events, Antibodies","Plasma based therapy",30
"NCT04383548","https://ClinicalTrials.gov/show/NCT04383548",NA,"Egypt","Asyut","2020-May","2020-Dec","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed, Healthy","Healthy Exposed, Unclear","Adverse Events, IgG, IgM or IgA","Igs",100
"NCT04389385","https://ClinicalTrials.gov/show/NCT04389385",NA,"Turkey","Kayseri","2020-May","2020-Sep","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Unclear",NA,"Other",60
"NCT04380376","https://ClinicalTrials.gov/show/NCT04380376",NA,"Russia","Moscow","2020-May","2020-Oct","Recruiting","Non-Randomised","Single",2,"Confirmed Or Suspected","Unclear","C-Reactive Protein, IL-6, Lymphocyte Count, D-Dimer","Chemotherapy, SOC",60
"PACTR202005622389003","https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11053",NA,"Senegal","Dakar","2020-May",NA,"Not Recruiting","Randomised","Unspecified",3,"Confirmed","Unclear","Viral Load or Clearance","HCQ + AZT, Zinc",384
"NCT04384380","https://ClinicalTrials.gov/show/NCT04384380",NA,"Taiwan","Taoyuan","2020-May","2020-Jun","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Adverse Events, Radiographic Findings","HCQ, SOC",45
"NCT04385199","https://ClinicalTrials.gov/show/NCT04385199",NA,"United States","Michigan","2020-May","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","ICU Admission, Radiographic Findings","Plasma based therapy, SOC",30
"CHICTR2000030892","http://www.chictr.org.cn/showproj.aspx?proj=51118",NA,"China","Guangdong","2020-Mar","2020-Dec","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Hospitalization, Hospital Discharge, Treatment-emergent Adverse Events, Radiographic Findings","Other, SOC",40
"NCT04425707","https://ClinicalTrials.gov/show/NCT04425707",NA,"Egypt","Cairo","2020-Jun","2020-Jul","Recruiting","Randomised","Open-Label",3,"Confirmed","Unclear","Viral Load or Clearance","Ivermectin, SOC",100
"NCT04409509","https://ClinicalTrials.gov/show/NCT04409509",NA,"United States","New Jersey","2020-Jun","2020-Dec","Recruiting","Randomised","Quadruple",2,"Confirmed","Unclear","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, Antibodies","mAb, SOC",124
"CHICTR2000031139","http://www.chictr.org.cn/showproj.aspx?proj=51404",NA,"China","Hubei","2020-Mar","2021-Mar","Recruiting","Single-Arm","Unspecified",1,"Confirmed","Unclear","Pneumonia or ARDS, Radiographic Findings, Quality of Life, Depression, Anxiety, Distress","Stem cells",20
"NCT04325893","https://ClinicalTrials.gov/show/NCT04325893",NA,"France","Paris","2020-Mar","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, IL-6, CK-MB, Procalcitonin, Radiographic Findings","HCQ, SOC",1300
"NCT04325893","https://ClinicalTrials.gov/show/NCT04325893",NA,"France","Cher","2020-Mar","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, IL-6, CK-MB, Procalcitonin, Radiographic Findings","HCQ, SOC",1300
"NCT04325893","https://ClinicalTrials.gov/show/NCT04325893",NA,"Monaco","Monaco","2020-Mar","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, IL-6, CK-MB, Procalcitonin, Radiographic Findings","HCQ, SOC",1300
"NCT04406064","https://clinicaltrials.gov/show/NCT04406064",NA,"United States","Washington, Dc","2020-May",NA,"Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Unclear",NA,"Other",100
"CHICTR2000030117","http://www.chictr.org.cn/showproj.aspx?proj=49762",NA,"China","Beijing","2020-Feb","2021-Dec","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Viral Load or Clearance, Fever","LPV/r + IFN, TCM",348
"CTRI/2020/04/024904","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43130",NA,"India","New Delhi","2020-Apr",NA,"Not Recruiting","Randomised","Unspecified",3,"Confirmed","Unclear","Mortality, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","HCQ, HCQ + AZT",300
"NCT04412486","https://ClinicalTrials.gov/show/NCT04412486",NA,"United States","Mississippi","2020-Jun","2022-May","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Unclear","ICU Admission, Hospitalization, Organ Failure or Dysfunction (SOFA), IgG, IgM or IgA, PaO2-FiO2, Respiratory Rate","Plasma based therapy",100
"NCT04273529","https://ClinicalTrials.gov/show/NCT04273529",NA,"China","Zhejiang","2020-Feb","2020-May","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Unclear","Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Serious Adverse Events, IL-1, IL-2, IL-6, IL-7, IL-8, IL-10, Tumor Necrosis Factor (Any), Granulocyte Stimulaiting Factor, IP-10, MCP-1, PaO2-FiO2, Respiratory Rate","Immunomodulators, SOC",100
"NCT04399798","https://ClinicalTrials.gov/show/NCT04399798",NA,"Italy","Pavia","2020-May","2020-Sep","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Unclear","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Labor Absenteeism, Adverse Events, IL-2, IL-6, IL-8, IL-10, IL-17, Tumor Necrosis Factor (Any), Interferon (Any), PaO2-FiO2, SpO2","JAKi",13
"NCT04425772","https://ClinicalTrials.gov/show/NCT04425772",NA,"China","Beijing","2020-Jun","2020-Aug","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Unclear","Viral Load or Clearance, Non-invasive Ventilation, Cough, Other Mild Symptoms, Adverse Events, Radiographic Findings","Antivirals, SOC",342
"CHICTR2000030484","http://www.chictr.org.cn/showproj.aspx?proj=50263",NA,"China","Hubei","2020-Mar","2021-Jan","Not Recruiting","Randomised","Unspecified",3,"Confirmed","Unclear","Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Dyspnea, Serious Adverse Events, C-Reactive Protein, PaO2-FiO2, Radiographic Findings","SOC, Stem cells",90
"CTRI/2020/04/024882","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42899",NA,"India","Haryana","2020-Apr",NA,"Not Recruiting","Non-Randomised","Unspecified",2,"Confirmed","Unclear","Hospital Discharge","Alternative therapy, SOC",60
"NCT04376788","https://ClinicalTrials.gov/show/NCT04376788",NA,"Egypt","Cairo","2020-May","2020-Jul","Recruiting","Randomised","Open-Label",3,"Confirmed","Unclear",NA,"Plasma based therapy, Plasma based therapy + Other, SOC",15
"NCT04427501","https://ClinicalTrials.gov/show/NCT04427501",NA,"United States","Arizona","2020-Jun","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, Hospitalization, Visits or Returns to Emergency Department, Viral Load or Clearance","mAB, SOC",400
"NCT04427501","https://ClinicalTrials.gov/show/NCT04427501",NA,"United States","California","2020-Jun","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, Hospitalization, Visits or Returns to Emergency Department, Viral Load or Clearance","mAB, SOC",400
"NCT04427501","https://ClinicalTrials.gov/show/NCT04427501",NA,"United States","District Of Columbia","2020-Jun","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, Hospitalization, Visits or Returns to Emergency Department, Viral Load or Clearance","mAB, SOC",400
"NCT04427501","https://ClinicalTrials.gov/show/NCT04427501",NA,"United States","Florida","2020-Jun","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, Hospitalization, Visits or Returns to Emergency Department, Viral Load or Clearance","mAB, SOC",400
"NCT04427501","https://ClinicalTrials.gov/show/NCT04427501",NA,"United States","Illinois","2020-Jun","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, Hospitalization, Visits or Returns to Emergency Department, Viral Load or Clearance","mAB, SOC",400
"NCT04427501","https://ClinicalTrials.gov/show/NCT04427501",NA,"United States","Indiana","2020-Jun","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, Hospitalization, Visits or Returns to Emergency Department, Viral Load or Clearance","mAB, SOC",400
"NCT04427501","https://ClinicalTrials.gov/show/NCT04427501",NA,"United States","Maryland","2020-Jun","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, Hospitalization, Visits or Returns to Emergency Department, Viral Load or Clearance","mAB, SOC",400
"NCT04427501","https://ClinicalTrials.gov/show/NCT04427501",NA,"United States","Massachusetts","2020-Jun","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, Hospitalization, Visits or Returns to Emergency Department, Viral Load or Clearance","mAB, SOC",400
"NCT04427501","https://ClinicalTrials.gov/show/NCT04427501",NA,"United States","Michigan","2020-Jun","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, Hospitalization, Visits or Returns to Emergency Department, Viral Load or Clearance","mAB, SOC",400
"NCT04427501","https://ClinicalTrials.gov/show/NCT04427501",NA,"United States","New York","2020-Jun","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, Hospitalization, Visits or Returns to Emergency Department, Viral Load or Clearance","mAB, SOC",400
"NCT04427501","https://ClinicalTrials.gov/show/NCT04427501",NA,"United States","North Carolina","2020-Jun","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, Hospitalization, Visits or Returns to Emergency Department, Viral Load or Clearance","mAB, SOC",400
"NCT04427501","https://ClinicalTrials.gov/show/NCT04427501",NA,"United States","Ohio","2020-Jun","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, Hospitalization, Visits or Returns to Emergency Department, Viral Load or Clearance","mAB, SOC",400
"NCT04427501","https://ClinicalTrials.gov/show/NCT04427501",NA,"United States","Pennsylvania","2020-Jun","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, Hospitalization, Visits or Returns to Emergency Department, Viral Load or Clearance","mAB, SOC",400
"NCT04427501","https://ClinicalTrials.gov/show/NCT04427501",NA,"United States","Texas","2020-Jun","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, Hospitalization, Visits or Returns to Emergency Department, Viral Load or Clearance","mAB, SOC",400
"NCT04427501","https://ClinicalTrials.gov/show/NCT04427501",NA,"United States","Virginia","2020-Jun","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, Hospitalization, Visits or Returns to Emergency Department, Viral Load or Clearance","mAB, SOC",400
"CTRI/2020/04/024729","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42933",NA,"India","New Delhi","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear",NA,"HCQ, SOC",60
"EUCTR2020-001206-35-AT","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001206-35",NA,"Austria","Vienna","2020-Mar",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Mortality, ICU Admission, Organ Failure or Dysfunction (SOFA), Angiotensins, ACE, ACE-II, PaO2-FiO2","ACEi + ARBs, Other",798
"JPRN-JRCTS061200002","https://jrct.niph.go.jp/latest-detail/jRCTs061200002",NA,"Japan","Okayama","2020-May",NA,"Recruiting","Randomised","Unspecified",2,"Confirmed Or Suspected","Unclear","Mortality, Fever, Adverse Events","Other, SOC",100
"CHICTR2000030535","http://www.chictr.org.cn/showproj.aspx?proj=49790",NA,"China","Sichuan","2020-Mar","2020-Mar","Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","Mortality, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Radiographic Findings","LPV/r + IFN, LPV/r + IFN + Other",100
"NCT04388514","https://ClinicalTrials.gov/show/NCT04388514",NA,"Italy","Udine","2020-May","2020-Oct","Recruiting","Randomised","Single",2,"Confirmed","Unclear","ICU Admission, Hospitalization","Respiratory support, SOC",90
"NCT04383535","https://ClinicalTrials.gov/show/NCT04383535",NA,"Argentina","Buenos Aires","2020-May","2020-Aug","Recruiting","Randomised","Quadruple",2,"Confirmed","Unclear","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, Ferritin, D-Dimer, Antibodies","Plasma based therapy, SOC",333
"NCT04392141","https://ClinicalTrials.gov/show/NCT04392141",NA,"Iran","Kermanshah","2020-May","2020-Jun","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, Hospitalization, C-Reactive Protein, IL-6, Lymphocyte Count, Erythrocyte Sedimentation Rate","Colchicine + Alternative therapy, SOC",200
"NCT04334044","https://ClinicalTrials.gov/show/NCT04334044",NA,"Mexico","Mexico","2020-Apr","2020-Jun","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Unclear","Mortality, ICU Admission, Pneumonia or ARDS, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, D-Dimer","JAKi",20
"NCT04398004","https://ClinicalTrials.gov/show/NCT04398004",NA,"Greece","Athens","2020-May","2022-May","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Unclear","Hospitalization, Viral Load or Clearance, Pneumonia or ARDS, IL-1, IL-6, IL-8, IL-10, Tumor Necrosis Factor (Any), Monocyte Count","Antibiotics",90
"NCT04401527","https://clinicaltrials.gov/show/NCT04401527",NA,"United States","Arizona","2020-May",NA,"Not Recruiting","Randomised","Quadruple",2,"Confirmed","Unclear",NA,"Antihypertensive, SOC",200
"CHICTR2000032915","http://www.chictr.org.cn/showproj.aspx?proj=53658",NA,"China","Heilongjiang","2020-May","2020-Dec","Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","Viral Load or Clearance, Fever, Urine Sample, Blood Pressure, ECG, Radiographic Findings, Renal Outcome (Unspecified)","Other, SOC",240
"NCT04403243","https://clinicaltrials.gov/show/NCT04403243",NA,"Russia","Moscow","2020-May",NA,"Recruiting","Randomised","Open-Label",4,"Confirmed","Unclear",NA,"Colchicine, JAKi, mAb, SOC",70
"CHICTR2000030020","http://www.chictr.org.cn/showproj.aspx?proj=49812",NA,"China","Hunan","2020-Feb","2022-Feb","Recruiting","Single-Arm","Open-Label",1,"Confirmed Or Suspected","Unclear","Viral Load or Clearance, Radiographic Findings","Stem cells",20
"NCT04425915","https://clinicaltrials.gov/show/NCT04425915",NA,"India","New Delhi","2020-Jul",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any)","Plasma based therapy, SOC",400
"CHICTR2000033774","http://www.chictr.org.cn/showproj.aspx?proj=55097",NA,"China","Zhejiang","2020-Jun","2020-Dec","Not Recruiting","Randomised","Unspecified",2,"Confirmed Or Suspected","Unclear","ICU Admission, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Dyspnea","Other, SOC",30
"CTRI/2020/05/025022","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43183",NA,"India","New Delhi","2020-May",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear",NA,"HCQ, SOC",166
"2020-001736-95","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001736-95/GB/",NA,"United Kingdom","London","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Blood Pressure, Heart Rate, Respiratory Rate, Quality of Life","Other, SOC",825
"NCT04403685","https://clinicaltrials.gov/show/NCT04403685",NA,"Brazil","Brasilia","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear",NA,"SOC, TCZ",150
"KCT0005105","http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16795",NA,"South Korea","Seoul","2020-Jun",NA,"Recruiting","Randomised","Unspecified",3,"Confirmed","Unclear",NA,"Corticosteroids, HCQ + Corticosteroids, SOC",141
"NCT04334512","https://ClinicalTrials.gov/show/NCT04334512",NA,"United States","California","2020-Apr","2021-Jun","Recruiting","Randomised","Double",5,"Confirmed","Unclear","Viral Load or Clearance, Radiographic Findings",NA,600
"JPRN-UMIN000040479","https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046202",NA,"Japan","Tokyo","2020-May",NA,"Recruiting","Single-Arm","Open-Label",3,"Healthy","Unclear",NA,"Other",30
"2020-002233-15","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-002233-15/DE/",NA,"Germany","Berlin","2020-May",NA,"Recruiting","Randomised","Single",3,"Confirmed","Unclear","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, C-Reactive Protein, Ferritin, IL-6, Weight, Height or BMI, Coagulation Test, LDH, Blood Pressure, SpO2, Respiratory Rate","Other, SOC",NA
"DRKS00021447","https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021447",NA,"Germany","Berlin","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Mortality, ICU Admission, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, IL-6, Renal Outcome (Unspecified)","Cytokine removal, SOC",100
"NCT04429711","https://ClinicalTrials.gov/show/NCT04429711",NA,"Israel","Jerusalem","2020-Jun","2020-Sep","Recruiting","Randomised","Quadruple",2,"Confirmed","Unclear","Viral Load or Clearance","Ivermectin, SOC",100
"IRCT20131215015805N2","http://en.irct.ir/trial/46887",NA,"Iran","Tehran","2020-May","2020-Jun","Completed","Randomised","Double",2,"Confirmed","Unclear","Mortality, Hospitalization, Pneumonia or ARDS, Radiographic Findings","Other, SOC",50
"IRCT20170210032478N3","http://en.irct.ir/trial/47173",NA,"Iran","Tehran","2020-Apr","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed","Unclear","Visits or Returns to Emergency Department, Clinical Improvement Score (Any), Pneumonia or ARDS, C-Reactive Protein","Other, SOC",50
"NCT04338698","https://ClinicalTrials.gov/show/NCT04338698",NA,"Pakistan","Islamabad","2020-Apr","2020-Sep","Not Recruiting","Randomised","Double",3,"Confirmed","Unclear","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO",NA,500
"NCT04363866","https://ClinicalTrials.gov/show/NCT04363866",NA,"United States","Oregon","2020-Apr","2020-Dec","Not Recruiting","Randomised","Single",2,"Confirmed And Suspected","Unclear","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events, Serious Adverse Events, Quality of Life","HCQ, SOC",40
"NCT04339712","https://ClinicalTrials.gov/show/NCT04339712",NA,"Greece","Athens","2020-Apr","2022-Apr","Recruiting","Non-Randomised","Open-Label",2,"Yes","Unclear","Mortality, Organ Failure or Dysfunction (SOFA)","Anakinra, TCZ",40
"NCT04351919","https://ClinicalTrials.gov/show/NCT04351919",NA,"Tunisia","Tunis","2020-Apr","2020-Jul","Not Recruiting","Single-Arm","Open-Label",1,"Yes","Unclear","Other Mild Symptoms","HCQ",400
"CHICTR2000031494","http://www.chictr.org.cn/showproj.aspx?proj=51904",NA,"China","Hubei","2020-Apr","2020-Dec","Recruiting","Single-Arm","Unspecified",2,"Confirmed","Unclear","Radiographic Findings",NA,36
"2020-001606-33","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001606-33/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Open-Label",3,"Confirmed","Unclear","Mortality, Hospitalization, Viral Load or Clearance, Pneumonia or ARDS, Fever, Adverse Events, Treatment-emergent Adverse Events, Ferritin, D-Dimer, LDH, PaO2-FiO2, Respiratory Rate",NA,NA
"NCT04409522","https://ClinicalTrials.gov/show/NCT04409522",NA,"Iran","Tehran","2020-Jun","2020-Jun","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Cough, C-Reactive Protein, Erythrocyte Sedimentation Rate, SpO2","Melatonin, SOC",55
"NCT04377503","https://clinicaltrials.gov/show/NCT04377503",NA,"Brazil","Maranhao","2020-Feb",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear",NA,"Corticosteroids, TCZ",40
"NCT04327349","https://ClinicalTrials.gov/show/NCT04327349",NA,"Iran","Mazandaran","2020-Mar","2020-May","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Unclear","Mortality, Hospitalization, Non-invasive Ventilation, C-Reactive Protein, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, Creatinine Phosphokinase, CK-MB, ALT, LDH, IgG, IgM or IgA, CD4, CD8, PaO2-FiO2","Plasma based therapy",30
"NCT04327401","https://ClinicalTrials.gov/show/NCT04327401",NA,"Brazil","Bahia","2020-Mar","2020-Aug","Not Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Unclear","Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","Dexamethasone, SOC",350
"NCT04327401","https://ClinicalTrials.gov/show/NCT04327401",NA,"Brazil","Distrito Federal","2020-Mar","2020-Aug","Not Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Unclear","Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","Dexamethasone, SOC",350
"NCT04327401","https://ClinicalTrials.gov/show/NCT04327401",NA,"Brazil","Brasilia","2020-Mar","2020-Aug","Not Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Unclear","Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","Dexamethasone, SOC",350
"NCT04327401","https://ClinicalTrials.gov/show/NCT04327401",NA,"Brazil","Minas Gerais","2020-Mar","2020-Aug","Not Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Unclear","Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","Dexamethasone, SOC",350
"NCT04327401","https://ClinicalTrials.gov/show/NCT04327401",NA,"Brazil","Para","2020-Mar","2020-Aug","Not Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Unclear","Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","Dexamethasone, SOC",350
"NCT04327401","https://ClinicalTrials.gov/show/NCT04327401",NA,"Brazil","Rio Grande Do Norte","2020-Mar","2020-Aug","Not Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Unclear","Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","Dexamethasone, SOC",350
"NCT04327401","https://ClinicalTrials.gov/show/NCT04327401",NA,"Brazil","Rio Grande Do Sul","2020-Mar","2020-Aug","Not Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Unclear","Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","Dexamethasone, SOC",350
"NCT04327401","https://ClinicalTrials.gov/show/NCT04327401",NA,"Brazil","Santa Catarina","2020-Mar","2020-Aug","Not Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Unclear","Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","Dexamethasone, SOC",350
"NCT04327401","https://ClinicalTrials.gov/show/NCT04327401",NA,"Israel","Jerusalem","2020-Mar","2020-Aug","Not Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Unclear","Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","Dexamethasone, SOC",350
"CHICTR2000029991","http://www.chictr.org.cn/showproj.aspx?proj=49666",NA,"China","Jiangxi","2020-Feb","2020-Jul","Recruiting","Randomised","Open-Label",3,"Confirmed","Unclear","Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever","SOC, TCM",72
"NCT04399889","https://ClinicalTrials.gov/show/NCT04399889",NA,"United States","North Carolina","2020-May","2021-Apr","Recruiting","Single-Arm","Quadruple",3,"Confirmed","Unclear",NA,"SOC, Stem cells",30
"IRCT20200611047735N1","http://en.irct.ir/trial/48843",NA,"Iran","Tehran","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Unclear",NA,"Alternative therapy, SOC",40
"2020-001667-85","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001667-85/FR/",NA,"France","Paris","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Unclear","Serious Adverse Events","Corticosteroids, SOC",NA
"NCT04395911","https://clinicaltrials.gov/show/NCT04395911",NA,"United States","Colorado","2020-May",NA,"Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Unclear","Mortality, Renal Outcome (Unspecified)","Device",35
"NCT04382391","https://ClinicalTrials.gov/show/NCT04382391",NA,"United States","Pennsylvania","2020-May","2020-Sep","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Mortality, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Device, SOC",20
"NCT04384588","https://clinicaltrials.gov/show/NCT04384588",NA,"Chile","Santiago","2020-Apr",NA,"Recruiting","Non-Randomised","Open-Label",4,"Confirmed","Unclear","Mortality","Plasma based therapy",100
"NCT04255017","https://clinicaltrials.gov/show/NCT04255017",NA,"China","Beijing","2020-Feb",NA,"Recruiting","Randomised","Single",4,"Confirmed","Unclear","Clinical Improvement Score (Any), Viral Load or Clearance, Cough, Fever, Dyspnea, Other Mild Symptoms, C-Reactive Protein, Erythrocyte Sedimentation Rate, CK-MB, ALT, PaO2-FiO2, Radiographic Findings","LPV/r, Oseltamivir, SOC, Umifenovir",400
"CHICTR2000030225","http://www.chictr.org.cn/showproj.aspx?proj=49945",NA,"China","Shanghai","2020-Feb","2020-Dec","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Hospitalization, Hospital Discharge, Clinical Improvement Score (Any)","SOC, TCM",186
"CHICTR2000032769","http://www.chictr.org.cn/showproj.aspx?proj=53368",NA,"China","Beijing","2020-May",NA,"Recruiting","Randomised","Double",2,"Confirmed","Unclear","Viral Load or Clearance, Non-invasive Ventilation, Cough, Fever, Other Mild Symptoms, Adverse Events, Radiographic Findings","DAA, SOC",342
"CHICTR2000031204","http://www.chictr.org.cn/showproj.aspx?proj=49420",NA,"China","Beijing","2020-Mar","2020-Apr","Recruiting","Randomised","Single",2,"Confirmed","Unclear","Viral Load or Clearance, Fever, Serious or Seconday Infections, C-Reactive Protein, Radiographic Findings","HCQ, SOC",300
"CHICTR2000031271","http://www.chictr.org.cn/showproj.aspx?proj=51194",NA,"China","Guangdong","2020-Mar","2021-Mar","Not Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","Mortality, ICU Admission, Hospitalization, Organ Failure or Dysfunction (SOFA), Quality of Life","Nutrition, SOC",80
"NCT04252274","https://ClinicalTrials.gov/show/NCT04252274",NA,"China","Shanghai","2020-Feb","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Mortality, Viral Load or Clearance, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO","DAA, SOC",30
"NCT04261517","https://ClinicalTrials.gov/show/NCT04261517","http://www.zjujournals.com/med/EN/10.3785/j.issn.1008-9292.2020.03.03#1","China","Shanghai","2020-Feb","2020-Feb","Completed w. Results","Randomised","Open-Label",2,"Confirmed","Unclear","Mortality","HCQ, SOC",30
"CHICTR2000031196","http://www.chictr.org.cn/showproj.aspx?proj=51112",NA,"China","Beijing","2020-Mar","2020-Dec","Recruiting","Non-Randomised","Unspecified",2,"Confirmed","Unclear","Viral Load or Clearance, Adverse Events","LPV/r + IFN, SOC",90
"NCT04252118","https://ClinicalTrials.gov/show/NCT04252118",NA,"China","Beijing","2020-Feb","2020-Dec","Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Unclear","Mortality, Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Dyspnea, Treatment-emergent Adverse Events, C-Reactive Protein, Creatinine Phosphokinase, ALT, CD4, CD8","SOC, Stem cells",20
"NCT04280224","https://ClinicalTrials.gov/show/NCT04280224",NA,"China","Henan","2020-Feb","2020-Sep","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Viral Load or Clearance, Treatment-emergent Adverse Events, CD4, CD8, Radiographic Findings","Natural Killer Cells, SOC",30
"CHICTR2000029869","http://www.chictr.org.cn/showproj.aspx?proj=49486",NA,"China","Hubei","2020-Feb","2020-Jun","Not Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","Mortality, ICU Admission, Pneumonia or ARDS, C-Reactive Protein, Tumor Necrosis Factor (Any), Interferon (Any), Creatinine Phosphokinase, CK-MB, eGFR, ALT, Albumin, Bilirubin, Radiographic Findings","SOC, TCM",300
"NCT04254874","https://clinicaltrials.gov/show/NCT04254874",NA,"China","Beijing","2020-Feb",NA,"Recruiting","Randomised","Single",2,"Confirmed","Unclear","Clinical Improvement Score (Any), Viral Load or Clearance, Cough, Fever, Dyspnea, Other Mild Symptoms, C-Reactive Protein, Erythrocyte Sedimentation Rate, CK-MB, ALT, PaO2-FiO2, Radiographic Findings","Umifenovir, Umifenovir + IFN",100
"NCT04275245","https://clinicaltrials.gov/show/NCT04275245","https://www.medrxiv.org/content/10.1101/2020.03.21.20040691v1.full.pdf","China","Beijing","2020-Jun",NA,"Completed w. Results","Single-Arm","Open-Label",1,"Confirmed","Unclear","Viral Load or Clearance, Pneumonia or ARDS, Fever, C-Reactive Protein, D-Dimer, PaO2-FiO2, Respiratory Rate, Radiographic Findings","mAb",20
"CHICTR2000030138","http://www.chictr.org.cn/showproj.aspx?proj=50004",NA,"China","Beijing","2020-Feb","2020-May","Not Recruiting","Randomised","Double",2,"Confirmed Or Suspected","Unclear","Clinical Improvement Score (Any)","SOC, Stem cells",60
"CHICTR2000030490","http://www.chictr.org.cn/showproj.aspx?proj=50487",NA,"China","Hubei","2020-Mar","2020-Mar","Recruiting","Single-Arm","Unspecified",1,"Confirmed Or Suspected","Unclear","Viral Load or Clearance","TCM",100
"NCT04428268","https://ClinicalTrials.gov/show/NCT04428268",NA,"Mexico","Nuevo Leon","2020-Jun","2020-Jun","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, Adverse Events, Radiographic Findings","HCQ, HCQ + losartan",20
"CHICTR2000029788","http://www.chictr.org.cn/showproj.aspx?proj=49452",NA,"China","Beijing","2020-Feb","2020-Dec","Not Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","Clinical Improvement Score (Any), Viral Load or Clearance, Fever","SOC, TCM",60
"CHICTR2000033133","http://www.chictr.org.cn/showproj.aspx?proj=53925",NA,"China","Zhejiang","2020-May","2020-Apr","Completed","Randomised","Open-Label",2,"Confirmed","Unclear","Viral Load or Clearance, Cough, Fever, Other Mild Symptoms","SOC, TCM",60
"CTRI/2020/04/024948","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43364",NA,"India","New Delhi","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",4,"Confirmed","Unclear",NA,"Corticosteroids, HCQ, Ivermectin, SOC",120
"NCT04390412","https://ClinicalTrials.gov/show/NCT04390412",NA,"Iran","Tehran","2020-May","2020-Aug","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Unclear","ICU Admission, Hospitalization, C-Reactive Protein, IL-6, Platelet Count, Erythrocyte Sedimentation Rate, Radiographic Findings","Radiation therapy",5
"NCT04391712","https://ClinicalTrials.gov/show/NCT04391712",NA,"United States","Massachusetts","2020-May","2020-May","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","C-Reactive Protein, IL-6, Radiographic Findings","Other, SOC",20
"IRCT20200413047063N1","http://en.irct.ir/trial/47156",NA,"Iran","Tehran","2020-May","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed","Unclear","ICU Admission, Clinical Improvement Score (Any), Pneumonia or ARDS, Adverse Events, Serious Adverse Events, PaO2-FiO2","SOC, Stem cells",20
"2020-001450-22","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001450-22/ES/",NA,"Spain","Madrid","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Mortality, Invasive Mechanical Ventilation or ECMO, Adverse Events, Ferritin, Monocyte Count, Lymphocyte Count, Neutrophils, D-Dimer, Troponin, Radiographic Findings","SOC, Stem cells",NA
"IRCT20171105037262N4","http://en.irct.ir/trial/47696",NA,"Iran","Tehran","2020-Jun","2020-Jul","Recruiting","Randomised","Single",2,"Confirmed","Unclear",NA,"HCQ, HCQ + mAb",100
"NCT04418531","https://ClinicalTrials.gov/show/NCT04418531",NA,"Italy","Bergamo","2020-Jun","2020-Sep","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed Or Suspected","Unclear","IL-1, IL-2, IL-6, IL-7, IL-10, Tumor Necrosis Factor (Any), MCP-1, IgG, IgM or IgA, Antibodies, Radiographic Findings","Igs",10
"NCT04418531","https://ClinicalTrials.gov/show/NCT04418531",NA,"Italy","Rome","2020-Jun","2020-Sep","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed Or Suspected","Unclear","IL-1, IL-2, IL-6, IL-7, IL-10, Tumor Necrosis Factor (Any), MCP-1, IgG, IgM or IgA, Antibodies, Radiographic Findings","Igs",10
"NCT04385849","https://ClinicalTrials.gov/show/NCT04385849",NA,"United States","California","2020-May","2020-Jul","Not Recruiting","Randomised","Triple",2,"Confirmed","Unclear","Adverse Events, White Blood Cell Count, Lymphocyte Count, Platelet Count, Hemoglobin","Other, SOC",30
"NCT04435587","https://clinicaltrials.gov/show/NCT04435587",NA,"Thailand","Nan","2020-Jun",NA,"Not Recruiting","Randomised","Single",2,"Confirmed","Unclear","Adverse Events","HCQ + Antivirals, Ivermectin",80
"NCT04414098","https://ClinicalTrials.gov/show/NCT04414098",NA,"United States","Massachusetts","2020-Jun","2020-Aug","Not Recruiting","Single-Arm","Open-Label",2,"Confirmed","Unclear","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections","JAKi, SOC",100
"NCT04408209","https://ClinicalTrials.gov/show/NCT04408209",NA,"Greece","Attiki","2020-May","2020-Jun","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Unclear","Clinical Improvement Score (Any)","Plasma based therapy",60
"NCT04408209","https://ClinicalTrials.gov/show/NCT04408209",NA,"Greece","Athens","2020-May","2020-Jun","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Unclear","Clinical Improvement Score (Any)","Plasma based therapy",60
"2020-001481-11","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001481-11/DE/",NA,"Germany","Berlin","2020-Apr",NA,"Recruiting","Unspecified","Unspecified",1,"Confirmed","Unclear","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Hyper-Inflammation, Radiographic Findings","JAKi",NA
"NCT04375046","https://ClinicalTrials.gov/show/NCT04375046",NA,"Egypt","Cairo","2020-May","2020-Sep","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Fever, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, IL-6, IL-8, Tumor Necrosis Factor (Any), PAI-1, von Wildebrandt Factor, Lymphocyte Count, Angiotensins, ACE, ACE-II, Surfactant Factor Protein, SRAGE, PaO2-FiO2, Radiographic Findings","Other, SOC",24
"NCT04382950","https://clinicaltrials.gov/show/NCT04382950",NA,"Egypt","Cairo","2020-Aug",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Fever","Other, SOC",24
"NCT04402203","https://ClinicalTrials.gov/show/NCT04402203",NA,"Bangladesh","Dhaka","2020-May","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, ICU Admission, Radiographic Findings","FPV, SOC",50
"CHICTR2000030027","http://www.chictr.org.cn/showproj.aspx?proj=49852",NA,"China","Beijing","2020-Feb","2021-Feb","Recruiting","Single-Arm","Unspecified",1,"Confirmed","Unclear","Clinical Improvement Score (Any)","TCM",60
"CHICTR2000029819","http://www.chictr.org.cn/showproj.aspx?proj=49490",NA,"China","Zhejiang","2020-Feb","2020-Aug","Recruiting","Non-Randomised","Unspecified",2,"Confirmed","Unclear","Viral Load or Clearance, Radiographic Findings","SOC, TCM",80
"EUCTR2020-001310-38-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001310-38",NA,"Germany","Berlin","2020-Mar",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","ICU Admission, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Antibodies","Plasma based therapy, SOC",120
"NCT04304313","https://ClinicalTrials.gov/show/NCT04304313",NA,"China","Hubei","2020-Mar","2020-Mar","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Unclear","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, CK-MB, ALT, PaO2-FiO2, Radiographic Findings","Other",10
"CHICTR2000029868","http://www.chictr.org.cn/showproj.aspx?proj=49524",NA,"China","Shanghai","2020-Feb","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed","Unclear","Viral Load or Clearance, Adverse Events","HCQ, SOC",360
"NCT04263402","https://clinicaltrials.gov/show/NCT04263402",NA,"China","Beijing","2020-Feb",NA,"Recruiting","Randomised","Single",2,"Confirmed","Unclear","ICU Admission, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Organ Failure or Dysfunction (SOFA), PaO2-FiO2, Radiographic Findings","Corticosteroids",100
"CHICTR2000032205","http://www.chictr.org.cn/showproj.aspx?proj=52662",NA,"China","Hubei","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Unclear",NA,"SOC, TCM",200
"JPRN-JRCTS031200026","https://jrct.niph.go.jp/latest-detail/jRCTs031200026",NA,"Japan","Tokyo","2020-Jan",NA,"Recruiting","Randomised","Single",2,"Confirmed","Unclear","Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Other Mild Symptoms, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Prothrombin, Coagulation Test, ALT, Bilirubin, Glucose, SpO2, Radiographic Findings, Renal Outcome (Unspecified)","Anticoagulants, FPV",160
"NCT04347915","https://ClinicalTrials.gov/show/NCT04347915",NA,"South Korea","Seoul","2020-Apr","2020-Sep","Recruiting","Randomised","Single",2,"Confirmed","Unclear","Viral Load or Clearance, Non-invasive Ventilation","Clevudine, HCQ",60
"CTRI/2020/05/025156","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43590",NA,"India","New Delhi","2020-May",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Viral Load or Clearance","Alternative therapy, SOC",60
"NCT04421508","https://ClinicalTrials.gov/show/NCT04421508",NA,"United States","Texas","2020-Jun","2021-Feb","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Unclear","Mortality, Hospitalization, Hospital Discharge, Viral Load or Clearance","Non-invasive respiratory support, SOC",500
"NCT04387760","https://ClinicalTrials.gov/show/NCT04387760",NA,"Bahrain","Manama","2020-May","2020-Jul","Not Recruiting","Randomised","Open-Label",3,"Confirmed","Unclear","Mortality, ICU Admission, Viral Load or Clearance, Ferritin, Lymphocyte Count, D-Dimer, Procalcitonin","FPV, HCQ, SOC",150
"NCT04374903","https://ClinicalTrials.gov/show/NCT04374903",NA,"Jordan","Amman","2020-May","2020-Aug","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO","HCQ + AZT, HCQ + Other",58
"NCT04379479","https://ClinicalTrials.gov/show/NCT04379479",NA,"Mexico","Mexico","2020-May","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed Or Suspected","Unclear",NA,"Other, SOC",562
"IRCT20200408046987N1","http://en.irct.ir/trial/47012",NA,"Iran","Tehran","2020-Apr","2020-Jun","Completed","Randomised","Double",4,"Confirmed","Unclear","Hospitalization, C-Reactive Protein, Radiographic Findings","Ivermectin, SOC",100
"NCT04363840","https://clinicaltrials.gov/show/NCT04363840",NA,"United States","Louisiana","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",3,"Confirmed","Unclear","Hospitalization","Antihypertensive, Antihypertensive + Nutrition, SOC",1080
"CHICTR2000032400","http://www.chictr.org.cn/showproj.aspx?proj=52958",NA,"China","Shanghai","2020-Apr","2020-Jun","Recruiting","Non-Randomised","Unspecified",2,"Confirmed","Unclear","C-Reactive Protein, Lymphocyte Count, Erythrocyte Sedimentation Rate, D-Dimer, Bilirubin, LDH, Urine Sample, CD4, PaO2-FiO2","SOC, TCM",120
"NCT04395768","https://ClinicalTrials.gov/show/NCT04395768",NA,"Australia","Victoria","2020-May","2021-May","Not Recruiting","Randomised","Double",6,"Confirmed","Unclear","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Renal Outcome (Unspecified)","HCQ + AZT + Zinc + Vitamins",200
"CHICTR2000032313","http://www.chictr.org.cn/showproj.aspx?proj=52916",NA,"China","Beijing","2020-Apr","2020-Dec","Not Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","Clinical Improvement Score (Any), Radiographic Findings, Quality of Life","SOC, TCM",60
"IRCT20200410047009N1","http://en.irct.ir/trial/47052",NA,"Iran","Tehran","2020-Apr","2020-Jul","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Mortality, Clinical Improvement Score (Any)","NSAIDs, SOC",101
"NCT04334265","https://ClinicalTrials.gov/show/NCT04334265",NA,"China","Anhui","2020-Apr","2020-Jun","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear",NA,"Alternative therapy, SOC",750
"NCT04334265","https://ClinicalTrials.gov/show/NCT04334265",NA,"China","Hubei","2020-Apr","2020-Jun","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear",NA,"Alternative therapy, SOC",750
"NCT04334265","https://ClinicalTrials.gov/show/NCT04334265",NA,"China","Zhejiang","2020-Apr","2020-Jun","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear",NA,"Alternative therapy, SOC",750
"IRCT20160131026298N3","http://en.irct.ir/trial/47019",NA,"Iran","Tehran","2020-Apr","2020-May","Completed","Randomised","Double",2,"Confirmed","Unclear","Cough, Dyspnea, Radiographic Findings, Quality of Life","Alternative therapy, SOC",80
"CTRI/2020/05/024962","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43237",NA,"India","New Delhi","2020-Jan",NA,"Not Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","Viral Load or Clearance","Hygiene, SOC",96
"2020-001431-27","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001431-27/DE/",NA,"Germany","Berlin","2020-Apr",NA,"Recruiting","Randomised","Unspecified",3,"Confirmed","Unclear","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO","ARBs, SOC",NA
"CHICTR2000032399","http://www.chictr.org.cn/showproj.aspx?proj=52942",NA,"China","Hubei","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Unclear",NA,"SOC, TCM",200
"2020-001717-20","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001717-20/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Viral Load or Clearance, Labor Absenteeism, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Dyspnea, Adverse Events, IL-2, IL-4, IL-6, IL-8, IL-12, Tumor Necrosis Factor (Any), Interferon (Any), MIP-1, Respiratory Rate","Vitamins",NA
"CHICTR2000031630","http://www.chictr.org.cn/showproj.aspx?proj=50474",NA,"China","Guangdong","2020-Apr","2020-Jun","Recruiting","Non-Randomised","Unspecified",2,"Confirmed","Unclear",NA,NA,60
"EUCTR2020-001721-31-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001721-31",NA,"United Kingdom","London","2020-Apr",NA,"Not Recruiting","Randomised","Double",3,"Confirmed Or Suspected","Unclear","Viral Load or Clearance","Hygiene, SOC",40
"EUCTR2020-001882-36-GR","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001882-36",NA,"Greece","Athens","2020-Apr",NA,"Not Recruiting","Unspecified","Open-Label",1,"Confirmed Or Suspected","Unclear","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Cough, Dyspnea","Antibiotics",90
"CTRI/2020/05/025049","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43313",NA,"India","New Delhi","2020-Jun",NA,"Not Recruiting","Randomised","Open-Label",1,"Confirmed Or Suspected","Unclear","Mortality","Alternative therapy",100
"NCT04351347","https://clinicaltrials.gov/show/NCT04351347",NA,"Egypt","Cairo","2020-Apr",NA,"Recruiting","Randomised","Open-Label",3,"Yes","Unclear","Viral Load or Clearance","Antivirals, HCQ, Ivermectin",300
"NCT04351295","https://clinicaltrials.gov/show/NCT04351295",NA,"Egypt","Cairo","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",2,"Yes","Unclear","Viral Load or Clearance","FPV, SOC",40
"NCT04431466","https://ClinicalTrials.gov/show/NCT04431466",NA,"Brazil","Brasilia","2020-Jun","2020-Dec","Not Recruiting","Randomised","Triple",5,"Confirmed","Unclear","Clinical Improvement Score (Any), Viral Load or Clearance, Lymphocyte Count, D-Dimer, Creatinine Phosphokinase, ALT, AST, LDH","Ivermectin, SOC",64
"NCT04324996","https://ClinicalTrials.gov/show/NCT04324996",NA,"China","Chongqing","2020-Mar","2020-May","Recruiting","Randomised","Quadruple",5,"Confirmed","Unclear","Clinical Improvement Score (Any), Pneumonia or ARDS, Adverse Events, Treatment-emergent Adverse Events","Natural Killer Cells",90
"NCT04382846","https://ClinicalTrials.gov/show/NCT04382846",NA,"Egypt","Cairo","2020-May","2030-Dec","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Unclear",NA,"Antivirals + AZT, Ivermectin + Antivirals, Ivermectin + Antivirals + AZT, Ivermectin + HCQ",80
"NCT04409873","https://ClinicalTrials.gov/show/NCT04409873",NA,"United States","California","2020-Jun","2020-Oct","Not Recruiting","Randomised","Double",4,"Confirmed","Unclear","Hospitalization, Viral Load or Clearance","Hygiene",120
"CHICTR2000030750","http://www.chictr.org.cn/showproj.aspx?proj=50928",NA,"China","Guangdong","2020-Mar","2021-Feb","Not Recruiting","Randomised","Unspecified",4,"Confirmed","Unclear","C-Reactive Protein, IL-17, Lymphocyte Count, Blood Gas","SOC, Vaccine",120
"IRCT20090609002017N35","http://en.irct.ir/trial/48058",NA,"Iran","East Azarbaijan","2020-May","2020-Jun","Completed","Randomised","Double",4,"Confirmed","Unclear","C-Reactive Protein","Other, SOC",40
"CHICTR2000029605","http://www.chictr.org.cn/showproj.aspx?proj=49051",NA,"China","Hubei","2020-Feb","2021-Feb","Recruiting","Randomised","Open-Label",4,"Confirmed","Unclear","ICU Admission, Viral Load or Clearance, Cough, Fever, Other Mild Symptoms","SOC, TCM",400
"NCT04410159","https://ClinicalTrials.gov/show/NCT04410159",NA,"Malaysia","Kuala Lumpur","2020-Jun","2020-Jul","Recruiting","Randomised","Open-Label",4,"Confirmed","Unclear","Viral Load or Clearance","Hygiene, SOC",20
"CHICTR2000029778","http://www.chictr.org.cn/showproj.aspx?proj=49422",NA,"China","Shanghai","2020-Feb","2020-May","Recruiting","Non-Randomised","Unspecified",5,"Confirmed","Unclear","Hospitalization, Viral Load or Clearance, Fever","SOC, TCM",600
"CHICTR2000029548","http://www.chictr.org.cn/showproj.aspx?proj=49015",NA,"China","Zhejiang","2020-Feb","2020-Jun","Not Recruiting","Randomised","Open-Label",3,"Confirmed","Unclear","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events","FPV, LPV/r, Other",30
"CHICTR2000029431","http://www.chictr.org.cn/showproj.aspx?proj=48907",NA,"China","Liaoning","2020-Feb",NA,"Recruiting","Randomised","Unspecified",3,"Confirmed","Unclear","Pneumonia or ARDS, Radiographic Findings","Other, SOC",45
"CHICTR2000029544","http://www.chictr.org.cn/showproj.aspx?proj=49013",NA,"China","Zhejiang","2020-Feb","2020-May","Not Recruiting","Randomised","Unspecified",3,"Confirmed","Unclear","Mortality, ICU Admission, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","Antivirals, FPV, SOC",30
"NCT04319900","https://ClinicalTrials.gov/show/NCT04319900",NA,"China","Beijing","2020-Mar","2020-Apr","Recruiting","Randomised","Double",3,"Confirmed","Unclear","Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Serious or Seconday Infections, C-Reactive Protein, Radiographic Findings","FPV, HCQ + FPV, SOC",150
"CHICTR2000029559","http://www.chictr.org.cn/showproj.aspx?proj=48880","https://www.medrxiv.org/content/10.1101/2020.03.22.20040758v1.full.pdf","China","Hubei","2020-Feb","2020-Feb","Completed w. Results","Randomised","Double",3,"Confirmed","Unclear","Viral Load or Clearance, CD4, CD8","HCQ, SOC",300
"NCT04421534","https://ClinicalTrials.gov/show/NCT04421534",NA,"Egypt","Cairo","2020-Jun","2020-Sep","Not Recruiting","Randomised","Open-Label",3,"Confirmed","Unclear","Clinical Improvement Score (Any)","Other, SOC",150
"NCT04252885","https://ClinicalTrials.gov/show/NCT04252885","https://www.medrxiv.org/content/medrxiv/early/2020/03/23/2020.03.19.20038984.full.pdf","China","Guangdong","2020-Feb","2020-Apr","Completed w. Results","Randomised","Open-Label",3,"Confirmed","Unclear","Mortality, Viral Load or Clearance, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Serious Adverse Events, Tumor Necrosis Factor (Any), Interferon (Any), Creatinine Phosphokinase, CK-MB, eGFR, Myoglobin, ALT, Bilirubin, Blood Pressure, Heart Rate, PaO2-FiO2, Respiratory Rate, Radiographic Findings","LPV/r, SOC, Umifenovir",86
"CHICTR2000030034","http://www.chictr.org.cn/showproj.aspx?proj=49647",NA,"China","Zhejiang","2020-Feb","2020-Jun","Recruiting","Randomised","Unspecified",3,"Confirmed","Unclear","Viral Load or Clearance, Pneumonia or ARDS, Fever","SOC, TCM",132
"NCT04310228","https://ClinicalTrials.gov/show/NCT04310228",NA,"China","Beijing","2020-Mar","2020-May","Recruiting","Randomised","Open-Label",3,"Confirmed","Unclear","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","FPV, FPV + TCZ, TCZ",150
"NCT04310228","https://ClinicalTrials.gov/show/NCT04310228",NA,"China","Hubei","2020-Mar","2020-May","Recruiting","Randomised","Open-Label",3,"Confirmed","Unclear","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","FPV, FPV + TCZ, TCZ",150
"CHICTR2000029400","http://www.chictr.org.cn/showproj.aspx?proj=48824",NA,"China","Beijing","2020-Jan","2020-Dec","Recruiting","Non-Randomised","Unspecified",3,"Confirmed","Unclear","Viral Load or Clearance, Fever, White Blood Cell Count, Monocyte Count, Hemoglobin, Erythrocyte Sedimentation Rate, Radiographic Findings","LPV/r, LPV/r + TCM, TCM",60
"CHICTR2000030703","http://www.chictr.org.cn/showproj.aspx?proj=50251",NA,"China","Hunan","2020-Mar","2020-May","Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","PaO2-FiO2, Respiratory Rate, Radiographic Findings","Antivirals, TCM + Antiviral",40
"CHICTR2000030940","http://www.chictr.org.cn/showproj.aspx?proj=51061",NA,"China","Shanghai","2020-Mar","2020-Jun","Not Recruiting","Non-Randomised","Unspecified",2,"Confirmed","Unclear","Clinical Improvement Score (Any), Pneumonia or ARDS, Cough, Fever, Dyspnea","TCM",76
"NCT04403555","https://clinicaltrials.gov/show/NCT04403555",NA,"Egypt","Cairo","2020-May",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear",NA,"HCQ, Ivermectin + Docycline",40
"CHICTR2000029939","http://www.chictr.org.cn/showproj.aspx?proj=49612",NA,"China","Zhejiang","2020-Feb","2021-Feb","Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","Mortality, Hospitalization, Clinical Improvement Score (Any), Secondary CoViD-19 Re-infection, Fever, Serious Adverse Events, C-Reactive Protein, IL-2, IL-4, IL-6, IL-10, Tumor Necrosis Factor (Any), ALT, Bilirubin, Radiographic Findings","HCQ, SOC",100
"CHICTR2000030113","http://www.chictr.org.cn/showproj.aspx?proj=49988",NA,"China","Guangdong","2020-Feb","2020-May","Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","Radiographic Findings, Renal Outcome (Unspecified)","DAA, FPV",30
"CHICTR2000031090","http://www.chictr.org.cn/showproj.aspx?proj=51148",NA,"China","Zhejiang","2020-Mar","2022-Mar","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Quality of Life, Depression, Anxiety, Distress","Psychological therapy",60
"NCT04331470","https://ClinicalTrials.gov/show/NCT04331470",NA,"Iran","Fars","2020-Apr","2020-Apr","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, IL-6, PaO2-FiO2","HCQ + LPV/r, LPV/r + HCQ + Other",30
"CHICTR2000030262","http://www.chictr.org.cn/showproj.aspx?proj=50136",NA,"China","Shanghai","2020-Feb",NA,"Recruiting","Non-Randomised","Unspecified",4,"Confirmed","Unclear","Hospitalization, Viral Load or Clearance, Radiographic Findings","IFN, SOC",140
"CHICTR2000030016","http://www.chictr.org.cn/showproj.aspx?proj=49799",NA,"China","Guangxi","2020-Feb","2022-Dec","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events","SOC, Vaccine",60
"CHICTR2000030187","http://www.chictr.org.cn/showproj.aspx?proj=50057",NA,"China","Hubei","2020-Feb","2020-Mar","Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms, C-Reactive Protein, Tumor Necrosis Factor (Any), Granulocyte Stimulaiting Factor, Erythrocyte Sedimentation Rate, Creatinine Phosphokinase, CK-MB, eGFR, Procalcitonin, ALT, Albumin, Bilirubin","LPV/r, SOC",60
"CHICTR2000029468","http://www.chictr.org.cn/showproj.aspx?proj=48919",NA,"China","Sichuan","2020-Feb","2020-Jun","Not Recruiting","Non-Randomised","Unspecified",2,"Confirmed","Unclear","Mortality, Hospitalization, Viral Load or Clearance, Pneumonia or ARDS","LPV/r",120
"IRCT20131129015584N2","http://en.irct.ir/trial/47639",NA,"Iran","Tehran","2020-May","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed","Unclear","Hospitalization, SpO2","LPV/r + AZT, LPV/r + AZT + Alternative therapy",152
"NCT04251871","https://ClinicalTrials.gov/show/NCT04251871",NA,"China","Beijing","2020-Feb","2021-Jan","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Mortality, Hospitalization, Viral Load or Clearance, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Dyspnea, Radiographic Findings","LPV/r + IFN + TCM + Non-invasive respiratory support, LPV/r + Non-invasive respiratory support + IFN",150
"CHICTR2000030218","http://www.chictr.org.cn/showproj.aspx?proj=50115",NA,"China","Jiangxi","2020-Feb","2020-Jun","Recruiting","Randomised","Unspecified",3,"Confirmed","Unclear","Viral Load or Clearance, Pneumonia or ARDS","LPV/r, LPV/r + TCM",80
"CHICTR2000029776","http://www.chictr.org.cn/showproj.aspx?proj=49342",NA,"China","Zhejiang","2020-Feb","2020-Dec","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","ICU Admission, Viral Load or Clearance, Cough, Fever, Other Mild Symptoms","Other, SOC",40
"NCT04381871","https://ClinicalTrials.gov/show/NCT04381871",NA,"Sudan","Khartoum","2020-May","2020-Aug","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Unclear","Mortality, Viral Load or Clearance","Other",110
"CHICTR2000029999","http://www.chictr.org.cn/showproj.aspx?proj=49717",NA,"China","Shanghai","2020-Feb",NA,"Not Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","Fever, C-Reactive Protein, IL-2, IL-4, IL-6, IL-10, IL-12, Tumor Necrosis Factor (Any), Erythrocyte Sedimentation Rate, D-Dimer, Weight, Height or BMI, ALT, AST, Albumin, IgG, IgM or IgA, Blood Urea Nitrogen, Blood Pressure, Heart Rate, ECG, Respiratory Rate, Radiographic Findings","Nutrition",60
"RPCEC00000307","https://rpcec.sld.cu/en/trials/RPCEC00000307-En",NA,"Cuba","Havana","2020-Apr",NA,"Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","Labor Absenteeism","IFN",120
"NCT04410354","https://ClinicalTrials.gov/show/NCT04410354",NA,"United States","Arizona","2020-Jun","2020-Jul","Recruiting","Randomised","Triple",3,"Confirmed","Unclear","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Adverse Events, SpO2","Merimepodib + Remdesivir, Remdesivir",40
"NCT04410354","https://ClinicalTrials.gov/show/NCT04410354",NA,"United States","Florida","2020-Jun","2020-Jul","Recruiting","Randomised","Triple",3,"Confirmed","Unclear","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Adverse Events, SpO2","Merimepodib + Remdesivir, Remdesivir",40
"NCT04410354","https://ClinicalTrials.gov/show/NCT04410354",NA,"United States","Minnesota","2020-Jun","2020-Jul","Recruiting","Randomised","Triple",3,"Confirmed","Unclear","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Adverse Events, SpO2","Merimepodib + Remdesivir, Remdesivir",40
"NCT04410354","https://ClinicalTrials.gov/show/NCT04410354",NA,"United States","New Jersey","2020-Jun","2020-Jul","Recruiting","Randomised","Triple",3,"Confirmed","Unclear","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Adverse Events, SpO2","Merimepodib + Remdesivir, Remdesivir",40
"NCT04410354","https://ClinicalTrials.gov/show/NCT04410354",NA,"United States","Texas","2020-Jun","2020-Jul","Recruiting","Randomised","Triple",3,"Confirmed","Unclear","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Adverse Events, SpO2","Merimepodib + Remdesivir, Remdesivir",40
"CHICTR2000029994","http://www.chictr.org.cn/showproj.aspx?proj=49309",NA,"China","Shanghai","2020-Feb","2020-Aug","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Hospitalization, Natural Killer Cell Count, Radiographic Findings, Renal Outcome (Unspecified)","SOC, TCM",200
"NCT04387240","https://ClinicalTrials.gov/show/NCT04387240",NA,"Saudi Arabia","Riyadh","2020-May","2020-Oct","Not Recruiting","Randomised","Triple",2,"Confirmed","Unclear","ICU Admission","Other, SOC",22
"NCT04320277","https://clinicaltrials.gov/show/NCT04320277",NA,"Italy","Rome","2020-Mar",NA,"Not Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Unclear","ICU Admission, Adverse Events, C-Reactive Protein, IL-6, Tumor Necrosis Factor (Any)","JAKi, SOC",200
"RPCEC00000317","https://rpcec.sld.cu/en/trials/RPCEC00000317-En",NA,"Cuba","Havana","2020-May",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear",NA,"Other, SOC",20
"CHICTR2000029976","http://www.chictr.org.cn/showproj.aspx?proj=49631",NA,"China","Shanghai","2020-Feb","2022-Feb","Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Unclear","Non-invasive Ventilation, Cough, Dyspnea, Other Mild Symptoms, Radiographic Findings, Quality of Life","Psychological therapy, SOC",160
"NCT04333589","https://ClinicalTrials.gov/show/NCT04333589",NA,"China","Anhui","2020-Apr","2020-Jun","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO","FPV, SOC",210
"NCT04333589","https://ClinicalTrials.gov/show/NCT04333589",NA,"China","Hubei","2020-Apr","2020-Jun","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO","FPV, SOC",210
"NCT04333589","https://ClinicalTrials.gov/show/NCT04333589",NA,"China","Zhejiang","2020-Apr","2020-Jun","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO","FPV, SOC",210
"TCTR20200514001","http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6236",NA,"Thailand","Nan","2020-Dec",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Fever, SpO2, Radiographic Findings","FPV, SOC",96
"CTRI/2020/05/024969","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43393",NA,"India","Delhi","2020-Jan",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Mortality","Alternative therapy, SOC",100
"CHICTR2000030988","http://www.chictr.org.cn/showproj.aspx?proj=51317",NA,"China","Guangdong","2020-Mar","2020-May","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Hospitalization, Hospital Discharge, Pneumonia or ARDS, Treatment-emergent Adverse Events","SOC, TCM",204
"CHICTR2000029740","http://www.chictr.org.cn/showproj.aspx?proj=49317",NA,"China","Beijing","2020-Feb","2020-Feb","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Viral Load or Clearance, Fever, Serious or Seconday Infections, Lymphocyte Count, IgG, IgM or IgA, Blood Pressure, Heart Rate, Respiratory Rate, Radiographic Findings","HCQ, SOC",78
"NCT04330495","https://clinicaltrials.gov/show/NCT04330495",NA,"Spain","Madrid","2020-Mar",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Unclear","Mortality, ICU Admission","HCQ, SOC",800
"NCT04374552","https://clinicaltrials.gov/show/NCT04374552",NA,"United States","Washington, Dc","2020-Feb",NA,"Not Recruiting","Randomised","Quadruple",3,"Confirmed","Unclear","Viral Load or Clearance","HCQ + AZT, SOC",140
"NCT04405843","https://ClinicalTrials.gov/show/NCT04405843",NA,"Colombia","Valle Del Cauca","2020-May","2020-Oct","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Unclear","Adverse Events","Ivermectin, SOC",400
"IRCT20171213037866N2","http://en.irct.ir/trial/47684",NA,"Iran","Semnan","2020-May","2020-Aug","Recruiting","Randomised","Single",2,"Confirmed","Unclear","Hospital Discharge, Radiographic Findings","Alternative therapy, SOC",68
"NCT04412395","https://ClinicalTrials.gov/show/NCT04412395",NA,"Egypt","Cairo","2020-Jun","2020-Aug","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Unclear","Viral Load or Clearance, Fever, Adverse Events, C-Reactive Protein, Ferritin, IL-1, IL-6, IL-10, Tumor Necrosis Factor (Any), Platelet Count, Erythrocyte Sedimentation Rate, D-Dimer, Prothrombin, ALT, AST, Albumin, Bilirubin, IgG, IgM or IgA, Blood Urea Nitrogen, Blood Pressure, SpO2, Respiratory Rate, Radiographic Findings","Nutrition, SOC",516
"CHICTR2000030058","http://www.chictr.org.cn/showproj.aspx?proj=49831",NA,"China","Hubei","2020-Feb","2020-May","Not Recruiting","Randomised","Double",2,"Confirmed","Unclear","Viral Load or Clearance, Fever, C-Reactive Protein, Radiographic Findings","DMARD, SOC",200
"CHICTR2000029434","http://www.chictr.org.cn/showproj.aspx?proj=48889",NA,"China","Hebei","2020-Feb","2020-Dec","Completed","Randomised","Open-Label",2,"Confirmed","Unclear","Viral Load or Clearance, Cough, Fever, Other Mild Symptoms, Radiographic Findings","SOC, TCM",240
"CHICTR2000032919","http://www.chictr.org.cn/showproj.aspx?proj=53274",NA,"China","Hubei","2020-May","2021-May","Recruiting","Randomised","Double",2,"Confirmed","Unclear","Other Mild Symptoms, Stool Sample","SOC, TCM",200
"CHICTR2000030418","http://www.chictr.org.cn/showproj.aspx?proj=50341",NA,"China","Fujian","2020-Mar","2021-Mar","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","IL-6, Quality of Life, Distress","Respiratory support, SOC",80
"CHICTR2000030173","http://www.chictr.org.cn/showproj.aspx?proj=49229",NA,"China","Hunan","2020-Feb","2020-Apr","Not Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","Viral Load or Clearance, Radiographic Findings","SOC, Stem cells",60
"NCT04389411","https://ClinicalTrials.gov/show/NCT04389411",NA,"Canada","Quebec","2020-May","2021-Feb","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Unclear","Mortality, ICU Admission, Hospitalization, Visits or Returns to Emergency Department","Other, SOC",600
"NCT04323345","https://ClinicalTrials.gov/show/NCT04323345",NA,"Egypt","Cairo","2020-Mar","2020-Dec","Recruiting","Randomised","Single",2,"Confirmed","Unclear","Mortality, Viral Load or Clearance, Fever, Radiographic Findings","Nutrition, SOC",1000
"NCT04407390","https://clinicaltrials.gov/show/NCT04407390",NA,"Denmark","Copenhagen","2020-May",NA,"Recruiting","Randomised","Quadruple",2,"Confirmed","Unclear",NA,"SOC, Vitamins",100
"NCT04392427","https://ClinicalTrials.gov/show/NCT04392427",NA,"Egypt","Cairo","2020-May","2022-May","Not Recruiting","Randomised","Single",2,"Confirmed","Unclear",NA,"Ivermectin + Antivirals, SOC",100
"IRCT20200326046868N1","http://en.irct.ir/trial/47934",NA,"Iran","Khuzestan","2020-May","2020-Jun","Completed","Randomised","Triple",2,"Confirmed","Unclear","Platelet Count","Alternative therapy, SOC",88
"CHICTR2000030480","http://www.chictr.org.cn/showproj.aspx?proj=50470",NA,"China","Hubei","2020-Mar","2020-Jul","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Treatment-emergent Adverse Events","IFN, SOC",328
"CHICTR2000030007","http://www.chictr.org.cn/showproj.aspx?proj=49619",NA,"China","Guangdong","2020-Feb","2020-Apr","Not Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","Viral Load or Clearance, Radiographic Findings","SOC, Stem cells",200
"NCT04299152","https://ClinicalTrials.gov/show/NCT04299152",NA,"China","Beijing","2020-Mar","2020-Oct","Not Recruiting","Randomised","Single",2,"Confirmed","Unclear","Viral Load or Clearance, Other Mild Symptoms, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, Natural Killer Cell Count, Radiographic Findings","SOC, Stem cells",20
"NCT04308317","https://ClinicalTrials.gov/show/NCT04308317",NA,"China","Zhejiang","2020-Mar","2021-Mar","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Mortality, Fever","Other, SOC",60
"CHICTR2000033320","http://www.chictr.org.cn/showproj.aspx?proj=54321",NA,"China","Shanghai","2020-May","2020-Dec","Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear",NA,"SOC, TCM",300
"CHICTR2000030188","http://www.chictr.org.cn/showproj.aspx?proj=50025",NA,"China","Guangdong","2020-Feb","2020-Mar","Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","Mortality, Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Dyspnea, Other Mild Symptoms, C-Reactive Protein, Erythrocyte Sedimentation Rate","SOC, TCM",120
"CHICTR2000030810","http://www.chictr.org.cn/showproj.aspx?proj=50986",NA,"China","Hubei","2020-Mar","2020-Mar","Recruiting","Non-Randomised","Unspecified",2,"Confirmed","Unclear","Hospital Discharge, Creatinine Phosphokinase, CK-MB, ALT, Blood Urea Nitrogen","SOC, TCM",100
"CHICTR2000029790","http://www.chictr.org.cn/showproj.aspx?proj=49453",NA,"China","Shanghai","2020-Feb","2020-Oct","Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","Hospitalization, Viral Load or Clearance, Fever","SOC, TCM",120
"CHICTR2000029747","http://www.chictr.org.cn/showproj.aspx?proj=49287",NA,"China","Anhui","2020-Feb","2021-Feb","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Radiographic Findings","SOC, TCM",200
"CHICTR2000029436","http://www.chictr.org.cn/showproj.aspx?proj=48884",NA,"China","Henan","2020-Feb","2020-Dec","Not Recruiting","Non-Randomised","Unspecified",2,"Confirmed","Unclear","Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Radiographic Findings, Quality of Life","SOC, TCM",100
"CHICTR2000030836","http://www.chictr.org.cn/showproj.aspx?proj=51054",NA,"China","Shanghai","2020-Mar","2020-Jun","Not Recruiting","Non-Randomised","Unspecified",2,"Confirmed","Unclear","Mortality, ICU Admission, Clinical Improvement Score (Any), Pneumonia or ARDS, Dyspnea, Organ Failure or Dysfunction (SOFA), C-Reactive Protein, IL-6, Interferon (Any), eGFR, Coagulation Test, ALT, Albumin, Bilirubin, PaO2-FiO2, Respiratory Rate","SOC, TCM",300
"CHICTR2000029993","http://www.chictr.org.cn/showproj.aspx?proj=49435",NA,"China","Guangdong","2020-Feb","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Mortality, Viral Load or Clearance, Cough, Fever, Dyspnea, Other Mild Symptoms, Serious or Seconday Infections, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","SOC, TCM + Umifenovir",40
"CHICTR2000032737","http://www.chictr.org.cn/showproj.aspx?proj=53458",NA,"China","Guangdong","2020-May","2021-Jun","Not Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","Pneumonia or ARDS, C-Reactive Protein, IL-2, IL-6, Tumor Necrosis Factor (Any), Interferon (Any), Lymphocyte Count, Erythrocyte Sedimentation Rate, D-Dimer, Myoglobin, Procalcitonin, Electrolytes, Glucose, Blood Gas, Renal Outcome (Unspecified)","Other, SOC",60
"CHICTR2000030518","http://www.chictr.org.cn/showproj.aspx?proj=50586",NA,"China","Zhejiang","2020-Mar","2020-May","Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Cough, Fever, IL-2, IL-4, IL-6, IL-10, Tumor Necrosis Factor (Any), Interferon (Any), CD4, CD8, Radiographic Findings","SOC, TCM",60
"CHICTR2000030288","http://www.chictr.org.cn/showproj.aspx?proj=50202",NA,"China","Beijing","2020-Feb","2020-Dec","Recruiting","Randomised","Open-Label",2,"Confirmed","Unclear","Clinical Improvement Score (Any), Viral Load or Clearance","SOC, TCM",204
"CHICTR2000029756","http://www.chictr.org.cn/showproj.aspx?proj=49222",NA,"China","Hubei","2020-Feb","2022-Feb","Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","ICU Admission, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Blood Pressure, Heart Rate, Surfactant Factor Protein, PaO2-FiO2, Respiratory Rate, Radiographic Findings","IFN, TCM",238
"NCT04385940","https://ClinicalTrials.gov/show/NCT04385940",NA,"Canada","Alberta","2020-May","2020-Aug","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Unclear","ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, Lymphocyte Count, Platelet Count","Vitamins",64
"CHICTR2000030487","http://www.chictr.org.cn/showproj.aspx?proj=50507",NA,"China","Henan","2020-Mar","2020-May","Recruiting","Single-Arm","Unspecified",1,"Confirmed","Unclear","Viral Load or Clearance, Cough, Fever, Dyspnea, Other Mild Symptoms, CD4, CD8","DAA",10
"CHICTR2000030424","http://www.chictr.org.cn/showproj.aspx?proj=50174",NA,"China","Henan","2020-Mar","2022-May","Not Recruiting","Single-Arm","Unspecified",1,"Confirmed","Unclear","Clinical Improvement Score (Any), Viral Load or Clearance, Cough, Fever, Other Mild Symptoms, CD4, CD8","DAA",30
"CHICTR2000029935","http://www.chictr.org.cn/showproj.aspx?proj=49607",NA,"China","Zhejiang","2020-Feb","2021-Feb","Recruiting","Single-Arm","Unspecified",1,"Confirmed","Unclear","Mortality, Hospitalization, Clinical Improvement Score (Any), Secondary CoViD-19 Re-infection, Serious Adverse Events, C-Reactive Protein","HCQ",100
"JPRN-UMIN000040407","https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046108",NA,"Japan","Tokyo","2020-May",NA,"Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Unclear",NA,"TCM",15
"NCT04313322","https://ClinicalTrials.gov/show/NCT04313322",NA,"Jordan","Amman","2020-Mar","2020-Jun","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Unclear","Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Dyspnea, Other Mild Symptoms, Radiographic Findings","Stem cells",5
"IRCT20140911019125N6","http://en.irct.ir/trial/46668",NA,"Iran","Kerman","2020-Apr","2020-Oct","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Unclear","Viral Load or Clearance","Stem cells",10
"CHICTR2000031138","http://www.chictr.org.cn/showproj.aspx?proj=51416",NA,"China","Hunan","2020-Mar",NA,"Recruiting","Randomised","Unspecified",2,"Confirmed","Unclear","Clinical Improvement Score (Any), Pneumonia or ARDS, PaO2-FiO2, Respiratory Rate","Other",40
"JPRN-UMIN000040341","https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046023",NA,"Japan","Tokyo","2020-Sep",NA,"Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Unclear",NA,"TCM",15
"CHICTR2000030864","http://www.chictr.org.cn/showproj.aspx?proj=50662",NA,"China","Hubei","2020-Mar","2020-Jul","Recruiting","Single-Arm","Unspecified",1,"Confirmed","Unclear","Viral Load or Clearance, Pneumonia or ARDS, White Blood Cell Count, Monocyte Count, Natural Killer Cell Count, Creatinine Phosphokinase, CK-MB, eGFR, ALT, Albumin, Bilirubin, Glucose, Radiographic Findings","TCM",50
"NCT04302766","https://ClinicalTrials.gov/show/NCT04302766",NA,"United States","Virginia","2020-Mar",NA,"Recruiting","Unspecified","Unspecified",1,"Confirmed","Unclear",NA,"Remdesivir",NA
"CHICTR2000030896","http://www.chictr.org.cn/showproj.aspx?proj=51028",NA,"China","Henan","2020-Mar","2021-Mar","Recruiting","Single-Arm","Unspecified",1,"Confirmed","Unclear","Pneumonia or ARDS, Cough, Fever, Dyspnea, Other Mild Symptoms, Radiographic Findings","TCM",24
"CHICTR2000030219","http://www.chictr.org.cn/showproj.aspx?proj=50110",NA,"China","Tianjin","2020-Feb","2020-Dec","Recruiting","Single-Arm","Unspecified",1,"Confirmed","Unclear","Viral Load or Clearance, C-Reactive Protein, Radiographic Findings","TCM",120
"CHICTR2000029578","http://www.chictr.org.cn/showproj.aspx?proj=49080",NA,"China","Zhejiang","2020-Feb","2020-Apr","Recruiting","Single-Arm","Unspecified",1,"Confirmed","Unclear","Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Cough, Fever, Other Mild Symptoms, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","TCM",1000
"NCT04407286","https://clinicaltrials.gov/show/NCT04407286",NA,"United States","Washington, Dc","2020-May",NA,"Recruiting","Single-Arm","Open-Label",1,"Confirmed","Unclear",NA,"Vitamins",100
"CHICTR2000030261","http://www.chictr.org.cn/showproj.aspx?proj=49963",NA,"China","Jiangsu","2020-Feb","2020-May","Not Recruiting","Randomised","Unspecified",2,"Confirmed Or Suspected","Unclear","Viral Load or Clearance, White Blood Cell Count, Radiographic Findings","Other, SOC",26
"DRKS00021626","https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021626",NA,"Germany","Berlin","2020-May",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Unclear","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","Non-invasive respiratory support, SOC",200
"CHICTR2000029549","http://www.chictr.org.cn/showproj.aspx?proj=49014",NA,"China","Sichuan","2020-Feb","2020-May","Recruiting","Randomised","Unspecified",2,"Confirmed Or Suspected","Unclear","Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2, Radiographic Findings","SOC, TCM",400
"CHICTR2000030420","http://www.chictr.org.cn/showproj.aspx?proj=50286",NA,"China","Liaoning","2020-Mar","2020-Aug","Not Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Unclear","Depression, Anxiety, Distress","TCM",60
"CHICTR2000030467","http://www.chictr.org.cn/showproj.aspx?proj=50378",NA,"China","Liaoning","2020-Mar","2020-Aug","Not Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Unclear","Quality of Life","TCM, TCM + Psychological therapy",60
"NCT04382768","https://ClinicalTrials.gov/show/NCT04382768",NA,"Argentina","Buenos Aires","2020-May","2021-Jan","Recruiting","Single-Arm","Open-Label",1,"Confirmed Or Suspected","Unclear","Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Organ Failure or Dysfunction (SOFA), Adverse Events, Lymphocyte Count","NSAIDs",40
"CHICTR2000029558","http://www.chictr.org.cn/showproj.aspx?proj=48792",NA,"China","Sichuan","2020-Feb","2020-May","Recruiting","Single-Arm","Unspecified",1,"Confirmed Or Suspected","Unclear","Viral Load or Clearance, C-Reactive Protein, Erythrocyte Sedimentation Rate, D-Dimer, Myoglobin, Troponin, Radiographic Findings","TCM",200
"NCT04428801","https://ClinicalTrials.gov/show/NCT04428801",NA,"United States","Texas","2020-Jun","2020-Jul","Not Recruiting","Randomised","Double",2,"Healthy","Unclear","Mortality, Pneumonia or ARDS, C-Reactive Protein, IL-1, IL-6, IL-8, IL-10, Tumor Necrosis Factor (Any), White Blood Cell Count, Lymphocyte Count, D-Dimer, Procalcitonin, Bilirubin, Stool Sample, IgG, IgM or IgA, Antibodies, Blood Gas","SOC, Stem cells",200
"CHICTR2000034076","http://www.chictr.org.cn/showproj.aspx?proj=55582",NA,"China","Shandong","2020-Jun","2022-Apr","Recruiting","Single-Arm","Unspecified",1,"Healthy","Unclear",NA,"Other",25
"CHICTR2000029433","http://www.chictr.org.cn/showproj.aspx?proj=48898",NA,"China","Hebei","2020-Feb","2020-Dec","Completed","Randomised","Open-Label",2,"Suspected","Unclear","Viral Load or Clearance, Cough, Fever, Other Mild Symptoms, Radiographic Findings","SOC, TCM",240
"CHICTR2000029517","http://www.chictr.org.cn/showproj.aspx?proj=48861",NA,"China","Zhejiang","2020-Feb","2020-Apr","Recruiting","Randomised","Double",2,"Suspected","Unclear","Mortality, Pneumonia or ARDS","SOC, TCM",100
"EUCTR2020-001367-88-DK","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001367-88",NA,"Denmark","Copenhagen","2020-Jan",NA,"Not Recruiting","Randomised","Double",6,NA,"Unclear","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events","HCQ, JAKi, Sarilumab, SOC",1500
"CHICTR2000032135","http://www.chictr.org.cn/showproj.aspx?proj=52506",NA,"China","Shanghai","2020-Apr","2020-Dec","Not Recruiting","Randomised","Unspecified",4,NA,"Unclear","Viral Load or Clearance, Adverse Events, Serious Adverse Events, Anti SARS-COV-2 Titers, CD4, PaO2-FiO2, Radiographic Findings","Other, SOC",50
"2020-001290-74","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001290-74/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Open-Label",3,NA,"Unclear","Mortality, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, IL-6, D-Dimer, Renal Outcome (Unspecified)","AZT, HCQ, Sarilumab",NA
"NCT04347954","https://ClinicalTrials.gov/show/NCT04347954",NA,"United States","California","2020-Apr","2020-Sep","Recruiting","Randomised","Double",3,NA,"Unclear","Viral Load or Clearance, Fever, Adverse Events, Anti SARS-COV-2 Titers","Hygiene",45
"CHICTR2000031781","http://www.chictr.org.cn/showproj.aspx?proj=52006",NA,"China","Jiangsu","2020-Apr",NA,"Not Recruiting","Randomised","Double",3,NA,"Unclear","Serious or Seconday Infections, Adverse Events, Anti SARS-COV-2 Titers","SOC, Vaccine",500
"NCT04361422","https://ClinicalTrials.gov/show/NCT04361422",NA,"Egypt","Cairo","2020-Apr","2020-Jun","Not Recruiting","Randomised","Open-Label",3,NA,"Unclear","Clinical Improvement Score (Any), Viral Load or Clearance, Other Mild Symptoms","Other, SOC",300
"NCT04341493","https://ClinicalTrials.gov/show/NCT04341493",NA,"Mexico","Mexico","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,NA,"Unclear","Hospitalization","HCQ, HCQ + Antivirals",86
"2020-001333-13","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001333-13/FR/",NA,"France","Paris","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,NA,"Unclear","Mortality, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections","Dexamethasone, HCQ",NA
"IRCT20200404046935N1","http://en.irct.ir/trial/46940",NA,"Iran","Tehran","2020-Apr","2020-Jun","Completed","Randomised","Open-Label",2,NA,"Unclear","Pneumonia or ARDS, Fever, Erythrocyte Sedimentation Rate","HCQ + LPV/r, HCQ + LPV/r + Alternative therapy",40
"IRCT20200314046764N1","http://en.irct.ir/trial/46533",NA,"Iran","Tehran","2020-Apr","2020-May","Completed","Randomised","Single",2,NA,"Unclear","Cough, Dyspnea, Other Mild Symptoms","LPV/r + HCQ + Oseltamivir + Antivirals, LPV/r + HCQ + Oseltamivir + Pirfenidone",40
"NCT04371601","https://ClinicalTrials.gov/show/NCT04371601",NA,"China","Fujian","2020-May","2021-Dec","Not Recruiting","Randomised","Open-Label",4,NA,"Unclear","C-Reactive Protein, IL-10, Tumor Necrosis Factor (Any), CD4, CD8, Blood Gas, PaO2-FiO2","Oseltamivir + Non-invasive respiratory support + Hormone therapy, Stem cells + Oseltamivir + Non-invasive respiratory support + Hormone therapy",60
"NCT04358926","https://ClinicalTrials.gov/show/NCT04358926",NA,"Israel","Jerusalem","2020-Apr","2020-Jun","Recruiting","Randomised","Double",2,NA,"Unclear","Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Cough, Dyspnea, Other Mild Symptoms, Adverse Events, Anti SARS-COV-2 Titers, C-Reactive Protein, Ferritin, IL-1, IL-2, IL-6, IL-10, Tumor Necrosis Factor (Any), White Blood Cell Count, Erythrocyte Sedimentation Rate, Procalcitonin, IgG, IgM or IgA, Antibodies, PaO2-FiO2","Non-invasive respiratory support",30
"NCT04360356","https://ClinicalTrials.gov/show/NCT04360356",NA,"Egypt","Cairo","2020-Apr","2020-Oct","Not Recruiting","Randomised","Double",2,NA,"Unclear","Mortality, Ferritin, IL-6, Tumor Necrosis Factor (Any), Platelet Count, Prothrombin, INR, Respiratory Rate","Ivermectin + Antivirals, Non-invasive respiratory support",100
"CHICTR2000032165","http://www.chictr.org.cn/showproj.aspx?proj=52679",NA,"China","Hubei","2020-Apr","2021-Mar","Not Recruiting","Randomised","Double",2,NA,"Unclear","6-Minute Walking Distance, Radiographic Findings, Quality of Life","Education, TCM + Education",60
"NCT04365309","https://ClinicalTrials.gov/show/NCT04365309",NA,"China","Shaanxi","2020-Apr","2020-Apr","Recruiting","Randomised","Open-Label",2,NA,"Unclear",NA,"Antihypertensive, SOC",128
"NCT04352959","https://clinicaltrials.gov/show/NCT04352959",NA,"France","Lyonnais","2020-Apr",NA,"Not Recruiting","Randomised","Triple",2,NA,"Unclear","Viral Load or Clearance","Hygiene, SOC",178
"NCT04361474","https://clinicaltrials.gov/show/NCT04361474",NA,"France","Paris","2020-Apr",NA,"Recruiting","Randomised","Single",2,NA,"Unclear","Clinical Improvement Score (Any), Blood Pressure, Heart Rate, Respiratory Rate","Corticosteroids, SOC",120
"NCT04355143","https://ClinicalTrials.gov/show/NCT04355143",NA,"United States","California","2020-Apr","2021-Apr","Recruiting","Randomised","Open-Label",2,NA,"Unclear","Mortality, ICU Admission, Hospitalization, Visits or Returns to Emergency Department, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, D-Dimer, Troponin, Cardiac Outcome (Unspecified)","Colchicine, SOC",150
"IRCT20200404046934N1","http://en.irct.ir/trial/46913",NA,"Iran","Qom","2020-Apr","2020-Apr","Completed","Randomised","Triple",2,NA,"Unclear","Fever, Blood Pressure, Respiratory Rate","Alternative therapy, SOC",130
"IRCT20080901001157N16","http://en.irct.ir/trial/46907",NA,"Iran","Tehran","2020-Apr","2020-May","Completed","Randomised","Triple",2,NA,"Unclear","Cough, Fever, C-Reactive Protein, Erythrocyte Sedimentation Rate, ALT, Blood Urea Nitrogen, Respiratory Rate, Lung Inflamation","Alternative therapy, SOC",60
"CHICTR2000032242","http://www.chictr.org.cn/showproj.aspx?proj=52824",NA,"China","Heilongjiang","2020-Apr","2021-May","Not Recruiting","Randomised","Open-Label",2,NA,"Unclear","Mortality, Hospitalization, Hospital Discharge, C-Reactive Protein, White Blood Cell Count, Coagulation Test, IgG, IgM or IgA, Antibodies","Other, SOC",350
"NCT04361643","https://ClinicalTrials.gov/show/NCT04361643",NA,"Spain","Madrid","2020-Apr","2020-Aug","Not Recruiting","Randomised","Quadruple",2,NA,"Unclear","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Neutrophils","Immunomodulators, SOC",120
"NCT04343651","https://ClinicalTrials.gov/show/NCT04343651",NA,"United States","California","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",2,NA,"Unclear","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Natural Killer Cell Count, CD4, CD8, SpO2, Radiographic Findings","mAb, SOC",75
"NCT04343651","https://ClinicalTrials.gov/show/NCT04343651",NA,"United States","Connecticut","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",2,NA,"Unclear","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Natural Killer Cell Count, CD4, CD8, SpO2, Radiographic Findings","mAb, SOC",75
"NCT04343651","https://ClinicalTrials.gov/show/NCT04343651",NA,"United States","Georgia","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",2,NA,"Unclear","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Natural Killer Cell Count, CD4, CD8, SpO2, Radiographic Findings","mAb, SOC",75
"NCT04343651","https://ClinicalTrials.gov/show/NCT04343651",NA,"United States","Massachusetts","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",2,NA,"Unclear","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Natural Killer Cell Count, CD4, CD8, SpO2, Radiographic Findings","mAb, SOC",75
"NCT04343651","https://ClinicalTrials.gov/show/NCT04343651",NA,"United States","New Jersey","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",2,NA,"Unclear","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Natural Killer Cell Count, CD4, CD8, SpO2, Radiographic Findings","mAb, SOC",75
"NCT04343651","https://ClinicalTrials.gov/show/NCT04343651",NA,"United States","New York","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",2,NA,"Unclear","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Natural Killer Cell Count, CD4, CD8, SpO2, Radiographic Findings","mAb, SOC",75
"NCT04343651","https://ClinicalTrials.gov/show/NCT04343651",NA,"United States","North Carolina","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",2,NA,"Unclear","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Natural Killer Cell Count, CD4, CD8, SpO2, Radiographic Findings","mAb, SOC",75
"NCT04343651","https://ClinicalTrials.gov/show/NCT04343651",NA,"United States","Ohio","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",2,NA,"Unclear","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Natural Killer Cell Count, CD4, CD8, SpO2, Radiographic Findings","mAb, SOC",75
"NCT04343651","https://ClinicalTrials.gov/show/NCT04343651",NA,"United States","Oregon","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",2,NA,"Unclear","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Natural Killer Cell Count, CD4, CD8, SpO2, Radiographic Findings","mAb, SOC",75
"2020-001301-23","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001301-23/FR/",NA,"France","Paris","2020-Mar",NA,"Recruiting","Randomised","Open-Label",2,NA,"Unclear","Mortality, Viral Load or Clearance, Organ Failure or Dysfunction (SOFA)","NSAIDs, SOC",NA
"NCT04371965","https://ClinicalTrials.gov/show/NCT04371965",NA,"France","Paris","2020-May","2020-Sep","Not Recruiting","Randomised","Open-Label",2,NA,"Unclear","ICU Admission, Hospitalization, Viral Load or Clearance, Cough, Other Mild Symptoms, Distress","Hygiene, SOC",24
"IRCT20200414047070N1","http://en.irct.ir/trial/47169",NA,"Iran","Tehran","2020-Apr","2020-Sep","Recruiting","Randomised","Open-Label",2,NA,"Unclear","Viral Load or Clearance","Other, SOC",50
"2020-001379-34","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001379-34/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,NA,"Unclear","Mortality, Non-invasive Ventilation, IL-1, IL-6, IL-8, Tumor Necrosis Factor (Any), PaO2-FiO2","Anesthetic, SOC",NA
"CHICTR2000032214","http://www.chictr.org.cn/showproj.aspx?proj=52781",NA,"China","Hubei","2020-Apr","2020-Jul","Not Recruiting","Randomised","Double",2,NA,"Unclear","Other Mild Symptoms","SOC, TCM",200
"IRCT20180610040049N4","http://en.irct.ir/trial/46850",NA,"Iran","Qom","2020-Apr","2020-May","Completed","Randomised","Triple",2,NA,"Unclear","C-Reactive Protein, Lung Inflamation","Alternative therapy, SOC",60
"IRCT20180520039738N2","http://en.irct.ir/trial/46974",NA,"Iran","Markazi","2020-Apr","2020-Apr","Completed","Randomised","Double",2,NA,"Unclear","Cough, Fever, C-Reactive Protein, Erythrocyte Sedimentation Rate, Creatinine Phosphokinase, LDH, Respiratory Rate, Blood pH","SOC, Vitamins",140
"CHICTR2000032237","http://www.chictr.org.cn/showproj.aspx?proj=52699",NA,"China","Hubei","2020-Apr","2020-Jun","Recruiting","Randomised","Double",2,NA,"Unclear","Other Mild Symptoms","SOC, TCM",200
"EUCTR2020-001466-11-GR","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001466-11",NA,"Greece","Athens","2020-Apr",NA,"Not Recruiting","Non-Randomised","Open-Label",1,NA,"Unclear","Other Mild Symptoms, Organ Failure or Dysfunction (SOFA)","Anakinra + Cotrimoxazole",100
"NCT04339426","https://ClinicalTrials.gov/show/NCT04339426",NA,"United States","Arizona","2020-Apr","2020-Oct","Recruiting","Single-Arm","Open-Label",1,NA,"Unclear","ICU Admission, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms, Serious Adverse Events, PaO2-FiO2, Respiratory Rate","AZT + Antibiotics",25
"NCT04353336","https://ClinicalTrials.gov/show/NCT04353336",NA,"Egypt","Cairo","2020-Apr","2020-Jul","Recruiting","Randomised","Open-Label",2,NA,"Unclear","Viral Load or Clearance","HCQ",200
"CHICTR2000032098","http://www.chictr.org.cn/showproj.aspx?proj=52477",NA,"China","Hubei","2020-Apr","2020-Jul","Recruiting","Single-Arm","Unspecified",1,NA,"Unclear","Viral Load or Clearance, C-Reactive Protein, Radiographic Findings","TCM",300
"IRCT20191125045492N2","http://en.irct.ir/trial/47149",NA,"Iran","Mazandaran","2020-Apr","2020-May","Completed","Randomised","Open-Label",2,NA,"Unclear","Cough, Fever, Dyspnea, Other Mild Symptoms, C-Reactive Protein","Non-invasive respiratory support",80
"ACTRN12620000470998","https://anzctr.org.au/ACTRN12620000470998.aspx",NA,"Australia","Canberra","2020-Apr",NA,"Not Recruiting","Non-Randomised","Unspecified",1,NA,"Unclear","Viral Load or Clearance","Hygiene",20
"IRCT20150303021315N17","http://en.irct.ir/trial/46550",NA,"Iran","Tehran","2020-Apr","2020-Jul","Recruiting","Single-Arm","Open-Label",1,NA,"Unclear","Mortality, Non-invasive Ventilation, Fever, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, PaO2-FiO2, Radiographic Findings","TCZ",85
"NCT04344236","https://ClinicalTrials.gov/show/NCT04344236",NA,"United States","New York","2020-Apr","2020-May","Recruiting","Randomised","Open-Label",4,NA,"Unclear","Viral Load or Clearance, Pneumonia or ARDS, Heart Rate","Hygiene, SOC",48
"NCT04410562","https://ClinicalTrials.gov/show/NCT04410562",NA,"Spain","Barcelona","2020-Jun","2021-May","Recruiting","Randomised","Quadruple",2,NA,"Unclear","Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Hemoglobin, Pregnancy or Birth Outcomes","HCQ, SOC",714
"NCT04410562","https://ClinicalTrials.gov/show/NCT04410562",NA,"Spain","Madrid","2020-Jun","2021-May","Recruiting","Randomised","Quadruple",2,NA,"Unclear","Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Hemoglobin, Pregnancy or Birth Outcomes","HCQ, SOC",714
"NCT04355936","https://ClinicalTrials.gov/show/NCT04355936",NA,"Argentina","Ciudad De Buenos Aires","2020-Apr","2020-Oct","Recruiting","Randomised","Open-Label",2,NA,"Unclear","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Troponin, LDH, Urine Sample","Antihypertensive, SOC",400
"NCT04345406","https://clinicaltrials.gov/show/NCT04345406",NA,"Egypt","Cairo","2020-Nov",NA,"Not Recruiting","Randomised","Open-Label",2,NA,"Unclear","Viral Load or Clearance, Radiographic Findings","Antihypertensive, SOC",60
"NCT04343729","https://ClinicalTrials.gov/show/NCT04343729",NA,"Brazil","Amazonas","2020-Apr","2020-Jun","Not Recruiting","Randomised","Quadruple",2,NA,"Unclear","Mortality, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Corticosteroids, SOC",416
"NCT04344041","https://ClinicalTrials.gov/show/NCT04344041",NA,"France","Paris","2020-Apr","2020-Jul","Recruiting","Randomised","Open-Label",2,NA,"Unclear","Mortality, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Serious Adverse Events","Vitamins",260
"NCT04342650","https://ClinicalTrials.gov/show/NCT04342650",NA,"Brazil","Amazonas","2020-Apr","2020-May","Completed","Randomised","Quadruple",2,NA,"Unclear","Adverse Events, Natural Killer Cell Count",NA,152
"CHICTR2000031888","http://www.chictr.org.cn/showproj.aspx?proj=52106",NA,"China","Guangdong","2020-Apr","2020-Nov","Recruiting","Randomised","Unspecified",2,NA,"Unclear","Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Fever, Dyspnea, C-Reactive Protein, White Blood Cell Count, CD4, CD8, Renal Outcome (Unspecified)",NA,300
"NCT04339660","https://ClinicalTrials.gov/show/NCT04339660",NA,"China","Hubei","2020-Apr","2020-Jun","Recruiting","Randomised","Triple",2,NA,"Unclear","Mortality, Viral Load or Clearance, Cough, Fever, Dyspnea, C-Reactive Protein, IL-1, IL-6, IL-8, Tumor Necrosis Factor (Any), Procalcitonin, CD4, CD8, SpO2, Radiographic Findings",NA,30
"NCT04345419","https://clinicaltrials.gov/show/NCT04345419",NA,"Egypt","Cairo","2020-Nov",NA,"Recruiting","Randomised","Single",5,NA,"Unclear","Hospitalization, Cough, Fever, Dyspnea, Other Mild Symptoms, Treatment-emergent Adverse Events",NA,120
"CHICTR2000033284","http://www.chictr.org.cn/showproj.aspx?proj=49590",NA,"China","Guangdong","2020-May","2025-May","Not Recruiting","Randomised","Unspecified",2,"Resolved","Resolved Discharged","Dyspnea, Weight, Height or BMI","Other, TCM + Other",150
"2020-001319-26","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001319-26/ES/",NA,"Spain","Madrid","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Resolved Discharged","Mortality","SOC, Statins",NA
"NCT04402983","https://clinicaltrials.gov/show/NCT04402983",NA,"Turkey","Ankara","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Resolved Discharged","Dyspnea, Other Mild Symptoms","Other, SOC",34
"CHICTR2000030433","http://www.chictr.org.cn/showproj.aspx?proj=50273",NA,"China","Fujian","2020-Mar","2020-Oct","Not Recruiting","Single-Arm","Unspecified",1,"Recovered","Resolved Discharged","Quality of Life","Respiratory support",80
"CHICTR2000032573","http://www.chictr.org.cn/showproj.aspx?proj=53225",NA,"China","Guangdong","2020-May","2021-May","Not Recruiting","Randomised","Double",2,"Recovery","Resolved Discharged","Clinical Improvement Score (Any), 6-Minute Walking Distance, Quality of Life","SOC, TCM",120
"CHICTR2000030920","http://www.chictr.org.cn/showproj.aspx?proj=50476",NA,"China","Zhejiang","2020-Mar","2021-May","Recruiting","Randomised","Unspecified",4,"Resolved","Resolved Discharged","Viral Load or Clearance, Secondary CoViD-19 Re-infection, C-Reactive Protein, IL-2, IL-4, IL-6, IL-10, Tumor Necrosis Factor (Any), Weight, Height or BMI, Albumin, IgG, IgM or IgA, Antibodies, CD4, CD8","SOC, TCM",100
"CHICTR2000030933","http://www.chictr.org.cn/showproj.aspx?proj=51184",NA,"China","Jiangxi","2020-Mar","2020-Dec","Not Recruiting","Randomised","Open-Label",3,"Resolved","Resolved Discharged","Fever, Respiratory Rate, 6-Minute Walking Distance, Quality of Life, Depression, Anxiety, Distress","Exercise, Exercise + Respiratory support, Respiratory support",108
"CHICTR2000029495","http://www.chictr.org.cn/showproj.aspx?proj=48971",NA,"China","Hubei","2020-Feb","2021-Dec","Not Recruiting","Randomised","Open-Label",3,"Resolved","Resolved Discharged","Quality of Life, Depression, Anxiety","Psychological therapy, TCM, TCM + Psychological therapy",90
"CHICTR2000030198","http://www.chictr.org.cn/showproj.aspx?proj=50066",NA,"China","Sichuan","2020-Feb","2020-Aug","Not Recruiting","Randomised","Unspecified",2,"Resolved","Resolved Discharged","Clinical Improvement Score (Any), PaO2-FiO2, Respiratory Rate, 6-Minute Walking Distance, Quality of Life, Depression, Anxiety","Psychological therapy, Respiratory + Education",60
"CHICTR2000031203","http://www.chictr.org.cn/showproj.aspx?proj=51030",NA,"China","Henan","2020-Mar","2022-Feb","Recruiting","Randomised","Unspecified",2,"Resolved","Resolved Discharged","Anxiety","SOC, TCM",28
"CHICTR2000029459","http://www.chictr.org.cn/showproj.aspx?proj=48929",NA,"China","Hubei","2020-Feb","2021-Dec","Not Recruiting","Randomised","Unspecified",2,"Resolved","Resolved Discharged","Adverse Events, Serious Adverse Events, PaO2-FiO2, Respiratory Rate, 6-Minute Walking Distance, Quality of Life","Psychological therapy, SOC",100
"CHICTR2000029956","http://www.chictr.org.cn/showproj.aspx?proj=49618",NA,"China","Sichuan","2020-Feb","2020-Jul","Not Recruiting","Randomised","Unspecified",2,"Resolved","Resolved Discharged","Cough, Fever, Dyspnea, Other Mild Symptoms, Quality of Life, Depression, Anxiety, Distress","SOC, TCM",120
"CHICTR2000029789","http://www.chictr.org.cn/showproj.aspx?proj=49348",NA,"China","Henan","2020-Feb","2021-Jun","Recruiting","Randomised","Unspecified",2,"Resolved","Resolved Discharged","Visits or Returns to Emergency Department, Pneumonia or ARDS, Radiographic Findings, Quality of Life","SOC, TCM",100
"CHICTR2000029493","http://www.chictr.org.cn/showproj.aspx?proj=48931",NA,"China","Hubei","2020-Feb","2021-Dec","Not Recruiting","Randomised","Unspecified",2,"Resolved","Resolved Discharged","Adverse Events, 6-Minute Walking Distance, Quality of Life","SOC, TCM",100
"NCT04412330","https://clinicaltrials.gov/show/NCT04412330",NA,"United States","Washington, Dc","2020-Dec",NA,"Recruiting","Single-Arm","Open-Label",1,"Resolved","Resolved Discharged","Adverse Events","Exercise",20
"NCT04368845","https://ClinicalTrials.gov/show/NCT04368845",NA,"Greece","Athens","2020-Apr","2020-Jul","Recruiting","Randomised","Single",2,NA,"Resolved Discharged","Dyspnea, Other Mild Symptoms, Quality of Life, Depression, Anxiety","Non-invasive respiratory support, SOC",100
"RPCEC00000309","https://rpcec.sld.cu/en/trials/RPCEC00000309-En",NA,"Mexico","Mexico","2020-May",NA,"Not Recruiting","Randomised","Double",5,"Confirmed","Outpatient, Hospital, ICU","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","Other, SOC",50
"ACTRN12620000500954","https://anzctr.org.au/ACTRN12620000500954.aspx",NA,"Australia","Canberra","2020-Apr",NA,"Not Recruiting","Non-Randomised","Open-Label",1,"Confirmed","Outpatient, Hospital, ICU","Mortality, Hospitalization, Adverse Events","Device",20
"NCT04381923","https://ClinicalTrials.gov/show/NCT04381923",NA,"United States","Pennsylvania","2020-May","2020-Aug","Not Recruiting","Randomised","Single",2,"Confirmed","Hospital, ICU","Mortality, ICU Admission, Dyspnea, Renal Outcome (Unspecified)","Non-invasive respiratory support",200
"2020-001995-13","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001995-13/ES/",NA,"Spain","Madrid","2020-May",NA,"Recruiting","Unspecified","Open-Label",1,"Confirmed","Hospital, ICU","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, D-Dimer, Procalcitonin, PaO2-FiO2, SpO2, Radiographic Findings, Renal Outcome (Unspecified)","TCZ",NA
"NCT04363853","https://clinicaltrials.gov/show/NCT04363853",NA,"Mexico","Mexico","2020-Apr",NA,"Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital, ICU","Pneumonia or ARDS, White Blood Cell Count, Hemoglobin, Glucose, Blood Urea Nitrogen, Radiographic Findings","TCZ",200
"IRCT20200418047116N1","http://en.irct.ir/trial/47219",NA,"Iran","Tehran","2020-May","2020-May","Completed","Non-Randomised","Open-Label",2,"Confirmed","Hospital, ICU","Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Radiographic Findings","Igs, LPV/r",20
"NCT04348305","https://clinicaltrials.gov/show/NCT04348305",NA,"Denmark","Copenhagen","2020-Nov",NA,"Not Recruiting","Randomised","Quadruple",2,"Yes","Hospital, ICU","Mortality, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Quality of Life","Corticosteroids, SOC",1000
"NCT04350281","https://clinicaltrials.gov/show/NCT04350281",NA,"China","Hong Kong","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Yes","Hospital, ICU","Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events","HCQ, IFN",80
"2020-000982-18","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000982-18/SE/",NA,"Sweden","Stockholm","2020-Apr",NA,"Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital, ICU","Mortality, ICU Admission, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, eGFR, Radiographic Findings, Quality of Life, Cardiac Outcome (Unspecified)","HCQ, Remdesivir",NA
"IRCT20200501047259N1","http://en.irct.ir/trial/47609",NA,"Iran","Tehran","2020-May","2020-Jun","Completed","Single-Arm","Triple",1,"Confirmed","Hospital, ICU","SpO2, Radiographic Findings","Igs",40
"CHICTR2000030333","http://www.chictr.org.cn/showproj.aspx?proj=48801",NA,"China","Hubei","2020-Feb","2020-Jul","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital, ICU","Mortality, Viral Load or Clearance, Cough, Dyspnea, IL-8","Other, SOC",292
"IRCT20150704023055N2","http://en.irct.ir/trial/46837",NA,"Iran","Mazandaran","2020-Apr","2020-Apr","Completed","Single-Arm","Open-Label",1,"Confirmed","Hospital, ICU","Clinical Improvement Score (Any), IL-6",NA,10
"NCT04374487","https://ClinicalTrials.gov/show/NCT04374487",NA,"India","Delhi","2020-May","2021-May","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital, ICU","Mortality, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Fever, Dyspnea, Other Mild Symptoms, Organ Failure or Dysfunction (SOFA), Adverse Events, PaO2-FiO2","Plasma based therapy, SOC",100
"NCT04260594","https://ClinicalTrials.gov/show/NCT04260594",NA,"China","Shanghai","2020-Feb","2020-Jul","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital, ICU","Mortality, Viral Load or Clearance, Cough, Fever, Dyspnea, Other Mild Symptoms, Treatment-emergent Adverse Events, Serious Adverse Events, PaO2-FiO2","SOC, Umifenovir",380
"CHICTR2000030028","http://www.chictr.org.cn/showproj.aspx?proj=49840",NA,"China","Sichuan","2020-Feb","2020-Aug","Not Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital, ICU","PD-1, Monocyte Count, Natural Killer Cell Count, Dendritic Cell Count, Neutrophils, CD4, CD8","mAb, SOC",40
"NCT04330638","https://ClinicalTrials.gov/show/NCT04330638",NA,"Belgium","Brussels","2020-Apr","2020-Sep","Recruiting","Randomised","Open-Label",6,"Confirmed Or Suspected","Hospital, ICU","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, C-Reactive Protein, Ferritin, IL-1, IL-6, Radiographic Findings, Hypoxia","Anakinra, Anakinra + Siltuximab, Anakinra + TCZ, Siltuximab, SOC, TCZ",342
"NCT04330638","https://ClinicalTrials.gov/show/NCT04330638",NA,"Belgium","Antwerp","2020-Apr","2020-Sep","Recruiting","Randomised","Open-Label",6,"Confirmed Or Suspected","Hospital, ICU","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, C-Reactive Protein, Ferritin, IL-1, IL-6, Radiographic Findings, Hypoxia","Anakinra, Anakinra + Siltuximab, Anakinra + TCZ, Siltuximab, SOC, TCZ",342
"NCT04382586","https://ClinicalTrials.gov/show/NCT04382586",NA,"United States","District Of Columbia","2020-May","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital, ICU","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",52
"NCT04382586","https://ClinicalTrials.gov/show/NCT04382586",NA,"United States","Illinois","2020-May","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital, ICU","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",52
"NCT04382586","https://ClinicalTrials.gov/show/NCT04382586",NA,"United States","Massachusetts","2020-May","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital, ICU","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",52
"NCT04382586","https://ClinicalTrials.gov/show/NCT04382586",NA,"United States","New Jersey","2020-May","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital, ICU","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",52
"NCT04382586","https://ClinicalTrials.gov/show/NCT04382586",NA,"United States","Texas","2020-May","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital, ICU","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",52
"NCT04382586","https://ClinicalTrials.gov/show/NCT04382586",NA,"United States","Wisconsin","2020-May","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital, ICU","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",52
"NCT04388683","https://ClinicalTrials.gov/show/NCT04388683",NA,"United States","Massachusetts","2020-May","2021-Apr","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital, ICU","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), D-Dimer, Fibrinogen, PaO2-FiO2","Non-invasive respiratory support, SOC",42
"2020-001541-39","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001541-39/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Unspecified","Open-Label",1,"Confirmed","Hospital, ICU","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Anti SARS-COV-2 Titers, White Blood Cell Count, Neutrophils, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, PaO2-FiO2, SpO2, Radiographic Findings, Renal Outcome (Unspecified)","mAb",NA
"NCT04377659","https://ClinicalTrials.gov/show/NCT04377659",NA,"United States","New York","2020-May","2021-May","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital, ICU","Mortality","TCZ",40
"IRCT20200414047072N1","http://en.irct.ir/trial/47163",NA,"Iran","Tehran","2020-Apr","2021-Apr","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital, ICU","Viral Load or Clearance, Fever, Dyspnea, Organ Failure or Dysfunction (SOFA), Respiratory Rate, Radiographic Findings","Plasma based therapy",357
"NCT04335123","https://ClinicalTrials.gov/show/NCT04335123",NA,"United States","Kansas","2020-Apr","2020-Sep","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital, ICU","Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Non-invasive Ventilation, Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Bicarbonates","ARBs",50
"2020-001364-29","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001364-29/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital, ICU","Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events, Serious Adverse Events, ACE","LPV/r + HCQ, Stem cells",NA
"IRCT20200310046736N1","http://en.irct.ir/trial/46424",NA,"Iran","Golestan","2020-Apr","2020-Jul","Not Recruiting","Randomised","Single",3,"Confirmed","Hospital, ICU","Clinical Improvement Score (Any), Viral Load or Clearance",NA,45
"NCT04377997","https://ClinicalTrials.gov/show/NCT04377997",NA,"United States","Massachusetts","2020-May","2021-Jan","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital, ICU","Mortality, Deep Vein Thrombosis or Pulmonary Embolism, Shock, Cardiac Outcome (Unspecified)","Anticoagulants",300
"NCT04321616","https://ClinicalTrials.gov/show/NCT04321616",NA,"Norway","Oslo","2020-Mar","2020-Aug","Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital, ICU","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA)","HCQ, Remdesivir, SOC",700
"2020-001784-88","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001784-88/FI/",NA,"Finland","Helsinki","2020-Apr",NA,"Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital, ICU","Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, Platelet Count, eGFR, Quality of Life, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","HCQ, Remdesivir, SOC",NA
"NCT04374461","https://ClinicalTrials.gov/show/NCT04374461",NA,"United States","New York","2020-May","2021-May","Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital, ICU","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any)","Other",86
"NCT04322123","https://ClinicalTrials.gov/show/NCT04322123",NA,"Brazil","Brasilia","2020-Mar","2020-Aug","Not Recruiting","Randomised","Open-Label",3,"Confirmed Or Suspected","Hospital, ICU","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, D-Dimer, Antibodies, PaO2-FiO2","HCQ, SOC",630
"NCT04322123","https://ClinicalTrials.gov/show/NCT04322123",NA,"Brazil","Distrito Federal","2020-Mar","2020-Aug","Not Recruiting","Randomised","Open-Label",3,"Confirmed Or Suspected","Hospital, ICU","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, D-Dimer, Antibodies, PaO2-FiO2","HCQ, SOC",630
"NCT04322123","https://ClinicalTrials.gov/show/NCT04322123",NA,"Brazil","Rio De Janeiro","2020-Mar","2020-Aug","Not Recruiting","Randomised","Open-Label",3,"Confirmed Or Suspected","Hospital, ICU","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, D-Dimer, Antibodies, PaO2-FiO2","HCQ, SOC",630
"NCT04373707","https://clinicaltrials.gov/show/NCT04373707",NA,"France","Paris","2020-Jan",NA,"Recruiting","Randomised","Single",2,"Confirmed, Suspected","Hospital, ICU",NA,"Anticoagulants",602
"NCT04356690","https://ClinicalTrials.gov/show/NCT04356690",NA,"United States","Massachusetts","2020-Apr","2020-Dec","Recruiting","Randomised","Open-Label",3,NA,"Hospital, ICU","Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, Ferritin, White Blood Cell Count, D-Dimer, PaO2-FiO2","Other, SOC",64
"2020-001437-12","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001437-12/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Open-Label",4,NA,"Hospital, ICU","Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Ferritin, IL-1, IL-2, IL-6, IL-12, Tumor Necrosis Factor (Any), D-Dimer, Triglycerides, SpO2","Cyclosporine, TCZ",NA
"NCT04345848","https://clinicaltrials.gov/show/NCT04345848",NA,"Switzerland","Bern","2020-Jul",NA,"Recruiting","Randomised","Single",2,NA,"Hospital, ICU","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Coagulation Test","Anticoagulants",200
"2020-001614-38","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001614-38/BE/",NA,"Belgium","Brussels","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,NA,"Hospital, ICU","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Lymphocyte Count, Neutrophils, Platelet Count, Hemoglobin, Creatinine Phosphokinase, eGFR, Troponin, ALT, AST, Bilirubin, Glucose, ECG, 6-Minute Walking Distance, Radiographic Findings, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","AZT, SOC",NA
"NCT04433910","https://ClinicalTrials.gov/show/NCT04433910",NA,"Germany","Berlin","2020-Jun","2020-Dec","Recruiting","Randomised","Open-Label",2,NA,"Hospital, ICU","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Anti SARS-COV-2 Titers, C-Reactive Protein, IL-6, Tumor Necrosis Factor (Any)","Plasma based therapy, SOC",106
"NCT04433910","https://ClinicalTrials.gov/show/NCT04433910",NA,"Germany","Saarland","2020-Jun","2020-Dec","Recruiting","Randomised","Open-Label",2,NA,"Hospital, ICU","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Anti SARS-COV-2 Titers, C-Reactive Protein, IL-6, Tumor Necrosis Factor (Any)","Plasma based therapy, SOC",106
"NCT04346797","https://clinicaltrials.gov/show/NCT04346797",NA,"France","Paris","2020-Jun",NA,"Recruiting","Randomised","Open-Label",2,NA,"Hospital, ICU","Organ Failure or Dysfunction (SOFA)","mAb, SOC",120
"NCT04355728","https://ClinicalTrials.gov/show/NCT04355728",NA,"United States","Florida","2020-Apr","2021-Apr","Recruiting","Randomised","Triple",2,NA,"Hospital, ICU","Mortality, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, D-Dimer, Troponin, Antibodies","SOC, Stem cells",24
"NCT04344756","https://ClinicalTrials.gov/show/NCT04344756",NA,"France","Paris","2020-Apr","2020-Jul","Not Recruiting","Randomised","Open-Label",2,NA,"Hospital, ICU","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Coagulation Test, Bicarbonates, Renal Outcome (Unspecified)","Anticoagulants, SOC",808
"NCT04361253","https://clinicaltrials.gov/show/NCT04361253",NA,"United States","Washington, Dc","2020-Apr",NA,"Recruiting","Randomised","Double",2,NA,"Hospital, ICU","Mortality, Clinical Improvement Score (Any)","Plasma based therapy, SOC",220
"NCT04347681","https://clinicaltrials.gov/show/NCT04347681",NA,"Saudi Arabia","Riyadh","2020-Aug",NA,"Recruiting","Non-Randomised","Open-Label",2,NA,"Hospital, ICU","Mortality, ICU Admission, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","Plasma based therapy",40
"IRCT20200217046526N1","http://en.irct.ir/trial/47030",NA,"Iran","Tehran","2020-Apr","2020-Mar","Completed","Single-Arm","Open-Label",1,NA,"Hospital, ICU","Adverse Events, SpO2","Stem cells",6
"NCT04352751","https://ClinicalTrials.gov/show/NCT04352751",NA,"Pakistan","Sind","2020-Apr","2021-Apr","Recruiting","Single-Arm","Open-Label",1,NA,"Hospital, ICU","Clinical Improvement Score (Any), Dyspnea, Other Mild Symptoms","Plasma based therapy",2000
"NCT04344106","https://ClinicalTrials.gov/show/NCT04344106",NA,"France","Paris","2020-Apr","2020-Apr","Recruiting","Single-Arm","Open-Label",1,NA,"Hospital, ICU","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Serious Adverse Events",NA,25
"2020-001409-21","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001409-21/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Double",2,NA,"Hospital, ICU","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events",NA,NA
"NCT04371822","https://ClinicalTrials.gov/show/NCT04371822",NA,"Egypt","Cairo","2020-May","2020-Oct","Not Recruiting","Non-Randomised","Open-Label",7,NA,"Healthy Unexposed, ICU","Mortality, ICU Admission, C-Reactive Protein, Ferritin, IL-1, IL-6, Tumor Necrosis Factor (Any), Interferon (Any), Lymphocyte Count, Erythrocyte Sedimentation Rate, D-Dimer","Other",56
"ACTRN12620000676910","https://anzctr.org.au/ACTRN12620000676910.aspx",NA,"Australia","Canberra","2020-Jun",NA,"Not Recruiting","Randomised","Unspecified",2,"Confirmed Or Suspected","ICU","Mortality, PaO2-FiO2","SOC, Stem cells",40
"NCT04390139","https://clinicaltrials.gov/show/NCT04390139",NA,"Spain","Madrid","2020-Jul",NA,"Recruiting","Randomised","Quadruple",2,"Confirmed","ICU","Mortality","SOC, Stem cells",30
"NCT04363502","https://clinicaltrials.gov/show/NCT04363502",NA,"United States","Washington, Dc","2020-Apr",NA,"Recruiting","Randomised","Triple",2,"Confirmed","ICU","C-Reactive Protein","mAb, SOC",30
"NCT04381338","https://ClinicalTrials.gov/show/NCT04381338",NA,"Italy","Padova","2020-May","2020-Sep","Not Recruiting","Non-Randomised","Open-Label",2,"Confirmed","ICU","ICU Admission, Hospitalization","Rehabilitation, SOC",92
"NCT04381338","https://ClinicalTrials.gov/show/NCT04381338",NA,"Italy","Verona","2020-May","2020-Sep","Not Recruiting","Non-Randomised","Open-Label",2,"Confirmed","ICU","ICU Admission, Hospitalization","Rehabilitation, SOC",92
"NL8523","https://trialregister.nl/trial/8523",NA,"Netherlands","Amsterdam","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed, Suspected","ICU","ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, PaO2-FiO2, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Anesthetic",20
"NCT04380935","https://clinicaltrials.gov/show/NCT04380935",NA,"Indonesia","Jakarta","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, Invasive Mechanical Ventilation or ECMO, Fever, Organ Failure or Dysfunction (SOFA), C-Reactive Protein, IL-6, D-Dimer, PaO2-FiO2","Plasma based therapy, SOC",60
"2020-001825-29","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001825-29/ES/",NA,"Spain","Madrid","2020-May",NA,"Recruiting","Randomised","Open-Label",4,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, SpO2","Anakinra, AZT, HCQ, LPV/r",NA
"CHICTR2000030841","http://www.chictr.org.cn/showproj.aspx?proj=51072",NA,"China","Hubei","2020-Mar","2020-May","Recruiting","Non-Randomised","Unspecified",2,"Confirmed","ICU","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Anti SARS-COV-2 Titers, PaO2-FiO2, Respiratory Rate, Radiographic Findings","Igs, SOC",10
"NCT04402840","https://ClinicalTrials.gov/show/NCT04402840",NA,"United States","West Virginia","2020-May","2020-Jul","Recruiting","Single-Arm","Open-Label",1,"Confirmed","ICU","Mortality, Adverse Events, Ferritin, D-Dimer, Troponin, LDH, PaO2-FiO2, SpO2, Radiographic Findings, Cardiac Outcome (Unspecified)","Other",5
"NCT04392778","https://ClinicalTrials.gov/show/NCT04392778",NA,"Turkey","Istanbul","2020-May","2020-Jul","Recruiting","Randomised","Quadruple",3,"Confirmed","ICU","Clinical Improvement Score (Any)","SOC, Stem cells",30
"IRCT20151226025699N3","http://en.irct.ir/trial/48213",NA,"Iran","Razavi Khorasan","2020-May","2020-Jun","Completed","Randomised","Triple",2,"Confirmed Or Suspected","ICU","C-Reactive Protein, White Blood Cell Count, Lymphocyte Count, Neutrophils, Creatinine Phosphokinase, LDH","Other, SOC",50
"CTRI/2020/04/024846","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43004",NA,"India","New Delhi","2020-Apr",NA,"Recruiting","Randomised","Unspecified",2,"Confirmed","ICU","ICU Admission, Organ Failure or Dysfunction (SOFA)","SOC, Vaccine",40
"NCT04427566","https://ClinicalTrials.gov/show/NCT04427566",NA,"United States","Ohio","2020-Jun","2021-Dec","Recruiting","Single-Arm","Open-Label",1,"Confirmed","ICU","Mortality, ICU Admission, Non-invasive Ventilation, Adverse Events, SpO2, Radiographic Findings","Radiation therapy",24
"NCT04411602","https://ClinicalTrials.gov/show/NCT04411602",NA,"United States","Michigan","2020-Jun","2020-Dec","Recruiting","Single-Arm","Open-Label",1,"Confirmed","ICU","Mortality, ICU Admission","Plasma based therapy",90
"NCT04331613","https://clinicaltrials.gov/show/NCT04331613",NA,"China","Beijing","2020-Jun",NA,"Recruiting","Single-Arm","Open-Label",1,"Confirmed","ICU","Mortality, Viral Load or Clearance, Fever, Adverse Events, Serious Adverse Events, C-Reactive Protein, IL-1, IL-2, IL-6, IL-8, CK-MB, Procalcitonin",NA,9
"NCT04424056","https://ClinicalTrials.gov/show/NCT04424056",NA,"France","Paris","2020-Jun","2022-Sep","Not Recruiting","Randomised","Open-Label",5,"Confirmed","ICU",NA,"Anakinra + Ruxolitinib, SOC, TCZ + Ruxolitinib",216
"NCT04389671","https://ClinicalTrials.gov/show/NCT04389671",NA,"United States","Pennsylvania","2020-May","2020-Oct","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","ICU","PaO2-FiO2, SpO2","Other",30
"NCT04351906","https://clinicaltrials.gov/show/NCT04351906",NA,"Germany","Berlin","2020-Sep",NA,"Recruiting","Single-Arm","Open-Label",1,"Yes","ICU","Adverse Events","Device",20
"NCT04345887","https://clinicaltrials.gov/show/NCT04345887",NA,"Turkey","Ankara","2020-Oct",NA,"Not Recruiting","Randomised","Triple",2,"Yes","ICU","Organ Failure or Dysfunction (SOFA), PaO2-FiO2","Other, SOC",60
"NCT04384900","https://ClinicalTrials.gov/show/NCT04384900",NA,"Denmark","Copenhagen","2020-May","2020-Nov","Recruiting","Randomised","Single",2,"Confirmed Or Suspected","ICU","Mortality, Invasive Mechanical Ventilation or ECMO, Renal Outcome (Unspecified)","Positioning",150
"IRCT20091012002582N21","http://en.irct.ir/trial/47197",NA,"Iran","Tehran","2020-May","2019-Aug","Completed","Randomised","Double",2,"Confirmed","ICU","Blood Gas","Plasma based therapy, SOC",30
"NCT04402944","https://clinicaltrials.gov/show/NCT04402944",NA,"United States","Massachusetts","2020-Dec",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","ICU",NA,"Other, SOC",60
"NCT04413864","https://clinicaltrials.gov/show/NCT04413864",NA,"France","Paris","2020-Apr",NA,"Recruiting","Single-Arm","Open-Label",1,"Confirmed","ICU",NA,"Other",50
"NCT04384731","https://ClinicalTrials.gov/show/NCT04384731",NA,"France","Paris","2020-May","2020-Nov","Not Recruiting","Randomised","Single",2,"Confirmed","ICU","Mortality, ICU Admission, Hospital Discharge, PaO2-FiO2, SpO2","Other, SOC",20
"EUCTR2020-001722-66-ES","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001722-66",NA,"Spain","Madrid","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, Renal Outcome (Unspecified)","Igs, Plasma based therapy",116
"NCT04345601","https://clinicaltrials.gov/show/NCT04345601",NA,"United States","Washington, Dc","2020-Oct",NA,"Not Recruiting","Single-Arm","Open-Label",1,"Yes","ICU","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, SpO2","Stem cells",30
"NCT04350580","https://ClinicalTrials.gov/show/NCT04350580",NA,"France","Paris","2020-Apr","2020-Jun","Recruiting","Randomised","Double",2,"Yes","ICU","Mortality, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, C-Reactive Protein, Procalcitonin, PaO2-FiO2, Radiographic Findings, Renal Outcome (Unspecified)","Igs, SOC",138
"NCT04406389","https://ClinicalTrials.gov/show/NCT04406389",NA,"United States","New York","2020-May","2020-Dec","Not Recruiting","Randomised","Open-Label",4,"Confirmed","ICU","Mortality, ICU Admission","Anticoagulants",186
"NCT04397510","https://clinicaltrials.gov/show/NCT04397510",NA,"United States","Washington, Dc","2020-May",NA,"Recruiting","Randomised","Quadruple",2,"Confirmed","ICU","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Adverse Events, PaO2-FiO2","Anticoagulants, SOC",50
"NCT04341285","https://ClinicalTrials.gov/show/NCT04341285",NA,"Germany","Berlin","2020-Apr","2022-Apr","Not Recruiting","Randomised","Open-Label",2,"Yes","ICU","Mortality, Hospital Discharge, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Renal Outcome (Unspecified)","ECMO",200
"NCT04348513","https://clinicaltrials.gov/show/NCT04348513",NA,"Greece","Athens","2020-Sep",NA,"Recruiting","Randomised","Triple",2,"Yes","ICU","Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Fever, Deep Vein Thrombosis or Pulmonary Embolism, C-Reactive Protein, White Blood Cell Count, Erythrocyte Sedimentation Rate, D-Dimer, Creatinine Phosphokinase, Fibrinogen, ALT, Bilirubin, Urine Sample, Blood Pressure, PaO2-FiO2, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Hormone therapy, SOC",60
"NCT04415060","https://ClinicalTrials.gov/show/NCT04415060",NA,"Canada","Alberta","2020-Jun","2022-Jun","Not Recruiting","Randomised","Open-Label",3,"Confirmed","ICU","Mortality, ICU Admission, Hospital Discharge, Pneumonia or ARDS, Quality of Life","Anesthetic, SOC",752
"NCT04415060","https://ClinicalTrials.gov/show/NCT04415060",NA,"Canada","Ontario","2020-Jun","2022-Jun","Not Recruiting","Randomised","Open-Label",3,"Confirmed","ICU","Mortality, ICU Admission, Hospital Discharge, Pneumonia or ARDS, Quality of Life","Anesthetic, SOC",752
"NCT04415060","https://ClinicalTrials.gov/show/NCT04415060",NA,"Canada","Quebec","2020-Jun","2022-Jun","Not Recruiting","Randomised","Open-Label",3,"Confirmed","ICU","Mortality, ICU Admission, Hospital Discharge, Pneumonia or ARDS, Quality of Life","Anesthetic, SOC",752
"NCT04415060","https://ClinicalTrials.gov/show/NCT04415060",NA,"Canada","Ottawa","2020-Jun","2022-Jun","Not Recruiting","Randomised","Open-Label",3,"Confirmed","ICU","Mortality, ICU Admission, Hospital Discharge, Pneumonia or ARDS, Quality of Life","Anesthetic, SOC",752
"NCT04311697","https://ClinicalTrials.gov/show/NCT04311697",NA,"United States","California","2020-Mar","2020-Aug","Recruiting","Randomised","Quadruple",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2, Radiographic Findings, Hypoxia","Inhaled solution, SOC",144
"NCT04311697","https://ClinicalTrials.gov/show/NCT04311697",NA,"United States","Florida","2020-Mar","2020-Aug","Recruiting","Randomised","Quadruple",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2, Radiographic Findings, Hypoxia","Inhaled solution, SOC",144
"NCT04311697","https://ClinicalTrials.gov/show/NCT04311697",NA,"United States","Kentucky","2020-Mar","2020-Aug","Recruiting","Randomised","Quadruple",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2, Radiographic Findings, Hypoxia","Inhaled solution, SOC",144
"NCT04311697","https://ClinicalTrials.gov/show/NCT04311697",NA,"United States","New York","2020-Mar","2020-Aug","Recruiting","Randomised","Quadruple",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2, Radiographic Findings, Hypoxia","Inhaled solution, SOC",144
"NCT04311697","https://ClinicalTrials.gov/show/NCT04311697",NA,"United States","Pennsylvania","2020-Mar","2020-Aug","Recruiting","Randomised","Quadruple",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2, Radiographic Findings, Hypoxia","Inhaled solution, SOC",144
"NCT04311697","https://ClinicalTrials.gov/show/NCT04311697",NA,"United States","Texas","2020-Mar","2020-Aug","Recruiting","Randomised","Quadruple",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2, Radiographic Findings, Hypoxia","Inhaled solution, SOC",144
"NCT04311697","https://ClinicalTrials.gov/show/NCT04311697",NA,"Israel","Haifa","2020-Mar","2020-Aug","Recruiting","Randomised","Quadruple",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2, Radiographic Findings, Hypoxia","Inhaled solution, SOC",144
"IRCT20120215009014N354","http://en.irct.ir/trial/48043",NA,"Iran","Hamadan","2020-May","2020-Aug","Recruiting","Randomised","Double",3,"Confirmed","ICU","Mortality","Corticosteroids, Dexamethasone",81
"NCT04321421","https://ClinicalTrials.gov/show/NCT04321421",NA,"Italy","Pavia","2020-Mar","2020-Apr","Completed","Single-Arm","Open-Label",1,"Confirmed","ICU","Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Antibodies","Plasma based therapy",49
"NCT04321421","https://ClinicalTrials.gov/show/NCT04321421",NA,"Italy","Mantova","2020-Mar","2020-Apr","Completed","Single-Arm","Open-Label",1,"Confirmed","ICU","Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Antibodies","Plasma based therapy",49
"NCT04399317","https://ClinicalTrials.gov/show/NCT04399317",NA,"Qatar","Doha","2020-May","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","ICU",NA,"Device, SOC",20
"NCT04386694","https://ClinicalTrials.gov/show/NCT04386694",NA,"Brazil","Brasilia","2020-May","2020-Jul","Recruiting","Randomised","Quadruple",2,"Confirmed","ICU","Hospital Discharge, C-Reactive Protein, Tumor Necrosis Factor (Any), Platelet Count, D-Dimer, IgG, IgM or IgA","Device, SOC",30
"2020-001686-36","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001686-36/FR/",NA,"France","Paris","2020-Apr",NA,"Recruiting","Randomised","Double",4,"Confirmed","ICU","ICU Admission, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), PaO2-FiO2","mAb, SOC",NA
"CHICTR2000029658","http://www.chictr.org.cn/showproj.aspx?proj=49074",NA,"China","Hubei","2020-Feb","2020-Apr","Suspended","Randomised","Unspecified",2,"Confirmed","ICU","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Hypoxia","Non-invasive respiratory support",60
"IRCT20150107020592N28","http://en.irct.ir/trial/48972",NA,"Iran","Tehran","2020-Jun","2020-Jun","Completed","Single-Arm","Open-Label",1,"Confirmed","ICU",NA,"Alternative therapy",50
"NCT04348461","https://clinicaltrials.gov/show/NCT04348461",NA,"Spain","Madrid","2020-Oct",NA,"Not Recruiting","Randomised","Quadruple",2,"Yes","ICU","Adverse Events","SOC, Stem cells",100
"NCT04420741","https://ClinicalTrials.gov/show/NCT04420741",NA,"Denmark","Copenhagen","2020-Jun","2021-May","Recruiting","Randomised","Quadruple",2,"Confirmed","ICU","Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, Renal Outcome (Unspecified)","Other, SOC",80
"NCT04381858","https://ClinicalTrials.gov/show/NCT04381858",NA,"Mexico","Aguascalientes","2020-May","2020-Aug","Recruiting","Randomised","Double",2,"Yes","ICU","Hospitalization, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO","Igs, Plasma based therapy",500
"CHICTR2000030540","http://www.chictr.org.cn/showproj.aspx?proj=50658",NA,"China","Hubei","2020-Mar","2020-Jun","Not Recruiting","Randomised","Unspecified",2,"Confirmed","ICU","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Erythrocyte Sedimentation Rate, Radiographic Findings","Other, SOC",152
"NCT04244591","https://ClinicalTrials.gov/show/NCT04244591",NA,"China","Beijing","2020-Jan","2020-Apr","Completed","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Radiographic Findings","Corticosteroids, SOC",80
"NCT04341038","https://ClinicalTrials.gov/show/NCT04341038",NA,"Spain","Barcelona","2020-Apr","2020-Jun","Recruiting","Randomised","Single",2,"Confirmed","ICU","Mortality, Hospital Discharge, Viral Load or Clearance, Ferritin, D-Dimer, PaO2-FiO2",NA,84
"NCT04325906","https://ClinicalTrials.gov/show/NCT04325906",NA,"United States","Illinois","2020-Mar","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed","ICU",NA,"Non-invasive respiratory support, Positioning + Non-invasive respiratory support",346
"NCT04306393","https://ClinicalTrials.gov/show/NCT04306393",NA,"United States","Alabama","2020-Mar","2021-Mar","Recruiting","Randomised","Single",2,"Confirmed","ICU",NA,"Non-invasive respiratory support, SOC",200
"NCT04306393","https://ClinicalTrials.gov/show/NCT04306393",NA,"United States","Louisiana","2020-Mar","2021-Mar","Recruiting","Randomised","Single",2,"Confirmed","ICU",NA,"Non-invasive respiratory support, SOC",200
"NCT04306393","https://ClinicalTrials.gov/show/NCT04306393",NA,"United States","Massachusetts","2020-Mar","2021-Mar","Recruiting","Randomised","Single",2,"Confirmed","ICU",NA,"Non-invasive respiratory support, SOC",200
"2020-001766-11","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001766-11/FR/",NA,"France","Paris","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Blood Pressure, Heart Rate, PaO2-FiO2","ARBs, Other",NA
"IRCT20150107020592N29","http://en.irct.ir/trial/48695",NA,"Iran","Tehran","2020-Jun","2020-May","Completed","Single-Arm","Open-Label",2,"Confirmed","ICU","IL-6","Other",12
"CHICTR2000030773","http://www.chictr.org.cn/showproj.aspx?proj=50934",NA,"China","Shanghai","2020-Mar","2020-Jul","Recruiting","Single-Arm","Unspecified",1,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","Other",20
"NCT04380519","https://ClinicalTrials.gov/show/NCT04380519",NA,"Russia","Moscow","2020-May","2020-Oct","Recruiting","Randomised","Double",3,"Confirmed","ICU","Mortality, Labor Absenteeism","mAb, Other, SOC",372
"NCT04332666","https://ClinicalTrials.gov/show/NCT04332666",NA,"Belgium","Brussels","2020-Apr","2020-May","Not Recruiting","Randomised","Triple",2,"Confirmed Or Suspected","ICU","ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Deep Vein Thrombosis or Pulmonary Embolism, Serious Adverse Events, IL-1, IL-2, IL-6, IL-7, IL-8, IL-10, Tumor Necrosis Factor (Any), Interferon (Any), Angiotensins, PaO2-FiO2, Radiographic Findings","Antihypertensive, SOC",60
"2020-001598-66","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001598-66/FR/",NA,"France","Paris","2020-Apr",NA,"Recruiting","Randomised","Single",2,"Confirmed","ICU","Mortality, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2, SpO2, Radiographic Findings","Other, SOC",20
"NCT04369599","https://clinicaltrials.gov/show/NCT04369599",NA,"United States","Washington, Dc","2020-Apr",NA,"Recruiting","Single-Arm","Open-Label",1,"Unclear","ICU",NA,"Device",24
"NCT04425031","https://clinicaltrials.gov/show/NCT04425031",NA,"Denmark","Copenhagen","2020-May",NA,"Not Recruiting","Randomised","Single",2,"Confirmed","ICU",NA,"Non-invasive respiratory support",780
"NCT04462757","https://ClinicalTrials.gov/show/NCT04462757",NA,"United Kingdom","Manchester","2020-Jul","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","ICU","IL-1, IL-6","Anakinra",30
"NCT04462757","https://ClinicalTrials.gov/show/NCT04462757",NA,"United Kingdom","Salford","2020-Jul","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","ICU","IL-1, IL-6","Anakinra",30
"CHICTR2000030944","http://www.chictr.org.cn/showproj.aspx?proj=50199",NA,"China","Jiangxi","2020-Mar","2020-Aug","Not Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, Treatment-emergent Adverse Events","SOC, Stem cells + Natural Killer Cells",20
"RPCEC00000313","https://rpcec.sld.cu/en/trials/RPCEC00000313-En",NA,"Cuba","Havana","2020-May",NA,"Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","ICU","Mortality, ICU Admission, Hospital Discharge","Other",16
"NCT04381052","https://ClinicalTrials.gov/show/NCT04381052",NA,"United States","New York","2020-May","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","ICU","ICU Admission, Serious Adverse Events, C-Reactive Protein, Renal Outcome (Unspecified)","mAb, SOC",30
"IRCT20140528017891N8","http://en.irct.ir/trial/46623",NA,"Iran","Tehran","2020-Mar","2020-Apr","Completed","Randomised","Double",2,"Confirmed","ICU","Mortality, Pneumonia or ARDS, C-Reactive Protein, Procalcitonin, CD4, CD8, Radiographic Findings","SOC, Stem cells",10
"NCT04374539","https://ClinicalTrials.gov/show/NCT04374539",NA,"Spain","Barcelona","2020-May","2021-May","Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, Invasive Mechanical Ventilation or ECMO","Plasma based therapy, SOC",116
"NCT04385771","https://ClinicalTrials.gov/show/NCT04385771",NA,"Germany","Berlin","2020-May","2021-May","Not Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","ICU Admission, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, IL-6, D-Dimer, Urine Sample","ECMO, ECMO + Cytokine removal",80
"NCT04394416","https://ClinicalTrials.gov/show/NCT04394416",NA,"United States","Maryland","2020-May","2022-Jun","Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events","Imatinib, SOC",204
"NCT04389580","https://ClinicalTrials.gov/show/NCT04389580",NA,"Egypt","Cairo","2020-May","2020-Aug","Not Recruiting","Randomised","Open-Label",3,"Confirmed","ICU","Mortality, ICU Admission, C-Reactive Protein, IL-1, IL-6, Tumor Necrosis Factor (Any), Interferon (Any), Lymphocyte Count, Erythrocyte Sedimentation Rate, D-Dimer","Hormone therapy, Hormone therapy + Other, SOC",160
"CTRI/2020/04/024804","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42849",NA,"India","Karnataka","2020-Apr",NA,"Recruiting","Non-Randomised","Open-Label",2,"Confirmed","ICU","Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Organ Failure or Dysfunction (SOFA), Antibodies, PaO2-FiO2, SpO2, Radiographic Findings, Distress, Renal Outcome (Unspecified)","Plasma based therapy, SOC",24
"NCT04420988","https://ClinicalTrials.gov/show/NCT04420988",NA,"United States","New Jersey","2020-Jun",NA,"Recruiting","Unspecified","Unspecified",1,"Confirmed","ICU",NA,"Plasma based therapy",NA
"NCT04391101","https://ClinicalTrials.gov/show/NCT04391101",NA,"Colombia","Antioquia","2020-May","2021-Jun","Not Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, Hospitalization, Fever, Adverse Events","Plasma based therapy, SOC",231
"NL8578","https://trialregister.nl/trial/8578",NA,"Netherlands","Amsterdam","2020-Feb",NA,"Not Recruiting","Randomised","Double",2,"Confirmed, Suspected","ICU","Mortality, Invasive Mechanical Ventilation or ECMO, Adverse Events, IL-6, IL-8, IL-10, Tumor Necrosis Factor (Any), Renal Outcome (Unspecified)","Other, SOC",124
"2020-001823-15","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001823-15/FR/",NA,"France","Paris","2020-Apr",NA,"Recruiting","Single-Arm","Open-Label",1,"Confirmed","ICU","Deep Vein Thrombosis or Pulmonary Embolism, C-Reactive Protein, D-Dimer, Fibrinogen, Renal Outcome (Unspecified)","Anticoagulants",NA
"NCT04409834","https://clinicaltrials.gov/show/NCT04409834",NA,"United States","Massachusetts","2020-May",NA,"Not Recruiting","Randomised","Open-Label",4,"Confirmed","ICU",NA,"Anticoagulants, Anticoagulants + Antiplatelets",750
"NCT04377620","https://ClinicalTrials.gov/show/NCT04377620",NA,"United States","District Of Columbia","2020-May","2020-Sep","Recruiting","Randomised","Double",3,"Confirmed","ICU","Mortality, ICU Admission, Organ Failure or Dysfunction (SOFA), Adverse Events","JAKi, SOC",500
"NCT04377620","https://ClinicalTrials.gov/show/NCT04377620",NA,"United States","Florida","2020-May","2020-Sep","Recruiting","Randomised","Double",3,"Confirmed","ICU","Mortality, ICU Admission, Organ Failure or Dysfunction (SOFA), Adverse Events","JAKi, SOC",500
"NCT04377620","https://ClinicalTrials.gov/show/NCT04377620",NA,"United States","Indiana","2020-May","2020-Sep","Recruiting","Randomised","Double",3,"Confirmed","ICU","Mortality, ICU Admission, Organ Failure or Dysfunction (SOFA), Adverse Events","JAKi, SOC",500
"NCT04377620","https://ClinicalTrials.gov/show/NCT04377620",NA,"United States","Massachusetts","2020-May","2020-Sep","Recruiting","Randomised","Double",3,"Confirmed","ICU","Mortality, ICU Admission, Organ Failure or Dysfunction (SOFA), Adverse Events","JAKi, SOC",500
"NCT04377620","https://ClinicalTrials.gov/show/NCT04377620",NA,"United States","North Carolina","2020-May","2020-Sep","Recruiting","Randomised","Double",3,"Confirmed","ICU","Mortality, ICU Admission, Organ Failure or Dysfunction (SOFA), Adverse Events","JAKi, SOC",500
"NCT04377620","https://ClinicalTrials.gov/show/NCT04377620",NA,"United States","Pennsylvania","2020-May","2020-Sep","Recruiting","Randomised","Double",3,"Confirmed","ICU","Mortality, ICU Admission, Organ Failure or Dysfunction (SOFA), Adverse Events","JAKi, SOC",500
"CHICTR2000029850","http://www.chictr.org.cn/showproj.aspx?proj=49533",NA,"China","Zhejiang","2020-Feb","2022-Feb","Recruiting","Non-Randomised","Unspecified",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Anti SARS-COV-2 Titers, PaO2-FiO2","Plasma based therapy, SOC",20
"NCT04432051","https://clinicaltrials.gov/show/NCT04432051",NA,"Turkey","Ankara","2020-Nov",NA,"Recruiting","Randomised","Triple",2,"Confirmed","ICU",NA,"Monitoring, SOC",100
"2020-001644-25","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001644-25/DE/",NA,"Argentina","Buenos Aires","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2","Acalabrutinib, SOC",140
"2020-001644-25","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001644-25/DE/",NA,"Brazil","Brasilia","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2","Acalabrutinib, SOC",140
"2020-001644-25","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001644-25/DE/",NA,"Chile","Santiago","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2","Acalabrutinib, SOC",140
"2020-001644-25","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001644-25/DE/",NA,"France","Paris","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2","Acalabrutinib, SOC",140
"2020-001644-25","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001644-25/DE/",NA,"Germany","Berlin","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2","Acalabrutinib, SOC",140
"2020-001644-25","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001644-25/DE/",NA,"Italy","Rome","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2","Acalabrutinib, SOC",140
"2020-001644-25","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001644-25/DE/",NA,"Japan","Tokyo","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2","Acalabrutinib, SOC",140
"2020-001644-25","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001644-25/DE/",NA,"Mexico","Mexico","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2","Acalabrutinib, SOC",140
"2020-001644-25","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001644-25/DE/",NA,"Peru","Lima","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2","Acalabrutinib, SOC",140
"2020-001644-25","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001644-25/DE/",NA,"Russia","Moscow","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2","Acalabrutinib, SOC",140
"2020-001644-25","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001644-25/DE/",NA,"South Africa","Pretoria","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2","Acalabrutinib, SOC",140
"2020-001644-25","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001644-25/DE/",NA,"Spain","Madrid","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2","Acalabrutinib, SOC",140
"2020-001644-25","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001644-25/DE/",NA,"Sweden","Stockholm","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2","Acalabrutinib, SOC",140
"2020-001644-25","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001644-25/DE/",NA,"Turkey","Ankara","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2","Acalabrutinib, SOC",140
"CHICTR2000030744","http://www.chictr.org.cn/showproj.aspx?proj=50910",NA,"China","Shandong","2020-Mar","2020-Aug","Recruiting","Non-Randomised","Unspecified",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization","ECMO, SOC",30
"NCT04404426","https://ClinicalTrials.gov/show/NCT04404426",NA,"France","Paris","2020-May","2021-Jun","Not Recruiting","Randomised","Triple",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Lymphocyte Count","Other, SOC",100
"NCT04383002","https://ClinicalTrials.gov/show/NCT04383002",NA,"Canada","Ontario","2020-May","2020-Dec","Not Recruiting","Randomised","Open-Label",2,"Confirmed","ICU",NA,"Non-invasive respiratory support, SOC",20
"NCT04441996","https://ClinicalTrials.gov/show/NCT04441996",NA,"United States","Georgia","2020-Jun","2020-Oct","Not Recruiting","Randomised","Open-Label",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Fever, Organ Failure or Dysfunction (SOFA), C-Reactive Protein, IL-6, Platelet Count, Hemoglobin, D-Dimer, Prothrombin, Fibrinogen, INR, Albumin, Bilirubin, Blood Urea Nitrogen, Blood Pressure, Heart Rate, Respiratory Rate","Plasma based therapy, SOC",20
"NCT04377750","https://ClinicalTrials.gov/show/NCT04377750",NA,"Israel","Jerusalem","2020-May","2020-Apr","Recruiting","Randomised","Open-Label",2,"Confirmed","ICU",NA,"SOC, TCZ",500
"IRCT20200510047383N1","http://en.irct.ir/trial/48024",NA,"Iran","Tehran","2020-May","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","ICU","Mortality, SpO2","SOC, TCZ",100
"NCT04333368","https://ClinicalTrials.gov/show/NCT04333368",NA,"France","Paris","2020-Apr","2020-Aug","Recruiting","Randomised","Triple",2,"Confirmed","ICU","Mortality, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, IL-1, IL-6, IL-8, IL-10, Tumor Necrosis Factor (Any), Antibodies, SRAGE, PaO2-FiO2, Quality of Life","SOC, Stem cells",40
"NCT04389710","https://ClinicalTrials.gov/show/NCT04389710",NA,"United States","Pennsylvania","2020-May","2021-Apr","Recruiting","Single-Arm","Open-Label",1,"Confirmed","ICU","ICU Admission, Hospitalization, Hospital Discharge, Adverse Events, C-Reactive Protein, Platelet Count, D-Dimer, Prothrombin, Fibrinogen","Plasma based therapy",100
"NCT04397523","https://ClinicalTrials.gov/show/NCT04397523",NA,"Macedonia","Skopje","2020-May","2021-Apr","Recruiting","Single-Arm","Open-Label",1,"Confirmed","ICU","Mortality, ICU Admission, Serious Adverse Events","Plasma based therapy",20
"NCT04288713","https://ClinicalTrials.gov/show/NCT04288713",NA,"United States","New York","2020-Feb",NA,"Recruiting","Unspecified","Unspecified",1,"Confirmed","ICU",NA,"mAb",NA
"NCT04370288","https://ClinicalTrials.gov/show/NCT04370288",NA,"Iran","Razavi Khorasan","2020-Apr","2020-Sep","Recruiting","Randomised","Single",2,"Confirmed","ICU","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, White Blood Cell Count, PaO2-FiO2","Other",20
"IRCT20150107020592N22","http://en.irct.ir/trial/48262",NA,"Iran","Tehran","2020-May","2020-Jun","Completed","Single-Arm","Open-Label",1,"Confirmed Or Suspected","ICU","SpO2, Radiographic Findings","Cyclosporine",60
"NCT04344730","https://ClinicalTrials.gov/show/NCT04344730",NA,"France","Paris","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",7,NA,"ICU","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Hypoxemia, Cardiac Outcome (Unspecified)","Dexamethasone, Dexamethasone + Non-invasive respiratory support, Mechanical ventilation + Dexamethasone, Non-invasive respiratory support, Non-invasive respiratory support + Dexamethasone, SOC",550
"NCT04343989","https://ClinicalTrials.gov/show/NCT04343989",NA,"United States","New York","2020-Apr","2020-Jul","Recruiting","Randomised","Double",3,NA,"ICU","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein","mAb, SOC",90
"NCT04353180","https://ClinicalTrials.gov/show/NCT04353180",NA,"Egypt","Cairo","2020-Apr","2020-Aug","Not Recruiting","Randomised","Open-Label",3,NA,"ICU","Mortality, ICU Admission, Clinical Improvement Score (Any), Viral Load or Clearance, Anti SARS-COV-2 Titers, C-Reactive Protein, IL-1, IL-6, Interferon (Any), Erythrocyte Sedimentation Rate, D-Dimer","Other, SOC",1000
"NCT04367831","https://ClinicalTrials.gov/show/NCT04367831",NA,"United States","New York","2020-Apr","2020-Nov","Recruiting","Randomised","Single",4,NA,"ICU","ICU Admission, Renal Outcome (Unspecified)","Anticoagulants",100
"NCT04366115","https://ClinicalTrials.gov/show/NCT04366115",NA,"United States","Washington","2020-Apr","2022-Jun","Not Recruiting","Randomised","Open-Label",3,NA,"ICU","Mortality","Corticosteroids, Dexamethasone + Other",126
"2020-001266-11","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001266-11/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Single",2,NA,"ICU","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, IL-1, IL-2, IL-4, IL-6, IL-8, IL-10, Tumor Necrosis Factor (Any), White Blood Cell Count, Lymphocyte Count, Natural Killer Cell Count, Platelet Count, Hemoglobin, D-Dimer, Creatinine Phosphokinase, Procalcitonin, Prothrombin, Fibrinogen, Coagulation Test, Electrolytes, INR, ALT, AST, Bilirubin, Glucose, LDH, IgG, IgM or IgA, CD4, CD8, Blood Urea Nitrogen, PaO2-FiO2, SpO2, Radiographic Findings","Stem cells",NA
"NCT04361435","https://ClinicalTrials.gov/show/NCT04361435",NA,"Canada","Quebec","2020-Apr","2020-Jul","Not Recruiting","Randomised","Open-Label",2,NA,"ICU","Fever, Blood Pressure, Heart Rate, SpO2, Respiratory Rate","Respiratory support",50
"2020-001640-26","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001640-26/GB/",NA,"United Kingdom","London","2020-Apr",NA,"Recruiting","Single-Arm","Unspecified",2,NA,"ICU","Mortality, ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, Fibrinogen, PaO2-FiO2","Anticoagulants, SOC",24
"NCT04371367","https://clinicaltrials.gov/show/NCT04371367",NA,"France","Paris","2020-Apr",NA,"Recruiting","Randomised","Double",3,NA,"ICU","Hospitalization","mAb, SOC",108
"IRCT20200324046851N1","http://en.irct.ir/trial/46712",NA,"Iran","East Azarbaijan","2020-Apr","2020-Apr","Completed","Non-Randomised","Double",2,NA,"ICU","Viral Load or Clearance","Alternative therapy, SOC",86
"NCT04361526","https://ClinicalTrials.gov/show/NCT04361526",NA,"Spain","Barcelona","2020-Apr","2020-Jul","Recruiting","Randomised","Open-Label",2,NA,"ICU","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","Cytokine removal, SOC",40
"NCT04344080","https://ClinicalTrials.gov/show/NCT04344080",NA,"Germany","Hamburg","2020-Apr","2020-Dec","Recruiting","Randomised","Open-Label",2,NA,"ICU","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), C-Reactive Protein, IL-6, IL-10, Tumor Necrosis Factor (Any), Procalcitonin, Bicarbonates, Renal Outcome (Unspecified)","Cytokine removal, SOC",24
"2020-001492-33","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001492-33/FR/",NA,"France","Paris","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,NA,"ICU","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","Inhaled solution, SOC",NA
"NCT04355364","https://ClinicalTrials.gov/show/NCT04355364",NA,"France","Paris","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,NA,"ICU","Clinical Improvement Score (Any)","Inhaled solution, SOC",100
"TCTR20200409006","http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6016",NA,"Thailand","Nan","2020-Mar",NA,"Not Recruiting","Randomised","Unspecified",2,NA,"ICU","Mortality, ICU Admission, Non-invasive Ventilation, IL-6","Hemoperfusion, SOC",206
"IRCT20151228025732N52","http://en.irct.ir/trial/46963",NA,"Iran","Semnan","2020-Apr","2020-Jun","Completed","Randomised","Open-Label",2,NA,"ICU","Organ Failure or Dysfunction (SOFA), Respiratory Rate, Radiographic Findings","Melatonin + Vitamins + Sulfate, SOC",30
"NCT04346368","https://ClinicalTrials.gov/show/NCT04346368",NA,"China","Guangdong","2020-Apr","2020-Dec","Not Recruiting","Randomised","Single",2,NA,"ICU","Mortality, Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Dyspnea, Adverse Events, C-Reactive Protein, CD4, CD8, PaO2-FiO2, Radiographic Findings","SOC, Stem cells",20
"EUCTR2020-001682-36-ES","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001682-36",NA,"Spain","Madrid","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,NA,"ICU","Mortality, Invasive Mechanical Ventilation or ECMO, Other Mild Symptoms, Radiographic Findings","SOC, Stem cells",24
"NCT04371393","https://clinicaltrials.gov/show/NCT04371393",NA,"United States","Washington, Dc","2020-Apr",NA,"Recruiting","Randomised","Triple",2,NA,"ICU","Mortality","SOC, Stem cells",300
"IRCT20200406046963N1","http://en.irct.ir/trial/47088",NA,"Iran","Tehran","2020-Apr","2020-May","Completed","Randomised","Open-Label",2,NA,"ICU","Mortality, ICU Admission, Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA), Radiographic Findings","Corticosteroids, SOC",40
"2020-001490-68","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001490-68/SE/",NA,"Sweden","Stockholm","2020-Apr",NA,"Recruiting","Randomised","Single",2,NA,"ICU","Mortality, PaO2-FiO2","Non-invasive respiratory support, SOC",NA
"IRCT20200409047007N1","http://en.irct.ir/trial/47058",NA,"Iran","Razavi Khorasan","2020-Apr","2020-Aug","Recruiting","Randomised","Open-Label",2,NA,"ICU","Mortality, ICU Admission","Plasma based therapy, SOC",32
"2020-001324-33","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001324-33/FR/",NA,"France","Paris","2020-Mar",NA,"Recruiting","Randomised","Open-Label",2,NA,"ICU","Mortality, ICU Admission, Hospitalization, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Quality of Life","Other, SOC",NA
"NCT04369469","https://ClinicalTrials.gov/show/NCT04369469",NA,"United States","District Of Columbia","2020-Apr","2020-Nov","Recruiting","Randomised","Open-Label",2,NA,"ICU","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), SpO2","mAb, SOC",270
"NCT04369469","https://ClinicalTrials.gov/show/NCT04369469",NA,"United States","Massachusetts","2020-Apr","2020-Nov","Recruiting","Randomised","Open-Label",2,NA,"ICU","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), SpO2","mAb, SOC",270
"NCT04369469","https://ClinicalTrials.gov/show/NCT04369469",NA,"United States","Michigan","2020-Apr","2020-Nov","Recruiting","Randomised","Open-Label",2,NA,"ICU","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), SpO2","mAb, SOC",270
"NCT04369469","https://ClinicalTrials.gov/show/NCT04369469",NA,"France","Paris","2020-Apr","2020-Nov","Recruiting","Randomised","Open-Label",2,NA,"ICU","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), SpO2","mAb, SOC",270
"NCT04369469","https://ClinicalTrials.gov/show/NCT04369469",NA,"Spain","Barcelona","2020-Apr","2020-Nov","Recruiting","Randomised","Open-Label",2,NA,"ICU","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), SpO2","mAb, SOC",270
"NCT04369469","https://ClinicalTrials.gov/show/NCT04369469",NA,"Spain","Madrid","2020-Apr","2020-Nov","Recruiting","Randomised","Open-Label",2,NA,"ICU","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), SpO2","mAb, SOC",270
"NCT04369469","https://ClinicalTrials.gov/show/NCT04369469",NA,"United Kingdom","London","2020-Apr","2020-Nov","Recruiting","Randomised","Open-Label",2,NA,"ICU","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), SpO2","mAb, SOC",270
"NCT04369469","https://ClinicalTrials.gov/show/NCT04369469",NA,"United Kingdom","Leeds","2020-Apr","2020-Nov","Recruiting","Randomised","Open-Label",2,NA,"ICU","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), SpO2","mAb, SOC",270
"NCT04355962","https://ClinicalTrials.gov/show/NCT04355962",NA,"Switzerland","Zurich","2020-Apr","2021-Mar","Recruiting","Randomised","Double",2,NA,"ICU","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), C-Reactive Protein, IL-6, MCP-1, Procalcitonin, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Anesthetic, SOC",64
"2020-001244-26","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001244-26/AT/",NA,"Austria","Vienna","2020-Mar",NA,"Recruiting","Randomised","Double",2,NA,"ICU","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Urine Sample, Blood Gas, Blood Pressure, Heart Rate, ECG, PaO2-FiO2, Respiratory Rate, Radiographic Findings, Cardiac Outcome (Unspecified)","Other, SOC",40
"IRCT20200406046968N1","http://en.irct.ir/trial/47021",NA,"Iran","Tehran","2020-Apr","2020-Jun","Completed","Single-Arm","Open-Label",2,NA,"ICU","Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","SOC, TCZ",10
"NCT04361032","https://clinicaltrials.gov/show/NCT04361032",NA,"Tunisia","Tunis","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",3,NA,"ICU","Mortality","SOC, TCZ + mAb",260
"IRCT20200319046819N1","http://en.irct.ir/trial/46838",NA,"Iran","Tehran","2020-Apr","2020-Jul","Completed","Randomised","Single",2,NA,"ICU","Mortality, Hospitalization, C-Reactive Protein, IL-6, Tumor Necrosis Factor (Any), Interferon (Any), White Blood Cell Count, Erythrocyte Sedimentation Rate","SOC, Vitamins",60
"NCT04353206","https://ClinicalTrials.gov/show/NCT04353206",NA,"United States","California","2020-Apr","2021-May","Recruiting","Single-Arm","Open-Label",1,NA,"ICU","Mortality","Plasma based therapy",60
"NCT04353206","https://ClinicalTrials.gov/show/NCT04353206",NA,"United States","Maryland","2020-Apr","2021-May","Recruiting","Single-Arm","Open-Label",1,NA,"ICU","Mortality","Plasma based therapy",60
"NCT04358211","https://ClinicalTrials.gov/show/NCT04358211",NA,"United States","Louisiana","2020-Apr",NA,"Recruiting","Unspecified","Unspecified",1,NA,"ICU",NA,"Plasma based therapy",NA
"NCT04357106","https://ClinicalTrials.gov/show/NCT04357106",NA,"Mexico","Puebla","2020-Apr","2020-Jul","Recruiting","Single-Arm","Open-Label",1,NA,"ICU","Mortality, Adverse Events, PaO2-FiO2","Plasma based therapy",10
"IRCT20200416047099N1","http://en.irct.ir/trial/47266",NA,"Iran","Tehran","2020-Apr","2020-May","Completed","Single-Arm","Open-Label",1,NA,"ICU","Fever, PaO2-FiO2, Respiratory Rate, Radiographic Findings","Plasma based therapy",10
"NCT04358835","https://ClinicalTrials.gov/show/NCT04358835",NA,"United States","Maryland","2020-Apr","2021-Sep","Not Recruiting","Single-Arm","Open-Label",1,NA,"ICU","ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, White Blood Cell Count, Platelet Count, Hemoglobin, Albumin, Blood Urea Nitrogen, Heart Rate, Blood pH, Bicarbonates","Nutrition",15
"IRCT20190717044241N2","http://en.irct.ir/trial/47110",NA,"Iran","Tehran","2020-Apr","2020-Jul","Recruiting","Single-Arm","Open-Label",1,NA,"ICU","PaO2-FiO2","Stem cells",10
"2020-001329-30","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001329-30/AT/",NA,"China","Beijing","2020-Apr",NA,"Recruiting","Randomised","Single",2,NA,"ICU","PaO2-FiO2","Non-invasive respiratory support",200
"2020-001329-30","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001329-30/AT/",NA,"United States","Washington, Dc","2020-Apr",NA,"Recruiting","Randomised","Single",2,NA,"ICU","PaO2-FiO2","Non-invasive respiratory support",200
"NCT04358003","https://clinicaltrials.gov/show/NCT04358003",NA,"United States","Washington, Dc","2020-Apr",NA,"Recruiting","Single-Arm","Open-Label",1,NA,"ICU","Mortality, Organ Failure or Dysfunction (SOFA)","Plasma based therapy",2000
"2020-001420-34","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001420-34/DK/",NA,"Denmark","Copenhagen","2020-Apr",NA,"Recruiting","Randomised","Open-Label",1,NA,"ICU","Mortality, Viral Load or Clearance, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Coagulation Test, Bilirubin, PaO2-FiO2, Renal Outcome (Unspecified)","Other",NA
"NCT04368377","https://ClinicalTrials.gov/show/NCT04368377",NA,"Italy","Milano","2020-Apr","2020-Apr","Completed","Single-Arm","Open-Label",1,NA,"ICU","Hemoglobin, PaO2-FiO2","Other",5
"NCT04361942","https://ClinicalTrials.gov/show/NCT04361942",NA,"Spain","Valladolid","2020-Apr","2020-Nov","Recruiting","Randomised","Triple",2,NA,"ICU","Mortality, Viral Load or Clearance, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO","SOC, Stem cells",24
"CHICTR2000030503","http://www.chictr.org.cn/showproj.aspx?proj=49632",NA,"China","Zhejiang","2020-Mar",NA,"Recruiting","Non-Randomised","Unspecified",2,NA,"ICU","Mortality, ICU Admission, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, IL-6, PaO2-FiO2","Other",60
"NCT04339816","https://ClinicalTrials.gov/show/NCT04339816",NA,"Czechia","Prague","2020-Apr","2021-Dec","Recruiting","Randomised","Triple",3,NA,"ICU","Mortality, Viral Load or Clearance, Treatment-emergent Adverse Events",NA,240
"NCT04329923","https://ClinicalTrials.gov/show/NCT04329923",NA,"United States","Pennsylvania","2020-Apr","2021-Apr","Recruiting","Randomised","Triple",6,"Confirmed And Healthy","Healthcare Workers, Outpatient, Hospital","ICU Admission, Hospitalization, Hospital Discharge, Adverse Events","HCQ, SOC",400
"NCT04390191","https://ClinicalTrials.gov/show/NCT04390191",NA,"United States","New York","2020-May","2021-Apr","Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Outpatient, Hospital","Mortality, ICU Admission, Household Members with CoViD-19, Invasive Mechanical Ventilation or ECMO, SpO2","Non-invasive respiratory support, SOC",200
"2020-001498-63","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001498-63/BE/",NA,"Belgium","Brussels","2020-May",NA,"Recruiting","Randomised","Double",2,"Confirmed","Outpatient, Hospital","Mortality, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, IL-6, Tumor Necrosis Factor (Any), D-Dimer, Angiotensins, ACE, ECG, SpO2","Other, SOC",310
"2020-001498-63","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001498-63/BE/",NA,"France","Paris","2020-May",NA,"Recruiting","Randomised","Double",2,"Confirmed","Outpatient, Hospital","Mortality, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, IL-6, Tumor Necrosis Factor (Any), D-Dimer, Angiotensins, ACE, ECG, SpO2","Other, SOC",310
"2020-001498-63","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001498-63/BE/",NA,"United Kingdom","London","2020-May",NA,"Recruiting","Randomised","Double",2,"Confirmed","Outpatient, Hospital","Mortality, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, IL-6, Tumor Necrosis Factor (Any), D-Dimer, Angiotensins, ACE, ECG, SpO2","Other, SOC",310
"2020-001498-63","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001498-63/BE/",NA,"United States","Washington, Dc","2020-May",NA,"Recruiting","Randomised","Double",2,"Confirmed","Outpatient, Hospital","Mortality, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, IL-6, Tumor Necrosis Factor (Any), D-Dimer, Angiotensins, ACE, ECG, SpO2","Other, SOC",310
"CHICTR2000030166","http://www.chictr.org.cn/showproj.aspx?proj=49696",NA,"China","Beijing","2020-Feb","2020-May","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient, Hospital","Viral Load or Clearance, Fever, 3CL Mpro, White Blood Cell Count, Monocyte Count, Natural Killer Cell Count, Dendritic Cell Count, Neutrophils, Creatinine Phosphokinase, CK-MB, ALT, Urine Sample, Stool Sample, Radiographic Findings","LPV/r + IFN, LPV/r + IFN + TCM",20
"NCT04391179","https://ClinicalTrials.gov/show/NCT04391179",NA,"United States","Michigan","2020-May","2020-Dec","Recruiting","Randomised","Single",2,"Confirmed","Outpatient, Hospital","D-Dimer","Other, SOC",80
"CHICTR2000033318","http://www.chictr.org.cn/showproj.aspx?proj=54326",NA,"China","Shanghai","2020-May","2020-Dec","Recruiting","Randomised","Unspecified",2,"Confirmed","Outpatient, Hospital","Dyspnea, Other Mild Symptoms","Exercise, SOC",104
"NCT04336332","https://ClinicalTrials.gov/show/NCT04336332",NA,"United States","New Jersey","2020-Apr","2021-Apr","Recruiting","Randomised","Open-Label",3,"Confirmed","Outpatient, Hospital","Hospital Discharge, Viral Load or Clearance, Fever","HCQ, HCQ + AZT, SOC",160
"NCT04336904","https://ClinicalTrials.gov/show/NCT04336904",NA,"Italy","Milano","2020-Apr","2020-Jul","Not Recruiting","Randomised","Double",2,"Confirmed","Outpatient, Hospital","Mortality, ICU Admission",NA,100
"NCT04419025","https://ClinicalTrials.gov/show/NCT04419025",NA,"United States","Massachusetts","2020-Jun","2020-Oct","Not Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Outpatient, Hospital","Hospitalization, Invasive Mechanical Ventilation or ECMO, Respiratory Rate","Other, SOC",200
"NCT04338828","https://ClinicalTrials.gov/show/NCT04338828",NA,"United States","Massachusetts","2020-Apr","2021-Apr","Recruiting","Randomised","Triple",2,"Suspected","Outpatient, Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Serious Adverse Events",NA,260
"2020-001860-27","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001860-27/GB/",NA,"United Kingdom","London","2020-Apr",NA,"Recruiting","Randomised","Double",2,"Confirmed","Outpatient, Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, Platelet Count, Hemoglobin, ALT, SpO2, Radiographic Findings","Other, SOC",250
"IRCT20190810044500N5","http://en.irct.ir/trial/46867",NA,"Iran","Tehran","2020-May","2021-Feb","Recruiting","Randomised","Double",2,"Confirmed","Outpatient, Hospital","Mortality, Hospitalization, Hospital Discharge, Cough, Fever, Dyspnea, C-Reactive Protein, Ferritin, Platelet Count, Erythrocyte Sedimentation Rate, D-Dimer, LDH, SpO2","Colchicine, HCQ + Colchicine",200
"CHICTR2000030215","http://www.chictr.org.cn/showproj.aspx?proj=50107",NA,"China","Jiangxi","2020-Feb",NA,"Not Recruiting","Randomised","Unspecified",6,"Confirmed","Outpatient, Hospital","Viral Load or Clearance, Fever, C-Reactive Protein, Erythrocyte Sedimentation Rate, CD4, Respiratory Rate, Radiographic Findings","SOC, TCM",120
"CHICTR2000029954","http://www.chictr.org.cn/showproj.aspx?proj=49402",NA,"China","Hubei","2020-Feb","2020-Feb","Recruiting","Randomised","Open-Label",3,"Confirmed","Outpatient, Hospital","ICU Admission, Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Other Mild Symptoms, Radiographic Findings","SOC, TCM",300
"NCT04295551","https://ClinicalTrials.gov/show/NCT04295551",NA,"China","Beijing","2020-Mar","2020-Jul","Not Recruiting","Randomised","Open-Label",3,"Confirmed","Outpatient, Hospital","Cough, Fever, Dyspnea","LPV/r, LPV/r + TCM",80
"CHICTR2000030471","http://www.chictr.org.cn/showproj.aspx?proj=50421",NA,"China","Guangdong","2020-Mar","2020-Apr","Recruiting","Randomised","Single",2,"Confirmed","Outpatient, Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), C-Reactive Protein, Erythrocyte Sedimentation Rate","Nutrition, SOC",394
"CHICTR2000029974","http://www.chictr.org.cn/showproj.aspx?proj=49321",NA,"China","Shandong","2020-Feb","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient, Hospital","Mortality, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Serious or Seconday Infections, Radiographic Findings","SOC, TCM",300
"2020-001493-29","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001493-29/DE/",NA,"Germany","Berlin","2020-Apr",NA,"Recruiting","Randomised","Double",2,"Confirmed","Outpatient, Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, Monocyte Count, Neutrophils, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Glucose, ECG","Other, SOC",NA
"NCT04324463","https://ClinicalTrials.gov/show/NCT04324463",NA,"Canada","Ontario","2020-Mar","2020-Dec","Recruiting","Randomised","Open-Label",4,"Confirmed","Outpatient, Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","HCQ + AZT, SOC",4000
"CHICTR2000030088","http://www.chictr.org.cn/showproj.aspx?proj=49902",NA,"China","Beijing","2020-Feb","2021-Dec","Not Recruiting","Randomised","Unspecified",2,"Confirmed","Outpatient, Hospital","Viral Load or Clearance, Radiographic Findings","SOC, Stem cells",40
"IRCT20160625028622N1","http://en.irct.ir/trial/46576",NA,"Iran","Tehran","2020-Mar","2020-Apr","Completed","Non-Randomised","Double",2,"Confirmed","Outpatient, Hospital","Cough, Radiographic Findings","Other, SOC",125
"CHICTR2000030102","http://www.chictr.org.cn/showproj.aspx?proj=49747",NA,"China","Tianjin","2020-Feb","2020-May","Recruiting","Randomised","Unspecified",6,"Confirmed","Outpatient, Hospital","Viral Load or Clearance, Cough, Fever, Dyspnea, Treatment-emergent Adverse Events, C-Reactive Protein, Blood Gas, SpO2, Radiographic Findings, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Non-invasive respiratory support, SOC",180
"NCT04416048","https://ClinicalTrials.gov/show/NCT04416048",NA,"Germany","Berlin","2020-Jun","2021-Apr","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient, Hospital","Mortality, Clinical Improvement Score (Any), Non-invasive Ventilation, Deep Vein Thrombosis or Pulmonary Embolism, Coagulation Test","Anticoagulants, SOC",400
"NCT04416048","https://ClinicalTrials.gov/show/NCT04416048",NA,"Germany","Bayern","2020-Jun","2021-Apr","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient, Hospital","Mortality, Clinical Improvement Score (Any), Non-invasive Ventilation, Deep Vein Thrombosis or Pulmonary Embolism, Coagulation Test","Anticoagulants, SOC",400
"NCT04416048","https://ClinicalTrials.gov/show/NCT04416048",NA,"Germany","Brandenburg","2020-Jun","2021-Apr","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient, Hospital","Mortality, Clinical Improvement Score (Any), Non-invasive Ventilation, Deep Vein Thrombosis or Pulmonary Embolism, Coagulation Test","Anticoagulants, SOC",400
"NCT04416048","https://ClinicalTrials.gov/show/NCT04416048",NA,"Germany","Hessen","2020-Jun","2021-Apr","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient, Hospital","Mortality, Clinical Improvement Score (Any), Non-invasive Ventilation, Deep Vein Thrombosis or Pulmonary Embolism, Coagulation Test","Anticoagulants, SOC",400
"NCT04416048","https://ClinicalTrials.gov/show/NCT04416048",NA,"Germany","Mecklenburg-Vorpommern","2020-Jun","2021-Apr","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient, Hospital","Mortality, Clinical Improvement Score (Any), Non-invasive Ventilation, Deep Vein Thrombosis or Pulmonary Embolism, Coagulation Test","Anticoagulants, SOC",400
"NCT04416048","https://ClinicalTrials.gov/show/NCT04416048",NA,"Germany","Niedersachsen","2020-Jun","2021-Apr","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient, Hospital","Mortality, Clinical Improvement Score (Any), Non-invasive Ventilation, Deep Vein Thrombosis or Pulmonary Embolism, Coagulation Test","Anticoagulants, SOC",400
"NCT04416048","https://ClinicalTrials.gov/show/NCT04416048",NA,"Germany","Nordrhein-Westfalen","2020-Jun","2021-Apr","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient, Hospital","Mortality, Clinical Improvement Score (Any), Non-invasive Ventilation, Deep Vein Thrombosis or Pulmonary Embolism, Coagulation Test","Anticoagulants, SOC",400
"NCT04416048","https://ClinicalTrials.gov/show/NCT04416048",NA,"Germany","Rheinland-Pfalz","2020-Jun","2021-Apr","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient, Hospital","Mortality, Clinical Improvement Score (Any), Non-invasive Ventilation, Deep Vein Thrombosis or Pulmonary Embolism, Coagulation Test","Anticoagulants, SOC",400
"NCT04416048","https://ClinicalTrials.gov/show/NCT04416048",NA,"Germany","Sachsen","2020-Jun","2021-Apr","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient, Hospital","Mortality, Clinical Improvement Score (Any), Non-invasive Ventilation, Deep Vein Thrombosis or Pulmonary Embolism, Coagulation Test","Anticoagulants, SOC",400
"NCT04416048","https://ClinicalTrials.gov/show/NCT04416048",NA,"Germany","Schleswig-Holstein","2020-Jun","2021-Apr","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient, Hospital","Mortality, Clinical Improvement Score (Any), Non-invasive Ventilation, Deep Vein Thrombosis or Pulmonary Embolism, Coagulation Test","Anticoagulants, SOC",400
"CHICTR2000029518","http://www.chictr.org.cn/showproj.aspx?proj=48860",NA,"China","Zhejiang","2020-Feb","2020-Apr","Recruiting","Randomised","Double",4,"Confirmed","Outpatient, Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Other Mild Symptoms, Adverse Events, Serious Adverse Events, Quality of Life","SOC, TCM",140
"CHICTR2000030002","http://www.chictr.org.cn/showproj.aspx?proj=49738",NA,"China","Anhui","2020-Feb","2020-Jul","Recruiting","Randomised","Unspecified",2,"Confirmed","Outpatient, Hospital","Mortality, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO","Other, SOC",60
"CHICTR2000030196","http://www.chictr.org.cn/showproj.aspx?proj=49883",NA,"China","Hubei","2020-Feb","2020-May","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Outpatient, Hospital","Adverse Events, Serious Adverse Events, IL-1, IL-6, Tumor Necrosis Factor (Any), Interferon (Any)","TCZ",60
"CHICTR2000030481","http://www.chictr.org.cn/showproj.aspx?proj=50453",NA,"China","Hubei","2020-Mar","2020-Apr","Recruiting","Randomised","Unspecified",3,"Confirmed","Outpatient, Hospital","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, Radiographic Findings, Renal Outcome (Unspecified)","Corticosteroids, SOC",200
"NCT04377308","https://ClinicalTrials.gov/show/NCT04377308",NA,"United States","Ohio","2020-May","2021-Apr","Recruiting","Non-Randomised","Open-Label",2,"Confirmed Or Suspected","Outpatient, Hospital","Mortality, Hospitalization, Depression, Anxiety","SOC, SSRIs",2000
"CHICTR2000030936","http://www.chictr.org.cn/showproj.aspx?proj=51100",NA,"China","Sichuan","2020-Mar","2020-May","Recruiting","Non-Randomised","Unspecified",2,"Confirmed Or Suspected","Outpatient, Hospital","Fever","SOC, TCM",2840
"2020-001302-30","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001302-30/AT/",NA,"Austria","Vienna","2020-Apr",NA,"Recruiting","Randomised","Open-Label",4,NA,"Outpatient, Hospital","Mortality, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Other Mild Symptoms, Serious or Seconday Infections, White Blood Cell Count, Hemoglobin, Creatinine Phosphokinase, Angiotensins, Bilirubin, Glucose, Quality of Life, Anxiety","Anticoagulants, ARBs, HCQ, LPV/r",NA
"NCT04354259","https://ClinicalTrials.gov/show/NCT04354259",NA,"Canada","Ontario","2020-Apr","2020-Aug","Recruiting","Randomised","Quadruple",4,NA,"Outpatient, Hospital","Mortality, ICU Admission, Hospitalization, Serious Adverse Events, Interferon (Any), Antibodies","IFN, SOC",140
"NCT04356508","https://ClinicalTrials.gov/show/NCT04356508",NA,"China","Hong Kong","2020-Apr","2020-Jun","Not Recruiting","Non-Randomised","Open-Label",2,NA,"Outpatient, Hospital","Hospitalization, Viral Load or Clearance, Treatment-emergent Adverse Events, IL-1, IL-2, IL-6, Tumor Necrosis Factor (Any)","mAb, SOC",15
"CHICTR2000029573","http://www.chictr.org.cn/showproj.aspx?proj=49065",NA,"China","Zhejiang","2020-Feb",NA,"Recruiting","Randomised","Unspecified",4,NA,"Outpatient, Hospital","Mortality, Viral Load or Clearance, Pneumonia or ARDS, Radiographic Findings","Other",480
"NCT04344951","https://ClinicalTrials.gov/show/NCT04344951",NA,"Greece","Athens","2020-Apr","2021-Apr","Recruiting","Single-Arm","Open-Label",1,NA,"Outpatient, Hospital","Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, PaO2-FiO2",NA,60
"2020-001700-42","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001700-42/FR/",NA,"France","Paris","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Cough, SpO2, Renal Outcome (Unspecified)","ACEi, SOC",NA
"CHICTR2000032011","http://www.chictr.org.cn/showproj.aspx?proj=52142",NA,"China","Beijing","2020-Apr","2020-May","Not Recruiting","Randomised","Unspecified",3,"Yes","Hospital","C-Reactive Protein, IL-6, PaO2-FiO2, Radiographic Findings","Non-invasive respiratory support, SOC",45
"NCT04350671","https://ClinicalTrials.gov/show/NCT04350671",NA,"Iran","Tehran","2020-Apr","2020-Apr","Recruiting","Randomised","Triple",3,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Serious Adverse Events","LPV/r + HCQ, LPV/r + IFN + HCQ",40
"NCT04335305","https://ClinicalTrials.gov/show/NCT04335305",NA,"Spain","Barcelona","2020-Apr","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Organ Failure or Dysfunction (SOFA), Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, White Blood Cell Count, Lymphocyte Count, Platelet Count, Hemoglobin, Coagulation Test, ALT, AST, Albumin, Bilirubin, Glucose, SpO2, Radiographic Findings, Renal Outcome (Unspecified)","SOC, TCZ + mAb",24
"NCT04335305","https://ClinicalTrials.gov/show/NCT04335305",NA,"Spain","Madrid","2020-Apr","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Organ Failure or Dysfunction (SOFA), Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, White Blood Cell Count, Lymphocyte Count, Platelet Count, Hemoglobin, Coagulation Test, ALT, AST, Albumin, Bilirubin, Glucose, SpO2, Radiographic Findings, Renal Outcome (Unspecified)","SOC, TCZ + mAb",24
"NCT04335305","https://ClinicalTrials.gov/show/NCT04335305",NA,"Spain","Valencia","2020-Apr","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Organ Failure or Dysfunction (SOFA), Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, White Blood Cell Count, Lymphocyte Count, Platelet Count, Hemoglobin, Coagulation Test, ALT, AST, Albumin, Bilirubin, Glucose, SpO2, Radiographic Findings, Renal Outcome (Unspecified)","SOC, TCZ + mAb",24
"NCT04335552","https://ClinicalTrials.gov/show/NCT04335552",NA,"United States","North Carolina","2020-Apr","2020-Aug","Recruiting","Randomised","Open-Label",3,"Presumed","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2","AZT, HCQ, SOC",500
"NCT04362813","https://ClinicalTrials.gov/show/NCT04362813",NA,"United States","California","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Adverse Events, C-Reactive Protein, Ferritin, D-Dimer","mAb, SOC",450
"NCT04362813","https://ClinicalTrials.gov/show/NCT04362813",NA,"United States","Illinois","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Adverse Events, C-Reactive Protein, Ferritin, D-Dimer","mAb, SOC",450
"NCT04362813","https://ClinicalTrials.gov/show/NCT04362813",NA,"United States","Maryland","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Adverse Events, C-Reactive Protein, Ferritin, D-Dimer","mAb, SOC",450
"NCT04362813","https://ClinicalTrials.gov/show/NCT04362813",NA,"United States","Massachusetts","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Adverse Events, C-Reactive Protein, Ferritin, D-Dimer","mAb, SOC",450
"NCT04362813","https://ClinicalTrials.gov/show/NCT04362813",NA,"United States","New York","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Adverse Events, C-Reactive Protein, Ferritin, D-Dimer","mAb, SOC",450
"NCT04362813","https://ClinicalTrials.gov/show/NCT04362813",NA,"United States","North Carolina","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Adverse Events, C-Reactive Protein, Ferritin, D-Dimer","mAb, SOC",450
"NCT04362813","https://ClinicalTrials.gov/show/NCT04362813",NA,"United States","Pennsylvania","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Adverse Events, C-Reactive Protein, Ferritin, D-Dimer","mAb, SOC",450
"NCT04362813","https://ClinicalTrials.gov/show/NCT04362813",NA,"United States","Texas","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Adverse Events, C-Reactive Protein, Ferritin, D-Dimer","mAb, SOC",450
"NCT04362813","https://ClinicalTrials.gov/show/NCT04362813",NA,"United States","Virginia","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Adverse Events, C-Reactive Protein, Ferritin, D-Dimer","mAb, SOC",450
"NCT04362813","https://ClinicalTrials.gov/show/NCT04362813",NA,"France","Rhone","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Adverse Events, C-Reactive Protein, Ferritin, D-Dimer","mAb, SOC",450
"NCT04362813","https://ClinicalTrials.gov/show/NCT04362813",NA,"France","Paris","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Adverse Events, C-Reactive Protein, Ferritin, D-Dimer","mAb, SOC",450
"NCT04362813","https://ClinicalTrials.gov/show/NCT04362813",NA,"Germany","Berlin","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Adverse Events, C-Reactive Protein, Ferritin, D-Dimer","mAb, SOC",450
"NCT04362813","https://ClinicalTrials.gov/show/NCT04362813",NA,"Italy","Bergamo","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Adverse Events, C-Reactive Protein, Ferritin, D-Dimer","mAb, SOC",450
"NCT04362813","https://ClinicalTrials.gov/show/NCT04362813",NA,"Italy","Milano","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Adverse Events, C-Reactive Protein, Ferritin, D-Dimer","mAb, SOC",450
"NCT04362813","https://ClinicalTrials.gov/show/NCT04362813",NA,"Italy","Rome","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Adverse Events, C-Reactive Protein, Ferritin, D-Dimer","mAb, SOC",450
"NCT04362813","https://ClinicalTrials.gov/show/NCT04362813",NA,"Russia","Moscow","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Adverse Events, C-Reactive Protein, Ferritin, D-Dimer","mAb, SOC",450
"NCT04362813","https://ClinicalTrials.gov/show/NCT04362813",NA,"Spain","Barcelona","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Adverse Events, C-Reactive Protein, Ferritin, D-Dimer","mAb, SOC",450
"NCT04362813","https://ClinicalTrials.gov/show/NCT04362813",NA,"Spain","Madrid","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Adverse Events, C-Reactive Protein, Ferritin, D-Dimer","mAb, SOC",450
"NCT04362813","https://ClinicalTrials.gov/show/NCT04362813",NA,"United Kingdom","Barnet","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Adverse Events, C-Reactive Protein, Ferritin, D-Dimer","mAb, SOC",450
"NCT04362813","https://ClinicalTrials.gov/show/NCT04362813",NA,"United Kingdom","Coventry","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Adverse Events, C-Reactive Protein, Ferritin, D-Dimer","mAb, SOC",450
"NCT04362813","https://ClinicalTrials.gov/show/NCT04362813",NA,"United Kingdom","Leeds","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Adverse Events, C-Reactive Protein, Ferritin, D-Dimer","mAb, SOC",450
"NCT04362813","https://ClinicalTrials.gov/show/NCT04362813",NA,"United Kingdom","London","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Adverse Events, C-Reactive Protein, Ferritin, D-Dimer","mAb, SOC",450
"NCT04363736","https://ClinicalTrials.gov/show/NCT04363736",NA,"United States","Arizona","2020-Apr","2020-Jul","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, IL-6","TCZ",100
"NCT04363736","https://ClinicalTrials.gov/show/NCT04363736",NA,"United States","California","2020-Apr","2020-Jul","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, IL-6","TCZ",100
"NCT04363736","https://ClinicalTrials.gov/show/NCT04363736",NA,"United States","Connecticut","2020-Apr","2020-Jul","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, IL-6","TCZ",100
"NCT04363736","https://ClinicalTrials.gov/show/NCT04363736",NA,"United States","District Of Columbia","2020-Apr","2020-Jul","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, IL-6","TCZ",100
"NCT04363736","https://ClinicalTrials.gov/show/NCT04363736",NA,"United States","Florida","2020-Apr","2020-Jul","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, IL-6","TCZ",100
"NCT04363736","https://ClinicalTrials.gov/show/NCT04363736",NA,"United States","Illinois","2020-Apr","2020-Jul","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, IL-6","TCZ",100
"NCT04363736","https://ClinicalTrials.gov/show/NCT04363736",NA,"United States","Louisiana","2020-Apr","2020-Jul","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, IL-6","TCZ",100
"NCT04363736","https://ClinicalTrials.gov/show/NCT04363736",NA,"United States","Maryland","2020-Apr","2020-Jul","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, IL-6","TCZ",100
"NCT04363736","https://ClinicalTrials.gov/show/NCT04363736",NA,"United States","Nevada","2020-Apr","2020-Jul","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, IL-6","TCZ",100
"NCT04363736","https://ClinicalTrials.gov/show/NCT04363736",NA,"United States","New Jersey","2020-Apr","2020-Jul","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, IL-6","TCZ",100
"NCT04363736","https://ClinicalTrials.gov/show/NCT04363736",NA,"United States","New York","2020-Apr","2020-Jul","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, IL-6","TCZ",100
"NCT04363736","https://ClinicalTrials.gov/show/NCT04363736",NA,"United States","North Carolina","2020-Apr","2020-Jul","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, IL-6","TCZ",100
"NCT04363736","https://ClinicalTrials.gov/show/NCT04363736",NA,"United States","Ohio","2020-Apr","2020-Jul","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, IL-6","TCZ",100
"NCT04363736","https://ClinicalTrials.gov/show/NCT04363736",NA,"United States","Pennsylvania","2020-Apr","2020-Jul","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, IL-6","TCZ",100
"NCT04363736","https://ClinicalTrials.gov/show/NCT04363736",NA,"United States","South Carolina","2020-Apr","2020-Jul","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, IL-6","TCZ",100
"NCT04363736","https://ClinicalTrials.gov/show/NCT04363736",NA,"United States","Texas","2020-Apr","2020-Jul","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, IL-6","TCZ",100
"IRCT20200325046859N2","http://en.irct.ir/trial/47200",NA,"Iran","Tehran","2020-Apr","2020-Jun","Completed","Randomised","Single",2,"Confirmed","Hospital","Fever, C-Reactive Protein, White Blood Cell Count, LDH, Respiratory Rate, Radiographic Findings","HCQ, HCQ + Umifenovir",100
"NCT04315987","https://ClinicalTrials.gov/show/NCT04315987",NA,"Brazil","Brasilia","2020-Mar","2020-Aug","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Platelet Count, CD4, CD8, PaO2-FiO2, Respiratory Rate, Hypoxia, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Stem cells",90
"NCT04346446","https://clinicaltrials.gov/show/NCT04346446",NA,"India","New Delhi","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), PaO2-FiO2","Plasma based therapy, SOC",29
"NCT04347980","https://ClinicalTrials.gov/show/NCT04347980",NA,"France","Paris","2020-Apr","2020-Jun","Recruiting","Randomised","Single",2,"Yes","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Patient Positioning","Dexamethasone + HCQ, HCQ",122
"NCT04336254","https://ClinicalTrials.gov/show/NCT04336254",NA,"China","Hubei","2020-Apr","2020-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Treatment-emergent Adverse Events, C-Reactive Protein, Respiratory Rate, Radiographic Findings",NA,20
"NCT04344782","https://ClinicalTrials.gov/show/NCT04344782",NA,"France","Paris","2020-Apr","2020-Sep","Not Recruiting","Randomised","Open-Label",2,"Yes","Hospital","ICU Admission, Invasive Mechanical Ventilation or ECMO, Dyspnea, Adverse Events, PaO2-FiO2, Radiographic Findings","mAb, SOC",130
"NCT04432272","https://ClinicalTrials.gov/show/NCT04432272",NA,"United States","Michigan","2020-Jun","2021-Jun","Not Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, IgG, IgM or IgA, Renal Outcome (Unspecified)","Plasma based therapy",500
"CTRI/2020/04/024947","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43259",NA,"India","New Delhi","2020-Apr",NA,"Not Recruiting","Randomised","Unspecified",1,"Confirmed","Hospital",NA,"Alternative therapy",100
"NCT04388527","https://ClinicalTrials.gov/show/NCT04388527",NA,"United States","Pennsylvania","2020-May","2020-Aug","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Glucose","Plasma based therapy",50
"NCT04378920","https://clinicaltrials.gov/show/NCT04378920",NA,"France","Paris","2020-May",NA,"Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","PaO2-FiO2","Other",180
"NCT04383613","https://clinicaltrials.gov/show/NCT04383613",NA,"Canada","Ottawa","2020-May",NA,"Recruiting","Randomised","Single",2,"Confirmed Or Suspected","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO","Positioning, SOC",350
"NCT04389840","https://ClinicalTrials.gov/show/NCT04389840",NA,"United States","Louisiana","2020-May","2021-Feb","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO","Anticoagulants, SOC",524
"CHICTR2000029990","http://www.chictr.org.cn/showproj.aspx?proj=49674",NA,"China","Beijing","2020-Feb","2020-Mar","Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital",NA,"SOC, Stem cells",120
"NCT04399980","https://clinicaltrials.gov/show/NCT04399980",NA,"United States","Washington, Dc","2020-May",NA,"Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital",NA,"mAb, SOC",60
"NCT04390178","https://ClinicalTrials.gov/show/NCT04390178",NA,"Sweden","Stockholm","2020-May","2020-Jun","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Fever, Adverse Events, Antibodies","Plasma based therapy",10
"2020-001203-16","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001203-16/GB/",NA,"United Kingdom","London","2020-Apr",NA,"Recruiting","Randomised","Single",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2, SpO2","NSAIDs, SOC",NA
"CTRI/2020/05/025071","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43447",NA,"India","New Delhi","2020-Aug",NA,"Not Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","ICU Admission, Invasive Mechanical Ventilation or ECMO","Non-invasive respiratory support, SOC",40
"NCT04320056","https://ClinicalTrials.gov/show/NCT04320056",NA,"Canada","Quebec","2020-Mar","2021-Apr","Recruiting","Randomised","Open-Label",2,"Suspected","Hospital","ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Non-invasive respiratory support, SOC",216
"CHICTR2000030835","http://www.chictr.org.cn/showproj.aspx?proj=51050",NA,"China","Henan","2020-Mar","2021-Feb","Recruiting","Single-Arm","Open-Label",2,"Confirmed","Hospital","C-Reactive Protein, IL-1, IL-2, IL-4, IL-6, IL-7, IL-8, IL-10, Tumor Necrosis Factor (Any), Granulocyte Stimulaiting Factor, IP-10, White Blood Cell Count, Monocyte Count, Natural Killer Cell Count, Procalcitonin, ALT, Albumin, Bilirubin, Glucose, Urine Sample, Radiographic Findings, Depression, Anxiety, Distress","Stem cells",20
"NCT04302519","https://ClinicalTrials.gov/show/NCT04302519",NA,"China","Beijing","2020-Mar","2021-Jun","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","PaO2-FiO2, Radiographic Findings, Hypoxia, Hypoxemia","Stem cells",24
"NCT04275414","https://ClinicalTrials.gov/show/NCT04275414",NA,"China","Hubei","2020-Feb","2020-Apr","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Dyspnea, C-Reactive Protein, PaO2-FiO2, SpO2, Radiographic Findings","mAb",20
"NCT04275414","https://ClinicalTrials.gov/show/NCT04275414",NA,"China","Shandong","2020-Feb","2020-Apr","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Dyspnea, C-Reactive Protein, PaO2-FiO2, SpO2, Radiographic Findings","mAb",20
"NCT04275414","https://ClinicalTrials.gov/show/NCT04275414",NA,"Italy","Rome","2020-Feb","2020-Apr","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Dyspnea, C-Reactive Protein, PaO2-FiO2, SpO2, Radiographic Findings","mAb",20
"CHICTR2000029572","http://www.chictr.org.cn/showproj.aspx?proj=41760",NA,"China","Hubei","2020-Feb","2021-Apr","Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Mortality, Hospitalization, Pneumonia or ARDS, Non-invasive Ventilation, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Radiographic Findings","SOC, Stem cells",30
"CHICTR2000029569","http://www.chictr.org.cn/showproj.aspx?proj=49062",NA,"China","Hubei","2020-Feb","2021-Apr","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Pneumonia or ARDS, Non-invasive Ventilation, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Radiographic Findings","SOC, Stem cells",30
"CHICTR2000029777","http://www.chictr.org.cn/showproj.aspx?proj=49380",NA,"China","Hubei","2020-Feb","2020-Jun","Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Organ Failure or Dysfunction (SOFA), Coagulation Test, Radiographic Findings","SOC, TCM",160
"NCT04305106","https://ClinicalTrials.gov/show/NCT04305106",NA,"China","Shandong","2020-Mar","2020-Jun","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Clinical Improvement Score (Any)","mAb, SOC",140
"NCT04395105","https://clinicaltrials.gov/show/NCT04395105",NA,"Argentina","Buenos Aires","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital",NA,"Dexamethasone, SOC",284
"NCT04435353","https://clinicaltrials.gov/show/NCT04435353",NA,"Kazakhstan","Astana","2020-Jun",NA,"Recruiting","Randomised","Single",2,"Confirmed","Hospital",NA,"Alternative therapy",200
"NCT04414631","https://ClinicalTrials.gov/show/NCT04414631",NA,"Switzerland","Bern","2020-Jun","2021-Jun","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Clinical Improvement Score (Any), Non-invasive Ventilation, PaO2-FiO2","Other, SOC",120
"CHICTR2000029386","http://www.chictr.org.cn/showproj.aspx?proj=48777",NA,"China","Chongqing","2020-Jan",NA,"Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO","Corticosteroids, SOC",48
"NCT04410510","https://ClinicalTrials.gov/show/NCT04410510",NA,"Colombia","Huila","2020-Jun","2020-Dec","Not Recruiting","Randomised","Triple",2,"Confirmed Or Suspected","Hospital","ICU Admission, Hospitalization, Clinical Improvement Score (Any), Treatment-emergent Adverse Events","HCQ + LPV/r, HCQ + LPV/r + Alternative therapy",100
"EUCTR2020-001449-38-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001449-38",NA,"United Kingdom","London","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",3,"Confirmed, Suspected","Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","FPV, HCQ + AZT + Zinc, SOC",450
"CHICTR2000029739","http://www.chictr.org.cn/showproj.aspx?proj=49283",NA,"China","Guangdong","2020-Feb","2021-Aug","Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms, C-Reactive Protein, Creatinine Phosphokinase, CK-MB, eGFR, Myoglobin, Troponin, Procalcitonin, Prothrombin, Fibrinogen, ALT, Albumin, Bilirubin, Quality of Life","Non-invasive respiratory support",440
"NCT04321993","https://ClinicalTrials.gov/show/NCT04321993",NA,"Canada","Nova Scotia","2020-Mar","2022-Feb","Recruiting","Non-Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Organ Failure or Dysfunction (SOFA), Adverse Events, SpO2","HCQ, JAKi, LPV/r, Sarilumab",1000
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"United States","Alabama","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"United States","California","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"United States","Colorado","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"United States","Georgia","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"United States","Illinois","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"United States","Louisiana","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"United States","Maryland","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"United States","Massachusetts","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"United States","Minnesota","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"United States","Missouri","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"United States","Nebraska","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"United States","New York","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"United States","North Carolina","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"United States","Pennsylvania","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"United States","Tennessee","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"United States","Texas","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"United States","Virginia","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"United States","Washington","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"Denmark","Copenhagen","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"Germany","Nordrhein-Westfalen","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"Germany","Berlin","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"Macedonia","Skopje","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"Greece","Athens","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"Japan","Tokyo","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"South Korea","Gyeonggi","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"South Korea","Seoul","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"Mexico","Mexico","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"Singapore","Singapore","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"Spain","Barcelona","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"United Kingdom","East Sussex","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"United Kingdom","City","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"United Kingdom","Newcastle Upon Tyne","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"United Kingdom","Leeds","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"NCT04280705","https://ClinicalTrials.gov/show/NCT04280705",NA,"United Kingdom","London","2020-Feb","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, SOC",1062
"2020-001052-18","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001052-18/ES/",NA,"Denmark","Copenhagen","2020-Apr",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose, Renal Outcome (Unspecified)","Remdesivir, SOC",440
"2020-001052-18","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001052-18/ES/",NA,"Germany","Berlin","2020-Apr",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose, Renal Outcome (Unspecified)","Remdesivir, SOC",440
"2020-001052-18","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001052-18/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose, Renal Outcome (Unspecified)","Remdesivir, SOC",440
"2020-001643-13","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001643-13/GB/",NA,"United Kingdom","London","2020-Apr",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Platelet Count, Hemoglobin, ALT, AST, Bilirubin","DPP1 inhibitor, SOC",300
"NCT04380961","https://ClinicalTrials.gov/show/NCT04380961",NA,"United States","Illinois","2020-May","2020-Jun","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, ALT, Bilirubin","mAb, SOC",270
"NCT04380961","https://ClinicalTrials.gov/show/NCT04380961",NA,"United States","Kentucky","2020-May","2020-Jun","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, ALT, Bilirubin","mAb, SOC",270
"NCT04380961","https://ClinicalTrials.gov/show/NCT04380961",NA,"United States","Louisiana","2020-May","2020-Jun","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, ALT, Bilirubin","mAb, SOC",270
"NCT04380961","https://ClinicalTrials.gov/show/NCT04380961",NA,"United States","Michigan","2020-May","2020-Jun","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, ALT, Bilirubin","mAb, SOC",270
"NCT04380961","https://ClinicalTrials.gov/show/NCT04380961",NA,"United States","Missouri","2020-May","2020-Jun","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, ALT, Bilirubin","mAb, SOC",270
"NCT04380961","https://ClinicalTrials.gov/show/NCT04380961",NA,"United States","Montana","2020-May","2020-Jun","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, ALT, Bilirubin","mAb, SOC",270
"NCT04380961","https://ClinicalTrials.gov/show/NCT04380961",NA,"United States","New Jersey","2020-May","2020-Jun","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, ALT, Bilirubin","mAb, SOC",270
"NCT04380961","https://ClinicalTrials.gov/show/NCT04380961",NA,"United States","New York","2020-May","2020-Jun","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, ALT, Bilirubin","mAb, SOC",270
"NCT04380961","https://ClinicalTrials.gov/show/NCT04380961",NA,"United States","North Carolina","2020-May","2020-Jun","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, ALT, Bilirubin","mAb, SOC",270
"NCT04380961","https://ClinicalTrials.gov/show/NCT04380961",NA,"United States","Texas","2020-May","2020-Jun","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, ALT, Bilirubin","mAb, SOC",270
"NCT04264858","https://clinicaltrials.gov/show/NCT04264858",NA,"China","Beijing","2020-Aug",NA,"Not Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Antibodies, PaO2-FiO2, Radiographic Findings","Igs",10
"CHICTR2000030475","http://www.chictr.org.cn/showproj.aspx?proj=50452",NA,"China","Beijing","2020-Mar","2020-Jun","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, ICU Admission, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, IL-6, IL-10, Tumor Necrosis Factor (Any)","Cytokine removal",19
"CHICTR2000030477","http://www.chictr.org.cn/showproj.aspx?proj=50458",NA,"China","Beijing","2020-Mar","2020-Jun","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, ICU Admission, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Serious Adverse Events, IL-6, IL-10, Tumor Necrosis Factor (Any)","Other",19
"NCT04315948","https://ClinicalTrials.gov/show/NCT04315948",NA,"Austria","Vienna","2020-Mar","2023-Mar","Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Platelet Count, Hemoglobin, Prothrombin, Electrolytes, INR, ALT, AST, Bilirubin, Glucose","HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",3100
"NCT04315948","https://ClinicalTrials.gov/show/NCT04315948",NA,"Austria","Salzburg","2020-Mar","2023-Mar","Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Platelet Count, Hemoglobin, Prothrombin, Electrolytes, INR, ALT, AST, Bilirubin, Glucose","HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",3100
"NCT04315948","https://ClinicalTrials.gov/show/NCT04315948",NA,"Belgium","Brussels","2020-Mar","2023-Mar","Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Platelet Count, Hemoglobin, Prothrombin, Electrolytes, INR, ALT, AST, Bilirubin, Glucose","HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",3100
"NCT04315948","https://ClinicalTrials.gov/show/NCT04315948",NA,"France","Paris","2020-Mar","2023-Mar","Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Platelet Count, Hemoglobin, Prothrombin, Electrolytes, INR, ALT, AST, Bilirubin, Glucose","HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",3100
"NCT04315948","https://ClinicalTrials.gov/show/NCT04315948",NA,"France","Martinique","2020-Mar","2023-Mar","Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Platelet Count, Hemoglobin, Prothrombin, Electrolytes, INR, ALT, AST, Bilirubin, Glucose","HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",3100
"NCT04315948","https://ClinicalTrials.gov/show/NCT04315948",NA,"Luxembourg","Luxembourg","2020-Mar","2023-Mar","Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Platelet Count, Hemoglobin, Prothrombin, Electrolytes, INR, ALT, AST, Bilirubin, Glucose","HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",3100
"NCT04420247","https://ClinicalTrials.gov/show/NCT04420247",NA,"Brazil","Parana","2020-Jun","2020-Aug","Recruiting","Randomised","Single",3,"Confirmed Or Suspected","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Lymphocyte Count, Renal Outcome (Unspecified)","HCQ, SOC",100
"CHICTR2000030522","http://www.chictr.org.cn/showproj.aspx?proj=44213",NA,"China","Sichuan","2020-Mar","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Clinical Improvement Score (Any), Viral Load or Clearance, Fever, C-Reactive Protein, White Blood Cell Count, Erythrocyte Sedimentation Rate, Radiographic Findings","SOC, TCM",100
"2020-002123-11","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-002123-11/ES/",NA,"Spain","Madrid","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Adverse Events","HCQ, HCQ + Cyclosporine",NA
"NCT04435717","https://ClinicalTrials.gov/show/NCT04435717",NA,"Spain","Madrid","2020-Jun","2020-Aug","Recruiting","Single-Arm","Open-Label",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Adverse Events, C-Reactive Protein, Ferritin, IL-6, IL-10, IL-12, IL-17, D-Dimer, Procalcitonin, PaO2-FiO2","SOC, TCZ",78
"2020-002032-69","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-002032-69/ES/",NA,"Spain","Madrid","2020-May",NA,"Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-1, IL-6, IL-10, IL-12, IL-17, D-Dimer, Procalcitonin, PaO2-FiO2, SpO2, Radiographic Findings, Quality of Life","SOC, TCZ",NA
"NCT04385186","https://ClinicalTrials.gov/show/NCT04385186",NA,"Colombia","Bogota","2020-May","2020-Nov","Not Recruiting","Randomised","Single",2,"Confirmed","Hospital","Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), IL-6, Hemoglobin, D-Dimer, Procalcitonin, AST, Bilirubin, Antibodies, Radiographic Findings","Plasma based therapy, SOC",60
"NCT04385186","https://ClinicalTrials.gov/show/NCT04385186",NA,"Colombia","Cundinamarca","2020-May","2020-Nov","Not Recruiting","Randomised","Single",2,"Confirmed","Hospital","Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), IL-6, Hemoglobin, D-Dimer, Procalcitonin, AST, Bilirubin, Antibodies, Radiographic Findings","Plasma based therapy, SOC",60
"NCT04385186","https://ClinicalTrials.gov/show/NCT04385186",NA,"Colombia","Risaralda","2020-May","2020-Nov","Not Recruiting","Randomised","Single",2,"Confirmed","Hospital","Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), IL-6, Hemoglobin, D-Dimer, Procalcitonin, AST, Bilirubin, Antibodies, Radiographic Findings","Plasma based therapy, SOC",60
"NCT04323592","https://clinicaltrials.gov/show/NCT04323592",NA,"Italy","Rome","2020-Mar",NA,"Recruiting","Single-Arm","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein","Corticosteroids, SOC",104
"IRCT20180425039414N3","http://en.irct.ir/trial/48083",NA,"Iran","Tehran","2020-Jun","2020-May","Completed","Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization","HCQ +  LPV/r + Vitamins, HCQ + LPV/r",80
"IRCT20180425039414N2","http://en.irct.ir/trial/47516",NA,"Iran","Tehran","2020-May","2020-May","Completed","Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization, Cough, Fever, Dyspnea, SpO2","HCQ, HCQ + Zinc",80
"NCT04341116","https://ClinicalTrials.gov/show/NCT04341116",NA,"United States","District Of Columbia","2020-Apr","2020-Sep","Recruiting","Randomised","Quadruple",3,"Yes","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, D-Dimer, Antibodies, PaO2-FiO2, SpO2","mAb, SOC",144
"NCT04341116","https://ClinicalTrials.gov/show/NCT04341116",NA,"United States","Illinois","2020-Apr","2020-Sep","Recruiting","Randomised","Quadruple",3,"Yes","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, D-Dimer, Antibodies, PaO2-FiO2, SpO2","mAb, SOC",144
"NCT04341116","https://ClinicalTrials.gov/show/NCT04341116",NA,"United States","Indiana","2020-Apr","2020-Sep","Recruiting","Randomised","Quadruple",3,"Yes","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, D-Dimer, Antibodies, PaO2-FiO2, SpO2","mAb, SOC",144
"NCT04341116","https://ClinicalTrials.gov/show/NCT04341116",NA,"United States","Louisiana","2020-Apr","2020-Sep","Recruiting","Randomised","Quadruple",3,"Yes","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, D-Dimer, Antibodies, PaO2-FiO2, SpO2","mAb, SOC",144
"NCT04341116","https://ClinicalTrials.gov/show/NCT04341116",NA,"United States","Maryland","2020-Apr","2020-Sep","Recruiting","Randomised","Quadruple",3,"Yes","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, D-Dimer, Antibodies, PaO2-FiO2, SpO2","mAb, SOC",144
"NCT04341116","https://ClinicalTrials.gov/show/NCT04341116",NA,"United States","Michigan","2020-Apr","2020-Sep","Recruiting","Randomised","Quadruple",3,"Yes","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, D-Dimer, Antibodies, PaO2-FiO2, SpO2","mAb, SOC",144
"NCT04341116","https://ClinicalTrials.gov/show/NCT04341116",NA,"United States","Mississippi","2020-Apr","2020-Sep","Recruiting","Randomised","Quadruple",3,"Yes","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, D-Dimer, Antibodies, PaO2-FiO2, SpO2","mAb, SOC",144
"NCT04341116","https://ClinicalTrials.gov/show/NCT04341116",NA,"United States","Nevada","2020-Apr","2020-Sep","Recruiting","Randomised","Quadruple",3,"Yes","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, D-Dimer, Antibodies, PaO2-FiO2, SpO2","mAb, SOC",144
"NCT04341116","https://ClinicalTrials.gov/show/NCT04341116",NA,"United States","Oregon","2020-Apr","2020-Sep","Recruiting","Randomised","Quadruple",3,"Yes","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, D-Dimer, Antibodies, PaO2-FiO2, SpO2","mAb, SOC",144
"NCT04341116","https://ClinicalTrials.gov/show/NCT04341116",NA,"United States","Pennsylvania","2020-Apr","2020-Sep","Recruiting","Randomised","Quadruple",3,"Yes","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, D-Dimer, Antibodies, PaO2-FiO2, SpO2","mAb, SOC",144
"NCT04341116","https://ClinicalTrials.gov/show/NCT04341116",NA,"United States","Texas","2020-Apr","2020-Sep","Recruiting","Randomised","Quadruple",3,"Yes","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, D-Dimer, Antibodies, PaO2-FiO2, SpO2","mAb, SOC",144
"IRCT20150808023559N21","http://en.irct.ir/trial/47594",NA,"Iran","Tehran","2020-May","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge","Plasma based therapy, SOC",60
"NCT04389801","https://ClinicalTrials.gov/show/NCT04389801",NA,"Egypt","Cairo","2020-May","2020-Sep","Not Recruiting","Randomised","Single",2,"Confirmed","Hospital","Mortality","Other, SOC",200
"IRCT20200518047497N1","http://en.irct.ir/trial/48289",NA,"Iran","East Azarbaijan","2020-May","2020-Jul","Recruiting","Randomised","Triple",2,"Confirmed Or Suspected","Hospital","Mortality, Hospitalization, Cough, Fever, Dyspnea, Other Mild Symptoms, C-Reactive Protein, White Blood Cell Count, SpO2, Respiratory Rate, Radiographic Findings","Alternative therapy, SOC",80
"NCT04412057","https://clinicaltrials.gov/show/NCT04412057",NA,"United States","Washington, Dc","2020-May",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital",NA,"Other, SOC",82
"EUCTR2020-001411-25-AT","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"United States","Washington, Dc","2020-Mar",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-AT","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Spain","Madrid","2020-Mar",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-AT","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Austria","Vienna","2020-Mar",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-AT","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Israel","Jerusalem","2020-Mar",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-AT","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Italy","Rome","2020-Mar",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-AT","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"United Kingdom","London","2020-Mar",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-AT","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"India","New Delhi","2020-Mar",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-AT","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"France","Paris","2020-Mar",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-AT","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Canada","Ottawa","2020-Mar",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-AT","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Belgium","Brussels","2020-Mar",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-AT","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Malaysia","Kuala Lumpur","2020-Mar",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-AT","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Australia","Canberra","2020-Mar",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"EUCTR2020-001411-25-AT","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Germany","Berlin","2020-Mar",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",300
"IRCT20080901001165N55","http://en.irct.ir/trial/48061",NA,"Iran","Tehran","2020-May","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Fever","Other, SOC",72
"CTRI/2020/04/024858","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43236",NA,"India","Delhi","2020-Apr",NA,"Not Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Viral Load or Clearance","Ivermectin, SOC",50
"NCT04424797","https://ClinicalTrials.gov/show/NCT04424797",NA,"United States","Colorado","2020-Jun","2020-Dec","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, SpO2, Patient Positioning","Positioning",100
"NCT04372979","https://ClinicalTrials.gov/show/NCT04372979",NA,"France","Paris","2020-May","2020-Oct","Not Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Mortality, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Anti SARS-COV-2 Titers, Quality of Life","Plasma based therapy, SOC",80
"NCT04424134","https://ClinicalTrials.gov/show/NCT04424134",NA,"Russia","Moscow","2020-Jun","2020-Jul","Recruiting","Randomised","Single",2,"Confirmed","Hospital","C-Reactive Protein, D-Dimer","Other, SOC",80
"NCT04408040","https://clinicaltrials.gov/show/NCT04408040",NA,"United States","Washington, Dc","2020-May",NA,"Not Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Mortality","Plasma based therapy",700
"NCT04393948","https://clinicaltrials.gov/show/NCT04393948",NA,"United States","Washington, Dc","2020-May",NA,"Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS","Radiation therapy, SOC",48
"NCT04380688","https://ClinicalTrials.gov/show/NCT04380688",NA,"United States","California","2020-May","2020-Nov","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2","Acalabrutinib, SOC",60
"NCT04380688","https://ClinicalTrials.gov/show/NCT04380688",NA,"United States","District Of Columbia","2020-May","2020-Nov","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2","Acalabrutinib, SOC",60
"NCT04380688","https://ClinicalTrials.gov/show/NCT04380688",NA,"United States","Kentucky","2020-May","2020-Nov","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2","Acalabrutinib, SOC",60
"NCT04380688","https://ClinicalTrials.gov/show/NCT04380688",NA,"United States","Maryland","2020-May","2020-Nov","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2","Acalabrutinib, SOC",60
"NCT04380688","https://ClinicalTrials.gov/show/NCT04380688",NA,"United States","New Jersey","2020-May","2020-Nov","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2","Acalabrutinib, SOC",60
"NCT04380688","https://ClinicalTrials.gov/show/NCT04380688",NA,"United States","New York","2020-May","2020-Nov","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2","Acalabrutinib, SOC",60
"NCT04380688","https://ClinicalTrials.gov/show/NCT04380688",NA,"United States","Pennsylvania","2020-May","2020-Nov","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2","Acalabrutinib, SOC",60
"NCT04394793","https://ClinicalTrials.gov/show/NCT04394793",NA,"India","Delhi","2020-May","2020-Jul","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization","Radiation therapy",10
"NCT04425460","https://ClinicalTrials.gov/show/NCT04425460",NA,"China","Zhejiang","2020-Jun","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Pneumonia or ARDS, Non-invasive Ventilation, Cough, Fever","FPV, SOC",256
"NCT04425460","https://ClinicalTrials.gov/show/NCT04425460",NA,"China","Beijing","2020-Jun","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Pneumonia or ARDS, Non-invasive Ventilation, Cough, Fever","FPV, SOC",256
"NCT04425460","https://ClinicalTrials.gov/show/NCT04425460",NA,"Germany","Berlin","2020-Jun","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Pneumonia or ARDS, Non-invasive Ventilation, Cough, Fever","FPV, SOC",256
"NCT04425460","https://ClinicalTrials.gov/show/NCT04425460",NA,"Romania","Cluj","2020-Jun","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Pneumonia or ARDS, Non-invasive Ventilation, Cough, Fever","FPV, SOC",256
"NCT04425460","https://ClinicalTrials.gov/show/NCT04425460",NA,"Romania","Bucharest","2020-Jun","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Pneumonia or ARDS, Non-invasive Ventilation, Cough, Fever","FPV, SOC",256
"NCT04425460","https://ClinicalTrials.gov/show/NCT04425460",NA,"Romania","Timis","2020-Jun","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Pneumonia or ARDS, Non-invasive Ventilation, Cough, Fever","FPV, SOC",256
"NCT04395716","https://ClinicalTrials.gov/show/NCT04395716",NA,"United States","California","2020-May","2021-Jun","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","ECG, SpO2","Respiratory support",50
"NCT04394208","https://ClinicalTrials.gov/show/NCT04394208",NA,"Egypt","Cairo","2020-May","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events","Alternative therapy, SOC",50
"NCT04390061","https://ClinicalTrials.gov/show/NCT04390061",NA,"Italy","Ancona","2020-May","2020-Sep","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events","HCQ, HCQ + JAKi",116
"CTRI/2020/04/024883","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43168",NA,"India","New Delhi","2020-Apr",NA,"Recruiting","Randomised","Single",2,"Confirmed","Hospital",NA,"Alternative therapy, SOC",112
"NCT04393311","https://ClinicalTrials.gov/show/NCT04393311",NA,"United States","California","2020-May","2021-Jan","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, SpO2","Other, SOC",150
"NCT04435015","https://clinicaltrials.gov/show/NCT04435015",NA,"United States","Connecticut","2020-Jun",NA,"Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","D-Dimer","Other, SOC",200
"EUCTR2020-001571-32-FR","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001571-32",NA,"France","Aude","2020-Jul",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), IL-2, PaO2-FiO2, Patient Positioning","Other, SOC",30
"NCT04386239","https://ClinicalTrials.gov/show/NCT04386239",NA,"Italy","Milano","2020-May","2020-Dec","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Viral Load or Clearance, Fever, Tumor Necrosis Factor (Any)","Sarilumab",40
"NCT04378712","https://ClinicalTrials.gov/show/NCT04378712",NA,"China","Guangdong","2020-May","2020-Mar","Completed","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Hospital Discharge, Cough, Dyspnea, SpO2, Distress","Non-invasive respiratory support, SOC",90
"NCT04441424","https://ClinicalTrials.gov/show/NCT04441424",NA,"Iraq","Baghdad","2020-Jun","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality","HCQ + AZT, HCQ + Plasma based therapy + AZT",49
"NCT04348877","https://ClinicalTrials.gov/show/NCT04348877",NA,"Egypt","Cairo","2020-Apr","2020-Oct","Not Recruiting","Single-Arm","Open-Label",1,"Yes","Hospital","Viral Load or Clearance, Fever, Radiographic Findings","Plasma based therapy",20
"NCT04438694","https://ClinicalTrials.gov/show/NCT04438694",NA,"Egypt","Cairo","2020-Jun","2021-May","Recruiting","Single-Arm","Open-Label",3,"Confirmed","Hospital","Hospitalization","Plasma based therapy, SOC",60
"NCT04333355","https://ClinicalTrials.gov/show/NCT04333355",NA,"Mexico","Nuevo Leon","2020-Apr","2020-Dec","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Viral Load or Clearance, Organ Failure or Dysfunction (SOFA), Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","Plasma based therapy",20
"IRCT20200506047319N1","http://en.irct.ir/trial/48095",NA,"Iran","Zanjan","2020-May","2020-Jul","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Cough, Fever, Dyspnea, Other Mild Symptoms","Alternative therapy, SOC",100
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"United States","Arizona","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"United States","California","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"United States","Georgia","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"United States","Illinois","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"United States","Indiana","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"United States","Maryland","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"United States","Massachusetts","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"United States","Michigan","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"United States","New York","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"United States","Oregon","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"United States","Pennsylvania","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"United States","Washington","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"Argentina","Buenos Aires","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"Argentina","Rio Negro","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"Argentina","Cordoba","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"Brazil","Minas Gerais","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"Brazil","Para","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"Brazil","Rio Grande Do Norte","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"Brazil","Brasilia","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"Brazil","Sao Paulo","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"Germany","Bayern","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"Germany","Schleswig-Holstein","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"Germany","Berlin","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"Italy","Chieti","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"Italy","Roma","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"Italy","Milano","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"Italy","Prato","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"Japan","Kanagawa","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"Japan","Tokyo","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"Mexico","Mexico","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"Mexico","Nuevo Leon","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"Russia","Moscow","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"Spain","Alava","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"Spain","Madrid","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"Spain","Valencia","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"United Kingdom","Cornwall","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04421027","https://ClinicalTrials.gov/show/NCT04421027",NA,"United Kingdom","London","2020-Jun","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","JAKi, SOC",400
"NCT04415151","https://ClinicalTrials.gov/show/NCT04415151",NA,"United States","Connecticut","2020-Jun","2021-Mar","Not Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events","JAKi, SOC",60
"NCT04395170","https://ClinicalTrials.gov/show/NCT04395170",NA,"Colombia","Antioquia","2020-May","2020-Dec","Not Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Adverse Events, IgG, IgM or IgA, Antibodies","Igs, Plasma based therapy, SOC",75
"NCT04351763","https://ClinicalTrials.gov/show/NCT04351763",NA,"Poland","Warsaw","2020-Apr","2021-Mar","Recruiting","Randomised","Single",3,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Fever, PaO2-FiO2, Cardiac Outcome (Unspecified)","CCB, Other, SOC",804
"2020-001934-37","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001934-37/ES/",NA,"Spain","Madrid","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA), PaO2-FiO2, Shock","Corticosteroids, SOC",NA
"NCT04425733","https://ClinicalTrials.gov/show/NCT04425733",NA,"United States","New Jersey","2020-Jun","2020-Nov","Not Recruiting","Randomised","Double",6,"Confirmed","Hospital","Adverse Events, Weight, Height or BMI, SpO2","Other, SOC",64
"NCT04393415","https://clinicaltrials.gov/show/NCT04393415",NA,"Egypt","Cairo","2020-May",NA,"Not Recruiting","Randomised","Double",3,"Confirmed","Hospital",NA,"SOC, Stem cells",100
"EUCTR2020-001411-25-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"United States","Washington, Dc","2020-Jan",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Labor Absenteeism, Fever, SpO2, Respiratory Rate","Other, SOC",230
"EUCTR2020-001411-25-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Spain","Madrid","2020-Jan",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Labor Absenteeism, Fever, SpO2, Respiratory Rate","Other, SOC",230
"EUCTR2020-001411-25-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Austria","Vienna","2020-Jan",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Labor Absenteeism, Fever, SpO2, Respiratory Rate","Other, SOC",230
"EUCTR2020-001411-25-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Israel","Jerusalem","2020-Jan",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Labor Absenteeism, Fever, SpO2, Respiratory Rate","Other, SOC",230
"EUCTR2020-001411-25-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Italy","Rome","2020-Jan",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Labor Absenteeism, Fever, SpO2, Respiratory Rate","Other, SOC",230
"EUCTR2020-001411-25-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"United Kingdom","London","2020-Jan",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Labor Absenteeism, Fever, SpO2, Respiratory Rate","Other, SOC",230
"EUCTR2020-001411-25-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"India","New Delhi","2020-Jan",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Labor Absenteeism, Fever, SpO2, Respiratory Rate","Other, SOC",230
"EUCTR2020-001411-25-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"France","Paris","2020-Jan",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Labor Absenteeism, Fever, SpO2, Respiratory Rate","Other, SOC",230
"EUCTR2020-001411-25-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Canada","Ottawa","2020-Jan",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Labor Absenteeism, Fever, SpO2, Respiratory Rate","Other, SOC",230
"EUCTR2020-001411-25-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Belgium","Brussels","2020-Jan",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Labor Absenteeism, Fever, SpO2, Respiratory Rate","Other, SOC",230
"EUCTR2020-001411-25-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Malaysia","Kuala Lumpur","2020-Jan",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Labor Absenteeism, Fever, SpO2, Respiratory Rate","Other, SOC",230
"EUCTR2020-001411-25-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Australia","Canberra","2020-Jan",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Labor Absenteeism, Fever, SpO2, Respiratory Rate","Other, SOC",230
"EUCTR2020-001411-25-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25",NA,"Germany","Berlin","2020-Jan",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Labor Absenteeism, Fever, SpO2, Respiratory Rate","Other, SOC",230
"NCT04393727","https://clinicaltrials.gov/show/NCT04393727",NA,"Italy","Rome","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Invasive Mechanical Ventilation or ECMO","Plasma based therapy",126
"NCT04376684","https://ClinicalTrials.gov/show/NCT04376684",NA,"United States","California","2020-May","2020-Dec","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"NCT04376684","https://ClinicalTrials.gov/show/NCT04376684",NA,"United States","Maryland","2020-May","2020-Dec","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"NCT04376684","https://ClinicalTrials.gov/show/NCT04376684",NA,"United States","Minnesota","2020-May","2020-Dec","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"NCT04376684","https://ClinicalTrials.gov/show/NCT04376684",NA,"United States","North Carolina","2020-May","2020-Dec","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"NCT04376684","https://ClinicalTrials.gov/show/NCT04376684",NA,"United States","Ohio","2020-May","2020-Dec","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"NCT04376684","https://ClinicalTrials.gov/show/NCT04376684",NA,"United States","Pennsylvania","2020-May","2020-Dec","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"NCT04376684","https://ClinicalTrials.gov/show/NCT04376684",NA,"United States","Washington","2020-May","2020-Dec","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"NCT04376684","https://ClinicalTrials.gov/show/NCT04376684",NA,"France","Paris","2020-May","2020-Dec","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"NCT04376684","https://ClinicalTrials.gov/show/NCT04376684",NA,"Netherlands","Amsterdam","2020-May","2020-Dec","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"NCT04376684","https://ClinicalTrials.gov/show/NCT04376684",NA,"Spain","Madrid","2020-May","2020-Dec","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"NCT04376684","https://ClinicalTrials.gov/show/NCT04376684",NA,"United Kingdom","Manchester","2020-May","2020-Dec","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"NCT04376684","https://ClinicalTrials.gov/show/NCT04376684",NA,"United Kingdom","Liverpool","2020-May","2020-Dec","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"NCT04426695","https://ClinicalTrials.gov/show/NCT04426695",NA,"United States","California","2020-Jun","2021-Jan","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies","mAB",1860
"NCT04426695","https://ClinicalTrials.gov/show/NCT04426695",NA,"United States","Colorado","2020-Jun","2021-Jan","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies","mAB",1860
"NCT04426695","https://ClinicalTrials.gov/show/NCT04426695",NA,"United States","Florida","2020-Jun","2021-Jan","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies","mAB",1860
"NCT04426695","https://ClinicalTrials.gov/show/NCT04426695",NA,"United States","Georgia","2020-Jun","2021-Jan","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies","mAB",1860
"NCT04426695","https://ClinicalTrials.gov/show/NCT04426695",NA,"United States","Illinois","2020-Jun","2021-Jan","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies","mAB",1860
"NCT04426695","https://ClinicalTrials.gov/show/NCT04426695",NA,"United States","Indiana","2020-Jun","2021-Jan","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies","mAB",1860
"NCT04426695","https://ClinicalTrials.gov/show/NCT04426695",NA,"United States","Louisiana","2020-Jun","2021-Jan","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies","mAB",1860
"NCT04426695","https://ClinicalTrials.gov/show/NCT04426695",NA,"United States","Minnesota","2020-Jun","2021-Jan","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies","mAB",1860
"NCT04426695","https://ClinicalTrials.gov/show/NCT04426695",NA,"United States","Missouri","2020-Jun","2021-Jan","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies","mAB",1860
"NCT04426695","https://ClinicalTrials.gov/show/NCT04426695",NA,"United States","New Jersey","2020-Jun","2021-Jan","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies","mAB",1860
"NCT04426695","https://ClinicalTrials.gov/show/NCT04426695",NA,"United States","New York","2020-Jun","2021-Jan","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies","mAB",1860
"NCT04426695","https://ClinicalTrials.gov/show/NCT04426695",NA,"United States","North Carolina","2020-Jun","2021-Jan","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies","mAB",1860
"NCT04426695","https://ClinicalTrials.gov/show/NCT04426695",NA,"United States","Ohio","2020-Jun","2021-Jan","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies","mAB",1860
"NCT04426695","https://ClinicalTrials.gov/show/NCT04426695",NA,"United States","Pennsylvania","2020-Jun","2021-Jan","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies","mAB",1860
"NCT04426695","https://ClinicalTrials.gov/show/NCT04426695",NA,"United States","Texas","2020-Jun","2021-Jan","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies","mAB",1860
"NCT04426695","https://ClinicalTrials.gov/show/NCT04426695",NA,"United States","Washington","2020-Jun","2021-Jan","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies","mAB",1860
"NCT04379076","https://ClinicalTrials.gov/show/NCT04379076",NA,"United Kingdom","London","2020-May","2020-Oct","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Serious or Seconday Infections, C-Reactive Protein, Ferritin, Lymphocyte Count, D-Dimer, CD4, CD8","Other, SOC",48
"EUCTR2020-001370-30-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001370-30",NA,"United States","Washington, Dc","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO","mAb, SOC",450
"EUCTR2020-001370-30-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001370-30",NA,"France","Paris","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO","mAb, SOC",450
"EUCTR2020-001370-30-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001370-30",NA,"Spain","Madrid","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO","mAb, SOC",450
"EUCTR2020-001370-30-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001370-30",NA,"Germany","Berlin","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO","mAb, SOC",450
"EUCTR2020-001370-30-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001370-30",NA,"United Kingdom","London","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO","mAb, SOC",450
"EUCTR2020-001370-30-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001370-30",NA,"Italy","Rome","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO","mAb, SOC",450
"EUCTR2020-001370-30-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001370-30",NA,"United States","Washington, Dc","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO","mAb, SOC",450
"EUCTR2020-001370-30-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001370-30",NA,"France","Paris","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO","mAb, SOC",450
"EUCTR2020-001370-30-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001370-30",NA,"Spain","Madrid","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO","mAb, SOC",450
"EUCTR2020-001370-30-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001370-30",NA,"Germany","Berlin","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO","mAb, SOC",450
"EUCTR2020-001370-30-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001370-30",NA,"Italy","Rome","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO","mAb, SOC",450
"EUCTR2020-001370-30-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001370-30",NA,"United Kingdom","London","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO","mAb, SOC",450
"NCT04382053","https://ClinicalTrials.gov/show/NCT04382053",NA,"Denmark","Copenhagen","2020-May","2020-Nov","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Quality of Life","Other, SOC",120
"NCT04382053","https://ClinicalTrials.gov/show/NCT04382053",NA,"Germany","Berlin","2020-May","2020-Nov","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Quality of Life","Other, SOC",120
"NCT04382053","https://ClinicalTrials.gov/show/NCT04382053",NA,"Hungary","Budapest","2020-May","2020-Nov","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Quality of Life","Other, SOC",120
"NCT04382651","https://ClinicalTrials.gov/show/NCT04382651",NA,"United States","California","2020-May","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Ferritin, Quality of Life","Other, SOC",120
"NCT04382651","https://ClinicalTrials.gov/show/NCT04382651",NA,"United States","District Of Columbia","2020-May","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Ferritin, Quality of Life","Other, SOC",120
"NCT04382651","https://ClinicalTrials.gov/show/NCT04382651",NA,"United States","Louisiana","2020-May","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Ferritin, Quality of Life","Other, SOC",120
"NCT04382651","https://ClinicalTrials.gov/show/NCT04382651",NA,"United States","Ohio","2020-May","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Ferritin, Quality of Life","Other, SOC",120
"NCT04422678","https://ClinicalTrials.gov/show/NCT04422678",NA,"Egypt","Al Iskandariyah","2020-Jun","2020-Sep","Not Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO","Imatinib, SOC",30
"2020-001904-41","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001904-41/GB/",NA,"United Kingdom","London","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital",NA,"FPV, SOC",302
"2020-001786-36","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001786-36/GB/",NA,"Belgium","Brussels","2020-Apr",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Serious or Seconday Infections, Adverse Events, C-Reactive Protein, Ferritin, Monocyte Count, Lymphocyte Count, D-Dimer, CD4, CD8, Radiographic Findings","Other, SOC",200
"2020-001786-36","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001786-36/GB/",NA,"France","Paris","2020-Apr",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Serious or Seconday Infections, Adverse Events, C-Reactive Protein, Ferritin, Monocyte Count, Lymphocyte Count, D-Dimer, CD4, CD8, Radiographic Findings","Other, SOC",200
"2020-001786-36","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001786-36/GB/",NA,"Italy","Rome","2020-Apr",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Serious or Seconday Infections, Adverse Events, C-Reactive Protein, Ferritin, Monocyte Count, Lymphocyte Count, D-Dimer, CD4, CD8, Radiographic Findings","Other, SOC",200
"2020-001786-36","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001786-36/GB/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Serious or Seconday Infections, Adverse Events, C-Reactive Protein, Ferritin, Monocyte Count, Lymphocyte Count, D-Dimer, CD4, CD8, Radiographic Findings","Other, SOC",200
"2020-001786-36","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001786-36/GB/",NA,"United States","Washington, Dc","2020-Apr",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Serious or Seconday Infections, Adverse Events, C-Reactive Protein, Ferritin, Monocyte Count, Lymphocyte Count, D-Dimer, CD4, CD8, Radiographic Findings","Other, SOC",200
"NCT04324489","https://ClinicalTrials.gov/show/NCT04324489",NA,"China","Hubei","2020-Mar","2020-Apr","Completed","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation",NA,4
"2020-001909-22","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001909-22/FR/",NA,"France","Paris","2020-Apr",NA,"Recruiting","Randomised","Double",2,"Confirmed, Suspected","Hospital","Mortality, ICU Admission, ALT, AST","Respiratory stimulant, SOC",NA
"ISRCTN54917435","http://isrctn.com/ISRCTN54917435",NA,"Sweden","Stockholm","2020-Jun",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Invasive Mechanical Ventilation or ECMO","Positioning, SOC",240
"NCT04415073","https://ClinicalTrials.gov/show/NCT04415073",NA,"United States","Arizona","2020-Jun","2020-Nov","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Hospitalization, Clinical Improvement Score (Any)","mAb, SOC",186
"NCT04415073","https://ClinicalTrials.gov/show/NCT04415073",NA,"United States","New York","2020-Jun","2020-Nov","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Hospitalization, Clinical Improvement Score (Any)","mAb, SOC",186
"JPRN-JRCT2031200035","https://rctportal.niph.go.jp/en/detail?trial_id=JRCT2031200035",NA,"United States","Washington, Dc","2020-May",NA,"Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, Remdesivir + JAKi",35
"JPRN-JRCT2031200035","https://rctportal.niph.go.jp/en/detail?trial_id=JRCT2031200035",NA,"Japan","Toyama","2020-May",NA,"Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose","Remdesivir, Remdesivir + JAKi",35
"NCT04432766","https://ClinicalTrials.gov/show/NCT04432766",NA,"China","Guangdong","2020-Jun","2020-Oct","Not Recruiting","Randomised","Double",6,"Confirmed","Hospital","Mortality, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events","Other, SOC",174
"NCT04429854","https://ClinicalTrials.gov/show/NCT04429854",NA,"Belgium","Antwerp","2020-Jun","2021-Nov","Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO","Plasma based therapy, SOC",483
"NCT04429854","https://ClinicalTrials.gov/show/NCT04429854",NA,"Belgium","Brussels","2020-Jun","2021-Nov","Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO","Plasma based therapy, SOC",483
"CHICTR2000029656","http://www.chictr.org.cn/showproj.aspx?proj=49086",NA,"China","Hubei","2020-Feb","2020-Apr","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Clinical Improvement Score (Any), Radiographic Findings","Corticosteroids, SOC",100
"CHICTR2000029308","http://www.chictr.org.cn/showproj.aspx?proj=48684","https://www.nejm.org/doi/pdf/10.1056/NEJMoa2001282?articleTools=true","China","Hubei","2020-Jan","2021-Jan","Completed w. Results","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events","LPV/r, SOC",160
"IRCT20200405046960N2","http://en.irct.ir/trial/48126",NA,"Iran","Tehran","2020-May","2020-Jul","Completed","Randomised","Double",2,"Confirmed Or Suspected","Hospital","Cough, Fever, C-Reactive Protein, White Blood Cell Count, Lymphocyte Count, SpO2, Respiratory Rate","Alternative therapy, SOC",60
"IRCT20200506047323N1","http://en.irct.ir/trial/48114",NA,"Iran","Tehran","2020-May","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Fever, Serious Adverse Events, C-Reactive Protein, SpO2, Respiratory Rate","Alternative therapy + HCQ, HCQ",84
"NCT04323514","https://ClinicalTrials.gov/show/NCT04323514",NA,"Italy","Palermo","2020-Mar","2021-Mar","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Hospitalization, Viral Load or Clearance, Cough, Fever, Dyspnea, Other Mild Symptoms, Peak RRadiographic Findings","Vitamins",500
"NCT04325061","https://ClinicalTrials.gov/show/NCT04325061",NA,"Spain","Barcelona","2020-Mar","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","Dexamethasone, SOC",200
"NCT04325061","https://ClinicalTrials.gov/show/NCT04325061",NA,"Spain","Las Palmas","2020-Mar","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","Dexamethasone, SOC",200
"NCT04325061","https://ClinicalTrials.gov/show/NCT04325061",NA,"Spain","Madrid","2020-Mar","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","Dexamethasone, SOC",200
"NCT04325061","https://ClinicalTrials.gov/show/NCT04325061",NA,"Spain","Ciudad Real","2020-Mar","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","Dexamethasone, SOC",200
"NCT04325061","https://ClinicalTrials.gov/show/NCT04325061",NA,"Spain","Murcia","2020-Mar","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","Dexamethasone, SOC",200
"NCT04325061","https://ClinicalTrials.gov/show/NCT04325061",NA,"Spain","Pontevedra","2020-Mar","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","Dexamethasone, SOC",200
"NCT04325061","https://ClinicalTrials.gov/show/NCT04325061",NA,"Spain","Valencia","2020-Mar","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","Dexamethasone, SOC",200
"NCT04325061","https://ClinicalTrials.gov/show/NCT04325061",NA,"Spain","Valladolid","2020-Mar","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","Dexamethasone, SOC",200
"NCT04441385","https://ClinicalTrials.gov/show/NCT04441385",NA,"Spain","Barcelona","2020-Jun","2020-Nov","Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Mortality, ICU Admission, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Adverse Events, ECG","Antivirals, SOC",200
"NCT04441385","https://ClinicalTrials.gov/show/NCT04441385",NA,"Spain","Madrid","2020-Jun","2020-Nov","Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Mortality, ICU Admission, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Adverse Events, ECG","Antivirals, SOC",200
"NCT04329650","https://ClinicalTrials.gov/show/NCT04329650",NA,"Spain","Madrid","2020-Apr","2020-May","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Ferritin, Lymphocyte Count, Platelet Count, Hemoglobin, D-Dimer, ALT, Bilirubin, LDH, SpO2, Hypoxemia","Corticosteroids, Siltuximab",200
"NCT04329650","https://ClinicalTrials.gov/show/NCT04329650",NA,"Spain","Barcelona","2020-Apr","2020-May","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Ferritin, Lymphocyte Count, Platelet Count, Hemoglobin, D-Dimer, ALT, Bilirubin, LDH, SpO2, Hypoxemia","Corticosteroids, Siltuximab",200
"NCT04329650","https://ClinicalTrials.gov/show/NCT04329650",NA,"Spain","Salamanca","2020-Apr","2020-May","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Ferritin, Lymphocyte Count, Platelet Count, Hemoglobin, D-Dimer, ALT, Bilirubin, LDH, SpO2, Hypoxemia","Corticosteroids, Siltuximab",200
"NCT04429334","https://ClinicalTrials.gov/show/NCT04429334",NA,"France","Paris","2020-Jun","2021-Mar","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Adverse Events","Other, SOC",60
"NCT04426344","https://ClinicalTrials.gov/show/NCT04426344",NA,"United States","Missouri","2020-Jun","2020-Nov","Not Recruiting","Randomised","Single",2,"Confirmed","Hospital","Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2","Other, SOC",20
"CHICTR2000030929","http://www.chictr.org.cn/showproj.aspx?proj=50696",NA,"China","Hubei","2020-Mar","2020-Jun","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Clinical Improvement Score (Any), Cough, Fever, Other Mild Symptoms","Plasma based therapy, SOC",60
"NCT04389450","https://clinicaltrials.gov/show/NCT04389450",NA,"United States","Washington, Dc","2020-May",NA,"Recruiting","Randomised","Quadruple",5,"Confirmed","Hospital",NA,"SOC, Stem cells",140
"NCT04389450","https://clinicaltrials.gov/show/NCT04389450",NA,"Israel","Jerusalem","2020-May",NA,"Recruiting","Randomised","Quadruple",5,"Confirmed","Hospital",NA,"SOC, Stem cells",140
"IRCT20120215009014N355","http://en.irct.ir/trial/48039",NA,"Iran","Hamadan","2020-May","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality","Other, SOC",92
"CHICTR2000032367","http://www.chictr.org.cn/showproj.aspx?proj=52972",NA,"China","Shanghai","2020-Apr","2020-Jul","Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Hospitalization, Dyspnea, Other Mild Symptoms","Exercise, SOC",186
"CTRI/2020/04/024806","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42843",NA,"India","New Delhi","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital",NA,"Imatinib, SOC",100
"NCT04348383","https://ClinicalTrials.gov/show/NCT04348383",NA,"Spain","Murcia","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Non-invasive Ventilation, C-Reactive Protein, IL-6, D-Dimer, Creatinine Phosphokinase, LDH, Radiographic Findings","Antithrombotics, SOC",120
"2020-001618-39","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001618-39/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Ferritin, IL-1, IL-6, Lymphocyte Count, Neutrophils, Platelet Count, D-Dimer, LDH, SpO2","Other, SOC",NA
"NCT04350320","https://ClinicalTrials.gov/show/NCT04350320",NA,"Spain","Murcia","2020-Apr","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), C-Reactive Protein, Ferritin, IL-1, IL-6, Tumor Necrosis Factor (Any), Granulocyte Stimulaiting Factor, White Blood Cell Count, D-Dimer, LDH","Colchicine, SOC",102
"JPRN-JRCT2031190264","https://jrct.niph.go.jp/latest-detail/jRCT2031190264",NA,"Japan","Toyama","2020-Mar",NA,"Not Recruiting","Randomised","Double",NA,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose, Renal Outcome (Unspecified)",NA,100
"JPRN-JRCT2031190264","https://jrct.niph.go.jp/latest-detail/jRCT2031190264",NA,"South Korea","Seoul","2020-Mar",NA,"Not Recruiting","Randomised","Double",NA,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose, Renal Outcome (Unspecified)",NA,100
"NCT04344535","https://clinicaltrials.gov/show/NCT04344535",NA,"United States","Washington, Dc","2020-Oct",NA,"Recruiting","Randomised","Quadruple",2,"Mixed","Hospital","Clinical Improvement Score (Any), Distress","Plasma based therapy, SOC",500
"IRCT20160310026998N11","http://en.irct.ir/trial/46690",NA,"Iran","East Azarbaijan","2020-Mar","2020-Apr","Completed","Randomised","Open-Label",2,"Mixed","Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO",NA,200
"NCT04351724","https://ClinicalTrials.gov/show/NCT04351724",NA,"Austria","Tirol","2020-Apr","2020-Dec","Recruiting","Randomised","Open-Label",9,"Yes","Hospital","Mortality, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events","Anticoagulants, HCQ, LPV/r, mAb, RAS blockade, SOC",500
"NCT04351724","https://ClinicalTrials.gov/show/NCT04351724",NA,"Austria","Vienna","2020-Apr","2020-Dec","Recruiting","Randomised","Open-Label",9,"Yes","Hospital","Mortality, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events","Anticoagulants, HCQ, LPV/r, mAb, RAS blockade, SOC",500
"NCT04392973","https://clinicaltrials.gov/show/NCT04392973",NA,"Saudi Arabia","Riyadh","2020-Oct",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Clinical Improvement Score (Any)","HCQ + FPV, SOC",520
"NCT04384445","https://ClinicalTrials.gov/show/NCT04384445",NA,"United States","Florida","2020-May","2020-Oct","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, D-Dimer, Radiographic Findings","Other, SOC",20
"NCT04384445","https://ClinicalTrials.gov/show/NCT04384445",NA,"United States","Georgia","2020-May","2020-Oct","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, D-Dimer, Radiographic Findings","Other, SOC",20
"NCT04396106","https://ClinicalTrials.gov/show/NCT04396106",NA,"United States","California","2020-May","2020-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Invasive Mechanical Ventilation or ECMO, Fever, Other Mild Symptoms, Adverse Events, Respiratory Rate","Other, SOC",190
"NCT04396106","https://ClinicalTrials.gov/show/NCT04396106",NA,"United States","Illinois","2020-May","2020-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Invasive Mechanical Ventilation or ECMO, Fever, Other Mild Symptoms, Adverse Events, Respiratory Rate","Other, SOC",190
"NCT04396106","https://ClinicalTrials.gov/show/NCT04396106",NA,"United States","Massachusetts","2020-May","2020-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Invasive Mechanical Ventilation or ECMO, Fever, Other Mild Symptoms, Adverse Events, Respiratory Rate","Other, SOC",190
"NCT04396106","https://ClinicalTrials.gov/show/NCT04396106",NA,"United States","Ohio","2020-May","2020-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Invasive Mechanical Ventilation or ECMO, Fever, Other Mild Symptoms, Adverse Events, Respiratory Rate","Other, SOC",190
"NCT04396106","https://ClinicalTrials.gov/show/NCT04396106",NA,"United States","South Carolina","2020-May","2020-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Invasive Mechanical Ventilation or ECMO, Fever, Other Mild Symptoms, Adverse Events, Respiratory Rate","Other, SOC",190
"NCT04379271","https://ClinicalTrials.gov/show/NCT04379271",NA,"Bulgaria","Sofia","2020-May","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, C-Reactive Protein, Tumor Necrosis Factor (Any), Interferon (Any), D-Dimer, Weight, Height or BMI, Troponin, Procalcitonin, LDH, IgG, IgM or IgA, Antibodies, Blood Pressure, Heart Rate, ECG, SpO2, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Immunomodulators, SOC",230
"NCT04379271","https://ClinicalTrials.gov/show/NCT04379271",NA,"Germany","Berlin","2020-May","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, C-Reactive Protein, Tumor Necrosis Factor (Any), Interferon (Any), D-Dimer, Weight, Height or BMI, Troponin, Procalcitonin, LDH, IgG, IgM or IgA, Antibodies, Blood Pressure, Heart Rate, ECG, SpO2, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Immunomodulators, SOC",230
"CTRI/2020/04/024775","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43149",NA,"India","Delhi","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Pneumonia or ARDS, PaO2-FiO2","Plasma based therapy, SOC",452
"NCT04373044","https://ClinicalTrials.gov/show/NCT04373044",NA,"United States","California","2020-May","2021-May","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, C-Reactive Protein, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, Hemoglobin, Blood Pressure, Respiratory Rate, Radiographic Findings, Cardiac Outcome (Unspecified)","JAKi + Antivirals",144
"NCT04434248","https://ClinicalTrials.gov/show/NCT04434248",NA,"Russia","Moscow","2020-Jun","2020-Jul","Not Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, ICU Admission, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Radiographic Findings","FPV, SOC",330
"NCT04434248","https://ClinicalTrials.gov/show/NCT04434248",NA,"Russia","Novgorod","2020-Jun","2020-Jul","Not Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, ICU Admission, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Radiographic Findings","FPV, SOC",330
"NCT04434248","https://ClinicalTrials.gov/show/NCT04434248",NA,"Russia","Kirov","2020-Jun","2020-Jul","Not Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, ICU Admission, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Radiographic Findings","FPV, SOC",330
"NCT04434248","https://ClinicalTrials.gov/show/NCT04434248",NA,"Russia","Saratov","2020-Jun","2020-Jul","Not Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, ICU Admission, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Radiographic Findings","FPV, SOC",330
"NCT04434248","https://ClinicalTrials.gov/show/NCT04434248",NA,"Russia","Smolensk","2020-Jun","2020-Jul","Not Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, ICU Admission, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Radiographic Findings","FPV, SOC",330
"2020-001805-21","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001805-21/GB/",NA,"United Kingdom","London","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Renal Outcome (Unspecified)","Oseltamivir, Oseltamivir + Other",120
"2020-001886-35","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001886-35/GB/",NA,"United Kingdom","London","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Glucose, Surfactant Factor Protein, PaO2-FiO2","Other, SOC",20
"NCT04442178","https://ClinicalTrials.gov/show/NCT04442178",NA,"United States","Washington","2020-Jun","2020-Nov","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Serious or Seconday Infections, C-Reactive Protein, Ferritin, Lymphocyte Count, D-Dimer, CD4, CD8","Other, SOC",48
"NCT04424901","https://ClinicalTrials.gov/show/NCT04424901",NA,"United States","Connecticut","2020-Jun","2021-May","Recruiting","Single-Arm","Open-Label",2,"Confirmed","Hospital","Coagulation Test","Other, SOC",100
"IRCT20200509047373N1","http://en.irct.ir/trial/48001",NA,"Iran","Fars","2020-May","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Hospitalization, Hospital Discharge, Fever, SpO2","Alternative therapy, SOC",60
"RPCEC00000311","https://rpcec.sld.cu/en/trials/RPCEC00000311-En",NA,"Cuba","Havana","2020-Dec",NA,"Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital",NA,"mAb",80
"NCT04402879","https://ClinicalTrials.gov/show/NCT04402879",NA,"Canada","Alberta","2020-May","2020-Dec","Recruiting","Randomised","Open-Label",2,"Suspected","Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, SpO2","Positioning, SOC",596
"NCT04442191","https://ClinicalTrials.gov/show/NCT04442191",NA,"United States","Illinois","2020-Jun","2021-May","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, C-Reactive Protein, Ferritin, Lymphocyte Count, D-Dimer, LDH","Plasma based therapy, SOC",50
"NCT04315480","https://clinicaltrials.gov/show/NCT04315480",NA,"Italy","Rome","2020-Mar",NA,"Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, D-Dimer, Antibodies, PaO2-FiO2","TCZ",38
"2020-001275-32","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001275-32/DK/",NA,"Denmark","Copenhagen","2020-Mar",NA,"Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, C-Reactive Protein","Sarilumab, TCZ",NA
"2020-001265-36","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001265-36/IE/",NA,"Ireland","Dublin","2020-Apr",NA,"Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, PaO2-FiO2","HCQ, HCQ + AZT, SOC",267
"NCT04312009","https://ClinicalTrials.gov/show/NCT04312009",NA,"United States","Florida","2020-Mar","2021-Apr","Recruiting","Randomised","Quadruple",2,"Confirmed Or Suspected","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Dyspnea, Organ Failure or Dysfunction (SOFA), PaO2-FiO2","ARBs",200
"NCT04312009","https://ClinicalTrials.gov/show/NCT04312009",NA,"United States","Minnesota","2020-Mar","2021-Apr","Recruiting","Randomised","Quadruple",2,"Confirmed Or Suspected","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Dyspnea, Organ Failure or Dysfunction (SOFA), PaO2-FiO2","ARBs",200
"NCT04312009","https://ClinicalTrials.gov/show/NCT04312009",NA,"United States","Mississippi","2020-Mar","2021-Apr","Recruiting","Randomised","Quadruple",2,"Confirmed Or Suspected","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Dyspnea, Organ Failure or Dysfunction (SOFA), PaO2-FiO2","ARBs",200
"NCT04276688","https://ClinicalTrials.gov/show/NCT04276688",NA,"China","Hong Kong","2020-Feb","2020-Mar","Completed","Randomised","Open-Label",3,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events, IL-6, Tumor Necrosis Factor (Any)","LPV/r, LPV/r + IFN",127
"NCT04316377","https://ClinicalTrials.gov/show/NCT04316377",NA,"Norway","Oslo","2020-Mar","2020-May","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance","HCQ, SOC",53
"NCT04317040","https://ClinicalTrials.gov/show/NCT04317040",NA,"United States","Florida","2020-Mar","2020-Sep","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Lymphocyte Count, D-Dimer","Immunomodulators, SOC",230
"NCT04317040","https://ClinicalTrials.gov/show/NCT04317040",NA,"United States","Georgia","2020-Mar","2020-Sep","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Lymphocyte Count, D-Dimer","Immunomodulators, SOC",230
"NCT04317040","https://ClinicalTrials.gov/show/NCT04317040",NA,"United States","Maryland","2020-Mar","2020-Sep","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Lymphocyte Count, D-Dimer","Immunomodulators, SOC",230
"NCT04317040","https://ClinicalTrials.gov/show/NCT04317040",NA,"United States","Michigan","2020-Mar","2020-Sep","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Lymphocyte Count, D-Dimer","Immunomodulators, SOC",230
"NCT04317040","https://ClinicalTrials.gov/show/NCT04317040",NA,"United States","New Jersey","2020-Mar","2020-Sep","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Lymphocyte Count, D-Dimer","Immunomodulators, SOC",230
"NCT04317040","https://ClinicalTrials.gov/show/NCT04317040",NA,"United States","Ohio","2020-Mar","2020-Sep","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Lymphocyte Count, D-Dimer","Immunomodulators, SOC",230
"NCT04317040","https://ClinicalTrials.gov/show/NCT04317040",NA,"United States","Pennsylvania","2020-Mar","2020-Sep","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Lymphocyte Count, D-Dimer","Immunomodulators, SOC",230
"NCT04351152","https://ClinicalTrials.gov/show/NCT04351152",NA,"United States","Arizona","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,"Yes","Hospital","Mortality, ICU Admission, Hospital Discharge, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, PaO2-FiO2","mAb, SOC",238
"NCT04351152","https://ClinicalTrials.gov/show/NCT04351152",NA,"United States","Florida","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,"Yes","Hospital","Mortality, ICU Admission, Hospital Discharge, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, PaO2-FiO2","mAb, SOC",238
"NCT04351152","https://ClinicalTrials.gov/show/NCT04351152",NA,"United States","Georgia","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,"Yes","Hospital","Mortality, ICU Admission, Hospital Discharge, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, PaO2-FiO2","mAb, SOC",238
"NCT04351152","https://ClinicalTrials.gov/show/NCT04351152",NA,"United States","Minnesota","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,"Yes","Hospital","Mortality, ICU Admission, Hospital Discharge, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, PaO2-FiO2","mAb, SOC",238
"NCT04351152","https://ClinicalTrials.gov/show/NCT04351152",NA,"United States","New Hampshire","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,"Yes","Hospital","Mortality, ICU Admission, Hospital Discharge, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, PaO2-FiO2","mAb, SOC",238
"NCT04351152","https://ClinicalTrials.gov/show/NCT04351152",NA,"United States","North Carolina","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,"Yes","Hospital","Mortality, ICU Admission, Hospital Discharge, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, PaO2-FiO2","mAb, SOC",238
"NCT04351152","https://ClinicalTrials.gov/show/NCT04351152",NA,"United States","Texas","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,"Yes","Hospital","Mortality, ICU Admission, Hospital Discharge, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, PaO2-FiO2","mAb, SOC",238
"ACTRN12620000445976","https://anzctr.org.au/ACTRN12620000445976.aspx",NA,"Australia","Canberra","2020-Jun",NA,"Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + HCQ",2500
"ACTRN12620000445976","https://anzctr.org.au/ACTRN12620000445976.aspx",NA,"New Zealand","Wellington","2020-Jun",NA,"Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + HCQ",2500
"EUCTR2020-001039-29-GR","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001039-29",NA,"Greece","Athens","2020-Mar",NA,"Not Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), PaO2-FiO2, Radiographic Findings","Anakinra, TCZ",40
"JPRN-JAPICCTI-205238","https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205238",NA,"Japan","Tokyo","2020-Mar",NA,"Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Adverse Events, Serious Adverse Events, Radiographic Findings","FPV, SOC",96
"NCT04381936","https://ClinicalTrials.gov/show/NCT04381936",NA,"United Kingdom","London","2020-May","2021-Dec","Recruiting","Randomised","Open-Label",6,"Confirmed","Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Renal Outcome (Unspecified)",NA,15000
"NL8490","https://trialregister.nl/trial/8490",NA,"Netherlands","Amsterdam","2020-Mar",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Clinical Improvement Score (Any), Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events",NA,950
"NCT04348071","https://ClinicalTrials.gov/show/NCT04348071",NA,"United States","Colorado","2020-Apr","2020-Aug","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, White Blood Cell Count, Hemoglobin, Creatinine Phosphokinase, Prothrombin, ALT, Bilirubin, Glucose","JAKi",80
"NCT04348409","https://ClinicalTrials.gov/show/NCT04348409",NA,"Brazil","Brasilia","2020-Apr","2020-Jul","Recruiting","Randomised","Quadruple",2,"Yes","Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Antivirals, SOC",50
"NCT04329572","https://ClinicalTrials.gov/show/NCT04329572",NA,"Brazil","Brasilia","2020-Apr","2020-May","Suspended","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea","HCQ + AZT",400
"NCT04336462","https://ClinicalTrials.gov/show/NCT04336462",NA,"China","Guangdong","2020-Apr","2020-Feb","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Dyspnea, C-Reactive Protein, White Blood Cell Count, Neutrophils, Hemoglobin, Urine Sample, IgG, IgM or IgA, Blood Urea Nitrogen",NA,100
"NCT04350684","https://ClinicalTrials.gov/show/NCT04350684",NA,"Iran","Tehran","2020-Apr","2020-Apr","Recruiting","Randomised","Triple",5,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Serious Adverse Events","HCQ + LPV/r + IFN, HCQ + LPV/r + IFN + Umifenovir",40
"NCT04363814","https://ClinicalTrials.gov/show/NCT04363814",NA,"Dominican Republic","Santiago","2020-Apr","2021-Jul","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Cough, Fever, Dyspnea, Other Mild Symptoms, Adverse Events, Blood Pressure, Heart Rate, SpO2, Cardiac Outcome (Unspecified)","Other, SOC",100
"NCT04420299","https://ClinicalTrials.gov/show/NCT04420299",NA,"Spain","Madrid","2020-Jun","2021-Mar","Recruiting","Randomised","Single",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, Ferritin, D-Dimer, Radiographic Findings","Other",120
"NCT04330690","https://ClinicalTrials.gov/show/NCT04330690",NA,"Canada","Alberta","2020-Apr","2022-Mar","Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events","LPV/r, SOC",2900
"NCT04330690","https://ClinicalTrials.gov/show/NCT04330690",NA,"Canada","British Columbia","2020-Apr","2022-Mar","Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events","LPV/r, SOC",2900
"NCT04330690","https://ClinicalTrials.gov/show/NCT04330690",NA,"Canada","Ontario","2020-Apr","2022-Mar","Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events","LPV/r, SOC",2900
"NCT04330690","https://ClinicalTrials.gov/show/NCT04330690",NA,"Canada","Quebec","2020-Apr","2022-Mar","Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events","LPV/r, SOC",2900
"NCT04335786","https://ClinicalTrials.gov/show/NCT04335786",NA,"Netherlands","Amsterdam","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation","ARBs, SOC",651
"NCT04335136","https://ClinicalTrials.gov/show/NCT04335136",NA,"Austria","Vienna","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO, LDH","Antihypertensive, SOC",200
"NCT04335136","https://ClinicalTrials.gov/show/NCT04335136",NA,"Austria","Wien","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO, LDH","Antihypertensive, SOC",200
"NCT04335136","https://ClinicalTrials.gov/show/NCT04335136",NA,"Denmark","Copenhagen","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO, LDH","Antihypertensive, SOC",200
"NCT04335136","https://ClinicalTrials.gov/show/NCT04335136",NA,"Germany","Hamburg","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO, LDH","Antihypertensive, SOC",200
"NCT04335136","https://ClinicalTrials.gov/show/NCT04335136",NA,"Germany","Berlin","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO, LDH","Antihypertensive, SOC",200
"NCT04342182","https://ClinicalTrials.gov/show/NCT04342182",NA,"Netherlands","Zuid-Holland","2020-Apr","2020-Jul","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Radiographic Findings","Plasma based therapy, SOC",426
"NCT04342182","https://ClinicalTrials.gov/show/NCT04342182",NA,"Netherlands","Amsterdam","2020-Apr","2020-Jul","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Radiographic Findings","Plasma based therapy, SOC",426
"NCT04342182","https://ClinicalTrials.gov/show/NCT04342182",NA,"Netherlands","Groningen","2020-Apr","2020-Jul","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Radiographic Findings","Plasma based therapy, SOC",426
"NCT04343755","https://ClinicalTrials.gov/show/NCT04343755",NA,"United States","New Jersey","2020-Apr","2021-Apr","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation","Plasma based therapy",55
"NCT04338126","https://ClinicalTrials.gov/show/NCT04338126",NA,"United States","Alabama","2020-Apr","2020-Dec","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms",NA,60
"NCT04338802","https://clinicaltrials.gov/show/NCT04338802",NA,"China","Hubei","2020-Jan",NA,"Not Recruiting","Randomised","Open-Label",1,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO",NA,96
"NCT04334460","https://clinicaltrials.gov/show/NCT04334460",NA,"United States","Washington, Dc","2020-Feb",NA,"Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation, Fever, Treatment-emergent Adverse Events, Serious Adverse Events, IL-6, PaO2-FiO2",NA,120
"NCT04343001","https://ClinicalTrials.gov/show/NCT04343001",NA,"Nigeria","Niger","2020-Apr","2021-Apr","Not Recruiting","Randomised","Open-Label",7,"Presumed","Hospital","Mortality, Hospital Discharge, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Lung Inflamation, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","ARBs, ARBs + Statins, NSAIDs, NSAIDs + ARBs, NSAIDs + ARBs + Statins, NSAIDs + Statins, Statins",10000
"NCT04343001","https://ClinicalTrials.gov/show/NCT04343001",NA,"Pakistan","Islamabad","2020-Apr","2021-Apr","Not Recruiting","Randomised","Open-Label",7,"Presumed","Hospital","Mortality, Hospital Discharge, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Lung Inflamation, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","ARBs, ARBs + Statins, NSAIDs, NSAIDs + ARBs, NSAIDs + ARBs + Statins, NSAIDs + Statins, Statins",10000
"NCT04346147","https://ClinicalTrials.gov/show/NCT04346147",NA,"Spain","Madrid","2020-Apr","2020-Aug","Recruiting","Randomised","Open-Label",4,"Yes","Hospital","Clinical Improvement Score (Any), Treatment-emergent Adverse Events, Serious Adverse Events","HCQ + Imatinib, HCQ + JAKi, HCQ + LPV/r",165
"NCT04343092","https://ClinicalTrials.gov/show/NCT04343092",NA,"Iraq","Baghdad","2020-Apr","2020-May","Completed","Randomised","Double",2,"Yes","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Serious Adverse Events","HCQ + AZT, HCQ + AZT + Other",100
"NCT04348695","https://ClinicalTrials.gov/show/NCT04348695",NA,"Spain","Madrid","2020-Apr","2020-May","Recruiting","Randomised","Open-Label",2,"Yes","Hospital","ICU Admission, Hospitalization, Clinical Improvement Score (Any), Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","JAKi + Statins, SOC",94
"NCT04349098","https://ClinicalTrials.gov/show/NCT04349098",NA,"United States","California","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH","Other, SOC",230
"NCT04349098","https://ClinicalTrials.gov/show/NCT04349098",NA,"United States","Florida","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH","Other, SOC",230
"NCT04349098","https://ClinicalTrials.gov/show/NCT04349098",NA,"United States","Georgia","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH","Other, SOC",230
"NCT04349098","https://ClinicalTrials.gov/show/NCT04349098",NA,"United States","Illinois","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH","Other, SOC",230
"NCT04349098","https://ClinicalTrials.gov/show/NCT04349098",NA,"United States","Kansas","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH","Other, SOC",230
"NCT04349098","https://ClinicalTrials.gov/show/NCT04349098",NA,"United States","Kentucky","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH","Other, SOC",230
"NCT04349098","https://ClinicalTrials.gov/show/NCT04349098",NA,"United States","Massachusetts","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH","Other, SOC",230
"NCT04349098","https://ClinicalTrials.gov/show/NCT04349098",NA,"United States","Michigan","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH","Other, SOC",230
"NCT04349098","https://ClinicalTrials.gov/show/NCT04349098",NA,"United States","New York","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH","Other, SOC",230
"NCT04349098","https://ClinicalTrials.gov/show/NCT04349098",NA,"United States","North Carolina","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH","Other, SOC",230
"NCT04349098","https://ClinicalTrials.gov/show/NCT04349098",NA,"United States","Pennsylvania","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH","Other, SOC",230
"NCT04349098","https://ClinicalTrials.gov/show/NCT04349098",NA,"United States","Texas","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH","Other, SOC",230
"NCT04349098","https://ClinicalTrials.gov/show/NCT04349098",NA,"United States","Washington","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH","Other, SOC",230
"NCT04349098","https://ClinicalTrials.gov/show/NCT04349098",NA,"Austria","Vienna","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH","Other, SOC",230
"NCT04349098","https://ClinicalTrials.gov/show/NCT04349098",NA,"France","Paris","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH","Other, SOC",230
"NCT04349098","https://ClinicalTrials.gov/show/NCT04349098",NA,"Israel","Jerusalem","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH","Other, SOC",230
"NCT04349098","https://ClinicalTrials.gov/show/NCT04349098",NA,"Spain","Barcelona","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH","Other, SOC",230
"NCT04349098","https://ClinicalTrials.gov/show/NCT04349098",NA,"Spain","Salamanca","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH","Other, SOC",230
"NCT04349098","https://ClinicalTrials.gov/show/NCT04349098",NA,"United Kingdom","Kent","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH","Other, SOC",230
"NCT04349098","https://ClinicalTrials.gov/show/NCT04349098",NA,"United Kingdom","London","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH","Other, SOC",230
"NCT04349098","https://ClinicalTrials.gov/show/NCT04349098",NA,"United Kingdom","Plymouth","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH","Other, SOC",230
"NCT04346615","https://ClinicalTrials.gov/show/NCT04346615",NA,"United States","District Of Columbia","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","Other, SOC",120
"NCT04346615","https://ClinicalTrials.gov/show/NCT04346615",NA,"United States","Pennsylvania","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","Other, SOC",120
"NCT04341688","https://ClinicalTrials.gov/show/NCT04341688",NA,"Pakistan","Sind","2020-Apr","2021-Jan","Not Recruiting","Randomised","Quadruple",6,"Yes","Hospital","Mortality, ICU Admission, Hospital Discharge, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, C-Reactive Protein","Hygiene, SOC",50
"NCT04343768","https://ClinicalTrials.gov/show/NCT04343768",NA,"Iran","Tehran","2020-Apr","2020-Apr","Completed","Randomised","Open-Label",4,"Yes","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, SpO2","HCQ + LPV/r, HCQ + LPV/r + IFN",60
"NCT04351490","https://clinicaltrials.gov/show/NCT04351490",NA,"France","Paris","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",2,"Yes","Hospital","Mortality, Viral Load or Clearance","SOC, Zinc + Vitamins",3140
"NCT04346589","https://ClinicalTrials.gov/show/NCT04346589",NA,"Italy","Rome","2020-Apr","2020-Aug","Recruiting","Single-Arm","Open-Label",1,"Yes","Hospital","Mortality, Hospital Discharge, Non-invasive Ventilation","Plasma based therapy",10
"NCT04346589","https://ClinicalTrials.gov/show/NCT04346589",NA,"Italy","Bergamo","2020-Apr","2020-Aug","Recruiting","Single-Arm","Open-Label",1,"Yes","Hospital","Mortality, Hospital Discharge, Non-invasive Ventilation","Plasma based therapy",10
"CHICTR2000031430","http://www.chictr.org.cn/showproj.aspx?proj=49254",NA,"China","Beijing","2020-Mar","2021-Dec","Recruiting","Non-Randomised","Unspecified",2,"Confirmed","Hospital","Clinical Improvement Score (Any), C-Reactive Protein, Ferritin, IL-6, Interferon (Any), Lymphocyte Count, D-Dimer, Creatinine Phosphokinase, CK-MB, eGFR, Myoglobin, Troponin, Procalcitonin, Prothrombin, Coagulation Test, ALT, Albumin, Bilirubin, IgG, IgM or IgA, Blood Gas, ECG, SpO2, 6-Minute Walking Distance, Radiographic Findings, Quality of Life, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","SOC, Stem cells",200
"2020-001270-29","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001270-29/DK/",NA,"Denmark","Copenhagen","2020-Mar",NA,"Status Unclear","Randomised","Open-Label",2,"Confirmed","Hospital","Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Fever, Adverse Events, Serious Adverse Events, PaO2-FiO2",NA,350
"NCT04400032","https://ClinicalTrials.gov/show/NCT04400032",NA,"Canada","Ontario","2020-May","2021-Jan","Not Recruiting","Non-Randomised","Open-Label",3,"Confirmed","Hospital","Adverse Events, Radiographic Findings","Stem cells",9
"NL8538","https://trialregister.nl/trial/8538",NA,"Netherlands","Amsterdam","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital",NA,"Positioning, SOC",342
"NCT04412772","https://ClinicalTrials.gov/show/NCT04412772",NA,"United States","Hawaii","2020-Jun","2021-Dec","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO","SOC, TCZ",300
"2020-001684-89","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001684-89/GB/",NA,"United Kingdom","London","2020-Apr",NA,"Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Serious or Seconday Infections, Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, Neutrophils, D-Dimer, Triglycerides, LDH, PaO2-FiO2, SpO2, Respiratory Rate","mAb, Other",NA
"NCT04335201","https://ClinicalTrials.gov/show/NCT04335201",NA,"Italy","Milano","2020-Apr","2020-Sep","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, IL-6, IL-10, Tumor Necrosis Factor (Any), Interferon (Any), LDH",NA,50
"2020-001632-10","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001632-10/DE/",NA,"Germany","Berlin","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO","Plasma based therapy, SOC",NA
"IRCT20200325046860N1","http://en.irct.ir/trial/46759",NA,"Iran","Tehran","2020-Mar","2020-Aug","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Respiratory Rate",NA,200
"NCT04346199","https://ClinicalTrials.gov/show/NCT04346199",NA,"France","Paris","2020-Apr","2020-Nov","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Serious Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2","Acalabrutinib, SOC",140
"NCT04346199","https://ClinicalTrials.gov/show/NCT04346199",NA,"Italy","Bologna","2020-Apr","2020-Nov","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Serious Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2","Acalabrutinib, SOC",140
"NCT04346199","https://ClinicalTrials.gov/show/NCT04346199",NA,"Italy","Firenze","2020-Apr","2020-Nov","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Serious Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2","Acalabrutinib, SOC",140
"NCT04346199","https://ClinicalTrials.gov/show/NCT04346199",NA,"Italy","Milano","2020-Apr","2020-Nov","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Serious Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2","Acalabrutinib, SOC",140
"NCT04346199","https://ClinicalTrials.gov/show/NCT04346199",NA,"Italy","Roma","2020-Apr","2020-Nov","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Serious Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2","Acalabrutinib, SOC",140
"NCT04346199","https://ClinicalTrials.gov/show/NCT04346199",NA,"Spain","Madrid","2020-Apr","2020-Nov","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Serious Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2","Acalabrutinib, SOC",140
"NCT04440007","https://ClinicalTrials.gov/show/NCT04440007",NA,"United States","California","2020-Jun","2021-Jan","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Treatment-emergent Adverse Events","Other, SOC",80
"NCT04411446","https://ClinicalTrials.gov/show/NCT04411446",NA,"Argentina","Buenos Aires","2020-Jun","2020-Dec","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), SpO2, Renal Outcome (Unspecified)","SOC, Vitamins",1265
"NCT04317092","https://ClinicalTrials.gov/show/NCT04317092",NA,"Italy","Alessandria","2020-Mar","2020-Dec","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2, Radiographic Findings","TCZ",400
"NCT04317092","https://ClinicalTrials.gov/show/NCT04317092",NA,"Italy","Rome","2020-Mar","2020-Dec","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2, Radiographic Findings","TCZ",400
"NCT04317092","https://ClinicalTrials.gov/show/NCT04317092",NA,"Italy","Catania","2020-Mar","2020-Dec","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2, Radiographic Findings","TCZ",400
"NCT04317092","https://ClinicalTrials.gov/show/NCT04317092",NA,"Italy","Cosenza","2020-Mar","2020-Dec","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2, Radiographic Findings","TCZ",400
"NCT04317092","https://ClinicalTrials.gov/show/NCT04317092",NA,"Italy","Modena","2020-Mar","2020-Dec","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2, Radiographic Findings","TCZ",400
"NCT04317092","https://ClinicalTrials.gov/show/NCT04317092",NA,"Italy","Ravenna","2020-Mar","2020-Dec","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2, Radiographic Findings","TCZ",400
"NCT04317092","https://ClinicalTrials.gov/show/NCT04317092",NA,"Italy","Reggio Calabria","2020-Mar","2020-Dec","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2, Radiographic Findings","TCZ",400
"NCT04317092","https://ClinicalTrials.gov/show/NCT04317092",NA,"Italy","Rimini","2020-Mar","2020-Dec","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2, Radiographic Findings","TCZ",400
"NCT04317092","https://ClinicalTrials.gov/show/NCT04317092",NA,"Italy","Varese","2020-Mar","2020-Dec","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2, Radiographic Findings","TCZ",400
"NCT04317092","https://ClinicalTrials.gov/show/NCT04317092",NA,"Italy","Verona","2020-Mar","2020-Dec","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2, Radiographic Findings","TCZ",400
"NCT04375202","https://ClinicalTrials.gov/show/NCT04375202",NA,"Italy","Rome","2020-May","2020-Jun","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Organ Failure or Dysfunction (SOFA), Ferritin, White Blood Cell Count, ALT","Colchicine, SOC",308
"NCT04348500","https://ClinicalTrials.gov/show/NCT04348500",NA,"United States","California","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",2,"Yes","Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation","mAb, SOC",60
"NCT04326426","https://ClinicalTrials.gov/show/NCT04326426",NA,"United States","New York","2020-Mar","2020-Aug","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Cough, Fever, Other Mild Symptoms, IL-6","Other, SOC",300
"NCT04363372","https://ClinicalTrials.gov/show/NCT04363372",NA,"United Kingdom","Plymouth","2020-Apr","2020-Aug","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events","Other, SOC",90
"NCT04363463","https://clinicaltrials.gov/show/NCT04363463",NA,"France","Paris","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Positioning, SOC",400
"NCT04401423","https://ClinicalTrials.gov/show/NCT04401423",NA,"United States","New York","2020-May","2021-Jun","Not Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Mortality, Non-invasive Ventilation, IL-6, Shock, Renal Outcome (Unspecified)","Antihypertensive, SOC",100
"NCT04421404","https://ClinicalTrials.gov/show/NCT04421404",NA,"United States","California","2020-Jun","2021-Apr","Recruiting","Randomised","Triple",2,"Confirmed","Hospital",NA,"Plasma based therapy, SOC",30
"NCT04310865","https://clinicaltrials.gov/show/NCT04310865",NA,"China","Beijing","2020-Mar",NA,"Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, PaO2-FiO2","TCM",116
"NCT04412291","https://ClinicalTrials.gov/show/NCT04412291",NA,"Sweden","Stockholm","2020-Jun","2020-Aug","Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, Respiratory Rate","Anakinra + Non-invasive respiratory support + Anticoagulants + Antibiotics + Other, Non-invasive respiratory support + Anticoagulants + Antibiotics + Other, TCZ + Non-invasive respiratory support + Anticoagulants + Antibiotics + Other",120
"ACTRN12620000517976","https://anzctr.org.au/ACTRN12620000517976.aspx",NA,"Australia","Canberra","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital",NA,"Anticoagulants, SOC",172
"NCT04325633","https://ClinicalTrials.gov/show/NCT04325633",NA,"France","Paris","2020-Mar","2021-May","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any)","NSAIDs, SOC",584
"NCT04346355","https://ClinicalTrials.gov/show/NCT04346355",NA,"Italy","Rome","2020-Apr","2020-Jun","Status Unclear","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2","SOC, TCZ",126
"NCT04346355","https://ClinicalTrials.gov/show/NCT04346355",NA,"Italy","Reggio Emilia","2020-Apr","2020-Jun","Status Unclear","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2","SOC, TCZ",126
"NCT04346355","https://ClinicalTrials.gov/show/NCT04346355",NA,"Italy","Alessandria","2020-Apr","2020-Jun","Status Unclear","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2","SOC, TCZ",126
"NCT04346355","https://ClinicalTrials.gov/show/NCT04346355",NA,"Italy","Bologna","2020-Apr","2020-Jun","Status Unclear","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2","SOC, TCZ",126
"NCT04346355","https://ClinicalTrials.gov/show/NCT04346355",NA,"Italy","Cremona","2020-Apr","2020-Jun","Status Unclear","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2","SOC, TCZ",126
"NCT04346355","https://ClinicalTrials.gov/show/NCT04346355",NA,"Italy","Cuneo","2020-Apr","2020-Jun","Status Unclear","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2","SOC, TCZ",126
"NCT04346355","https://ClinicalTrials.gov/show/NCT04346355",NA,"Italy","Ferrara","2020-Apr","2020-Jun","Status Unclear","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2","SOC, TCZ",126
"NCT04346355","https://ClinicalTrials.gov/show/NCT04346355",NA,"Italy","Firenze","2020-Apr","2020-Jun","Status Unclear","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2","SOC, TCZ",126
"NCT04346355","https://ClinicalTrials.gov/show/NCT04346355",NA,"Italy","Genova","2020-Apr","2020-Jun","Status Unclear","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2","SOC, TCZ",126
"NCT04346355","https://ClinicalTrials.gov/show/NCT04346355",NA,"Italy","Imperia","2020-Apr","2020-Jun","Status Unclear","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2","SOC, TCZ",126
"NCT04346355","https://ClinicalTrials.gov/show/NCT04346355",NA,"Italy","La Spezia","2020-Apr","2020-Jun","Status Unclear","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2","SOC, TCZ",126
"NCT04346355","https://ClinicalTrials.gov/show/NCT04346355",NA,"Italy","Mantova","2020-Apr","2020-Jun","Status Unclear","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2","SOC, TCZ",126
"NCT04346355","https://ClinicalTrials.gov/show/NCT04346355",NA,"Italy","Milano","2020-Apr","2020-Jun","Status Unclear","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2","SOC, TCZ",126
"NCT04346355","https://ClinicalTrials.gov/show/NCT04346355",NA,"Italy","Novara","2020-Apr","2020-Jun","Status Unclear","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2","SOC, TCZ",126
"NCT04346355","https://ClinicalTrials.gov/show/NCT04346355",NA,"Italy","Padova","2020-Apr","2020-Jun","Status Unclear","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2","SOC, TCZ",126
"NCT04346355","https://ClinicalTrials.gov/show/NCT04346355",NA,"Italy","Parma","2020-Apr","2020-Jun","Status Unclear","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2","SOC, TCZ",126
"NCT04346355","https://ClinicalTrials.gov/show/NCT04346355",NA,"Italy","Piacenza","2020-Apr","2020-Jun","Status Unclear","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2","SOC, TCZ",126
"NCT04346355","https://ClinicalTrials.gov/show/NCT04346355",NA,"Italy","Pisa","2020-Apr","2020-Jun","Status Unclear","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2","SOC, TCZ",126
"NCT04346355","https://ClinicalTrials.gov/show/NCT04346355",NA,"Italy","Bergamo","2020-Apr","2020-Jun","Status Unclear","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2","SOC, TCZ",126
"NCT04346355","https://ClinicalTrials.gov/show/NCT04346355",NA,"Italy","Treviso","2020-Apr","2020-Jun","Status Unclear","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2","SOC, TCZ",126
"NCT04346355","https://ClinicalTrials.gov/show/NCT04346355",NA,"Italy","Venezia","2020-Apr","2020-Jun","Status Unclear","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2","SOC, TCZ",126
"NCT04346355","https://ClinicalTrials.gov/show/NCT04346355",NA,"Italy","Verona","2020-Apr","2020-Jun","Status Unclear","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2","SOC, TCZ",126
"NCT04335032","https://clinicaltrials.gov/show/NCT04335032",NA,"Switzerland","Bern","2020-Jan",NA,"Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital",NA,"Nutrition",240
"NCT04374526","https://ClinicalTrials.gov/show/NCT04374526",NA,"Italy","Roma","2020-May","2020-Sep","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital",NA,"Plasma based therapy, SOC",182
"NCT04374526","https://ClinicalTrials.gov/show/NCT04374526",NA,"Italy","Chieti","2020-May","2020-Sep","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital",NA,"Plasma based therapy, SOC",182
"NCT04374526","https://ClinicalTrials.gov/show/NCT04374526",NA,"Italy","Rome","2020-May","2020-Sep","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital",NA,"Plasma based therapy, SOC",182
"2020-001500-41","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001500-41/BE/",NA,"Belgium","Brussels","2020-Apr",NA,"Recruiting","Randomised","Open-Label",6,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Organ Failure or Dysfunction (SOFA), C-Reactive Protein, Ferritin, IL-1, IL-6, PaO2-FiO2, Radiographic Findings, Hypoxia","Siltuximab, TCZ",NA
"NCT04390152","https://ClinicalTrials.gov/show/NCT04390152",NA,"Colombia","Antioquia","2020-May","2020-Dec","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, Ferritin, IL-6, IL-8, IL-10, Tumor Necrosis Factor (Any), Lymphocyte Count, D-Dimer","HCQ + LPV/r or AZT, Stem cells",40
"EUCTR2020-001696-32-ES","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001696-32",NA,"Spain","Madrid","2020-Aug",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","Igs, SOC",100
"NCT04432324","https://ClinicalTrials.gov/show/NCT04432324",NA,"Spain","Madrid","2020-Jun","2020-Jul","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Hospital Discharge, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Fever, Distress","Igs",100
"NCT04432324","https://ClinicalTrials.gov/show/NCT04432324",NA,"Spain","Barcelona","2020-Jun","2020-Jul","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Hospital Discharge, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Fever, Distress","Igs",100
"NCT04334629","https://ClinicalTrials.gov/show/NCT04334629",NA,"United Kingdom","London","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2","NSAIDs, SOC",230
"NCT04391140","https://ClinicalTrials.gov/show/NCT04391140",NA,"Spain","Barcelona","2020-May","2020-Dec","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality","Positioning + Respiratory support, Respiratory support",248
"2020-001734-36","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001734-36/FR/",NA,"France","Paris","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, Platelet Count, D-Dimer, Fibrinogen, LDH, PaO2-FiO2, SpO2, Respiratory Rate, Shock","Anakinra, SOC",NA
"NCT04379037","https://ClinicalTrials.gov/show/NCT04379037",NA,"Argentina","Buenos Aires","2020-May","2020-Sep","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO","Device",50
"NCT04413838","https://ClinicalTrials.gov/show/NCT04413838",NA,"France","Paris","2020-Jun","2021-Jun","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Adverse Events, IL-1, IL-6, IL-10, Tumor Necrosis Factor (Any), Interferon (Any), PD-1, Lymphocyte Count, CD4, CD8","mAb, SOC",120
"CTRI/2020/05/025161","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43442",NA,"India","New Delhi","2020-May",NA,"Not Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Hospital Discharge, Cough, Fever, Dyspnea","Alternative therapy, SOC",120
"CTRI/2020/05/024959","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42878",NA,"India","New Delhi","2020-Jan",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality","mAb, SOC",30
"NCT04402957","https://ClinicalTrials.gov/show/NCT04402957",NA,"Canada","Ontario","2020-May","2020-Dec","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Dyspnea, Organ Failure or Dysfunction (SOFA), Radiographic Findings, Distress, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Other, SOC",60
"NCT04439006","https://clinicaltrials.gov/show/NCT04439006",NA,"United States","Washington, Dc","2020-Jun",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality","Other, SOC",72
"CTRI/2020/05/025114","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43504",NA,"India","New Delhi","2020-Dec",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital",NA,"FPV, SOC",150
"2020-001759-42","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001759-42/BE/",NA,"Argentina","Buenos Aires","2020-Jun",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"2020-001759-42","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001759-42/BE/",NA,"Belgium","Brussels","2020-Jun",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"2020-001759-42","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001759-42/BE/",NA,"Brazil","Brasilia","2020-Jun",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"2020-001759-42","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001759-42/BE/",NA,"Canada","Ottawa","2020-Jun",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"2020-001759-42","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001759-42/BE/",NA,"Chile","Santiago","2020-Jun",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"2020-001759-42","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001759-42/BE/",NA,"France","Paris","2020-Jun",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"2020-001759-42","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001759-42/BE/",NA,"Japan","Tokyo","2020-Jun",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"2020-001759-42","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001759-42/BE/",NA,"Mexico","Mexico","2020-Jun",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"2020-001759-42","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001759-42/BE/",NA,"Netherlands","Amsterdam","2020-Jun",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"2020-001759-42","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001759-42/BE/",NA,"Poland","Warsaw","2020-Jun",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"2020-001759-42","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001759-42/BE/",NA,"South Africa","Pretoria","2020-Jun",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"2020-001759-42","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001759-42/BE/",NA,"Spain","Madrid","2020-Jun",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"2020-001759-42","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001759-42/BE/",NA,"Sweden","Stockholm","2020-Jun",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"2020-001759-42","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001759-42/BE/",NA,"United Kingdom","London","2020-Jun",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"2020-001759-42","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001759-42/BE/",NA,"United States","Washington, Dc","2020-Jun",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events","mAb, SOC",800
"IRCT20190418043307N1","http://en.irct.ir/trial/47209",NA,"Iran","Tehran","2020-May","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, C-Reactive Protein, Ferritin, White Blood Cell Count, Platelet Count","HCQ, HCQ + Other",100
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","California","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","Colorado","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","Connecticut","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","Hawaii","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","Illinois","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","Indiana","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","Iowa","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","Louisiana","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","Maine","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","Maryland","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","Massachusetts","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","Michigan","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","Minnesota","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","Montana","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","New Hampshire","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","New Jersey","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","New York","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","North Carolina","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","Ohio","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","Oregon","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","Pennsylvania","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","Rhode Island","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","South Carolina","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","Texas","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","Utah","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","Virginia","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United States","Washington","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"China","Beijing","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"France","Paris","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Germany","Berlin","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Germany","Hamburg","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Germany","Schleswig-Holstein","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"China","Hong Kong","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Italy","Bergamo","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Italy","Brescia","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Italy","Cremona","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Italy","Milano","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Italy","Rome","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Italy","Padova","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Italy","Parma","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Italy","Pavia","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Italy","Piacenza","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Italy","Roma","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Japan","Kanagawa","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Japan","Tokyo","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"South Korea","Daegu","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"South Korea","Seoul","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Netherlands","Amsterdam","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Singapore","Singapore","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Spain","Asturias","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Spain","Madrid","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Spain","Barcelona","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Spain","Bizkaia","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Spain","Sevilla","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Spain","Valencia","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Sweden","Stockholm","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Switzerland","Bern","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Taiwan","Taipei","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"Taiwan","Taipei City","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United Kingdom","London","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United Kingdom","Edinburgh","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United Kingdom","Glasgow","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United Kingdom","Liverpool","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United Kingdom","Manchester","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United Kingdom","Plymouth","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04292730","https://ClinicalTrials.gov/show/NCT04292730",NA,"United Kingdom","Sheffield","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events","Remdesivir, SOC",1600
"NCT04386616","https://ClinicalTrials.gov/show/NCT04386616",NA,"United States","California","2020-May","2020-Sep","Recruiting","Randomised","Double",4,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Antibodies, Blood Pressure, Heart Rate, ECG, SpO2, Respiratory Rate, Radiographic Findings, Hypoxemia","mAb, Other, SOC",300
"NCT04386616","https://ClinicalTrials.gov/show/NCT04386616",NA,"United States","Florida","2020-May","2020-Sep","Recruiting","Randomised","Double",4,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Antibodies, Blood Pressure, Heart Rate, ECG, SpO2, Respiratory Rate, Radiographic Findings, Hypoxemia","mAb, Other, SOC",300
"NCT04386616","https://ClinicalTrials.gov/show/NCT04386616",NA,"United States","Louisiana","2020-May","2020-Sep","Recruiting","Randomised","Double",4,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Antibodies, Blood Pressure, Heart Rate, ECG, SpO2, Respiratory Rate, Radiographic Findings, Hypoxemia","mAb, Other, SOC",300
"NCT04386616","https://ClinicalTrials.gov/show/NCT04386616",NA,"United States","Michigan","2020-May","2020-Sep","Recruiting","Randomised","Double",4,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Antibodies, Blood Pressure, Heart Rate, ECG, SpO2, Respiratory Rate, Radiographic Findings, Hypoxemia","mAb, Other, SOC",300
"NCT04386616","https://ClinicalTrials.gov/show/NCT04386616",NA,"United States","New Jersey","2020-May","2020-Sep","Recruiting","Randomised","Double",4,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Antibodies, Blood Pressure, Heart Rate, ECG, SpO2, Respiratory Rate, Radiographic Findings, Hypoxemia","mAb, Other, SOC",300
"NCT04386616","https://ClinicalTrials.gov/show/NCT04386616",NA,"United States","New York","2020-May","2020-Sep","Recruiting","Randomised","Double",4,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Antibodies, Blood Pressure, Heart Rate, ECG, SpO2, Respiratory Rate, Radiographic Findings, Hypoxemia","mAb, Other, SOC",300
"NCT04386616","https://ClinicalTrials.gov/show/NCT04386616",NA,"United States","North Carolina","2020-May","2020-Sep","Recruiting","Randomised","Double",4,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Antibodies, Blood Pressure, Heart Rate, ECG, SpO2, Respiratory Rate, Radiographic Findings, Hypoxemia","mAb, Other, SOC",300
"NCT04386616","https://ClinicalTrials.gov/show/NCT04386616",NA,"United States","Ohio","2020-May","2020-Sep","Recruiting","Randomised","Double",4,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Antibodies, Blood Pressure, Heart Rate, ECG, SpO2, Respiratory Rate, Radiographic Findings, Hypoxemia","mAb, Other, SOC",300
"NCT04386616","https://ClinicalTrials.gov/show/NCT04386616",NA,"United States","Pennsylvania","2020-May","2020-Sep","Recruiting","Randomised","Double",4,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Antibodies, Blood Pressure, Heart Rate, ECG, SpO2, Respiratory Rate, Radiographic Findings, Hypoxemia","mAb, Other, SOC",300
"NCT04386616","https://ClinicalTrials.gov/show/NCT04386616",NA,"United States","Texas","2020-May","2020-Sep","Recruiting","Randomised","Double",4,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Antibodies, Blood Pressure, Heart Rate, ECG, SpO2, Respiratory Rate, Radiographic Findings, Hypoxemia","mAb, Other, SOC",300
"NCT04386616","https://ClinicalTrials.gov/show/NCT04386616",NA,"United States","Virginia","2020-May","2020-Sep","Recruiting","Randomised","Double",4,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Antibodies, Blood Pressure, Heart Rate, ECG, SpO2, Respiratory Rate, Radiographic Findings, Hypoxemia","mAb, Other, SOC",300
"NCT04386616","https://ClinicalTrials.gov/show/NCT04386616",NA,"United States","Washington","2020-May","2020-Sep","Recruiting","Randomised","Double",4,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Antibodies, Blood Pressure, Heart Rate, ECG, SpO2, Respiratory Rate, Radiographic Findings, Hypoxemia","mAb, Other, SOC",300
"NCT04401410","https://clinicaltrials.gov/show/NCT04401410",NA,"United States","Washington, Dc","2020-May",NA,"Not Recruiting","Single-Arm","Open-Label",2,"Confirmed","Hospital","Hospitalization, Invasive Mechanical Ventilation or ECMO","Other",20
"CHICTR2000030000","http://www.chictr.org.cn/showproj.aspx?proj=49748",NA,"China","Jiangxi","2020-Feb",NA,"Recruiting","Non-Randomised","Unspecified",5,"Confirmed","Hospital","Viral Load or Clearance, Adverse Events, PaO2-FiO2, Respiratory Rate","DAA, IFN, TCM",50
"CHICTR2000029759","http://www.chictr.org.cn/showproj.aspx?proj=49352",NA,"China","Chongqing","2020-Feb","2020-May","Suspended","Randomised","Open-Label",3,"Confirmed","Hospital","ICU Admission, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea","IFN + Other, LPV/r + IFN, Umifenovir + IFN",60
"CHICTR2000030702","http://www.chictr.org.cn/showproj.aspx?proj=50537",NA,"China","Beijing","2020-Mar","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Dyspnea, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","Plasma based therapy, SOC",50
"CHICTR2000030260","http://www.chictr.org.cn/showproj.aspx?proj=50130",NA,"China","Sichuan","2020-Feb","2021-Feb","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","C-Reactive Protein, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, Albumin","Nutrition, SOC",20
"NCT04333420","https://ClinicalTrials.gov/show/NCT04333420",NA,"Netherlands","Amsterdam","2020-Apr","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Viral Load or Clearance, PaO2-FiO2","IFN, SOC",130
"IRCT20080901001165N52","http://en.irct.ir/trial/47641",NA,"Iran","Tehran","2020-May","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Hospitalization, Hospital Discharge, Shock, Hypoxemia","Corticosteroids, SOC",50
"CHICTR2000030179","http://www.chictr.org.cn/showproj.aspx?proj=50059",NA,"China","Jiangxi","2020-Feb","2020-Apr","Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Mortality, Hospitalization, Viral Load or Clearance","Plasma based therapy, SOC",100
"NCT04293887","https://ClinicalTrials.gov/show/NCT04293887",NA,"China","Hebei","2020-Mar","2020-May","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Treatment-emergent Adverse Events, Respiratory Rate","IFN, SOC",328
"CHICTR2000030167","http://www.chictr.org.cn/showproj.aspx?proj=49567",NA,"China","Hubei","2020-Feb","2020-Sep","Not Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Mortality, Hospitalization, Viral Load or Clearance, C-Reactive Protein, Natural Killer Cell Count, CD4, CD8","IFN, SOC",80
"CHICTR2000029765","http://www.chictr.org.cn/showproj.aspx?proj=49409",NA,"China","Anhui","2020-Feb","2020-May","Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Mortality, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO","SOC, TCZ",188
"NCT04291729","https://ClinicalTrials.gov/show/NCT04291729",NA,"China","Jiangxi","2020-Mar","2020-Mar","Completed","Single-Arm","Open-Label",1,"Confirmed","Hospital","ICU Admission, Hospitalization, Visits or Returns to Emergency Department, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms, Adverse Events, Serious Adverse Events","DAA + IFN",11
"NCT04332042","https://ClinicalTrials.gov/show/NCT04332042",NA,"Italy","Ancona","2020-Apr","2020-Jun","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","JAKi",50
"IRCT20200421047150N1","http://en.irct.ir/trial/47964",NA,"Iran","Tehran","2020-May","2020-Oct","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Mortality, Pneumonia or ARDS, Radiographic Findings","SOC, Stem cells",90
"NCT04412252","https://ClinicalTrials.gov/show/NCT04412252",NA,"United States","Ohio","2020-Jun","2020-Sep","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","JAKi, SOC",240
"CHICTR2000033372","http://www.chictr.org.cn/showproj.aspx?proj=54408",NA,"China","Shandong","2020-May","2020-May","Completed","Non-Randomised","Unspecified",2,"Confirmed","Hospital",NA,"DMARD, SOC",30
"NCT04394182","https://clinicaltrials.gov/show/NCT04394182",NA,"Spain","Madrid","2020-May",NA,"Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","SpO2","Radiation therapy + Non-invasive respiratory support + LPV/r + HCQ + AZT + Other + Anticoagulants + Corticosteroids + TCZ",15
"CHICTR2000029781","http://www.chictr.org.cn/showproj.aspx?proj=49138",NA,"China","Hubei","2020-Feb","2020-Jun","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Fever","SOC, TCM",160
"NCT04288102","https://ClinicalTrials.gov/show/NCT04288102",NA,"China","Hubei","2020-Feb","2020-May","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, CD4, PaO2-FiO2, Radiographic Findings","SOC, Stem cells",100
"KCT0005003","http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16635",NA,"South Korea","Seoul","2020-May",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Hospital Discharge, Clinical Improvement Score (Any)","Anticoagulants, SOC",84
"NCT04420390","https://ClinicalTrials.gov/show/NCT04420390",NA,"Spain","Madrid","2020-Jun","2020-Jul","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Hospitalization, Adverse Events, C-Reactive Protein, Ferritin, D-Dimer, LDH, PaO2-FiO2","Radiation therapy",41
"NCT04411680","https://ClinicalTrials.gov/show/NCT04411680",NA,"United States","Washington","2020-Jun","2020-Oct","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Serious Adverse Events","Other, SOC",60
"2020-001254-22","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001254-22/BE/",NA,"Belgium","Brussels","2020-Mar",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, Ferritin, IL-2, IL-7, Tumor Necrosis Factor (Any), Granulocyte Stimulaiting Factor, Interferon (Any), MCP-1, MIP-1, White Blood Cell Count, Lymphocyte Count, PaO2-FiO2, SpO2, Radiographic Findings","Other, SOC",NA
"NCT04326920","https://ClinicalTrials.gov/show/NCT04326920",NA,"Belgium","Brussels","2020-Mar","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Adverse Events, Serious Adverse Events, PaO2-FiO2","Other",80
"NCT04382755","https://ClinicalTrials.gov/show/NCT04382755",NA,"Belgium","Brussels","2020-May","2021-May","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, D-Dimer, PaO2-FiO2, Radiographic Findings, Hypoxia, Distress","Other, SOC",81
"NCT04415086","https://ClinicalTrials.gov/show/NCT04415086",NA,"Brazil","Sao Paulo","2020-Jun","2022-Apr","Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Hospital Discharge, Clinical Improvement Score (Any), Adverse Events, IgG, IgM or IgA, Antibodies","Plasma-based therapy, SOC",120
"NCT04398290","https://clinicaltrials.gov/show/NCT04398290",NA,"United States","Washington, Dc","2020-May",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Adverse Events, Hemoglobin, Hypoxemia","Non-invasive respiratory support, SOC",30
"NCT04405310","https://ClinicalTrials.gov/show/NCT04405310",NA,"Mexico","Mexico","2020-May","2020-Jun","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","HCQ + AZT, Plasma based therapy + HCQ + AZT",80
"NCT04321278","https://ClinicalTrials.gov/show/NCT04321278",NA,"Brazil","Brasilia","2020-Mar","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Quality of Life","HCQ, HCQ + AZT",440
"NCT04321278","https://ClinicalTrials.gov/show/NCT04321278",NA,"Brazil","Distrito Federal","2020-Mar","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Quality of Life","HCQ, HCQ + AZT",440
"NCT04321278","https://ClinicalTrials.gov/show/NCT04321278",NA,"Brazil","Espirito Santo","2020-Mar","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Quality of Life","HCQ, HCQ + AZT",440
"NCT04321278","https://ClinicalTrials.gov/show/NCT04321278",NA,"Brazil","Goias","2020-Mar","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Quality of Life","HCQ, HCQ + AZT",440
"NCT04321278","https://ClinicalTrials.gov/show/NCT04321278",NA,"Brazil","Minas Gerais","2020-Mar","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Quality of Life","HCQ, HCQ + AZT",440
"NCT04321278","https://ClinicalTrials.gov/show/NCT04321278",NA,"Brazil","Para","2020-Mar","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Quality of Life","HCQ, HCQ + AZT",440
"NCT04321278","https://ClinicalTrials.gov/show/NCT04321278",NA,"Brazil","Parana","2020-Mar","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Quality of Life","HCQ, HCQ + AZT",440
"NCT04321278","https://ClinicalTrials.gov/show/NCT04321278",NA,"Brazil","Rio Grande Do Norte","2020-Mar","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Quality of Life","HCQ, HCQ + AZT",440
"NCT04321278","https://ClinicalTrials.gov/show/NCT04321278",NA,"Brazil","Rio Grande Do Sul","2020-Mar","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Quality of Life","HCQ, HCQ + AZT",440
"NCT04321278","https://ClinicalTrials.gov/show/NCT04321278",NA,"Brazil","Rio De Janeiro","2020-Mar","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Quality of Life","HCQ, HCQ + AZT",440
"NCT04321278","https://ClinicalTrials.gov/show/NCT04321278",NA,"Brazil","Santa Catarina","2020-Mar","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Quality of Life","HCQ, HCQ + AZT",440
"NCT04321278","https://ClinicalTrials.gov/show/NCT04321278",NA,"Israel","Jerusalem","2020-Mar","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Quality of Life","HCQ, HCQ + AZT",440
"NCT04389944","https://ClinicalTrials.gov/show/NCT04389944",NA,"Switzerland","Bern","2020-May","2020-Jun","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Serious Adverse Events","Plasma based therapy",15
"IRCT20200418047126N1","http://en.irct.ir/trial/47707",NA,"Iran","Tehran","2020-May","2020-Jun","Completed","Randomised","Single",2,"Confirmed","Hospital","Hospitalization, Fever","HCQ, HCQ + Colchicine",100
"CHICTR2000030006","http://www.chictr.org.cn/showproj.aspx?proj=49737",NA,"China","Hubei","2020-Feb","2020-May","Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Mortality, Viral Load or Clearance, Fever, Radiographic Findings, Lung Inflamation","Other, SOC",60
"2020-001953-36","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001953-36/ES/",NA,"Spain","Madrid","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Blood Pressure, Heart Rate, SpO2","Other, SOC",NA
"2020-001354-22","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001354-22/GB/",NA,"United Kingdom","London","2020-Apr",NA,"Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Renal Outcome (Unspecified)","JAKi, mAb, SOC",NA
"NCT04381377","https://ClinicalTrials.gov/show/NCT04381377",NA,"Russia","Moscow","2020-May","2021-Apr","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO","Immunomodulators, SOC",394
"NCT04381377","https://ClinicalTrials.gov/show/NCT04381377",NA,"Russia","Novgorod","2020-May","2021-Apr","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO","Immunomodulators, SOC",394
"NCT04381377","https://ClinicalTrials.gov/show/NCT04381377",NA,"Russia","Orenburg","2020-May","2021-Apr","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO","Immunomodulators, SOC",394
"NCT04381377","https://ClinicalTrials.gov/show/NCT04381377",NA,"Russia","Vladimir","2020-May","2021-Apr","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO","Immunomodulators, SOC",394
"NCT04365985","https://ClinicalTrials.gov/show/NCT04365985",NA,"United States","Michigan","2020-Apr","2021-May","Recruiting","Randomised","Triple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Renal Outcome (Unspecified)","Opiate antagonists, Opiate antagonists + Anesthetic, SOC",500
"NCT04348656","https://ClinicalTrials.gov/show/NCT04348656",NA,"United States","New York","2020-Apr","2020-Oct","Recruiting","Randomised","Open-Label",2,"Yes","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Plasma based therapy, SOC",1200
"NCT04348656","https://ClinicalTrials.gov/show/NCT04348656",NA,"Canada","Ontario","2020-Apr","2020-Oct","Recruiting","Randomised","Open-Label",2,"Yes","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Plasma based therapy, SOC",1200
"NCT04348656","https://ClinicalTrials.gov/show/NCT04348656",NA,"Canada","Quebec","2020-Apr","2020-Oct","Recruiting","Randomised","Open-Label",2,"Yes","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Plasma based therapy, SOC",1200
"NCT04433546","https://ClinicalTrials.gov/show/NCT04433546",NA,"United States","Maryland","2020-Jun","2020-Dec","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Serious Adverse Events, IL-1, IL-6, Tumor Necrosis Factor (Any), Troponin, Antibodies, ECG, Cardiac Outcome (Unspecified)","Other",210
"NCT04418518","https://ClinicalTrials.gov/show/NCT04418518",NA,"United States","New York","2020-Jun","2021-Jun","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Renal Outcome (Unspecified)","Plasma-based therapy, SOC",1200
"NCT04401293","https://ClinicalTrials.gov/show/NCT04401293",NA,"United States","New Jersey","2020-May","2020-Oct","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Mortality, Hospitalization, Pneumonia or ARDS","Anticoagulants",308
"NCT04401293","https://ClinicalTrials.gov/show/NCT04401293",NA,"United States","New York","2020-May","2020-Oct","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Mortality, Hospitalization, Pneumonia or ARDS","Anticoagulants",308
"NCT04381364","https://ClinicalTrials.gov/show/NCT04381364",NA,"Sweden","Stockholm","2020-May","2020-Dec","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Dyspnea","Corticosteroids, SOC",446
"NCT04375397","https://ClinicalTrials.gov/show/NCT04375397",NA,"United States","California","2020-May","2020-Aug","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events","Other, SOC",46
"NCT04375397","https://ClinicalTrials.gov/show/NCT04375397",NA,"United States","District Of Columbia","2020-May","2020-Aug","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events","Other, SOC",46
"NCT04375397","https://ClinicalTrials.gov/show/NCT04375397",NA,"United States","Florida","2020-May","2020-Aug","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events","Other, SOC",46
"NCT04375397","https://ClinicalTrials.gov/show/NCT04375397",NA,"United States","Massachusetts","2020-May","2020-Aug","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events","Other, SOC",46
"NCT04375397","https://ClinicalTrials.gov/show/NCT04375397",NA,"United States","Utah","2020-May","2020-Aug","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events","Other, SOC",46
"NCT04411667","https://ClinicalTrials.gov/show/NCT04411667",NA,"United States","California","2020-Jun","2020-Nov","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Invasive Mechanical Ventilation or ECMO","Igs + Corticosteroids, SOC",40
"NCT04409262","https://ClinicalTrials.gov/show/NCT04409262",NA,"United States","Arizona","2020-Jun","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","Remdesivir, Remdesivir + TCZ",450
"NCT04409262","https://ClinicalTrials.gov/show/NCT04409262",NA,"United States","California","2020-Jun","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","Remdesivir, Remdesivir + TCZ",450
"NCT04409262","https://ClinicalTrials.gov/show/NCT04409262",NA,"United States","Florida","2020-Jun","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","Remdesivir, Remdesivir + TCZ",450
"NCT04409262","https://ClinicalTrials.gov/show/NCT04409262",NA,"United States","Idaho","2020-Jun","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","Remdesivir, Remdesivir + TCZ",450
"NCT04409262","https://ClinicalTrials.gov/show/NCT04409262",NA,"United States","Illinois","2020-Jun","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","Remdesivir, Remdesivir + TCZ",450
"NCT04409262","https://ClinicalTrials.gov/show/NCT04409262",NA,"United States","Louisiana","2020-Jun","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","Remdesivir, Remdesivir + TCZ",450
"NCT04409262","https://ClinicalTrials.gov/show/NCT04409262",NA,"United States","Maryland","2020-Jun","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","Remdesivir, Remdesivir + TCZ",450
"NCT04409262","https://ClinicalTrials.gov/show/NCT04409262",NA,"United States","Massachusetts","2020-Jun","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","Remdesivir, Remdesivir + TCZ",450
"NCT04409262","https://ClinicalTrials.gov/show/NCT04409262",NA,"United States","Michigan","2020-Jun","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","Remdesivir, Remdesivir + TCZ",450
"NCT04409262","https://ClinicalTrials.gov/show/NCT04409262",NA,"United States","Nebraska","2020-Jun","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","Remdesivir, Remdesivir + TCZ",450
"NCT04409262","https://ClinicalTrials.gov/show/NCT04409262",NA,"United States","New Jersey","2020-Jun","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","Remdesivir, Remdesivir + TCZ",450
"NCT04409262","https://ClinicalTrials.gov/show/NCT04409262",NA,"United States","New York","2020-Jun","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","Remdesivir, Remdesivir + TCZ",450
"NCT04409262","https://ClinicalTrials.gov/show/NCT04409262",NA,"United States","North Carolina","2020-Jun","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","Remdesivir, Remdesivir + TCZ",450
"NCT04409262","https://ClinicalTrials.gov/show/NCT04409262",NA,"United States","Ohio","2020-Jun","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","Remdesivir, Remdesivir + TCZ",450
"NCT04409262","https://ClinicalTrials.gov/show/NCT04409262",NA,"United States","Pennsylvania","2020-Jun","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","Remdesivir, Remdesivir + TCZ",450
"NCT04409262","https://ClinicalTrials.gov/show/NCT04409262",NA,"United States","Texas","2020-Jun","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","Remdesivir, Remdesivir + TCZ",450
"NCT04409262","https://ClinicalTrials.gov/show/NCT04409262",NA,"United States","Utah","2020-Jun","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","Remdesivir, Remdesivir + TCZ",450
"NCT04409262","https://ClinicalTrials.gov/show/NCT04409262",NA,"United States","Washington","2020-Jun","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","Remdesivir, Remdesivir + TCZ",450
"NCT04409262","https://ClinicalTrials.gov/show/NCT04409262",NA,"United States","West Virginia","2020-Jun","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","Remdesivir, Remdesivir + TCZ",450
"NCT04409262","https://ClinicalTrials.gov/show/NCT04409262",NA,"Brazil","Brasilia","2020-Jun","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","Remdesivir, Remdesivir + TCZ",450
"NCT04409262","https://ClinicalTrials.gov/show/NCT04409262",NA,"Brazil","Rio De Janeiro","2020-Jun","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","Remdesivir, Remdesivir + TCZ",450
"NCT04409262","https://ClinicalTrials.gov/show/NCT04409262",NA,"Brazil","Sao Paulo","2020-Jun","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate","Remdesivir, Remdesivir + TCZ",450
"2020-001243-15","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001243-15/BE/",NA,"Belgium","Brussels","2020-Mar",NA,"Completed","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO",NA,NA
"NCT04405102","https://ClinicalTrials.gov/show/NCT04405102",NA,"France","Paris","2020-May","2022-Jan","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, SpO2","Immunomodulators, SOC",48
"NCT04433949","https://ClinicalTrials.gov/show/NCT04433949",NA,"United States","Georgia","2020-Jun","2022-May","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Non-invasive Ventilation, C-Reactive Protein, Ferritin, IL-6, Platelet Count, D-Dimer, Myoglobin, Troponin, Procalcitonin, Prothrombin, Fibrinogen, Triglycerides, ALT, AST, Albumin, LDH, Antibodies, CD4, CD8, Blood Gas, Blood Pressure, Heart Rate, SpO2, Respiratory Rate, Radiographic Findings, Blood pH, Cardiac Outcome (Unspecified)","Radiation therapy, SOC",52
"NCT04401475","https://ClinicalTrials.gov/show/NCT04401475",NA,"Canada","Ontario","2020-May","2021-Feb","Not Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS, Fever, Organ Failure or Dysfunction (SOFA), C-Reactive Protein, IL-6, Troponin, SpO2, Radiographic Findings, Renal Outcome (Unspecified)","Other, SOC",865
"NCT04435184","https://ClinicalTrials.gov/show/NCT04435184",NA,"United States","Maryland","2020-Jun","2020-Oct","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Hospital Discharge, Adverse Events, C-Reactive Protein, von Wildebrandt Factor, D-Dimer","mAb, SOC",40
"2020-002120-37","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-002120-37/GB/",NA,"France","Paris","2020-Jun",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospital Discharge, SpO2","Other, SOC",300
"2020-002120-37","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-002120-37/GB/",NA,"Germany","Berlin","2020-Jun",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospital Discharge, SpO2","Other, SOC",300
"2020-002120-37","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-002120-37/GB/",NA,"Italy","Rome","2020-Jun",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospital Discharge, SpO2","Other, SOC",300
"2020-002120-37","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-002120-37/GB/",NA,"Netherlands","Amsterdam","2020-Jun",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospital Discharge, SpO2","Other, SOC",300
"2020-002120-37","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-002120-37/GB/",NA,"Spain","Madrid","2020-Jun",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospital Discharge, SpO2","Other, SOC",300
"2020-002120-37","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-002120-37/GB/",NA,"United Kingdom","London","2020-Jun",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospital Discharge, SpO2","Other, SOC",300
"2020-002120-37","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-002120-37/GB/",NA,"United States","Washington, Dc","2020-Jun",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospital Discharge, SpO2","Other, SOC",300
"NCT04382924","https://clinicaltrials.gov/show/NCT04382924",NA,"Canada","British Columbia","2020-Aug",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2, SpO2, Quality of Life","Other, SOC",462
"NCT04384497","https://ClinicalTrials.gov/show/NCT04384497",NA,"Sweden","Stockholm","2020-May","2020-Jun","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Fever, Adverse Events, Antibodies","Plasma based therapy",50
"IRCT20170211032494N3","http://en.irct.ir/trial/47735",NA,"Iran","Tehran","2020-May","2020-Jun","Completed","Single-Arm","Open-Label",1,"Confirmed","Hospital","IL-1, SpO2","Radiation therapy",10
"NCT04335071","https://ClinicalTrials.gov/show/NCT04335071",NA,"Switzerland","Bern","2020-Apr","2020-Oct","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism","SOC, TCZ",100
"NCT04335071","https://ClinicalTrials.gov/show/NCT04335071",NA,"Switzerland","Vaud","2020-Apr","2020-Oct","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism","SOC, TCZ",100
"NCT04335071","https://ClinicalTrials.gov/show/NCT04335071",NA,"Switzerland","Zurich","2020-Apr","2020-Oct","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism","SOC, TCZ",100
"NCT04382729","https://ClinicalTrials.gov/show/NCT04382729",NA,"Italy","Rome","2020-May","2020-Jul","Recruiting","Randomised","Single",2,"Confirmed","Hospital","Clinical Improvement Score (Any), Other Mild Symptoms, 6-Minute Walking Distance, Quality of Life","Exercise, Other",80
"NCT04386447","https://ClinicalTrials.gov/show/NCT04386447",NA,"France","Paris","2020-May","2020-Oct","Not Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Mortality","Hormone therapy, SOC",145
"NCT04386447","https://ClinicalTrials.gov/show/NCT04386447",NA,"Italy","Parma","2020-May","2020-Oct","Not Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Mortality","Hormone therapy, SOC",145
"NCT04432298","https://ClinicalTrials.gov/show/NCT04432298",NA,"United States","North Carolina","2020-Jun","2020-Dec","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2","mAb, SOC",130
"NCT04273581","https://ClinicalTrials.gov/show/NCT04273581",NA,"China","Beijing","2020-Feb","2020-Apr","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, IL-1, IL-2, IL-6, IL-7, IL-8, IL-10, Tumor Necrosis Factor (Any), Granulocyte Stimulaiting Factor, IP-10, MCP-1, MIP-1","Immunomodulators, SOC",40
"CHICTR2000031319","http://www.chictr.org.cn/showproj.aspx?proj=51647",NA,"China","Hubei","2020-Mar","2020-Jul","Not Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Viral Load or Clearance, Fever, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, Neutrophils, Creatinine Phosphokinase, CK-MB, Troponin, Procalcitonin, ALT, LDH, CD4, CD8, Respiratory Rate, Radiographic Findings","SOC, Stem cells",20
"IRCT20081019001369N6","http://en.irct.ir/trial/47188",NA,"Iran","Tehran","2020-May","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), PaO2-FiO2","Alternative therapy, SOC",30
"NCT04382547","https://ClinicalTrials.gov/show/NCT04382547",NA,"Belarus","Minsk","2020-May","2021-Jun","Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events","SOC, Stem cells",40
"IRCT20200501047258N1","http://en.irct.ir/trial/47629",NA,"Iran","Tehran","2020-May","2021-May","Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital",NA,"Plasma based therapy, SOC",120
"NCT04428021","https://ClinicalTrials.gov/show/NCT04428021",NA,"Italy","Turin","2020-Jun","2021-Jun","Not Recruiting","Randomised","Triple",3,"Confirmed","Hospital","ICU Admission, Viral Load or Clearance, Organ Failure or Dysfunction (SOFA), IgG, IgM or IgA","Plasma based therapy, SOC",180
"NCT04402060","https://ClinicalTrials.gov/show/NCT04402060",NA,"United States","Florida","2020-May","2020-Nov","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, Serious Adverse Events","Other, SOC",66
"NCT04402060","https://ClinicalTrials.gov/show/NCT04402060",NA,"United States","Kentucky","2020-May","2020-Nov","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, Serious Adverse Events","Other, SOC",66
"NCT04402060","https://ClinicalTrials.gov/show/NCT04402060",NA,"United States","New York","2020-May","2020-Nov","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, Serious Adverse Events","Other, SOC",66
"NCT04392232","https://ClinicalTrials.gov/show/NCT04392232",NA,"United States","Ohio","2020-May","2020-Dec","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital",NA,"Plasma based therapy",100
"EUCTR2020-001662-11-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001662-11",NA,"United States","Washington, Dc","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","ICU Admission, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"EUCTR2020-001662-11-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001662-11",NA,"France","Paris","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","ICU Admission, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"EUCTR2020-001662-11-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001662-11",NA,"Spain","Madrid","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","ICU Admission, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"EUCTR2020-001662-11-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001662-11",NA,"Germany","Berlin","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","ICU Admission, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"EUCTR2020-001662-11-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001662-11",NA,"United Kingdom","London","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","ICU Admission, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"EUCTR2020-001662-11-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001662-11",NA,"Italy","Rome","2020-Apr",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","ICU Admission, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"NCT04374149","https://clinicaltrials.gov/show/NCT04374149",NA,"United States","South Carolina","2020-Apr",NA,"Not Recruiting","Non-Randomised","Open-Label",3,"Confirmed","Hospital",NA,"Plasma based therapy, Plasma based therapy + JAKi",20
"NCT04409886","https://ClinicalTrials.gov/show/NCT04409886",NA,"United States","New York","2020-Jun","2020-Dec","Not Recruiting","Randomised","Single",2,"Confirmed","Hospital","SpO2","Non-invasive respiratory support",30
"NCT04411433","https://ClinicalTrials.gov/show/NCT04411433",NA,"Turkey","Ankara","2020-Jun","2020-Jul","Recruiting","Randomised","Open-Label",6,"Confirmed Or Suspected","Hospital","Hospital Discharge, Viral Load or Clearance, Fever, Adverse Events, C-Reactive Protein, D-Dimer, Prothrombin, ALT, AST, Blood Pressure, Respiratory Rate","FPV, FPV + AZT, HCQ, HCQ + AZT, HCQ + FPV",1000
"IRCT20200406046968N3","http://en.irct.ir/trial/47152",NA,"Iran","East Azarbaijan","2020-May","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality","HCQ + LPV/r, HCQ + LPV/r + Other",60
"NCT04403477","https://clinicaltrials.gov/show/NCT04403477",NA,"Bangladesh","Dhaka","2020-May",NA,"Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Mortality","Plasma based therapy, SOC",20
"IRCT20151227025726N13","http://en.irct.ir/trial/46681",NA,"Iran","Tehran","2020-Mar","2020-May","Completed","Single-Arm","Open-Label",1,"Confirmed","Hospital","Hospitalization, Viral Load or Clearance, Cough, Fever, Dyspnea, Treatment-emergent Adverse Events, Radiographic Findings","TCZ + LPV/r + HCQ",40
"2020-001777-71","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001777-71/GB/",NA,"United Kingdom","London","2020-Apr",NA,"Recruiting","Unspecified","Open-Label",1,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, D-Dimer, Radiographic Findings","JAKi",NA
"2020-001770-30","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001770-30/BE/",NA,"Belgium","Brussels","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, C-Reactive Protein, Respiratory Rate, Radiographic Findings","SOC, TCZ",60
"IRCT20200128046294N2","http://en.irct.ir/trial/46463",NA,"Iran","Tehran","2020-Mar","2020-Jun","Completed","Randomised","Single",2,"Confirmed","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Respiratory Rate","DAA, SOC",70
"NCT04252664","https://ClinicalTrials.gov/show/NCT04252664",NA,"China","Hubei","2020-Feb","2020-Apr","Suspended","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms, Serious Adverse Events, PaO2-FiO2, Respiratory Rate","Remdesivir, SOC",308
"NCT04408235","https://clinicaltrials.gov/show/NCT04408235",NA,"Italy","Rome","2020-May",NA,"Not Recruiting","Randomised","Single",2,"Confirmed","Hospital",NA,"Anticoagulants",300
"NCT04345614","https://ClinicalTrials.gov/show/NCT04345614",NA,"United States","Michigan","2020-Apr","2020-Jul","Recruiting","Randomised","Open-Label",2,"Yes","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, IL-6, IL-17, Tumor Necrosis Factor (Any), Procalcitonin, PaO2-FiO2, SpO2, Blood pH","Other, SOC",120
"NCT04345614","https://ClinicalTrials.gov/show/NCT04345614",NA,"United States","Minnesota","2020-Apr","2020-Jul","Recruiting","Randomised","Open-Label",2,"Yes","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, IL-6, IL-17, Tumor Necrosis Factor (Any), Procalcitonin, PaO2-FiO2, SpO2, Blood pH","Other, SOC",120
"CHICTR2000030704","http://www.chictr.org.cn/showproj.aspx?proj=50778",NA,"China","Jiangsu","2020-Mar","2020-Mar","Suspended","Randomised","Unspecified",2,"Confirmed","Hospital","Non-invasive Ventilation, White Blood Cell Count, Creatinine Phosphokinase, CK-MB, ALT, PaO2-FiO2, Respiratory Rate","SOC, TCM",50
"IRCT20200428047228N1","http://en.irct.ir/trial/47559",NA,"Iran","Tehran","2020-May","2020-Jun","Completed","Randomised","Double",2,"Confirmed","Hospital","Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2","HCQ, HCQ + FPV",50
"IRCT20200516047468N1","http://en.irct.ir/trial/48176",NA,"Iran","Tehran","2020-May","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Radiographic Findings","Antibiotics + AZT + LPV/r, Vitamins + Antibiotics + AZT + LPV/r",50
"NCT04400058","https://ClinicalTrials.gov/show/NCT04400058",NA,"United States","California","2020-May","2020-Dec","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO, Dyspnea, Serious Adverse Events, Ferritin, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Troponin, Fibrinogen, INR, ALT, AST, Albumin, Bilirubin, Glucose, LDH, IgG, IgM or IgA, Blood Urea Nitrogen, SpO2, Radiographic Findings, Quality of Life","Plasma based therapy, SOC",208
"NCT04400058","https://ClinicalTrials.gov/show/NCT04400058",NA,"United States","Iowa","2020-May","2020-Dec","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO, Dyspnea, Serious Adverse Events, Ferritin, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Troponin, Fibrinogen, INR, ALT, AST, Albumin, Bilirubin, Glucose, LDH, IgG, IgM or IgA, Blood Urea Nitrogen, SpO2, Radiographic Findings, Quality of Life","Plasma based therapy, SOC",208
"NCT04400058","https://ClinicalTrials.gov/show/NCT04400058",NA,"United States","Louisiana","2020-May","2020-Dec","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO, Dyspnea, Serious Adverse Events, Ferritin, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Troponin, Fibrinogen, INR, ALT, AST, Albumin, Bilirubin, Glucose, LDH, IgG, IgM or IgA, Blood Urea Nitrogen, SpO2, Radiographic Findings, Quality of Life","Plasma based therapy, SOC",208
"NCT04407182","https://clinicaltrials.gov/show/NCT04407182",NA,"Ecuador","Quito","2020-May",NA,"Recruiting","Randomised","Triple",2,"Confirmed","Hospital",NA,"Alternative therapy, SOC",60
"CHICTR2000029988","http://www.chictr.org.cn/showproj.aspx?proj=49218",NA,"China","Hubei","2020-Feb","2020-May","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events","HCQ, SOC",80
"CHICTR2000030388","http://www.chictr.org.cn/showproj.aspx?proj=50306",NA,"China","Hubei","2020-Mar",NA,"Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Treatment-emergent Adverse Events, C-Reactive Protein, IL-6, IL-8, Tumor Necrosis Factor (Any), White Blood Cell Count, Shock","SOC, TCM",60
"2020-001236-10","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001236-10/NL/",NA,"Netherlands","Amsterdam","2020-Mar",NA,"Recruiting","Randomised","Single",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, White Blood Cell Count, Monocyte Count, Erythrocyte Sedimentation Rate, Creatinine Phosphokinase, CK-MB, eGFR, Myoglobin, Troponin, Procalcitonin, Prothrombin, Fibrinogen, Coagulation Test, ALT, Albumin, Bilirubin, PaO2-FiO2",NA,304
"NL8491","https://trialregister.nl/trial/8491",NA,"Netherlands","Amsterdam","2020-Mar",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, Albumin, PaO2-FiO2",NA,386
"NCT04257656","https://clinicaltrials.gov/show/NCT04257656",NA,"China","Beijing","2020-Jan",NA,"Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Treatment-emergent Adverse Events, Serious Adverse Events, PaO2-FiO2, Respiratory Rate","Remdesivir, SOC",237
"NCT04374591","https://ClinicalTrials.gov/show/NCT04374591",NA,"Egypt","Cairo","2020-May","2020-Jun","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital",NA,"Other",40
"NCT04328480","https://ClinicalTrials.gov/show/NCT04328480",NA,"Argentina","Santa Fe","2020-Mar","2020-Jun","Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","Colchicine, SOC",2500
"NCT04393051","https://clinicaltrials.gov/show/NCT04393051",NA,"Italy","Rome","2020-May",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Invasive Mechanical Ventilation or ECMO","JAKi, SOC",126
"NCT04403269","https://clinicaltrials.gov/show/NCT04403269",NA,"France","Paris","2020-May",NA,"Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality","Igs",35
"2020-001768-27","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001768-27/FR/",NA,"France","Paris","2020-Apr",NA,"Recruiting","Unspecified","Open-Label",1,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, C-Reactive Protein, Ferritin, Lymphocyte Count, Platelet Count, LDH","Igs",NA
"NCT04416139","https://ClinicalTrials.gov/show/NCT04416139",NA,"Mexico","Mexico","2020-Jun","2021-Apr","Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Fever, Adverse Events, C-Reactive Protein, Ferritin, IL-6, IL-10, IL-17, Tumor Necrosis Factor (Any), Lymphocyte Count, Dendritic Cell Count, Platelet Count, D-Dimer, Fibrinogen, CD4, CD8, Heart Rate, PaO2-FiO2, Respiratory Rate, Cardiac Outcome (Unspecified)","SOC, Stem cells",10
"NCT04397562","https://ClinicalTrials.gov/show/NCT04397562",NA,"Russia","Kaluga","2020-May","2021-Apr","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality","mAb, SOC",204
"NCT04397562","https://ClinicalTrials.gov/show/NCT04397562",NA,"Russia","Dagestan","2020-May","2021-Apr","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality","mAb, SOC",204
"NCT04397562","https://ClinicalTrials.gov/show/NCT04397562",NA,"Russia","Moscow","2020-May","2021-Apr","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality","mAb, SOC",204
"NCT04315896","https://ClinicalTrials.gov/show/NCT04315896",NA,"Mexico","Mexico","2020-Mar","2020-Oct","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events","HCQ, SOC",500
"NCT04425538","https://ClinicalTrials.gov/show/NCT04425538",NA,"United States","Massachusetts","2020-Jun","2020-Sep","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections","mAB",17
"NCT04398303","https://ClinicalTrials.gov/show/NCT04398303",NA,"United States","Florida","2020-May","2020-Oct","Not Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission","SOC, Stem cells",70
"NCT04429763","https://ClinicalTrials.gov/show/NCT04429763",NA,"United States","Illinois","2020-Jun","2020-Sep","Not Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Mortality","SOC, Stem cells",30
"NCT04397497","https://clinicaltrials.gov/show/NCT04397497",NA,"Italy","Rome","2020-May",NA,"Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Anti SARS-COV-2 Titers, IL-1, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, Hemoglobin, PaO2-FiO2, SpO2, Radiographic Findings","mAb, SOC",50
"DRKS00021248","https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021248",NA,"Germany","Baden-Wurttemberg","2020-May",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, IL-6, D-Dimer, Urine Sample","ECMO, ECMO + Cytokine removal",80
"NCT04395456","https://clinicaltrials.gov/show/NCT04395456",NA,"United States","Pennsylvania","2020-May",NA,"Not Recruiting","Randomised","Single",2,"Confirmed","Hospital","Pneumonia or ARDS, PaO2-FiO2","Other, SOC",144
"2020-002482-34","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-002482-34/3rd/",NA,"United States","Washington, Dc","2020-May",NA,"Status Unclear","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Serious Adverse Events, SpO2, Respiratory Rate, Radiographic Findings, Quality of Life","Plasma based therapy, SOC",54
"NCT04273646","https://ClinicalTrials.gov/show/NCT04273646",NA,"China","Hubei","2020-Feb","2020-Jun","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, C-Reactive Protein, Procalcitonin, CD4, CD8, PaO2-FiO2","SOC, Stem cells",48
"CHICTR2000029769","http://www.chictr.org.cn/showproj.aspx?proj=49415",NA,"China","Zhejiang","2020-Feb","2020-Apr","Not Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Mortality","SOC, TCM",40
"CHICTR2000030010","http://www.chictr.org.cn/showproj.aspx?proj=49777",NA,"China","Hubei","2020-Feb","2020-May","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Clinical Improvement Score (Any), Cough, Fever, Dyspnea, Other Mild Symptoms","Plasma based therapy, SOC",100
"CHICTR2000029757","http://www.chictr.org.cn/showproj.aspx?proj=49081",NA,"China","Beijing","2020-Feb","2021-Feb","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","Plasma based therapy, SOC",200
"CHICTR2000032716","http://www.chictr.org.cn/showproj.aspx?proj=53389",NA,"China","Shanghai","2020-May","2020-Apr","Completed","Unspecified","Unspecified",2,"Confirmed","Hospital","C-Reactive Protein, Lymphocyte Count, CD4, PaO2-FiO2","Vitamins",12
"NCT04412668","https://ClinicalTrials.gov/show/NCT04412668",NA,"United States","Alabama","2020-Jun","2020-Oct","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Non-invasive Ventilation, Fever, Treatment-emergent Adverse Events, SpO2","Other, SOC",30
"NCT04412668","https://ClinicalTrials.gov/show/NCT04412668",NA,"United States","District Of Columbia","2020-Jun","2020-Oct","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Non-invasive Ventilation, Fever, Treatment-emergent Adverse Events, SpO2","Other, SOC",30
"NCT04412668","https://ClinicalTrials.gov/show/NCT04412668",NA,"United States","Iowa","2020-Jun","2020-Oct","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Non-invasive Ventilation, Fever, Treatment-emergent Adverse Events, SpO2","Other, SOC",30
"NCT04412668","https://ClinicalTrials.gov/show/NCT04412668",NA,"United States","New Jersey","2020-Jun","2020-Oct","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Non-invasive Ventilation, Fever, Treatment-emergent Adverse Events, SpO2","Other, SOC",30
"NCT04412668","https://ClinicalTrials.gov/show/NCT04412668",NA,"United States","Virginia","2020-Jun","2020-Oct","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Non-invasive Ventilation, Fever, Treatment-emergent Adverse Events, SpO2","Other, SOC",30
"2020-001497-30","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001497-30/FR/",NA,"France","Paris","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), SpO2","mAb, SOC",270
"2020-001497-30","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001497-30/FR/",NA,"Germany","Berlin","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), SpO2","mAb, SOC",270
"2020-001497-30","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001497-30/FR/",NA,"Italy","Rome","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), SpO2","mAb, SOC",270
"2020-001497-30","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001497-30/FR/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), SpO2","mAb, SOC",270
"2020-001497-30","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001497-30/FR/",NA,"United Kingdom","London","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), SpO2","mAb, SOC",270
"2020-001497-30","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001497-30/FR/",NA,"United States","Washington, Dc","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), SpO2","mAb, SOC",270
"NCT04396067","https://clinicaltrials.gov/show/NCT04396067",NA,"Egypt","Cairo","2020-May",NA,"Not Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital",NA,"Other, SOC",360
"NCT04276987","https://ClinicalTrials.gov/show/NCT04276987",NA,"China","Beijing","2020-Feb","2020-May","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, IL-1, IL-2, IL-6, IL-8, D-Dimer, LDH, Radiographic Findings","Stem cells",30
"NCT04397757","https://ClinicalTrials.gov/show/NCT04397757",NA,"United States","Pennsylvania","2020-May","2020-Sep","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Glucose","Plasma based therapy",80
"NCT04397718","https://ClinicalTrials.gov/show/NCT04397718",NA,"United States","California","2020-May","2020-Dec","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Fever","Hormone therapy, SOC",198
"NCT04397718","https://ClinicalTrials.gov/show/NCT04397718",NA,"United States","New York","2020-May","2020-Dec","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Fever","Hormone therapy, SOC",198
"NCT04397718","https://ClinicalTrials.gov/show/NCT04397718",NA,"United States","Washington","2020-May","2020-Dec","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Fever","Hormone therapy, SOC",198
"NCT04397692","https://ClinicalTrials.gov/show/NCT04397692",NA,"United States","Arkansas","2020-May","2020-Sep","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, SpO2","Non-invasive respiratory support, SOC",20
"2020-001635-27","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001635-27/FR/",NA,"France","Paris","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Glucose, Radiographic Findings","Alternative therapy + Other, HCQ",NA
"NCT04395144","https://ClinicalTrials.gov/show/NCT04395144",NA,"Canada","Quebec","2020-May","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","Positioning, SOC",346
"NCT04452435","https://ClinicalTrials.gov/show/NCT04452435",NA,"India","Gujarat","2020-Jun","2020-Sep","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, C-Reactive Protein, Ferritin, IL-6, IL-10, Tumor Necrosis Factor (Any)","Other, SOC",100
"NCT04452435","https://ClinicalTrials.gov/show/NCT04452435",NA,"India","Maharashtra","2020-Jun","2020-Sep","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, C-Reactive Protein, Ferritin, IL-6, IL-10, Tumor Necrosis Factor (Any)","Other, SOC",100
"NCT04452435","https://ClinicalTrials.gov/show/NCT04452435",NA,"United Kingdom","London","2020-Jun","2020-Sep","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, C-Reactive Protein, Ferritin, IL-6, IL-10, Tumor Necrosis Factor (Any)","Other, SOC",100
"NCT04423861","https://ClinicalTrials.gov/show/NCT04423861",NA,"Brazil","Brasilia","2020-Jun","2020-Aug","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO","Antivirals, SOC",50
"NCT04388709","https://clinicaltrials.gov/show/NCT04388709",NA,"United States","Washington, Dc","2020-Dec",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Hypoxia","IFN, SOC",66
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","California","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","Colorado","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","Connecticut","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","Hawaii","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","Illinois","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","Indiana","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","Iowa","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","Louisiana","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","Maine","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","Maryland","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","Massachusetts","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","Michigan","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","Minnesota","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","Montana","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","New Hampshire","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","New Jersey","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","New York","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","North Carolina","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","Ohio","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","Oregon","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","Pennsylvania","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","Rhode Island","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","South Carolina","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","Texas","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","Utah","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","Virginia","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United States","Washington","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"China","Beijing","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"France","Paris","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Germany","Berlin","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Germany","Hamburg","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Germany","Schleswig-Holstein","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"China","Hong Kong","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Italy","Bergamo","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Italy","Brescia","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Italy","Cremona","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Italy","Milano","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Italy","Rome","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Italy","Padova","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Italy","Parma","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Italy","Pavia","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Italy","Piacenza","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Italy","Roma","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Japan","Kanagawa","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Japan","Tokyo","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"South Korea","Daegu","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"South Korea","Seoul","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Netherlands","Amsterdam","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Singapore","Singapore","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Spain","Asturias","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Spain","Madrid","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Spain","Barcelona","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Spain","Bizkaia","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Spain","Sevilla","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Sweden","Stockholm","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Switzerland","Bern","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Taiwan","Taipei","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"Taiwan","Taipei City","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United Kingdom","London","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United Kingdom","Edinburgh","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United Kingdom","Glasgow","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United Kingdom","Liverpool","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United Kingdom","Manchester","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United Kingdom","Plymouth","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04292899","https://ClinicalTrials.gov/show/NCT04292899",NA,"United Kingdom","Sheffield","2020-Mar","2020-Jun","Not Recruiting","Randomised","Open-Label",4,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events","Remdesivir",6000
"NCT04338958","https://ClinicalTrials.gov/show/NCT04338958",NA,"Germany","Berlin","2020-Apr","2021-Jan","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Viral Load or Clearance, Antibodies","JAKi",200
"JPRN-JAPICCTI-205270","https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205270",NA,"Japan","Tokyo","2020-Apr",NA,"Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Clinical Improvement Score (Any), Adverse Events, Serious Adverse Events, C-Reactive Protein, IL-6","TCZ",10
"IRCT20171122037571N2","http://en.irct.ir/trial/46660",NA,"Iran","Tehran","2020-Apr","2020-May","Completed","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Cough, Fever, Adverse Events, PaO2-FiO2, SpO2, Respiratory Rate, Radiographic Findings","Remdesivir + Chloroqines + LPV/r or Atazanavir",120
"NCT04331366","https://ClinicalTrials.gov/show/NCT04331366",NA,"United States","Georgia","2020-Apr","2020-Aug","Recruiting","Single-Arm","Open-Label",2,"Confirmed","Hospital","Blood Gas, Blood Pressure, Heart Rate, SpO2, Respiratory Rate, Blood pH, Bicarbonates","Non-invasive respiratory support, SOC",5
"NCT04332081","https://ClinicalTrials.gov/show/NCT04332081",NA,"United States","New York","2020-Apr","2020-May","Status Unclear","Single-Arm","Open-Label",1,"Confirmed","Hospital","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6",NA,20
"NCT04407130","https://ClinicalTrials.gov/show/NCT04407130",NA,"Bangladesh","Dhaka","2020-May","2020-Jul","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, Hospitalization, Cough, Fever, SpO2, Radiographic Findings","Ivermectin, Ivermectin + Antibiotics, SOC",72
"NCT04429555","https://clinicaltrials.gov/show/NCT04429555",NA,"United States","California","2020-Sep",NA,"Not Recruiting","Randomised","Triple",2,"Confirmed","Hospital",NA,"Other, SOC",40
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"United States","California","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"United States","Colorado","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"United States","Florida","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"United States","Illinois","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"United States","Louisiana","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"United States","Massachusetts","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"United States","Minnesota","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"United States","New Jersey","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"United States","New York","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"United States","North Carolina","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"United States","Ohio","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"United States","Pennsylvania","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"United States","Texas","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"United States","Utah","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"United States","Washington","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"Canada","Ontario","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"Canada","Quebec","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"Denmark","Copenhagen","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"France","Vendee","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"France","Paris","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"Germany","Berlin","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"Italy","Napoli","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"Italy","Roma","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"Italy","Bergamo","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"Italy","Milano","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"Italy","Rome","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"Italy","Pavia","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"Netherlands","Amsterdam","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"Netherlands","Utrecht","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"Spain","Barcelona","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"Spain","Madrid","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"United Kingdom","Glasgow","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"United Kingdom","Leeds","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"United Kingdom","London","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"United Kingdom","Manchester","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04320615","https://ClinicalTrials.gov/show/NCT04320615",NA,"United Kingdom","Salford","2020-Mar","2020-Aug","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life","SOC, TCZ",450
"NCT04347174","https://ClinicalTrials.gov/show/NCT04347174",NA,"India","Chhattisgarh","2020-Apr","2020-Jun","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA)","Other, SOC",40
"NCT04347174","https://ClinicalTrials.gov/show/NCT04347174",NA,"India","Madhya Pradesh","2020-Apr","2020-Jun","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA)","Other, SOC",40
"NCT04347174","https://ClinicalTrials.gov/show/NCT04347174",NA,"India","Chandigarh","2020-Apr","2020-Jun","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA)","Other, SOC",40
"NCT04347174","https://ClinicalTrials.gov/show/NCT04347174",NA,"India","Delhi","2020-Apr","2020-Jun","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA)","Other, SOC",40
"NCT04391309","https://ClinicalTrials.gov/show/NCT04391309",NA,"United States","Washington","2020-May","2021-Jul","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein","mAb, SOC",300
"NCT04411628","https://ClinicalTrials.gov/show/NCT04411628",NA,"United States","California","2020-Jun","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Viral Load or Clearance, Adverse Events","Other, SOC",40
"NCT04411628","https://ClinicalTrials.gov/show/NCT04411628",NA,"United States","Georgia","2020-Jun","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Viral Load or Clearance, Adverse Events","Other, SOC",40
"NCT04411628","https://ClinicalTrials.gov/show/NCT04411628",NA,"United States","Massachusetts","2020-Jun","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Viral Load or Clearance, Adverse Events","Other, SOC",40
"NCT04411628","https://ClinicalTrials.gov/show/NCT04411628",NA,"United States","Michigan","2020-Jun","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Viral Load or Clearance, Adverse Events","Other, SOC",40
"NCT04411628","https://ClinicalTrials.gov/show/NCT04411628",NA,"United States","Nebraska","2020-Jun","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Viral Load or Clearance, Adverse Events","Other, SOC",40
"NCT04411628","https://ClinicalTrials.gov/show/NCT04411628",NA,"United States","New York","2020-Jun","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Viral Load or Clearance, Adverse Events","Other, SOC",40
"NCT04411628","https://ClinicalTrials.gov/show/NCT04411628",NA,"United States","North Carolina","2020-Jun","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Viral Load or Clearance, Adverse Events","Other, SOC",40
"NCT04411628","https://ClinicalTrials.gov/show/NCT04411628",NA,"United States","Pennsylvania","2020-Jun","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Viral Load or Clearance, Adverse Events","Other, SOC",40
"NCT04438980","https://ClinicalTrials.gov/show/NCT04438980",NA,"Spain","Barcelona","2020-Jun","2020-Dec","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Adverse Events","Corticosteroids, SOC",72
"NCT04438980","https://ClinicalTrials.gov/show/NCT04438980",NA,"Spain","Navarra","2020-Jun","2020-Dec","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Adverse Events","Corticosteroids, SOC",72
"IRCT20200427047215N1","http://en.irct.ir/trial/47520",NA,"Iran","Tehran","2020-May","2020-Jul","Completed","Randomised","Single",2,"Confirmed","Hospital","Hospitalization, Hospital Discharge, SpO2","Other, SOC",60
"NCT04341675","https://ClinicalTrials.gov/show/NCT04341675",NA,"United States","Illinois","2020-Apr","2020-Jul","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Fever, Ferritin, Lymphocyte Count, D-Dimer, LDH","Other, SOC",30
"NCT04341675","https://ClinicalTrials.gov/show/NCT04341675",NA,"United States","Ohio","2020-Apr","2020-Jul","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Fever, Ferritin, Lymphocyte Count, D-Dimer, LDH","Other, SOC",30
"2020-001473-79","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001473-79/GB/",NA,"Italy","Rome","2020-Apr",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","SGLT2, SOC",900
"2020-001473-79","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001473-79/GB/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","SGLT2, SOC",900
"2020-001473-79","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001473-79/GB/",NA,"United Kingdom","London","2020-Apr",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","SGLT2, SOC",900
"2020-001473-79","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001473-79/GB/",NA,"United States","Washington, Dc","2020-Apr",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","SGLT2, SOC",900
"NCT04350593","https://ClinicalTrials.gov/show/NCT04350593",NA,"United States","Illinois","2020-Apr","2020-Oct","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Organ Failure or Dysfunction (SOFA), Renal Outcome (Unspecified)","SGLT2, SOC",900
"NCT04350593","https://ClinicalTrials.gov/show/NCT04350593",NA,"United States","Mississippi","2020-Apr","2020-Oct","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Organ Failure or Dysfunction (SOFA), Renal Outcome (Unspecified)","SGLT2, SOC",900
"NCT04350593","https://ClinicalTrials.gov/show/NCT04350593",NA,"United States","Missouri","2020-Apr","2020-Oct","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Organ Failure or Dysfunction (SOFA), Renal Outcome (Unspecified)","SGLT2, SOC",900
"NCT04350593","https://ClinicalTrials.gov/show/NCT04350593",NA,"United States","New York","2020-Apr","2020-Oct","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Organ Failure or Dysfunction (SOFA), Renal Outcome (Unspecified)","SGLT2, SOC",900
"NCT04350593","https://ClinicalTrials.gov/show/NCT04350593",NA,"United States","Virginia","2020-Apr","2020-Oct","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Organ Failure or Dysfunction (SOFA), Renal Outcome (Unspecified)","SGLT2, SOC",900
"NCT04305457","https://ClinicalTrials.gov/show/NCT04305457",NA,"United States","Louisiana","2020-Mar","2021-Apr","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","Non-invasive respiratory support, SOC",67
"NCT04305457","https://ClinicalTrials.gov/show/NCT04305457",NA,"United States","Massachusetts","2020-Mar","2021-Apr","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","Non-invasive respiratory support, SOC",67
"NCT04417257","https://ClinicalTrials.gov/show/NCT04417257",NA,"Canada","British Columbia","2020-Jun","2020-Dec","Recruiting","Randomised","Quadruple",2,"Confirmed Or Suspected","Hospital","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events","Other, SOC",300
"NCT04417257","https://ClinicalTrials.gov/show/NCT04417257",NA,"Canada","Quebec","2020-Jun","2020-Dec","Recruiting","Randomised","Quadruple",2,"Confirmed Or Suspected","Hospital","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events","Other, SOC",300
"CHICTR2000032717","http://www.chictr.org.cn/showproj.aspx?proj=53322",NA,"China","Shaanxi","2020-May","2021-Jan","Completed","Randomised","Unspecified",6,"Confirmed","Hospital","Viral Load or Clearance, Other Mild Symptoms, Blood Gas, Radiographic Findings","SOC, TCM, TCM + Vitamins",60
"NCT04395807","https://clinicaltrials.gov/show/NCT04395807",NA,"Sweden","Stockholm","2020-May",NA,"Recruiting","Randomised","Single",2,"Confirmed","Hospital",NA,"Non-invasive respiratory support",120
"NCT04402866","https://ClinicalTrials.gov/show/NCT04402866",NA,"United Kingdom","Manchester","2020-May","2020-Oct","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Dyspnea","Other, SOC",159
"NCT04403100","https://ClinicalTrials.gov/show/NCT04403100",NA,"Brazil","Minas Gerais","2020-May","2020-Sep","Recruiting","Randomised","Quadruple",4,"Confirmed Or Suspected","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events","HCQ, HCQ + LPV/r, LPV/r, SOC",1968
"CTRI/2020/05/025013","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42858",NA,"India","New Delhi","2020-May",NA,"Not Recruiting","Non-Randomised","Unspecified",2,"Confirmed","Hospital","Hospitalization, Hospital Discharge, Distress","SOC, Vaccine",60
"NCT04332991","https://ClinicalTrials.gov/show/NCT04332991",NA,"United States","Arizona","2020-Apr","2020-Jul","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",479
"NCT04332991","https://ClinicalTrials.gov/show/NCT04332991",NA,"United States","California","2020-Apr","2020-Jul","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",479
"NCT04332991","https://ClinicalTrials.gov/show/NCT04332991",NA,"United States","Colorado","2020-Apr","2020-Jul","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",479
"NCT04332991","https://ClinicalTrials.gov/show/NCT04332991",NA,"United States","Florida","2020-Apr","2020-Jul","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",479
"NCT04332991","https://ClinicalTrials.gov/show/NCT04332991",NA,"United States","Kentucky","2020-Apr","2020-Jul","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",479
"NCT04332991","https://ClinicalTrials.gov/show/NCT04332991",NA,"United States","Louisiana","2020-Apr","2020-Jul","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",479
"NCT04332991","https://ClinicalTrials.gov/show/NCT04332991",NA,"United States","Maine","2020-Apr","2020-Jul","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",479
"NCT04332991","https://ClinicalTrials.gov/show/NCT04332991",NA,"United States","Massachusetts","2020-Apr","2020-Jul","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",479
"NCT04332991","https://ClinicalTrials.gov/show/NCT04332991",NA,"United States","Michigan","2020-Apr","2020-Jul","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",479
"NCT04332991","https://ClinicalTrials.gov/show/NCT04332991",NA,"United States","Mississippi","2020-Apr","2020-Jul","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",479
"NCT04332991","https://ClinicalTrials.gov/show/NCT04332991",NA,"United States","New York","2020-Apr","2020-Jul","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",479
"NCT04332991","https://ClinicalTrials.gov/show/NCT04332991",NA,"United States","North Carolina","2020-Apr","2020-Jul","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",479
"NCT04332991","https://ClinicalTrials.gov/show/NCT04332991",NA,"United States","Ohio","2020-Apr","2020-Jul","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",479
"NCT04332991","https://ClinicalTrials.gov/show/NCT04332991",NA,"United States","Oregon","2020-Apr","2020-Jul","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",479
"NCT04332991","https://ClinicalTrials.gov/show/NCT04332991",NA,"United States","Pennsylvania","2020-Apr","2020-Jul","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",479
"NCT04332991","https://ClinicalTrials.gov/show/NCT04332991",NA,"United States","South Carolina","2020-Apr","2020-Jul","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",479
"NCT04332991","https://ClinicalTrials.gov/show/NCT04332991",NA,"United States","Tennessee","2020-Apr","2020-Jul","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",479
"NCT04332991","https://ClinicalTrials.gov/show/NCT04332991",NA,"United States","Texas","2020-Apr","2020-Jul","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",479
"NCT04332991","https://ClinicalTrials.gov/show/NCT04332991",NA,"United States","Utah","2020-Apr","2020-Jul","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",479
"NCT04332991","https://ClinicalTrials.gov/show/NCT04332991",NA,"United States","Virginia","2020-Apr","2020-Jul","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",479
"NCT04332991","https://ClinicalTrials.gov/show/NCT04332991",NA,"United States","Washington","2020-Apr","2020-Jul","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",479
"NCT04414618","https://ClinicalTrials.gov/show/NCT04414618",NA,"United States","Arizona","2020-Jun","2020-Sep","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever","Other, SOC",40
"NCT04414618","https://ClinicalTrials.gov/show/NCT04414618",NA,"United States","New York","2020-Jun","2020-Sep","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever","Other, SOC",40
"NCT04414618","https://ClinicalTrials.gov/show/NCT04414618",NA,"United States","Oregon","2020-Jun","2020-Sep","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever","Other, SOC",40
"IRCT20080901001165N56","http://en.irct.ir/trial/48116",NA,"Iran","Tehran","2020-May","2020-Jul","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Cough, Fever, Dyspnea, Adverse Events","Alternative therapy + Polyphenols, SOC",60
"NCT04392414","https://ClinicalTrials.gov/show/NCT04392414",NA,"Russia","Moscow","2020-May","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Fever, C-Reactive Protein, Antibodies","Plasma based therapy, SOC",60
"CTRI/2020/04/024773","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42897",NA,"Argentina","Buenos Aires","2020-Apr",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","HCQ, LPV/r, Remdesivir, SOC",7000
"CTRI/2020/04/024773","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42897",NA,"Brazil","Brasilia","2020-Apr",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","HCQ, LPV/r, Remdesivir, SOC",7000
"CTRI/2020/04/024773","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42897",NA,"Canada","Ottawa","2020-Apr",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","HCQ, LPV/r, Remdesivir, SOC",7000
"CTRI/2020/04/024773","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42897",NA,"Germany","Berlin","2020-Apr",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","HCQ, LPV/r, Remdesivir, SOC",7000
"CTRI/2020/04/024773","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42897",NA,"India","New Delhi","2020-Apr",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","HCQ, LPV/r, Remdesivir, SOC",7000
"CTRI/2020/04/024773","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42897",NA,"Indonesia","Jakarta","2020-Apr",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","HCQ, LPV/r, Remdesivir, SOC",7000
"CTRI/2020/04/024773","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42897",NA,"Iran","Tehran","2020-Apr",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","HCQ, LPV/r, Remdesivir, SOC",7000
"CTRI/2020/04/024773","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42897",NA,"Norway","Oslo","2020-Apr",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","HCQ, LPV/r, Remdesivir, SOC",7000
"CTRI/2020/04/024773","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42897",NA,"Peru","Lima","2020-Apr",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","HCQ, LPV/r, Remdesivir, SOC",7000
"CTRI/2020/04/024773","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42897",NA,"Qatar","Doha","2020-Apr",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","HCQ, LPV/r, Remdesivir, SOC",7000
"CTRI/2020/04/024773","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42897",NA,"South Africa","Pretoria","2020-Apr",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","HCQ, LPV/r, Remdesivir, SOC",7000
"CTRI/2020/04/024773","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42897",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","HCQ, LPV/r, Remdesivir, SOC",7000
"CTRI/2020/04/024773","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42897",NA,"Switzerland","Bern","2020-Apr",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","HCQ, LPV/r, Remdesivir, SOC",7000
"CTRI/2020/04/024773","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42897",NA,"Thailand","Nan","2020-Apr",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","HCQ, LPV/r, Remdesivir, SOC",7000
"2020-001198-55","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001198-55/DK/",NA,"Denmark","Copenhagen","2020-Mar",NA,"Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Visits or Returns to Emergency Department, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2, Blood pH, Quality of Life","AZT, HCQ, SOC",NA
"NCT04392531","https://ClinicalTrials.gov/show/NCT04392531",NA,"Spain","Madrid","2020-May","2020-Jul","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Viral Load or Clearance, Adverse Events, C-Reactive Protein, Ferritin, IL-6, D-Dimer, Creatinine Phosphokinase, LDH, Antibodies","Cyclosporine, SOC",120
"NCT04392531","https://ClinicalTrials.gov/show/NCT04392531",NA,"Spain","Navarra","2020-May","2020-Jul","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Viral Load or Clearance, Adverse Events, C-Reactive Protein, Ferritin, IL-6, D-Dimer, Creatinine Phosphokinase, LDH, Antibodies","Cyclosporine, SOC",120
"ISRCTN40580903","http://isrctn.com/ISRCTN40580903",NA,"United Kingdom","London","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, PaO2-FiO2, SpO2","Other, SOC",588
"NCT04394442","https://ClinicalTrials.gov/show/NCT04394442",NA,"Saudi Arabia","Riyadh","2020-May","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",200
"IRCT20200115046144N2","http://en.irct.ir/trial/47645",NA,"Iran","Semnan","2020-May","2020-Nov","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Other Mild Symptoms","Alternative therapy, SOC",40
"2020-001417-21","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001417-21/BE/",NA,"Belgium","Brussels","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization, Viral Load or Clearance, Other Mild Symptoms, Adverse Events, Serious Adverse Events","HCQ",NA
"IRCT20150914024017N1","http://en.irct.ir/trial/46665",NA,"Iran","Tehran","2020-Apr","2021-Feb","Recruiting","Randomised","Triple",2,"Confirmed","Hospital","ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Fever, Treatment-emergent Adverse Events","IFN, SOC",40
"2020-001271-33","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001271-33/FR/",NA,"France","Paris","2020-Mar",NA,"Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Deep Vein Thrombosis or Pulmonary Embolism, C-Reactive Protein, IL-1, IL-2, IL-4, IL-6, IL-8, Tumor Necrosis Factor (Any), IgG, IgM or IgA, Antibodies",NA,NA
"IRCT20200317046797N1","http://en.irct.ir/trial/46573",NA,"Iran","Tehran","2020-Apr","2020-May","Completed","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Radiographic Findings",NA,40
"IRCT20140617018126N2","http://en.irct.ir/trial/46637",NA,"Iran","East Azarbaijan","2020-Mar","2020-Apr","Completed","Randomised","Open-Label",2,"Confirmed","Hospital","C-Reactive Protein, White Blood Cell Count, Respiratory Rate",NA,60
"IRCT20160316027081N1","http://en.irct.ir/trial/46678",NA,"Iran","Fars","2020-Mar","2020-Apr","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospital Discharge, Respiratory Rate",NA,374
"IRCT20200323046841N1","http://en.irct.ir/trial/46715",NA,"Iran","Tehran","2020-Mar","2020-May","Completed","Randomised","Triple",2,"Confirmed","Hospital","Clinical Improvement Score (Any)",NA,60
"IRCT20200324046850N5","http://en.irct.ir/trial/46751",NA,"Iran","Tehran","2020-Apr","2020-May","Completed","Randomised","Double",2,"Confirmed","Hospital","Mortality, Hospitalization, Cough, Fever, Respiratory Rate",NA,40
"IRCT20200317046797N2","http://en.irct.ir/trial/46786",NA,"Iran","Tehran","2020-Apr","2020-May","Completed","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Cough, Dyspnea",NA,40
"IRCT20180802040678N4","http://en.irct.ir/trial/46824",NA,"Iran","Tehran","2020-Apr","2020-Apr","Completed","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any)",NA,100
"NCT04393246","https://ClinicalTrials.gov/show/NCT04393246",NA,"United Kingdom","Cambridgeshire","2020-May","2021-Feb","Recruiting","Randomised","Open-Label",4,"Confirmed Or Suspected","Hospital","Mortality, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, IL-6, Lymphocyte Count, D-Dimer, LDH, Renal Outcome (Unspecified)","Other, SGLT2 + Other, SOC",1407
"IRCT20131129015584N3","http://en.irct.ir/trial/47665",NA,"Iran","Tehran","2020-May","2020-Jun","Completed","Randomised","Open-Label",2,"Suspected","Hospital","Hospitalization, SpO2","Alternative therapy + AZT + LPV/r, AZT + LPV/r",68
"NCT04373733","https://ClinicalTrials.gov/show/NCT04373733",NA,"United Kingdom","Westminster","2020-May","2021-Mar","Recruiting","Randomised","Open-Label",3,"Suspected Or Confirmed","Hospital","ICU Admission, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, SpO2, Respiratory Rate","FPV, HCQ + AZT + Zinc, SOC",450
"NCT04373733","https://ClinicalTrials.gov/show/NCT04373733",NA,"United Kingdom","London","2020-May","2021-Mar","Recruiting","Randomised","Open-Label",3,"Suspected Or Confirmed","Hospital","ICU Admission, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, SpO2, Respiratory Rate","FPV, HCQ + AZT + Zinc, SOC",450
"CTRI/2020/04/024915","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43332",NA,"India","Delhi","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Pneumonia or ARDS, PaO2-FiO2","Plasma based therapy, SOC",100
"NCT04422509","https://ClinicalTrials.gov/show/NCT04422509",NA,"Netherlands","Amsterdam","2020-Jun","2021-Jun","Not Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Adverse Events","mAB, SOC",80
"NCT04422509","https://ClinicalTrials.gov/show/NCT04422509",NA,"Netherlands","Utrecht","2020-Jun","2021-Jun","Not Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Adverse Events","mAB, SOC",80
"ISRCTN85216856","http://isrctn.com/ISRCTN85216856",NA,"Ecuador","Quito","2020-Nov",NA,"Recruiting","Randomised","Triple",2,"Confirmed","Hospital",NA,"Plasma based therapy, SOC",200
"CHICTR2000029609","http://www.chictr.org.cn/showproj.aspx?proj=49145",NA,"China","Guangdong","2020-Feb","2020-Dec","Not Recruiting","Non-Randomised","Open-Label",5,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance","HCQ, LPV/r, LPV/r + HCQ",205
"ISRCTN83971151","http://isrctn.com/ISRCTN83971151",NA,"Indonesia","Jakarta","2020-Mar",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",10000
"ISRCTN83971151","http://isrctn.com/ISRCTN83971151",NA,"Iran","Tehran","2020-Mar",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",10000
"ISRCTN83971151","http://isrctn.com/ISRCTN83971151",NA,"Ireland","Dublin","2020-Mar",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",10000
"ISRCTN83971151","http://isrctn.com/ISRCTN83971151",NA,"Israel","Jerusalem","2020-Mar",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",10000
"ISRCTN83971151","http://isrctn.com/ISRCTN83971151",NA,"Italy","Rome","2020-Mar",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",10000
"ISRCTN83971151","http://isrctn.com/ISRCTN83971151",NA,"Kenya","Nairobi","2020-Mar",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",10000
"ISRCTN83971151","http://isrctn.com/ISRCTN83971151",NA,"Lebanon","Beirut","2020-Mar",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",10000
"ISRCTN83971151","http://isrctn.com/ISRCTN83971151",NA,"Malaysia","Kuala Lumpur","2020-Mar",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",10000
"ISRCTN83971151","http://isrctn.com/ISRCTN83971151",NA,"Norway","Oslo","2020-Mar",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",10000
"ISRCTN83971151","http://isrctn.com/ISRCTN83971151",NA,"Peru","Lima","2020-Mar",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",10000
"ISRCTN83971151","http://isrctn.com/ISRCTN83971151",NA,"Philippines","Manila","2020-Mar",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",10000
"ISRCTN83971151","http://isrctn.com/ISRCTN83971151",NA,"Qatar","Doha","2020-Mar",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",10000
"ISRCTN83971151","http://isrctn.com/ISRCTN83971151",NA,"Saudi Arabia","Riyadh","2020-Mar",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",10000
"ISRCTN83971151","http://isrctn.com/ISRCTN83971151",NA,"South Africa","Pretoria","2020-Mar",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",10000
"ISRCTN83971151","http://isrctn.com/ISRCTN83971151",NA,"Spain","Madrid","2020-Mar",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",10000
"ISRCTN83971151","http://isrctn.com/ISRCTN83971151",NA,"Switzerland","Bern","2020-Mar",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",10000
"ISRCTN83971151","http://isrctn.com/ISRCTN83971151",NA,"Thailand","Nan","2020-Mar",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",10000
"ISRCTN83971151","http://isrctn.com/ISRCTN83971151",NA,"Argentina","Buenos Aires","2020-Mar",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",10000
"ISRCTN83971151","http://isrctn.com/ISRCTN83971151",NA,"Brazil","Brasilia","2020-Mar",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",10000
"ISRCTN83971151","http://isrctn.com/ISRCTN83971151",NA,"Canada","Ottawa","2020-Mar",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",10000
"ISRCTN83971151","http://isrctn.com/ISRCTN83971151",NA,"Germany","Berlin","2020-Mar",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",10000
"ISRCTN83971151","http://isrctn.com/ISRCTN83971151",NA,"Honduras","Tegucigalpa","2020-Mar",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",10000
"ISRCTN83971151","http://isrctn.com/ISRCTN83971151",NA,"India","New Delhi","2020-Mar",NA,"Recruiting","Randomised","Open-Label",5,"Confirmed","Hospital",NA,"HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC",10000
"NCT04328012","https://ClinicalTrials.gov/show/NCT04328012",NA,"United States","New York","2020-Mar","2021-Jan","Recruiting","Randomised","Quadruple",4,"Confirmed","Hospital","Clinical Improvement Score (Any), C-Reactive Protein, D-Dimer","ARBs, HCQ, LPV/r, SOC",4000
"CHICTR2000029996","http://www.chictr.org.cn/showproj.aspx?proj=49510",NA,"China","Beijing","2020-Feb","2020-Apr","Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Other Mild Symptoms","FPV",60
"CHICTR2000029496","http://www.chictr.org.cn/showproj.aspx?proj=48809",NA,"China","Hunan","2020-Feb","2021-Jan","Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Viral Load or Clearance, Adverse Events","LPV/r, LPV/r + Other, Other",90
"NCT04382066","https://ClinicalTrials.gov/show/NCT04382066",NA,"Spain","Madrid","2020-May","2020-Nov","Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Creatinine Phosphokinase, ALT, AST, Bilirubin, ECG","Other",27
"NCT04382066","https://ClinicalTrials.gov/show/NCT04382066",NA,"Spain","Barcelona","2020-May","2020-Nov","Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Creatinine Phosphokinase, ALT, AST, Bilirubin, ECG","Other",27
"NCT04382066","https://ClinicalTrials.gov/show/NCT04382066",NA,"Spain","Ciudad Real","2020-May","2020-Nov","Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Creatinine Phosphokinase, ALT, AST, Bilirubin, ECG","Other",27
"NCT04382066","https://ClinicalTrials.gov/show/NCT04382066",NA,"Spain","Guadalajara","2020-May","2020-Nov","Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Creatinine Phosphokinase, ALT, AST, Bilirubin, ECG","Other",27
"CHICTR2000030003","http://www.chictr.org.cn/showproj.aspx?proj=49770",NA,"China","Sichuan","2020-Feb","2020-Jul","Not Recruiting","Randomised","Unspecified",3,"Confirmed","Hospital","Hospitalization, Hospital Discharge, Fever","TCM",480
"NCT04405739","https://ClinicalTrials.gov/show/NCT04405739",NA,"United States","Maryland","2020-May","2020-Aug","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Adverse Events","Antivirals, SOC",60
"NCT04322344","https://ClinicalTrials.gov/show/NCT04322344",NA,"Italy","Catanzaro","2020-Mar","2020-Jun","Recruiting","Non-Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Alternative therapy, SOC",120
"CHICTR2000030545","http://www.chictr.org.cn/showproj.aspx?proj=50126",NA,"China","Hubei","2020-Mar","2020-Apr","Recruiting","Randomised","Unspecified",3,"Confirmed","Hospital","ICU Admission, Hospitalization, Pneumonia or ARDS, Cough, Fever, Dyspnea, Other Mild Symptoms, Radiographic Findings","SOC, TCM",300
"NCT04374279","https://ClinicalTrials.gov/show/NCT04374279",NA,"United States","Maryland","2020-May","2021-Jun","Not Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events","Ivermectin, Other, SOC",60
"NCT04416113","https://ClinicalTrials.gov/show/NCT04416113",NA,"Egypt","Cairo","2020-Jun","2020-Dec","Not Recruiting","Randomised","Single",3,"Confirmed","Hospital",NA,"Alternative therapy, SOC",60
"NCT04327388","https://ClinicalTrials.gov/show/NCT04327388",NA,"Argentina","Buenos Aires","2020-Mar","2020-Jul","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Respiratory Rate, Hypoxemia","Sarilumab, SOC",400
"NCT04327388","https://ClinicalTrials.gov/show/NCT04327388",NA,"Brazil","Brasilia","2020-Mar","2020-Jul","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Respiratory Rate, Hypoxemia","Sarilumab, SOC",400
"NCT04327388","https://ClinicalTrials.gov/show/NCT04327388",NA,"Brazil","Sao Paulo","2020-Mar","2020-Jul","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Respiratory Rate, Hypoxemia","Sarilumab, SOC",400
"NCT04327388","https://ClinicalTrials.gov/show/NCT04327388",NA,"Canada","Ottawa","2020-Mar","2020-Jul","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Respiratory Rate, Hypoxemia","Sarilumab, SOC",400
"NCT04327388","https://ClinicalTrials.gov/show/NCT04327388",NA,"Chile","Santiago","2020-Mar","2020-Jul","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Respiratory Rate, Hypoxemia","Sarilumab, SOC",400
"NCT04327388","https://ClinicalTrials.gov/show/NCT04327388",NA,"France","Paris","2020-Mar","2020-Jul","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Respiratory Rate, Hypoxemia","Sarilumab, SOC",400
"NCT04327388","https://ClinicalTrials.gov/show/NCT04327388",NA,"Germany","Berlin","2020-Mar","2020-Jul","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Respiratory Rate, Hypoxemia","Sarilumab, SOC",400
"NCT04327388","https://ClinicalTrials.gov/show/NCT04327388",NA,"Israel","Jerusalem","2020-Mar","2020-Jul","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Respiratory Rate, Hypoxemia","Sarilumab, SOC",400
"NCT04327388","https://ClinicalTrials.gov/show/NCT04327388",NA,"Italy","Milano","2020-Mar","2020-Jul","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Respiratory Rate, Hypoxemia","Sarilumab, SOC",400
"NCT04327388","https://ClinicalTrials.gov/show/NCT04327388",NA,"Italy","Modena","2020-Mar","2020-Jul","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Respiratory Rate, Hypoxemia","Sarilumab, SOC",400
"NCT04327388","https://ClinicalTrials.gov/show/NCT04327388",NA,"Italy","Parma","2020-Mar","2020-Jul","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Respiratory Rate, Hypoxemia","Sarilumab, SOC",400
"NCT04327388","https://ClinicalTrials.gov/show/NCT04327388",NA,"Italy","Rome","2020-Mar","2020-Jul","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Respiratory Rate, Hypoxemia","Sarilumab, SOC",400
"NCT04327388","https://ClinicalTrials.gov/show/NCT04327388",NA,"Japan","Tokyo","2020-Mar","2020-Jul","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Respiratory Rate, Hypoxemia","Sarilumab, SOC",400
"NCT04327388","https://ClinicalTrials.gov/show/NCT04327388",NA,"Russia","Moscow","2020-Mar","2020-Jul","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Respiratory Rate, Hypoxemia","Sarilumab, SOC",400
"NCT04327388","https://ClinicalTrials.gov/show/NCT04327388",NA,"Spain","Barcelona","2020-Mar","2020-Jul","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Respiratory Rate, Hypoxemia","Sarilumab, SOC",400
"NCT04327388","https://ClinicalTrials.gov/show/NCT04327388",NA,"Spain","Madrid","2020-Mar","2020-Jul","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Respiratory Rate, Hypoxemia","Sarilumab, SOC",400
"CHICTR2000029541","http://www.chictr.org.cn/showproj.aspx?proj=48992",NA,"China","Hubei","2020-Feb","2020-Dec","Not Recruiting","Randomised","Unspecified",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Radiographic Findings","DRV/c + Other, LPV/r + Other, Other",100
"CHICTR2000030894","http://www.chictr.org.cn/showproj.aspx?proj=51126",NA,"China","Beijing","2020-Mar","2020-May","Recruiting","Randomised","Unspecified",3,"Confirmed","Hospital","Mortality, Hospitalization, Viral Load or Clearance, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Fever, C-Reactive Protein, Radiographic Findings","FPV, FPV + TCZ, TCZ",150
"IRCT20160706028815N5","http://en.irct.ir/trial/47682",NA,"Iran","Tehran","2020-May","2020-Jul","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization","Antivirals, Other + Antivirals",40
"CHICTR2000029603","http://www.chictr.org.cn/showproj.aspx?proj=49075",NA,"China","Zhejiang","2020-Feb","2020-May","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, PaO2-FiO2, Respiratory Rate","LPV/r, Other",160
"NCT04371406","https://ClinicalTrials.gov/show/NCT04371406",NA,"France","Paris","2020-May","2020-Aug","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Other Mild Symptoms, Adverse Events, Serious Adverse Events, Quality of Life","HCQ + AZT, Nutrition",2770
"CHICTR2000029542","http://www.chictr.org.cn/showproj.aspx?proj=48968",NA,"China","Guangdong","2020-Feb","2020-Jul","Recruiting","Non-Randomised","Unspecified",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein","HCQ, SOC",20
"RPCEC00000320","https://rpcec.sld.cu/en/trials/RPCEC00000320-En",NA,"Cuba","Havana","2020-May",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Cough, Fever, Dyspnea, Other Mild Symptoms","HCQ + Anitvirals + Inferon, Other + HCQ + Anitvirals + Inferon",32
"NCT04329195","https://ClinicalTrials.gov/show/NCT04329195",NA,"France","Paris","2020-Apr","2020-May","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Antihypertensive",554
"NCT04432103","https://ClinicalTrials.gov/show/NCT04432103",NA,"Mexico","Morelos","2020-Jun","2020-Jul","Not Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO","Plasma based therapy",36
"CHICTR2000030627","http://www.chictr.org.cn/showproj.aspx?proj=50727",NA,"China","Henan","2020-Mar","2020-May","Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Mortality, Hospitalization, Viral Load or Clearance, Fever, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","Plasma based therapy, SOC",30
"NCT04427098","https://ClinicalTrials.gov/show/NCT04427098",NA,"Italy","Bologna","2020-Jun","2020-Oct","Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization","Anticoagulants",300
"NCT04427098","https://ClinicalTrials.gov/show/NCT04427098",NA,"Italy","Parma","2020-Jun","2020-Oct","Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization","Anticoagulants",300
"NCT04427098","https://ClinicalTrials.gov/show/NCT04427098",NA,"Italy","Foggia","2020-Jun","2020-Oct","Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization","Anticoagulants",300
"NCT04427098","https://ClinicalTrials.gov/show/NCT04427098",NA,"Italy","Brescia","2020-Jun","2020-Oct","Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization","Anticoagulants",300
"NCT04427098","https://ClinicalTrials.gov/show/NCT04427098",NA,"Italy","Catania","2020-Jun","2020-Oct","Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization","Anticoagulants",300
"NCT04427098","https://ClinicalTrials.gov/show/NCT04427098",NA,"Italy","Cremona","2020-Jun","2020-Oct","Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization","Anticoagulants",300
"NCT04427098","https://ClinicalTrials.gov/show/NCT04427098",NA,"Italy","Rome","2020-Jun","2020-Oct","Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization","Anticoagulants",300
"NCT04427098","https://ClinicalTrials.gov/show/NCT04427098",NA,"Italy","Mantova","2020-Jun","2020-Oct","Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization","Anticoagulants",300
"NCT04427098","https://ClinicalTrials.gov/show/NCT04427098",NA,"Italy","Potenza","2020-Jun","2020-Oct","Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization","Anticoagulants",300
"NCT04427098","https://ClinicalTrials.gov/show/NCT04427098",NA,"Italy","Milano","2020-Jun","2020-Oct","Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization","Anticoagulants",300
"NCT04427098","https://ClinicalTrials.gov/show/NCT04427098",NA,"Italy","Verona","2020-Jun","2020-Oct","Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization","Anticoagulants",300
"2020-001891-14","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001891-14/ES/",NA,"Spain","Madrid","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, SpO2, Respiratory Rate","Anticoagulants",NA
"NCT04394377","https://ClinicalTrials.gov/show/NCT04394377",NA,"Brazil","Minas Gerais","2020-May","2020-Dec","Recruiting","Randomised","Single",2,"Confirmed","Hospital","Mortality, D-Dimer, Troponin","Anticoagulants",600
"NCT04394377","https://ClinicalTrials.gov/show/NCT04394377",NA,"Brazil","Brasilia","2020-May","2020-Dec","Recruiting","Randomised","Single",2,"Confirmed","Hospital","Mortality, D-Dimer, Troponin","Anticoagulants",600
"NCT04394377","https://ClinicalTrials.gov/show/NCT04394377",NA,"Israel","Jerusalem","2020-May","2020-Dec","Recruiting","Randomised","Single",2,"Confirmed","Hospital","Mortality, D-Dimer, Troponin","Anticoagulants",600
"CHICTR2000030472","http://www.chictr.org.cn/showproj.aspx?proj=49753",NA,"China","Liaoning","2020-Mar","2020-Jun","Recruiting","Non-Randomised","Unspecified",2,"Confirmed","Hospital","Viral Load or Clearance, Adverse Events, Serious Adverse Events, PaO2-FiO2, Respiratory Rate","DAA, SOC",20
"IRCT20200330046899N1","http://en.irct.ir/trial/48365",NA,"Iran","Tehran","2020-Jun","2020-Jul","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","White Blood Cell Count","Alternative therapy, SOC",50
"NCT04405921","https://ClinicalTrials.gov/show/NCT04405921",NA,"Tunisia","Sousse","2020-May","2020-Dec","Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Viral Load or Clearance","HCQ, HCQ + AZT",200
"NCT04390594","https://ClinicalTrials.gov/show/NCT04390594",NA,"Senegal","Dakar","2020-May","2020-Dec","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization, Viral Load or Clearance, Organ Failure or Dysfunction (SOFA), Serious Adverse Events","HCQ, HCQ + AZT",258
"IRCT20200511047396N1","http://en.irct.ir/trial/48048",NA,"Iran","Tehran","2020-May","2020-Nov","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Viral Load or Clearance, Cough","HCQ, HCQ + IFN",50
"NCT04332835","https://ClinicalTrials.gov/show/NCT04332835",NA,"Colombia","Cundinamarca","2020-Apr","2020-Aug","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, IgG, IgM or IgA","HCQ + AZT, Plasma based therapy + HCQ + AZT",80
"NCT04376814","https://clinicaltrials.gov/show/NCT04376814",NA,"Iran","Tehran","2020-Mar",NA,"Not Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Dyspnea, C-Reactive Protein, SpO2","HCQ + FPV, HCQ + LPV/r",40
"JPRN-JRCTS031190227","https://jrct.niph.go.jp/latest-detail/jRCTs031190227",NA,"Japan","Gunma","2020-Feb",NA,"Not Recruiting","Single-Arm","Open-Label",2,"Confirmed","Hospital","Viral Load or Clearance, C-Reactive Protein","HCQ + LPV/r, Oseltamivir + HCQ + LPV/r",50
"NCT04380818","https://clinicaltrials.gov/show/NCT04380818",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Non-Randomised","Open-Label",7,"Confirmed","Hospital",NA,"HCQ + LPV/r + TCZ + AZT + Corticosteroids + Anticoagulants + Non-invasive respiratory support, Radiation therapy + HCQ + LPV/r + TCZ + AZT + Corticosteroids + Anticoagulants + Non-invasive respiratory support",106
"ACTRN12620000557932","https://anzctr.org.au/ACTRN12620000557932.aspx",NA,"Australia","Canberra","2020-Nov",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO","HCQ + Zinc + Vitamins + AZT",200
"ACTRN12620000557932","https://anzctr.org.au/ACTRN12620000557932.aspx",NA,"United States","Washington, Dc","2020-Nov",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO","HCQ + Zinc + Vitamins + AZT",200
"ACTRN12620000557932","https://anzctr.org.au/ACTRN12620000557932.aspx",NA,"Germany","Berlin","2020-Nov",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO","HCQ + Zinc + Vitamins + AZT",200
"NCT04391127","https://ClinicalTrials.gov/show/NCT04391127",NA,"Mexico","Aguascalientes","2020-May","2020-Aug","Recruiting","Randomised","Double",3,"Confirmed","Hospital","Hospitalization, Invasive Mechanical Ventilation or ECMO","HCQ + Ivermectin, Ivermectin",200
"NCT04261907","https://ClinicalTrials.gov/show/NCT04261907",NA,"China","Beijing","2020-Feb","2020-May","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","ICU Admission, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms, Adverse Events, PaO2-FiO2, Respiratory Rate","LPV/r, Other",160
"IRCT20151227025726N15","http://en.irct.ir/trial/48018",NA,"Iran","Tehran","2020-May","2020-Jul","Completed","Randomised","Open-Label",2,"Confirmed","Hospital","Invasive Mechanical Ventilation or ECMO, Dyspnea","LPV/r, Umifenovir",100
"CHICTR2000030946","http://www.chictr.org.cn/showproj.aspx?proj=51265",NA,"China","Guangdong","2020-Mar","2020-Apr","Recruiting","Non-Randomised","Unspecified",2,"Confirmed","Hospital",NA,"Anticoagulants, Other",120
"CHICTR2000030116","http://www.chictr.org.cn/showproj.aspx?proj=49901",NA,"China","Jiangxi","2020-Feb","2020-Aug","Recruiting","Single-Arm","Unspecified",2,"Confirmed","Hospital","Invasive Mechanical Ventilation or ECMO","Stem cells",16
"NCT04418128","https://ClinicalTrials.gov/show/NCT04418128",NA,"South Korea","Seoul","2020-Jun","2021-Mar","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events","Anticoagulants, SOC",84
"CHICTR2000029851","http://www.chictr.org.cn/showproj.aspx?proj=49534",NA,"China","Shanghai","2020-Feb","2020-Mar","Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Viral Load or Clearance","Other, SOC",68
"CHICTR2000029853","http://www.chictr.org.cn/showproj.aspx?proj=49532",NA,"China","Henan","2020-Feb","2020-Apr","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Viral Load or Clearance, Cough, Fever, Other Mild Symptoms, CD4, Radiographic Findings","Antivirals, SOC",20
"CHICTR2000029768","http://www.chictr.org.cn/showproj.aspx?proj=49131",NA,"China","Hubei","2020-Feb","2020-May","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization, Hospital Discharge, Viral Load or Clearance","Other, SOC",60
"NCT04333251","https://ClinicalTrials.gov/show/NCT04333251",NA,"United States","Texas","2020-Apr","2022-Dec","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Non-invasive respiratory support, Plasma based therapy",115
"CHICTR2000029898","http://www.chictr.org.cn/showproj.aspx?proj=49482",NA,"China","Beijing","2020-Feb","2020-Apr","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, IgG, IgM or IgA","HCQ",100
"CHICTR2000029849","http://www.chictr.org.cn/showproj.aspx?proj=49530",NA,"China","Henan","2020-Feb","2021-Feb","Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Mortality, Hospitalization, Pneumonia or ARDS, Fever","SOC, TCM",60
"CHICTR2000030089","http://www.chictr.org.cn/showproj.aspx?proj=49889",NA,"China","Shanghai","2020-Feb","2020-Aug","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events","mAb, SOC",60
"NCT04385836","https://ClinicalTrials.gov/show/NCT04385836",NA,"Saudi Arabia","Riyadh","2020-May","2020-Sep","Recruiting","Randomised","Single",2,"Confirmed","Hospital","Clinical Improvement Score (Any)","Other, SOC",150
"NCT04375124","https://ClinicalTrials.gov/show/NCT04375124",NA,"Turkey","Istanbul","2020-May","2020-Aug","Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Mortality","Antihypertensive, SOC",20
"NCT04403646","https://ClinicalTrials.gov/show/NCT04403646",NA,"Argentina","Buenos Aires","2020-May","2020-Sep","Not Recruiting","Randomised","Triple",2,"Confirmed","Hospital","Mortality, Hospital Discharge","Other, SOC",140
"NCT04382040","https://ClinicalTrials.gov/show/NCT04382040",NA,"Israel","Haifa","2020-May","2020-Jul","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2","Other, SOC",50
"NCT04382040","https://ClinicalTrials.gov/show/NCT04382040",NA,"Israel","Jerusalem","2020-May","2020-Jul","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2","Other, SOC",50
"IRCT20200413047062N1","http://en.irct.ir/trial/47146",NA,"Iran","Tehran","2020-May","2020-May","Completed","Non-Randomised","Single",2,"Confirmed","Hospital","Mortality","SOC, Statins",76
"CHICTR2000030398","http://www.chictr.org.cn/showproj.aspx?proj=50173",NA,"China","Hubei","2020-Mar",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Dyspnea, SpO2, Radiographic Findings","Other, SOC",340
"2020-001306-35","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001306-35/FR/",NA,"France","Paris","2020-Mar",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Serious Adverse Events, C-Reactive Protein, PaO2-FiO2","Corticosteroids + Other, SOC",NA
"NCT04331054","https://clinicaltrials.gov/show/NCT04331054",NA,"France","Paris","2020-Mar",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, PaO2-FiO2","Corticosteroids, SOC",436
"NCT04321096","https://ClinicalTrials.gov/show/NCT04321096",NA,"Denmark","Copenhagen","2020-Mar","2020-Dec","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",580
"CHICTR2000030718","http://www.chictr.org.cn/showproj.aspx?proj=50843",NA,"China","Hubei","2020-Mar","2020-May","Recruiting","Randomised","Open-Label",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Dyspnea, Serious Adverse Events, Granulocyte Stimulaiting Factor, White Blood Cell Count, Monocyte Count, Natural Killer Cell Count, Neutrophils, ALT, Albumin, Bilirubin, IgG, IgM or IgA","Cyclosporine, HCQ, SOC",80
"NCT04328493","https://ClinicalTrials.gov/show/NCT04328493",NA,"Vietnam","Hanoi","2020-Mar","2021-Apr","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Fever, Adverse Events","HCQ, SOC",250
"NCT04328493","https://ClinicalTrials.gov/show/NCT04328493",NA,"Vietnam","Ho Chi Minh City","2020-Mar","2021-Apr","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Fever, Adverse Events","HCQ, SOC",250
"NCT04377568","https://ClinicalTrials.gov/show/NCT04377568",NA,"Canada","Alberta","2020-May","2021-Dec","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Adverse Events, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Plasma based therapy, SOC",100
"NCT04377568","https://ClinicalTrials.gov/show/NCT04377568",NA,"Canada","British Columbia","2020-May","2021-Dec","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Adverse Events, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Plasma based therapy, SOC",100
"NCT04377568","https://ClinicalTrials.gov/show/NCT04377568",NA,"Canada","Manitoba","2020-May","2021-Dec","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Adverse Events, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Plasma based therapy, SOC",100
"NCT04377568","https://ClinicalTrials.gov/show/NCT04377568",NA,"Canada","Nova Scotia","2020-May","2021-Dec","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Adverse Events, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Plasma based therapy, SOC",100
"NCT04377568","https://ClinicalTrials.gov/show/NCT04377568",NA,"Canada","Ontario","2020-May","2021-Dec","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Adverse Events, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Plasma based therapy, SOC",100
"NCT04377568","https://ClinicalTrials.gov/show/NCT04377568",NA,"Canada","Quebec","2020-May","2021-Dec","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Adverse Events, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Plasma based therapy, SOC",100
"NCT04377568","https://ClinicalTrials.gov/show/NCT04377568",NA,"Canada","Saskatchewan","2020-May","2021-Dec","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Adverse Events, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Plasma based therapy, SOC",100
"NCT04388410","https://ClinicalTrials.gov/show/NCT04388410",NA,"Mexico","Mexico","2020-May","2020-Oct","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Antibodies","Plasma based therapy, SOC",250
"IRCT20200316046792N1","http://en.irct.ir/trial/46554",NA,"Iran","Tehran","2020-Mar","2020-May","Completed","Randomised","Double",3,"Confirmed","Hospital","Mortality, Hospitalization, Cough, Fever, Treatment-emergent Adverse Events, Respiratory Rate","Alternative therapy, SOC",150
"IRCT20200317046797N6","http://en.irct.ir/trial/48500",NA,"Iran","East Azarbaijan","2020-Jun","2020-Jul","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization, Invasive Mechanical Ventilation or ECMO","Other, SOC",30
"CHICTR2000030701","http://www.chictr.org.cn/showproj.aspx?proj=50795",NA,"China","Guangdong","2020-Mar","2020-Sep","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Respiratory Rate","Anticoagulants, SOC",60
"CHICTR2000030700","http://www.chictr.org.cn/showproj.aspx?proj=50786",NA,"China","Hubei","2020-Mar","2020-Sep","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Respiratory Rate","Anticoagulants, SOC",60
"NCT04280588","https://ClinicalTrials.gov/show/NCT04280588",NA,"China","Beijing","2020-Feb","2020-Jul","Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Pneumonia or ARDS","Immunomodulators, SOC",30
"IRCT20200502047268N1","http://en.irct.ir/trial/47692",NA,"Iran","Tehran","2020-May","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Lymphocyte Count","Other, SOC",10
"NCT04372589","https://ClinicalTrials.gov/show/NCT04372589",NA,"United States","Illinois","2020-May","2021-Jan","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cardiac Outcome (Unspecified)","Anticoagulants, SOC",3000
"NCT04372589","https://ClinicalTrials.gov/show/NCT04372589",NA,"United States","Louisiana","2020-May","2021-Jan","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cardiac Outcome (Unspecified)","Anticoagulants, SOC",3000
"NCT04372589","https://ClinicalTrials.gov/show/NCT04372589",NA,"United States","Maine","2020-May","2021-Jan","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cardiac Outcome (Unspecified)","Anticoagulants, SOC",3000
"NCT04372589","https://ClinicalTrials.gov/show/NCT04372589",NA,"United States","Michigan","2020-May","2021-Jan","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cardiac Outcome (Unspecified)","Anticoagulants, SOC",3000
"NCT04372589","https://ClinicalTrials.gov/show/NCT04372589",NA,"United States","Missouri","2020-May","2021-Jan","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cardiac Outcome (Unspecified)","Anticoagulants, SOC",3000
"NCT04372589","https://ClinicalTrials.gov/show/NCT04372589",NA,"United States","New Jersey","2020-May","2021-Jan","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cardiac Outcome (Unspecified)","Anticoagulants, SOC",3000
"NCT04372589","https://ClinicalTrials.gov/show/NCT04372589",NA,"United States","New York","2020-May","2021-Jan","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cardiac Outcome (Unspecified)","Anticoagulants, SOC",3000
"NCT04372589","https://ClinicalTrials.gov/show/NCT04372589",NA,"United States","Tennessee","2020-May","2021-Jan","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cardiac Outcome (Unspecified)","Anticoagulants, SOC",3000
"NCT04372589","https://ClinicalTrials.gov/show/NCT04372589",NA,"Brazil","Brasilia","2020-May","2021-Jan","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cardiac Outcome (Unspecified)","Anticoagulants, SOC",3000
"NCT04372589","https://ClinicalTrials.gov/show/NCT04372589",NA,"Canada","British Columbia","2020-May","2021-Jan","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cardiac Outcome (Unspecified)","Anticoagulants, SOC",3000
"NCT04372589","https://ClinicalTrials.gov/show/NCT04372589",NA,"Canada","Manitoba","2020-May","2021-Jan","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cardiac Outcome (Unspecified)","Anticoagulants, SOC",3000
"NCT04372589","https://ClinicalTrials.gov/show/NCT04372589",NA,"Canada","Ontario","2020-May","2021-Jan","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cardiac Outcome (Unspecified)","Anticoagulants, SOC",3000
"NCT04372589","https://ClinicalTrials.gov/show/NCT04372589",NA,"Canada","Quebec","2020-May","2021-Jan","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cardiac Outcome (Unspecified)","Anticoagulants, SOC",3000
"NCT04372589","https://ClinicalTrials.gov/show/NCT04372589",NA,"Canada","Saskatchewan","2020-May","2021-Jan","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cardiac Outcome (Unspecified)","Anticoagulants, SOC",3000
"NCT04372589","https://ClinicalTrials.gov/show/NCT04372589",NA,"Mexico","Mexico","2020-May","2021-Jan","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cardiac Outcome (Unspecified)","Anticoagulants, SOC",3000
"CHICTR2000029822","http://www.chictr.org.cn/showproj.aspx?proj=49502",NA,"China","Hebei","2020-Feb","2020-Apr","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization, Viral Load or Clearance, Fever, Respiratory Rate","SOC, TCM",110
"CHICTR2000030258","http://www.chictr.org.cn/showproj.aspx?proj=49887",NA,"China","Heilongjiang","2020-Feb","2020-Aug","Not Recruiting","Single-Arm","Open-Label",2,"Confirmed","Hospital","Mortality, Viral Load or Clearance, Cough, Fever, SpO2, Respiratory Rate, 6-Minute Walking Distance, Radiographic Findings, Quality of Life, Depression, Anxiety","Respiratory support, SOC",60
"NCT04379492","https://ClinicalTrials.gov/show/NCT04379492",NA,"United States","New York","2020-May","2021-May","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO","HCQ, SOC",120
"EUCTR2020-001224-33-DE","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001224-33",NA,"Germany","Berlin","2020-Mar",NA,"Not Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",220
"NCT04322396","https://ClinicalTrials.gov/show/NCT04322396",NA,"Denmark","Copenhagen","2020-Mar","2020-Oct","Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Blood Gas, Blood pH","HCQ + AZT, SOC",226
"2020-001010-38","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001010-38/NO/",NA,"Norway","Oslo","2020-Mar",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",NA
"IRCT20080901001165N53","http://en.irct.ir/trial/48066",NA,"Iran","Tehran","2020-May","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Fever","IFN, SOC",100
"2020-001023-14","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001023-14/GB/",NA,"United Kingdom","London","2020-Mar",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Dyspnea, Other Mild Symptoms, Blood Pressure, Heart Rate, SpO2, Respiratory Rate","IFN, SOC",400
"NCT04407689","https://ClinicalTrials.gov/show/NCT04407689",NA,"France","Paris","2020-May","2020-Oct","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Serious or Seconday Infections, C-Reactive Protein, Ferritin, Lymphocyte Count, D-Dimer, CD4, CD8","Other, SOC",48
"NCT04381884","https://ClinicalTrials.gov/show/NCT04381884",NA,"Argentina","Ciudad De Buenos Aires","2020-May","2020-Jun","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Viral Load or Clearance, Adverse Events, Antibodies","Ivermectin, SOC",45
"NCT04373824","https://clinicaltrials.gov/show/NCT04373824",NA,"India","New Delhi","2020-Apr",NA,"Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital",NA,"Ivermectin, SOC",50
"NCT04390217","https://ClinicalTrials.gov/show/NCT04390217",NA,"United States","California","2020-May","2020-Dec","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","Other, SOC",120
"CHICTR2000030578","http://www.chictr.org.cn/showproj.aspx?proj=50690",NA,"China","Shandong","2020-Mar","2021-Feb","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Quality of Life","Respiratory support, SOC",40
"NCT04374032","https://ClinicalTrials.gov/show/NCT04374032",NA,"Bosnia & Herzegovina","Sarajevo","2020-May","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization, Adverse Events, Radiographic Findings","Other, SOC",120
"NCT04273321","https://ClinicalTrials.gov/show/NCT04273321",NA,"China","Hubei","2020-Feb","2020-Apr","Completed","Single-Arm","Open-Label",2,"Confirmed","Hospital",NA,"Corticosteroids, SOC",86
"NCT04273321","https://ClinicalTrials.gov/show/NCT04273321",NA,"China","Beijing","2020-Feb","2020-Apr","Completed","Single-Arm","Open-Label",2,"Confirmed","Hospital",NA,"Corticosteroids, SOC",86
"NCT04436458","https://clinicaltrials.gov/show/NCT04436458",NA,"United States","Massachusetts","2020-Jun",NA,"Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Stool Sample","Other, SOC",100
"NCT04401202","https://ClinicalTrials.gov/show/NCT04401202",NA,"Saudi Arabia","Riyadh","2020-May","2020-Dec","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Pneumonia or ARDS, Radiographic Findings, Hypoxia","Other, SOC",200
"CHICTR2000030265","http://www.chictr.org.cn/showproj.aspx?proj=49691",NA,"China","Heilongjiang","2020-Feb","2021-Feb","Not Recruiting","Randomised","Unspecified",3,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO","Other, SOC",30
"NCT04404361","https://clinicaltrials.gov/show/NCT04404361",NA,"United States","Washington, Dc","2020-May",NA,"Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Invasive Mechanical Ventilation or ECMO","JAKi, SOC",358
"CHICTR2000030022","http://www.chictr.org.cn/showproj.aspx?proj=49797",NA,"China","Anhui","2020-Feb","2020-May","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Clinical Improvement Score (Any), Viral Load or Clearance, Lung Inflamation","SOC, TCM",100
"NCT04333472","https://ClinicalTrials.gov/show/NCT04333472",NA,"Israel","Jerusalem","2020-Apr","2021-Mar","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Mortality, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, PaO2-FiO2","Other, SOC",40
"NCT04282902","https://ClinicalTrials.gov/show/NCT04282902",NA,"China","Hubei","2020-Feb","2020-Apr","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, PaO2-FiO2, Radiographic Findings","Other, SOC",294
"NCT04385043","https://ClinicalTrials.gov/show/NCT04385043",NA,"Italy","Catanzaro","2020-May","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Lymphocyte Count","Plasma based therapy, SOC",400
"NCT04385043","https://ClinicalTrials.gov/show/NCT04385043",NA,"Italy","Cosenza","2020-May","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Lymphocyte Count","Plasma based therapy, SOC",400
"NCT04385043","https://ClinicalTrials.gov/show/NCT04385043",NA,"Italy","Rome","2020-May","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Lymphocyte Count","Plasma based therapy, SOC",400
"NCT04385043","https://ClinicalTrials.gov/show/NCT04385043",NA,"Italy","Reggio Calabria","2020-May","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Lymphocyte Count","Plasma based therapy, SOC",400
"NCT04385043","https://ClinicalTrials.gov/show/NCT04385043",NA,"Italy","Vibo Valentia","2020-May","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Lymphocyte Count","Plasma based therapy, SOC",400
"NCT04390477","https://ClinicalTrials.gov/show/NCT04390477",NA,"Spain","Alicante","2020-May","2020-Jul","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospital Discharge, Adverse Events","Nutrition, SOC",40
"NCT04439071","https://ClinicalTrials.gov/show/NCT04439071",NA,"United States","Georgia","2020-Jun","2021-Jan","Not Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Cough, Dyspnea, Treatment-emergent Adverse Events, Respiratory Rate","Other, SOC",380
"NCT04439071","https://ClinicalTrials.gov/show/NCT04439071",NA,"United States","Maryland","2020-Jun","2021-Jan","Not Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Cough, Dyspnea, Treatment-emergent Adverse Events, Respiratory Rate","Other, SOC",380
"NCT04439071","https://ClinicalTrials.gov/show/NCT04439071",NA,"Spain","Barcelona","2020-Jun","2021-Jan","Not Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Cough, Dyspnea, Treatment-emergent Adverse Events, Respiratory Rate","Other, SOC",380
"NCT04439071","https://ClinicalTrials.gov/show/NCT04439071",NA,"Spain","Madrid","2020-Jun","2021-Jan","Not Recruiting","Randomised","Quadruple",3,"Confirmed","Hospital","Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Cough, Dyspnea, Treatment-emergent Adverse Events, Respiratory Rate","Other, SOC",380
"IRCT20200508047346N1","http://en.irct.ir/trial/47953",NA,"Iran","Tehran","2020-May","2021-Mar","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Fever, PaO2-FiO2","Other, SOC",124
"EUCTR2020-001162-12-FR","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001162-12",NA,"France","Paris","2020-Mar",NA,"Not Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections, Serious Adverse Events, ALT","Sarilumab, SOC",460
"EUCTR2020-001162-12-FR","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001162-12",NA,"Canada","Ottawa","2020-Mar",NA,"Not Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections, Serious Adverse Events, ALT","Sarilumab, SOC",460
"EUCTR2020-001162-12-FR","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001162-12",NA,"Spain","Madrid","2020-Mar",NA,"Not Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections, Serious Adverse Events, ALT","Sarilumab, SOC",460
"EUCTR2020-001162-12-FR","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001162-12",NA,"Russia","Moscow","2020-Mar",NA,"Not Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections, Serious Adverse Events, ALT","Sarilumab, SOC",460
"EUCTR2020-001162-12-FR","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001162-12",NA,"Israel","Jerusalem","2020-Mar",NA,"Not Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections, Serious Adverse Events, ALT","Sarilumab, SOC",460
"EUCTR2020-001162-12-FR","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001162-12",NA,"Germany","Berlin","2020-Mar",NA,"Not Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections, Serious Adverse Events, ALT","Sarilumab, SOC",460
"EUCTR2020-001162-12-FR","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001162-12",NA,"Japan","Tokyo","2020-Mar",NA,"Not Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections, Serious Adverse Events, ALT","Sarilumab, SOC",460
"EUCTR2020-001162-12-FR","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001162-12",NA,"Italy","Rome","2020-Mar",NA,"Not Recruiting","Randomised","Double",3,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections, Serious Adverse Events, ALT","Sarilumab, SOC",460
"IRCT20170922036314N4","http://en.irct.ir/trial/47383",NA,"Iran","Razavi Khorasan","2020-Jun","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Hospital Discharge, Serious or Seconday Infections, Depression, Anxiety","Psychological therapy, SOC",112
"NCT04437823","https://ClinicalTrials.gov/show/NCT04437823",NA,"Pakistan","Punjab","2020-Jun","2021-May","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Organ Failure or Dysfunction (SOFA), Adverse Events, Radiographic Findings","SOC, Stem cells",20
"IRCT20180610040049N3","http://en.irct.ir/trial/46697",NA,"Iran","Markazi","2020-Mar","2020-May","Completed","Randomised","Triple",2,"Confirmed","Hospital","C-Reactive Protein, Lung Inflamation","Alternative therapy, SOC",60
"NCT04323332","https://ClinicalTrials.gov/show/NCT04323332",NA,"China","Beijing","2020-Mar","2020-Mar","Not Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Non-invasive Ventilation, Adverse Events, C-Reactive Protein, Ferritin, IL-6, White Blood Cell Count, Neutrophils, Erythrocyte Sedimentation Rate, D-Dimer, Creatinine Phosphokinase, CK-MB, LDH, Antibodies, Radiographic Findings","SOC, TCM",50
"CHICTR2000030759","http://www.chictr.org.cn/showproj.aspx?proj=49284",NA,"China","Zhejiang","2020-Mar","2020-May","Not Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Viral Load or Clearance, Pneumonia or ARDS, Fever, C-Reactive Protein, IL-1, IL-2, IL-4, IL-6, IL-7, IL-8, IL-10, Tumor Necrosis Factor (Any), Interferon (Any), Myoglobin, Troponin, Procalcitonin, Prothrombin, Coagulation Test, Triglycerides, ALT, Albumin, Bilirubin, Glucose, Urine Sample, Radiographic Findings","SOC, TCM",70
"CHICTR2000029763","http://www.chictr.org.cn/showproj.aspx?proj=49408",NA,"China","Beijing","2020-Feb","2020-May","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Fever, Radiographic Findings, Quality of Life","SOC, TCM",408
"CHICTR2000029438","http://www.chictr.org.cn/showproj.aspx?proj=48911",NA,"China","Beijing","2020-Feb","2021-Dec","Not Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Fever, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism","SOC, TCM",100
"CHICTR2000030779","http://www.chictr.org.cn/showproj.aspx?proj=50973",NA,"China","Shanghai","2020-Mar","2020-May","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Serious Adverse Events","Other, SOC",100
"IRCT20170117032004N3","http://en.irct.ir/trial/46564",NA,"Iran","East Azarbaijan","2020-Mar","2020-Jul","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Hospitalization","SOC, Vitamins",30
"IRCT20081011001323N25","http://en.irct.ir/trial/47935",NA,"Iran","Tehran","2020-May","2020-Dec","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Radiographic Findings","Alternative therapy, SOC",80
"CHICTR2000029418","http://www.chictr.org.cn/showproj.aspx?proj=48886",NA,"China","Beijing","2020-Jan","2020-Aug","Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","ICU Admission, PaO2-FiO2, Respiratory Rate","SOC, TCM",42
"CHICTR2000029755","http://www.chictr.org.cn/showproj.aspx?proj=49301",NA,"China","Hubei","2020-Feb","2020-May","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Clinical Improvement Score (Any)","SOC, TCM",120
"CHICTR2000030469","http://www.chictr.org.cn/showproj.aspx?proj=50082",NA,"China","Shanghai","2020-Mar","2020-May","Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Hospitalization, Pneumonia or ARDS, Fever, Radiographic Findings","SOC, TCM",96
"CHICTR2000029813","http://www.chictr.org.cn/showproj.aspx?proj=49425",NA,"China","Shanghai","2020-Feb","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Viral Load or Clearance, Cough, Fever, C-Reactive Protein","SOC, TCM",72
"CHICTR2000030580","http://www.chictr.org.cn/showproj.aspx?proj=50693",NA,"China","Shanghai","2020-Mar","2020-Apr","Recruiting","Randomised","Unspecified",2,"Confirmed","Hospital","Viral Load or Clearance, IL-6, IL-10, Tumor Necrosis Factor (Any), Radiographic Findings","SOC, TCZ + Adalimumab",60
"CHICTR2000030001","http://www.chictr.org.cn/showproj.aspx?proj=49723",NA,"China","Heilongjiang","2020-Feb","2020-May","Recruiting","Randomised","Double",2,"Confirmed","Hospital","Mortality, Viral Load or Clearance, Fever, Radiographic Findings, Lung Inflamation","Other, SOC",240
"CHICTR2000030254","http://www.chictr.org.cn/showproj.aspx?proj=50137","https://www.medrxiv.org/content/10.1101/2020.03.17.20037432v1.full.pdf","China","Hubei","2020-Feb",NA,"Completed w. Results","Randomised","Unspecified",2,"Confirmed","Hospital","Mortality, ICU Admission, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Organ Failure or Dysfunction (SOFA), Serious Adverse Events","FPV, Umifenovir",240
"CHICTR2000029975","http://www.chictr.org.cn/showproj.aspx?proj=49592",NA,"China","Jilin","2020-Feb","2020-May","Not Recruiting","Single-Arm","Unspecified",1,"Confirmed","Hospital","Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Cough, Fever, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","HCQ",10
"NCT04434131","https://ClinicalTrials.gov/show/NCT04434131",NA,"United States","New Mexico","2020-Jun","2021-Apr","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital",NA,"Plasma based therapy",30
"NCT04375098","https://ClinicalTrials.gov/show/NCT04375098",NA,"Chile","Santiago","2020-May","2020-Dec","Recruiting","Randomised","Open-Label",2,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Fever","Plasma based therapy",58
"NCT04374565","https://ClinicalTrials.gov/show/NCT04374565",NA,"United States","Virginia","2020-May","2021-Apr","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, Antibodies, Renal Outcome (Unspecified)","Plasma based therapy",29
"NCT04372368","https://ClinicalTrials.gov/show/NCT04372368",NA,"United States","Colorado","2020-May",NA,"Recruiting","Unspecified","Unspecified",1,"Confirmed","Hospital",NA,"Plasma based therapy",NA
"NCT04332380","https://ClinicalTrials.gov/show/NCT04332380",NA,"Colombia","Cundinamarca","2020-Apr","2020-Aug","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, IgG, IgM or IgA","Plasma based therapy",10
"CHICTR2000030046","http://www.chictr.org.cn/showproj.aspx?proj=49861",NA,"China","Jiangxi","2020-Feb","2020-Apr","Recruiting","Single-Arm","Unspecified",1,"Confirmed","Hospital","Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Dyspnea, C-Reactive Protein, ALT, Bilirubin, Antibodies","Plasma based therapy",10
"NCT04407208","https://ClinicalTrials.gov/show/NCT04407208",NA,"Indonesia","Jakarta","2020-May","2020-Jun","Completed","Single-Arm","Open-Label",1,"Confirmed","Hospital","Adverse Events, C-Reactive Protein, D-Dimer, INR, Radiographic Findings","Plasma based therapy",10
"NCT04412785","https://ClinicalTrials.gov/show/NCT04412785",NA,"United States","Pennsylvania","2020-Jun","2020-Sep","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","ICU Admission, Ferritin, IL-6, Lymphocyte Count, D-Dimer","Cyclosporine",20
"NCT04378244","https://clinicaltrials.gov/show/NCT04378244",NA,"United States","California","2020-Apr",NA,"Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital",NA,"Other",18
"CHICTR2000030853","http://www.chictr.org.cn/showproj.aspx?proj=51081",NA,"China","Guizhou","2020-Mar","2020-May","Not Recruiting","Single-Arm","Unspecified",1,"Confirmed","Hospital","CK-MB, LDH","Other",200
"NCT04372602","https://ClinicalTrials.gov/show/NCT04372602",NA,"United States","Missouri","2020-May","2021-Jul","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, Renal Outcome (Unspecified)","Other",25
"JPRN-JRCTS031190226","https://jrct.niph.go.jp/latest-detail/jRCTs031190226",NA,"Japan","Gunma","2020-Feb",NA,"Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Viral Load or Clearance, C-Reactive Protein","FPV",50
"CHICTR2000030041","http://www.chictr.org.cn/showproj.aspx?proj=49891",NA,"China","Hubei","2020-Feb","2020-Jun","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Viral Load or Clearance",NA,40
"NCT04319731","https://ClinicalTrials.gov/show/NCT04319731",NA,"United States","Utah","2020-Mar","2021-Mar","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Mortality, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, IL-6","Other",10
"2020-000890-25","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000890-25/FR/","https://www.sciencedirect.com/science/article/pii/S0924857920300996","France","Paris","2020-Mar",NA,"Completed w. Results","Unspecified","Unspecified",1,"Confirmed","Hospital","Mortality, Hospitalization, Viral Load or Clearance, Fever, Respiratory Rate","HCQ",NA
"IRCT20151227025726N12","http://en.irct.ir/trial/46561",NA,"Iran","Tehran","2020-Mar","2020-Apr","Completed","Single-Arm","Open-Label",1,"Confirmed","Hospital","Hospitalization, Cough, Fever, Dyspnea, Other Mild Symptoms, Treatment-emergent Adverse Events, Radiographic Findings","HCQ + Oseltamivir + LPV/r + IFN",20
"2020-002472-12","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-002472-12/NL/",NA,"Netherlands","Amsterdam","2020-May",NA,"Status Unclear","Single-Arm","Open-Label",1,"Confirmed","Hospital","Adverse Events","mAb",80
"NCT04431453","https://ClinicalTrials.gov/show/NCT04431453",NA,"United States","California","2020-Jun","2020-Dec","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed","Hospital","Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Bilirubin","Remdesivir",52
"NCT04331795","https://ClinicalTrials.gov/show/NCT04331795",NA,"United States","Illinois","2020-Apr","2020-Jun","Completed","Single-Arm","Open-Label",1,"Confirmed","Hospital","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","TCZ",32
"NCT04388826","https://ClinicalTrials.gov/show/NCT04388826",NA,"United States","Arizona","2020-May","2020-Jul","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Hospital Discharge, Clinical Improvement Score (Any), Fever","Other, SOC",40
"NCT04388826","https://ClinicalTrials.gov/show/NCT04388826",NA,"United States","Minnesota","2020-May","2020-Jul","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Hospital Discharge, Clinical Improvement Score (Any), Fever","Other, SOC",40
"NCT04388826","https://ClinicalTrials.gov/show/NCT04388826",NA,"United States","Nevada","2020-May","2020-Jul","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Hospital Discharge, Clinical Improvement Score (Any), Fever","Other, SOC",40
"NCT04388826","https://ClinicalTrials.gov/show/NCT04388826",NA,"United States","New Jersey","2020-May","2020-Jul","Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Hospital Discharge, Clinical Improvement Score (Any), Fever","Other, SOC",40
"CHICTR2000029636","http://www.chictr.org.cn/showproj.aspx?proj=49215",NA,"China","Hubei","2020-Feb","2020-Jul","Recruiting","Single-Arm","Unspecified",1,"Confirmed","Hospital","Viral Load or Clearance, Cough, Fever, Other Mild Symptoms","Other",40
"NCT04338906","https://clinicaltrials.gov/show/NCT04338906",NA,"Germany","Berlin","2020-Mar",NA,"Not Recruiting","Randomised","Quadruple",2,"Confirmed","Hospital","Clinical Improvement Score (Any), C-Reactive Protein, Troponin",NA,334
"NCT04329832","https://ClinicalTrials.gov/show/NCT04329832",NA,"United States","Utah","2020-Apr","2020-Dec","Recruiting","Randomised","Open-Label",2,"Confirmed And Suspected","Hospital","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","AZT, HCQ",300
"2020-001709-21","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001709-21/FR/",NA,"France","Paris","2020-Apr",NA,"Recruiting","Randomised","Open-Label",7,"Confirmed Or Suspected","Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Dyspnea, Deep Vein Thrombosis or Pulmonary Embolism, Hemoglobin, Radiographic Findings, Renal Outcome (Unspecified)","Anticoagulants",NA
"NCT04410328","https://ClinicalTrials.gov/show/NCT04410328",NA,"United States","New Jersey","2020-Jun","2020-Dec","Not Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation","Other, SOC",132
"CHICTR2000032456","http://www.chictr.org.cn/showproj.aspx?proj=53048",NA,"China","Shanghai","2020-Apr","2020-May","Completed","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Quality of Life, Depression, Anxiety","Education + Non-invasive respiratory support, SOC",100
"IRCT20100228003449N28","http://en.irct.ir/trial/46538",NA,"Iran","Tehran","2020-Mar","2020-Apr","Completed","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Hospitalization, Clinical Improvement Score (Any), Adverse Events","IFN, SOC",30
"IRCT20100228003449N27","http://en.irct.ir/trial/46545",NA,"Iran","Tehran","2020-Mar","2020-May","Completed","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Hospitalization, Clinical Improvement Score (Any), Adverse Events","IFN, SOC",30
"2020-002293-28","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-002293-28/SE/",NA,"Sweden","Stockholm","2020-May",NA,"Recruiting","Randomised","Single",2,"Confirmed Or Suspected","Hospital","Mortality, ICU Admission, Hospitalization, Platelet Count, Troponin, Coagulation Test, Urine Sample, Antibodies, Cardiac Outcome (Unspecified)","Other, SOC",NA
"IRCT20100228003449N29","http://en.irct.ir/trial/46567",NA,"Iran","Tehran","2020-Mar","2020-May","Completed","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital","Radiographic Findings, Renal Outcome (Unspecified)","DAA, SOC",50
"NCT04432987","https://ClinicalTrials.gov/show/NCT04432987",NA,"Turkey","Istanbul","2020-Jun","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Hospital",NA,"Inhaled solution, SOC",60
"IRCT20100228003449N30","http://en.irct.ir/trial/46536",NA,"Iran","Tehran","2020-Mar","2020-May","Completed","Single-Arm","Open-Label",1,"Confirmed Or Suspected","Hospital","Hospitalization, Clinical Improvement Score (Any), Adverse Events, Treatment-emergent Adverse Events","HCQ + LPV/r",50
"NCT04423042","https://ClinicalTrials.gov/show/NCT04423042",NA,"Canada","Alberta","2020-Jun","2021-Jun","Not Recruiting","Single-Arm","Open-Label",1,"Confirmed Or Suspected","Hospital","Mortality","TCZ",30
"NCT04390464","https://ClinicalTrials.gov/show/NCT04390464",NA,"United Kingdom","Cambridgeshire","2020-May","2021-May","Recruiting","Randomised","Open-Label",3,"Suspected","Hospital","Mortality, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Renal Outcome (Unspecified)","JAKi, mAb, SOC",1167
"IRCT20140907019073N4","http://en.irct.ir/trial/46736",NA,"Iran","Fars","2020-Mar","2020-Jul","Completed","Randomised","Double",2,"Suspected","Hospital","Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms, C-Reactive Protein","Alternative therapy, SOC",60
"NCT04380402","https://ClinicalTrials.gov/show/NCT04380402",NA,"United States","Massachusetts","2020-May","2021-Dec","Not Recruiting","Randomised","Open-Label",2,"Suspected","Hospital","Mortality, ICU Admission, Visits or Returns to Emergency Department, Clinical Improvement Score (Any)","SOC, Statins",300
"2020-001262-11","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001262-11/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Open-Label",7,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Ferritin, IL-6, Lymphocyte Count, D-Dimer, Creatinine Phosphokinase, LDH, CD4, Blood Pressure, Renal Outcome (Unspecified)","Cyclosporine, Darunavir, HCQ, IFN, LPV/r, Other, TCZ",NA
"EUCTR2020-001303-16-FR","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001303-16",NA,"France","Paris","2020-Mar",NA,"Not Recruiting","Randomised","Double",4,NA,"Hospital","Mortality, ICU Admission, Viral Load or Clearance, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms, Serious or Seconday Infections, Serious Adverse Events, C-Reactive Protein, Blood Pressure, 6-Minute Walking Distance","Alternative therapy, ARBs, AZT, HCQ",1600
"NCT04359095","https://ClinicalTrials.gov/show/NCT04359095",NA,"Colombia","Huila","2020-Apr","2020-Oct","Not Recruiting","Randomised","Open-Label",4,NA,"Hospital","Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Serious Adverse Events","AZT, HCQ, LPV/r, SOC",1600
"NCT04359095","https://ClinicalTrials.gov/show/NCT04359095",NA,"Colombia","Bogota","2020-Apr","2020-Oct","Not Recruiting","Randomised","Open-Label",4,NA,"Hospital","Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Serious Adverse Events","AZT, HCQ, LPV/r, SOC",1600
"NCT04362189","https://ClinicalTrials.gov/show/NCT04362189",NA,"United States","Texas","2020-Apr","2020-Oct","Not Recruiting","Randomised","Quadruple",4,NA,"Hospital","Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, IL-6, IL-10, Tumor Necrosis Factor (Any), White Blood Cell Count, Monocyte Count, Lymphocyte Count, Neutrophils, Platelet Count, Hemoglobin, D-Dimer, Creatinine Phosphokinase, Myoglobin, Troponin, Prothrombin, Electrolytes, INR, ALT, Albumin, Bilirubin, Glucose, CD4, CD8, Blood Urea Nitrogen, Blood Gas, ECG, SpO2, Bicarbonates, Renal Outcome (Unspecified)","HCQ + AZT, HCQ + AZT + Stem cells, SOC, Stem cells",100
"IRCT20200324046850N1","http://en.irct.ir/trial/46732",NA,"Iran","Khuzestan","2020-Mar","2020-Jul","Completed","Randomised","Double",4,NA,"Hospital","Cough, Fever, Dyspnea","Other, SOC, Vitamins, Vitamins + Other",100
"IRCT20130812014333N147","http://en.irct.ir/trial/46853",NA,"Iran","Tehran","2020-Apr","2020-Jun","Completed","Randomised","Single",4,NA,"Hospital","Hospitalization","DAA, HCQ, Lithium, Other",80
"IRCT20120225009124N4","http://en.irct.ir/trial/46810",NA,"Iran","Fars","2020-Apr","2020-Jun","Completed","Randomised","Open-Label",3,NA,"Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO","Corticosteroids + Igs + IFN, HCQ + Antivirals",105
"IRCT20200318046812N2","http://en.irct.ir/trial/46968",NA,"Iran","Tehran","2020-Apr","2021-Apr","Recruiting","Randomised","Open-Label",3,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Dyspnea, Adverse Events, Serious Adverse Events, C-Reactive Protein, Radiographic Findings","HCQ + AZT + Corticosteroids, HCQ + AZT + NSAIDs, HCQ + LPV/r",906
"NCT04363346","https://ClinicalTrials.gov/show/NCT04363346",NA,"United States","Minnesota","2020-Apr","2022-Jan","Recruiting","Non-Randomised","Open-Label",3,NA,"Hospital","Hospital Discharge, Non-invasive Ventilation, Stool Sample","Natural Killer Cells",12
"NCT04359251","https://clinicaltrials.gov/show/NCT04359251",NA,"China","Beijing","2020-Apr",NA,"Not Recruiting","Non-Randomised","Open-Label",3,NA,"Hospital","PaO2-FiO2","Non-invasive respiratory support",20
"NCT04344444","https://ClinicalTrials.gov/show/NCT04344444",NA,"United States","Louisiana","2020-Apr","2021-Apr","Recruiting","Randomised","Open-Label",3,NA,"Hospital",NA,"HCQ, HCQ + AZT, SOC",600
"NL8521","https://trialregister.nl/trial/8521",NA,"Netherlands","Amsterdam","2020-Apr",NA,"Not Recruiting","Single-Arm","Open-Label",3,NA,"Hospital","Clinical Improvement Score (Any), Dyspnea, Adverse Events, Heart Rate, PaO2-FiO2, Quality of Life","Device, SOC",13
"NCT04357730","https://ClinicalTrials.gov/show/NCT04357730",NA,"United States","Colorado","2020-Apr","2020-Sep","Recruiting","Randomised","Open-Label",3,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2","Anticoagulants, SOC",60
"NCT04365153","https://clinicaltrials.gov/show/NCT04365153",NA,"United States","Washington, Dc","2020-Apr",NA,"Recruiting","Randomised","Quadruple",3,NA,"Hospital","Hospital Discharge, Clinical Improvement Score (Any)","mAb, SOC",45
"IRCT20200413047056N1","http://en.irct.ir/trial/47212",NA,"Iran","South Khorasan","2020-Apr","2020-Jun","Completed","Randomised","Open-Label",3,NA,"Hospital","Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, White Blood Cell Count, Erythrocyte Sedimentation Rate, LDH, Blood Gas, SpO2, Radiographic Findings","Igs, Plasma based therapy, SOC",15
"NCT04372082","https://clinicaltrials.gov/show/NCT04372082",NA,"France","Nord","2020-Apr",NA,"Not Recruiting","Randomised","Single",5,NA,"Hospital","Mortality, Hospitalization","CCB + Other, HCQ, SOC",480
"NCT04370262","https://ClinicalTrials.gov/show/NCT04370262",NA,"United States","New York","2020-Apr","2020-Sep","Recruiting","Randomised","Triple",3,NA,"Hospital","Mortality","HCQ, HCQ + Other, SOC",942
"NCT04358081","https://ClinicalTrials.gov/show/NCT04358081",NA,"United States","California","2020-Apr","2020-Jun","Recruiting","Randomised","Quadruple",3,NA,"Hospital","Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events","HCQ, HCQ + AZT, SOC",444
"NCT04358081","https://ClinicalTrials.gov/show/NCT04358081",NA,"United States","Florida","2020-Apr","2020-Jun","Recruiting","Randomised","Quadruple",3,NA,"Hospital","Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events","HCQ, HCQ + AZT, SOC",444
"NCT04358081","https://ClinicalTrials.gov/show/NCT04358081",NA,"United States","Illinois","2020-Apr","2020-Jun","Recruiting","Randomised","Quadruple",3,NA,"Hospital","Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events","HCQ, HCQ + AZT, SOC",444
"NCT04358081","https://ClinicalTrials.gov/show/NCT04358081",NA,"United States","Louisiana","2020-Apr","2020-Jun","Recruiting","Randomised","Quadruple",3,NA,"Hospital","Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events","HCQ, HCQ + AZT, SOC",444
"NCT04358081","https://ClinicalTrials.gov/show/NCT04358081",NA,"United States","Maryland","2020-Apr","2020-Jun","Recruiting","Randomised","Quadruple",3,NA,"Hospital","Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events","HCQ, HCQ + AZT, SOC",444
"NCT04358081","https://ClinicalTrials.gov/show/NCT04358081",NA,"United States","Missouri","2020-Apr","2020-Jun","Recruiting","Randomised","Quadruple",3,NA,"Hospital","Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events","HCQ, HCQ + AZT, SOC",444
"NCT04358081","https://ClinicalTrials.gov/show/NCT04358081",NA,"United States","North Carolina","2020-Apr","2020-Jun","Recruiting","Randomised","Quadruple",3,NA,"Hospital","Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events","HCQ, HCQ + AZT, SOC",444
"NCT04358081","https://ClinicalTrials.gov/show/NCT04358081",NA,"United States","Washington","2020-Apr","2020-Jun","Recruiting","Randomised","Quadruple",3,NA,"Hospital","Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events","HCQ, HCQ + AZT, SOC",444
"NCT04355052","https://clinicaltrials.gov/show/NCT04355052",NA,"Israel","Jerusalem","2020-Apr",NA,"Recruiting","Single-Arm","Open-Label",3,NA,"Hospital","Mortality, ICU Admission, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO","HCQ + AZT, HCQ + Other, SOC",250
"NCT04366063","https://ClinicalTrials.gov/show/NCT04366063",NA,"Iran","Tehran","2020-Apr","2020-Jun","Recruiting","Randomised","Open-Label",3,NA,"Hospital","ICU Admission, Pneumonia or ARDS, Adverse Events, Serious Adverse Events","SOC, Stem cells",60
"2020-001531-27","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001531-27/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Open-Label",3,NA,"Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Adverse Events, C-Reactive Protein, IL-1, IL-6, IL-8, IL-10, IL-12, Tumor Necrosis Factor (Any), PAI-1, Interferon (Any), White Blood Cell Count, Neutrophils, Platelet Count, Hemoglobin, D-Dimer, ALT, AST, Bilirubin, Renal Outcome (Unspecified)","Sarilumab, SOC",NA
"NCT04357860","https://clinicaltrials.gov/show/NCT04357860",NA,"Spain","Madrid","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",3,NA,"Hospital",NA,"Sarilumab, SOC",120
"NCT04359953","https://ClinicalTrials.gov/show/NCT04359953",NA,"France","Paris","2020-Apr","2021-Jun","Not Recruiting","Randomised","Open-Label",3,NA,"Hospital","Mortality, ICU Admission, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea","ARBs, AZT, HCQ",1600
"NCT04359316","https://ClinicalTrials.gov/show/NCT04359316",NA,"Iran","Tehran","2020-Apr","2020-May","Not Recruiting","Randomised","Triple",2,NA,"Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Serious Adverse Events","AZT, HCQ",40
"NCT04355026","https://ClinicalTrials.gov/show/NCT04355026",NA,"Slovenia","Celje","2020-Apr","2020-Jun","Recruiting","Randomised","Open-Label",2,NA,"Hospital","ICU Admission, Hospitalization, Hospital Discharge, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","HCQ, HCQ + Other",90
"NCT04363060","https://ClinicalTrials.gov/show/NCT04363060",NA,"France","Paris","2020-Apr","2020-Jul","Not Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events","Amoxicillin/clavulanate, AZT + Amoxicillin/clavulanate",104
"2020-001406-27","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001406-27/FR/",NA,"France","Paris","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, PaO2-FiO2, Respiratory Rate, Radiographic Findings","AZT, HCQ",NA
"NCT04358614","https://clinicaltrials.gov/show/NCT04358614",NA,"Italy","Rome","2020-Apr",NA,"Not Recruiting","Non-Randomised","Open-Label",2,NA,"Hospital","ICU Admission, Hospital Discharge, Adverse Events, Serious Adverse Events","JAKi",12
"NCT04366960","https://ClinicalTrials.gov/show/NCT04366960",NA,"Italy","Milano","2020-Apr","2020-Aug","Recruiting","Randomised","Open-Label",2,NA,"Hospital","ICU Admission, Hospitalization, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, C-Reactive Protein, IL-6, D-Dimer, Radiographic Findings, Cardiac Outcome (Unspecified)","Anticoagulants",2712
"NCT04360824","https://ClinicalTrials.gov/show/NCT04360824",NA,"United States","Iowa","2020-Apr","2021-Apr","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Deep Vein Thrombosis or Pulmonary Embolism, Cardiac Outcome (Unspecified)","Anticoagulants",170
"NCT04360824","https://ClinicalTrials.gov/show/NCT04360824",NA,"United States","Wisconsin","2020-Apr","2021-Apr","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Deep Vein Thrombosis or Pulmonary Embolism, Cardiac Outcome (Unspecified)","Anticoagulants",170
"IRCT20170207032444N3","http://en.irct.ir/trial/47119",NA,"Iran","Tehran","2020-Apr","2020-Jun","Completed","Randomised","Open-Label",2,NA,"Hospital","Mortality, Blood Pressure","HCQ, HCQ + Immunomodulators",60
"IRCT20200408046992N1","http://en.irct.ir/trial/47006",NA,"Iran","Tehran","2020-Apr","2020-Jul","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Fever, C-Reactive Protein, Blood Pressure, Heart Rate, ECG, SpO2, Respiratory Rate, Radiographic Findings, Renal Outcome (Unspecified)","HCQ, HCQ + Other",70
"IRCT20200411047025N1","http://en.irct.ir/trial/47078",NA,"Iran","Tehran","2020-Apr","2020-May","Completed","Randomised","Open-Label",2,NA,"Hospital","Fever, C-Reactive Protein, Respiratory Rate","HCQ + Antiretroviral, HCQ + Antiretroviral + Vitamins",110
"IRCT20200322046833N1","http://en.irct.ir/trial/46731",NA,"Iran","Tehran","2020-Apr","2020-Apr","Completed","Randomised","Double",2,NA,"Hospital","Cough, Fever, Dyspnea, Adverse Events, Serious Adverse Events","HCQ + Antiretrovirals, HCQ + Antiretrovirals + Umifenovir",100
"NCT04345861","https://ClinicalTrials.gov/show/NCT04345861",NA,"France","Paris","2020-Apr","2020-Jun","Status Unclear","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Radiographic Findings","HCQ, HCQ + AZT",7
"2020-001527-14","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001527-14/NL/",NA,"Netherlands","Amsterdam","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Fever, Adverse Events, C-Reactive Protein, Respiratory Rate","HCQ, HCQ + AZT",60
"NCT04366089","https://ClinicalTrials.gov/show/NCT04366089",NA,"Italy","Rome","2020-Apr","2020-Oct","Recruiting","Randomised","Single",4,NA,"Hospital","Mortality, IL-6, IL-10, Tumor Necrosis Factor (Any), CD8","HCQ + AZT, HCQ + AZT + Non-invasive respiratory support + Nutrition",152
"NCT04366245","https://clinicaltrials.gov/show/NCT04366245",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, Radiographic Findings","HCQ + AZT or LPV/r + IFN, Plasma based therapy",72
"IRCT20150808023559N20","http://en.irct.ir/trial/47022",NA,"Iran","Tehran","2020-Apr","2020-Jul","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Hospitalization","FPV + HCQ, HCQ + LPV/r",100
"IRCT20200318046812N1","http://en.irct.ir/trial/46783",NA,"Iran","Tehran","2020-Apr","2020-Jun","Completed","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Fever, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Radiographic Findings","HCQ + FPV, HCQ + LPV/r",324
"IRCT20130812014333N145","http://en.irct.ir/trial/46790",NA,"Iran","Tehran","2020-Mar","2020-Jul","Completed","Randomised","Single",2,NA,"Hospital","Clinical Improvement Score (Any)","HCQ + LPV/r, HCQ + LPV/r + DAA",80
"IRCT20180725040596N2","http://en.irct.ir/trial/46897",NA,"Iran","Tehran","2020-Apr","2020-Sep","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Fever, C-Reactive Protein, Erythrocyte Sedimentation Rate, Radiographic Findings","HCQ + LPV/r, HCQ + Umifenovir",100
"IRCT20190804044429N1","http://en.irct.ir/trial/46741",NA,"Iran","Mazandaran","2020-Apr","2020-Jun","Completed","Unspecified","Open-Label",2,NA,"Hospital","Mortality, Hospitalization, Cough, Fever, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, LDH","HCQ + LPV/r, IFN + HCQ + LPV/r",70
"IRCT20200324046852N1","http://en.irct.ir/trial/46706",NA,"Iran","Tehran","2020-Apr","2020-Apr","Completed","Randomised","Double",2,NA,"Hospital","Viral Load or Clearance, C-Reactive Protein, Radiographic Findings","Corticosteroids + Other + HCQ + LPV/r, HCQ + LPV/r",30
"IRCT20200420047147N1","http://en.irct.ir/trial/47334",NA,"Iran","Tehran","2020-Apr","2020-Aug","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Adverse Events, Radiographic Findings","DPP-4i, HCQ + LPV/r",84
"IRCT20200317046797N3","http://en.irct.ir/trial/47014",NA,"Iran","East Azarbaijan","2020-Apr","2020-Jul","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Invasive Mechanical Ventilation or ECMO, Radiographic Findings","HCQ + LPV/r + Antivirals, Igs + HCQ + LPV/r + Antivirals",100
"IRCT20161204031229N3","http://en.irct.ir/trial/46814",NA,"Iran","Tehran","2020-Apr","2020-Jun","Completed","Randomised","Open-Label",2,NA,"Hospital","Fever, Other Mild Symptoms, C-Reactive Protein, White Blood Cell Count, Erythrocyte Sedimentation Rate, Blood Pressure, Respiratory Rate, Radiographic Findings","HCQ + DAA, HCQ + LPV/r (or + DAA + Antibiotics)",40
"IRCT20151227025726N14","http://en.irct.ir/trial/46942",NA,"Iran","Tehran","2020-Apr","2020-Jul","Completed","Randomised","Open-Label",2,NA,"Hospital","Mortality, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Radiographic Findings","FPV, LPV/r",84
"NCT04359810","https://ClinicalTrials.gov/show/NCT04359810",NA,"United States","New York","2020-Apr","2020-Dec","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation","Plasma based therapy, SOC",105
"IRCT20200415047092N1","http://en.irct.ir/trial/47244",NA,"Iran","Tehran","2020-Apr","2020-May","Completed","Randomised","Open-Label",2,NA,"Hospital","ICU Admission, Hospitalization, Fever","AZT + Oseltamivir + LPV/r + Antiretroviral + HCQ, Oseltamivir + LPV/r + Antiretroviral + HCQ",110
"NCT04356677","https://ClinicalTrials.gov/show/NCT04356677",NA,"United States","New Jersey","2020-Apr","2021-Apr","Not Recruiting","Non-Randomised","Open-Label",2,NA,"Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2","Antivirals",50
"NCT04341870","https://ClinicalTrials.gov/show/NCT04341870",NA,"France","Paris","2020-Apr","2020-May","Suspended","Randomised","Open-Label",3,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","HCQ + AZT + Sarilumab, Sarilumab",27
"NCT04355676","https://ClinicalTrials.gov/show/NCT04355676",NA,"United States","Massachusetts","2020-Apr","2020-Aug","Not Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH","Other",80
"2020-001413-20","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001413-20/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Suspended","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Ferritin, White Blood Cell Count, Lymphocyte Count, Platelet Count, Hemoglobin, D-Dimer, ALT, Bilirubin, LDH, SpO2, Radiographic Findings, Hypoxemia, Renal Outcome (Unspecified)","Corticosteroids, Siltuximab",NA
"NCT04345692","https://ClinicalTrials.gov/show/NCT04345692",NA,"United States","Hawaii","2020-Apr","2021-Dec","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Heart Rate","HCQ, SOC",350
"NCT04357457","https://clinicaltrials.gov/show/NCT04357457",NA,"France","Paris","2020-Apr",NA,"Not Recruiting","Randomised","Quadruple",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","Respiratory stimulant, SOC",212
"IRCT20200312046749N1","http://en.irct.ir/trial/46551",NA,"Iran","Tehran","2020-Mar","2020-Sep","Recruiting","Non-Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Radiographic Findings","SOC, TNF inhibitor",80
"NCT04347382","https://ClinicalTrials.gov/show/NCT04347382",NA,"Pakistan","Punjab","2020-Apr","2020-Aug","Recruiting","Randomised","Quadruple",3,NA,"Hospital","Mortality, Pneumonia or ARDS, SpO2, Radiographic Findings","Alternative therapy, SOC",30
"PACTR202004761408382","https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10957",NA,"Nigeria","Niger","2020-Apr",NA,"Not Recruiting","Randomised","Unspecified",2,NA,"Hospital","Hospital Discharge, Viral Load or Clearance, Cough, Other Mild Symptoms, Adverse Events, Anti SARS-COV-2 Titers, Creatinine Phosphokinase, Electrolytes, ALT, CD4, CD8, Blood Urea Nitrogen","Alternative therapy, SOC",72
"NCT04362111","https://ClinicalTrials.gov/show/NCT04362111",NA,"United States","Alabama","2020-Apr","2020-Jul","Not Recruiting","Randomised","Triple",2,NA,"Hospital","Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, D-Dimer, LDH","Anakinra, SOC",20
"NCT04366232","https://ClinicalTrials.gov/show/NCT04366232",NA,"France","Paris","2020-Apr","2020-Aug","Not Recruiting","Randomised","Open-Label",3,NA,"Hospital","Mortality, ICU Admission, Organ Failure or Dysfunction (SOFA)","Anakinra with/without JAKi, SOC",54
"NCT04366232","https://ClinicalTrials.gov/show/NCT04366232",NA,"France","Var","2020-Apr","2020-Aug","Not Recruiting","Randomised","Open-Label",3,NA,"Hospital","Mortality, ICU Admission, Organ Failure or Dysfunction (SOFA)","Anakinra with/without JAKi, SOC",54
"NCT04364893","https://ClinicalTrials.gov/show/NCT04364893",NA,"Brazil","Brasilia","2020-Apr","2020-Oct","Recruiting","Randomised","Open-Label",2,NA,"Hospital",NA,"ARBs + ACEi, SOC",700
"IRCT20101219005416N2","http://en.irct.ir/trial/46775",NA,"Iran","Kerman","2020-Apr","2020-May","Completed","Randomised","Double",2,NA,"Hospital","Mortality, Hospitalization, Cough, Fever, Dyspnea, Other Mild Symptoms, SpO2, Respiratory Rate","Alternative therapy, SOC",80
"NCT04365699","https://ClinicalTrials.gov/show/NCT04365699",NA,"United States","New York","2020-Apr","2020-Dec","Recruiting","Single-Arm","Open-Label",2,NA,"Hospital","Hospitalization, Invasive Mechanical Ventilation or ECMO, Adverse Events, Cardiac Outcome (Unspecified)","Other, SOC",500
"IRCT20190727044343N2","http://en.irct.ir/trial/46639",NA,"Iran","Tehran","2020-Apr","2020-Apr","Completed","Randomised","Double",2,NA,"Hospital","Mortality, Hospital Discharge, C-Reactive Protein","SOC, Statins",100
"NCT04360096","https://ClinicalTrials.gov/show/NCT04360096",NA,"United States","Florida","2020-Apr","2020-Oct","Not Recruiting","Randomised","Quadruple",3,NA,"Hospital","Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Dyspnea, PaO2-FiO2, 6-Minute Walking Distance","Inhaled solution, SOC",288
"IRCT20200415047082N1","http://en.irct.ir/trial/47193",NA,"Iran","East Azarbaijan","2020-Apr","2020-Jun","Completed","Randomised","Double",2,NA,"Hospital","Fever, Other Mild Symptoms, C-Reactive Protein, Blood Pressure, Heart Rate, Respiratory Rate, Radiographic Findings","Alternative therapy, SOC",10
"IRCT20200317046797N4","http://en.irct.ir/trial/46969",NA,"Iran","East Azarbaijan","2020-Apr","2020-May","Completed","Randomised","Open-Label",2,NA,"Hospital","Mortality, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO","Other, SOC",60
"NCT04355637","https://ClinicalTrials.gov/show/NCT04355637",NA,"Spain","Barcelona","2020-Apr","2020-Aug","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, C-Reactive Protein, Ferritin, White Blood Cell Count, D-Dimer, LDH, Cardiac Outcome (Unspecified)","Corticosteroids, SOC",300
"NCT04386850","https://ClinicalTrials.gov/show/NCT04386850",NA,"Iran","Tehran","2020-May","2020-Nov","Recruiting","Randomised","Quadruple",2,NA,"Hospital","Viral Load or Clearance, Dyspnea","SOC, Vitamins",1500
"NCT04366908","https://ClinicalTrials.gov/show/NCT04366908",NA,"Spain","Cordoba","2020-Apr","2020-Jul","Not Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Dyspnea, Adverse Events","SOC, Vitamins",1008
"NCT04355429","https://ClinicalTrials.gov/show/NCT04355429",NA,"France","Paris","2020-Apr","2020-Jul","Not Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Invasive Mechanical Ventilation or ECMO","ACEi, SOC",230
"NCT04354805","https://ClinicalTrials.gov/show/NCT04354805",NA,"Egypt","Cairo","2020-Apr","2020-Oct","Not Recruiting","Randomised","Single",2,NA,"Hospital","LDH","Other, SOC",100
"NCT04366739","https://ClinicalTrials.gov/show/NCT04366739",NA,"France","Paris","2020-Apr","2020-Aug","Not Recruiting","Randomised","Single",2,NA,"Hospital","Mortality, Hospital Discharge, Viral Load or Clearance, Serious Adverse Events, C-Reactive Protein, Lymphocyte Count, Creatinine Phosphokinase, ECG, Radiographic Findings, Anxiety","Other, SOC",40
"NCT04367168","https://ClinicalTrials.gov/show/NCT04367168",NA,"Mexico","Mexico","2020-Apr","2021-Apr","Recruiting","Randomised","Quadruple",2,NA,"Hospital","Fever, Other Mild Symptoms, Ferritin, D-Dimer, Fibrinogen, PaO2-FiO2, Respiratory Rate","Colchicine, SOC",174
"NCT04363437","https://ClinicalTrials.gov/show/NCT04363437",NA,"United States","New York","2020-Apr","2020-May","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Non-invasive Ventilation, C-Reactive Protein, Troponin","Colchicine, SOC",70
"NCT04360980","https://ClinicalTrials.gov/show/NCT04360980",NA,"Iran","Tehran","2020-Apr","2020-May","Recruiting","Randomised","Double",2,NA,"Hospital","Clinical Improvement Score (Any), Viral Load or Clearance, Fever, C-Reactive Protein, LDH","Colchicine, SOC",80
"2020-001511-25","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001511-25/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), C-Reactive Protein, Ferritin, IL-1, IL-6, Tumor Necrosis Factor (Any), D-Dimer, LDH","Colchicine, SOC",NA
"NCT04364737","https://ClinicalTrials.gov/show/NCT04364737",NA,"United States","Connecticut","2020-Apr","2023-Jan","Recruiting","Randomised","Double",2,NA,"Hospital","Clinical Improvement Score (Any)","Plasma based therapy, SOC",300
"NCT04364737","https://ClinicalTrials.gov/show/NCT04364737",NA,"United States","New York","2020-Apr","2023-Jan","Recruiting","Randomised","Double",2,NA,"Hospital","Clinical Improvement Score (Any)","Plasma based therapy, SOC",300
"NCT04358783","https://ClinicalTrials.gov/show/NCT04358783",NA,"Mexico","Nuevo Leon","2020-Apr","2021-Feb","Recruiting","Randomised","Quadruple",2,NA,"Hospital","Mortality, Viral Load or Clearance, Anti SARS-COV-2 Titers","Plasma based therapy, SOC",30
"NCT04362176","https://ClinicalTrials.gov/show/NCT04362176",NA,"United States","Tennessee","2020-Apr","2021-Apr","Recruiting","Randomised","Triple",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Deep Vein Thrombosis or Pulmonary Embolism, Quality of Life, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Plasma based therapy, SOC",500
"IRCT20151228025732N53","http://en.irct.ir/trial/46931",NA,"Iran","Semnan","2020-Apr","2020-Jun","Completed","Non-Randomised","Open-Label",2,NA,"Hospital","Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, White Blood Cell Count, CD4, CD8","Plasma based therapy, SOC",12
"NCT04362059","https://clinicaltrials.gov/show/NCT04362059",NA,"United States","New Hampshire","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",2,NA,"Hospital","Adverse Events, Serious Adverse Events, PaO2-FiO2","Other, SOC",24
"NCT04354389","https://ClinicalTrials.gov/show/NCT04354389",NA,"Italy","Milano","2020-Apr","2020-Jun","Not Recruiting","Randomised","Triple",2,NA,"Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance","Antivirals, SOC",82
"NCT04354389","https://ClinicalTrials.gov/show/NCT04354389",NA,"Italy","Modena","2020-Apr","2020-Jun","Not Recruiting","Randomised","Triple",2,NA,"Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance","Antivirals, SOC",82
"NCT04360876","https://ClinicalTrials.gov/show/NCT04360876",NA,"United States","Colorado","2020-Apr","2020-Sep","Not Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, Quality of Life, Renal Outcome (Unspecified)","Dexamethasone, SOC",90
"NCT04359654","https://ClinicalTrials.gov/show/NCT04359654",NA,"United Kingdom","London","2020-Apr","2020-Aug","Not Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, PaO2-FiO2","Inhaled solution, SOC",50
"NCT04358549","https://ClinicalTrials.gov/show/NCT04358549",NA,"United States","Arizona","2020-Apr","2020-Aug","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Clinical Improvement Score (Any), Viral Load or Clearance","FPV, SOC",50
"NCT04358549","https://ClinicalTrials.gov/show/NCT04358549",NA,"United States","Massachusetts","2020-Apr","2020-Aug","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Clinical Improvement Score (Any), Viral Load or Clearance","FPV, SOC",50
"NCT04358549","https://ClinicalTrials.gov/show/NCT04358549",NA,"United States","New Jersey","2020-Apr","2020-Aug","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Clinical Improvement Score (Any), Viral Load or Clearance","FPV, SOC",50
"NCT04358549","https://ClinicalTrials.gov/show/NCT04358549",NA,"United States","Texas","2020-Apr","2020-Aug","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Clinical Improvement Score (Any), Viral Load or Clearance","FPV, SOC",50
"NCT04362085","https://ClinicalTrials.gov/show/NCT04362085",NA,"Canada","Ontario","2020-Apr","2020-Nov","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Platelet Count, D-Dimer, Prothrombin, Fibrinogen","Anticoagulants, SOC",462
"IRCT20180712040449N2","http://en.irct.ir/trial/46782",NA,"Iran","Tehran","2020-Apr","2020-Jun","Completed","Randomised","Open-Label",2,NA,"Hospital","Lung Inflamation","Alternative therapy, SOC",68
"IRCT20151228025732N51","http://en.irct.ir/trial/46828",NA,"Iran","Semnan","2020-Apr","2020-Jun","Completed","Non-Randomised","Open-Label",2,NA,"Hospital","Cough, Fever, Dyspnea, Other Mild Symptoms","Alternative therapy, SOC",60
"NCT04369742","https://ClinicalTrials.gov/show/NCT04369742",NA,"United States","New York","2020-Apr","2021-Jun","Suspended","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Fever, C-Reactive Protein, IL-6, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Glucose, LDH","HCQ, SOC",626
"CTRI/2020/04/024479","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42713",NA,"India","New Delhi","2020-Jul",NA,"Not Recruiting","Randomised","Open-Label",2,NA,"Hospital","Hospitalization, Invasive Mechanical Ventilation or ECMO, Adverse Events, Heart Rate","HCQ, SOC",32
"NCT04361318","https://ClinicalTrials.gov/show/NCT04361318",NA,"Egypt","Cairo","2020-Apr","2020-Oct","Not Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, Viral Load or Clearance, Ferritin, IL-6, Tumor Necrosis Factor (Any), Prothrombin, PaO2-FiO2, Respiratory Rate","HCQ + Antivirals, SOC",100
"NCT04357444","https://ClinicalTrials.gov/show/NCT04357444",NA,"France","Paris","2020-Apr","2020-Jul","Not Recruiting","Randomised","Quadruple",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, C-Reactive Protein, IL-2, CD4, CD8, PaO2-FiO2, Patient Positioning","Immunomodulators, SOC",30
"NCT04357613","https://clinicaltrials.gov/show/NCT04357613",NA,"France","Paris","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events","Imatinib, SOC",99
"IRCT20200404046937N1","http://en.irct.ir/trial/46903",NA,"Iran","Tehran","2020-Apr","2020-Jun","Completed","Randomised","Double",2,NA,"Hospital","Viral Load or Clearance, Cough, Fever, Dyspnea, C-Reactive Protein, Radiographic Findings","Alternative therapy, SOC",60
"NCT04366271","https://clinicaltrials.gov/show/NCT04366271",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality","SOC, Stem cells",106
"IRCT20200404046947N1","http://en.irct.ir/trial/46904",NA,"Iran","Tehran","2020-Apr","2020-May","Completed","Randomised","Single",2,NA,"Hospital","Mortality, Non-invasive Ventilation, Radiographic Findings","Corticosteroids, SOC",68
"IRCT20200204046369N1","http://en.irct.ir/trial/46776",NA,"Iran","Tehran","2020-Apr","2020-Jun","Completed","Non-Randomised","Open-Label",2,NA,"Hospital","Fever, Blood Urea Nitrogen, PaO2-FiO2, Respiratory Rate, Radiographic Findings","Corticosteroids, SOC",48
"NCT04367077","https://ClinicalTrials.gov/show/NCT04367077",NA,"United States","Ohio","2020-Apr","2021-Sep","Recruiting","Randomised","Quadruple",2,NA,"Hospital","Mortality, Treatment-emergent Adverse Events, Radiographic Findings","SOC, Stem cells",400
"NCT04352400","https://ClinicalTrials.gov/show/NCT04352400",NA,"Italy","Padova","2020-Apr","2021-Dec","Not Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), PaO2-FiO2, Cardiac Outcome (Unspecified)","Anticoagulants, SOC",256
"NCT04365101","https://ClinicalTrials.gov/show/NCT04365101",NA,"United States","New Jersey","2020-Apr","2020-Nov","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA), Adverse Events","Natural Killer Cells, SOC",86
"NCT04365101","https://ClinicalTrials.gov/show/NCT04365101",NA,"United States","Washington","2020-Apr","2020-Nov","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA), Adverse Events","Natural Killer Cells, SOC",86
"NCT04356833","https://clinicaltrials.gov/show/NCT04356833",NA,"United Kingdom","London","2020-Apr",NA,"Recruiting","Non-Randomised","Open-Label",2,NA,"Hospital","Mortality, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, Fibrinogen, PaO2-FiO2","Other, SOC",24
"NCT04370223","https://ClinicalTrials.gov/show/NCT04370223",NA,"Spain","Madrid","2020-Apr","2020-Oct","Not Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Ferritin, Lymphocyte Count, Neutrophils","Non-invasive respiratory support, SOC",208
"NCT04370223","https://ClinicalTrials.gov/show/NCT04370223",NA,"Spain","Asturias","2020-Apr","2020-Oct","Not Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Ferritin, Lymphocyte Count, Neutrophils","Non-invasive respiratory support, SOC",208
"NCT04370223","https://ClinicalTrials.gov/show/NCT04370223",NA,"Spain","Valencia","2020-Apr","2020-Oct","Not Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Ferritin, Lymphocyte Count, Neutrophils","Non-invasive respiratory support, SOC",208
"NCT04370223","https://ClinicalTrials.gov/show/NCT04370223",NA,"Spain","Valladolid","2020-Apr","2020-Oct","Not Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Hospital Discharge, Clinical Improvement Score (Any), Ferritin, Lymphocyte Count, Neutrophils","Non-invasive respiratory support, SOC",208
"IRCT20200404046937N2","http://en.irct.ir/trial/47016",NA,"Iran","Tehran","2020-Apr","2020-Jun","Completed","Randomised","Double",2,NA,"Hospital","Viral Load or Clearance, Cough, Fever, C-Reactive Protein, Radiographic Findings","Alternative therapy, SOC",60
"IRCT20200416047104N1","http://en.irct.ir/trial/47251",NA,"Iran","Tehran","2020-Apr","2020-Jun","Completed","Randomised","Double",2,NA,"Hospital","Mortality, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Cough, Dyspnea, Other Mild Symptoms, C-Reactive Protein, Ferritin, Creatinine Phosphokinase, LDH, Blood Pressure, Respiratory Rate","Alternative therapy, SOC",66
"NCT04365257","https://ClinicalTrials.gov/show/NCT04365257",NA,"United States","Maryland","2020-Apr","2020-Dec","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events","Other, SOC",220
"NCT04359511","https://ClinicalTrials.gov/show/NCT04359511",NA,"France","Paris","2020-Apr","2020-Dec","Not Recruiting","Randomised","Single",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Quality of Life","Corticosteroids, SOC",210
"NCT04365127","https://ClinicalTrials.gov/show/NCT04365127",NA,"United States","California","2020-Apr","2020-Sep","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Hormone therapy, SOC",40
"NCT04368000","https://ClinicalTrials.gov/show/NCT04368000",NA,"United States","Utah","2020-Apr","2020-Dec","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2, SpO2","Positioning, SOC",60
"NCT04366856","https://clinicaltrials.gov/show/NCT04366856",NA,"France","Paris","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO","Positioning, SOC",500
"NCT04343963","https://ClinicalTrials.gov/show/NCT04343963",NA,"Mexico","Mexico","2020-Apr","2020-Sep","Recruiting","Randomised","Quadruple",2,NA,"Hospital","Mortality, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, IL-6","Other, SOC",436
"NCT04366050","https://ClinicalTrials.gov/show/NCT04366050",NA,"United States","California","2020-Apr","2021-May","Recruiting","Randomised","Triple",2,NA,"Hospital","Mortality, ICU Admission","ACEi, SOC",560
"NCT04358406","https://clinicaltrials.gov/show/NCT04358406",NA,"United States","New Jersey","2020-Apr",NA,"Not Recruiting","Single-Arm","Quadruple",2,NA,"Hospital","Mortality, Hospitalization, Hospital Discharge, Visits or Returns to Emergency Department, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Antibodies","Plasma based therapy, SOC",60
"NCT04362137","https://ClinicalTrials.gov/show/NCT04362137",NA,"United States","Colorado","2020-Apr","2020-Oct","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"NCT04362137","https://ClinicalTrials.gov/show/NCT04362137",NA,"United States","Connecticut","2020-Apr","2020-Oct","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"NCT04362137","https://ClinicalTrials.gov/show/NCT04362137",NA,"United States","Massachusetts","2020-Apr","2020-Oct","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"NCT04362137","https://ClinicalTrials.gov/show/NCT04362137",NA,"United States","Michigan","2020-Apr","2020-Oct","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"NCT04362137","https://ClinicalTrials.gov/show/NCT04362137",NA,"United States","New Jersey","2020-Apr","2020-Oct","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"NCT04362137","https://ClinicalTrials.gov/show/NCT04362137",NA,"United States","New York","2020-Apr","2020-Oct","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"NCT04362137","https://ClinicalTrials.gov/show/NCT04362137",NA,"United States","Washington","2020-Apr","2020-Oct","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"NCT04362137","https://ClinicalTrials.gov/show/NCT04362137",NA,"United States","Wisconsin","2020-Apr","2020-Oct","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"NCT04362137","https://ClinicalTrials.gov/show/NCT04362137",NA,"Germany","Berlin","2020-Apr","2020-Oct","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"NCT04362137","https://ClinicalTrials.gov/show/NCT04362137",NA,"Italy","Bologna","2020-Apr","2020-Oct","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"NCT04362137","https://ClinicalTrials.gov/show/NCT04362137",NA,"Italy","Firenze","2020-Apr","2020-Oct","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"NCT04362137","https://ClinicalTrials.gov/show/NCT04362137",NA,"Italy","Milano","2020-Apr","2020-Oct","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"NCT04362137","https://ClinicalTrials.gov/show/NCT04362137",NA,"Italy","Rome","2020-Apr","2020-Oct","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"NCT04362137","https://ClinicalTrials.gov/show/NCT04362137",NA,"Russia","Moscow","2020-Apr","2020-Oct","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"NCT04362137","https://ClinicalTrials.gov/show/NCT04362137",NA,"Spain","Salamanca","2020-Apr","2020-Oct","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"NCT04362137","https://ClinicalTrials.gov/show/NCT04362137",NA,"Spain","Barcelona","2020-Apr","2020-Oct","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"NCT04362137","https://ClinicalTrials.gov/show/NCT04362137",NA,"Spain","Madrid","2020-Apr","2020-Oct","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"NCT04362137","https://ClinicalTrials.gov/show/NCT04362137",NA,"United Kingdom","Blackpool","2020-Apr","2020-Oct","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"NCT04362137","https://ClinicalTrials.gov/show/NCT04362137",NA,"United Kingdom","Harrow","2020-Apr","2020-Oct","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"NCT04362137","https://ClinicalTrials.gov/show/NCT04362137",NA,"United Kingdom","Leeds","2020-Apr","2020-Oct","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"NCT04362137","https://ClinicalTrials.gov/show/NCT04362137",NA,"United Kingdom","London","2020-Apr","2020-Oct","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"NCT04362137","https://ClinicalTrials.gov/show/NCT04362137",NA,"United Kingdom","Manchester","2020-Apr","2020-Oct","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2","JAKi, SOC",402
"NCT04357808","https://ClinicalTrials.gov/show/NCT04357808",NA,"Spain","Madrid","2020-Apr","2020-Jun","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever","Sarilumab, SOC",30
"NCT04359901","https://clinicaltrials.gov/show/NCT04359901",NA,"United States","Washington, Dc","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Non-invasive Ventilation","Sarilumab, SOC",120
"NCT04371640","https://ClinicalTrials.gov/show/NCT04371640",NA,"United States","Pennsylvania","2020-May","2020-Jul","Recruiting","Randomised","Quadruple",2,NA,"Hospital","Adverse Events","Other, SOC",40
"NCT04365517","https://clinicaltrials.gov/show/NCT04365517",NA,"Italy","Rome","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",2,NA,"Hospital","Clinical Improvement Score (Any)","DPP-4i, SOC",170
"IRCT20200328046886N1","http://en.irct.ir/trial/46885",NA,"Iran","Mazandaran","2020-Apr","2020-Mar","Completed","Randomised","Double",2,NA,"Hospital","Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","DAA + Antiviral, SOC",48
"NCT04364763","https://ClinicalTrials.gov/show/NCT04364763",NA,"United States","Texas","2020-Apr","2021-Jun","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Fever, Organ Failure or Dysfunction (SOFA), SpO2, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Other, SOC",252
"IRCT20080901001165N48","http://en.irct.ir/trial/47318",NA,"Iran","Tehran","2020-Apr","2020-Jul","Completed","Randomised","Open-Label",2,NA,"Hospital","Cough, Fever","Alternative therapy, SOC",100
"NCT04359303","https://ClinicalTrials.gov/show/NCT04359303",NA,"Spain","Valencia","2020-Apr","2020-Nov","Not Recruiting","Randomised","Double",2,NA,"Hospital","Hospitalization, Clinical Improvement Score (Any), Serious or Seconday Infections, Radiographic Findings","Non-invasive respiratory support, SOC",50
"NCT04363541","https://ClinicalTrials.gov/show/NCT04363541",NA,"Mexico","Mexico","2020-Apr","2020-Sep","Not Recruiting","Randomised","Open-Label",2,NA,"Hospital","ICU Admission, Hospitalization","Alternative therapy, SOC",298
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"United States","Arizona","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"United States","California","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"United States","Colorado","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"United States","Connecticut","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"United States","District Of Columbia","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"United States","Florida","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"United States","Georgia","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"United States","Idaho","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"United States","Kansas","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"United States","Louisiana","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"United States","Maryland","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"United States","Michigan","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"United States","Nevada","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"United States","New Jersey","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"United States","New Mexico","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"United States","New York","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"United States","North Carolina","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"United States","Pennsylvania","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"United States","South Dakota","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"United States","Texas","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"United States","Wisconsin","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"Kenya","Nairobi","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"Mexico","Mexico","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"Peru","Lima","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"NCT04372186","https://ClinicalTrials.gov/show/NCT04372186",NA,"South Africa","Pretoria","2020-May","2020-Aug","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2, Respiratory Rate, Renal Outcome (Unspecified)","SOC, TCZ",379
"2020-001408-41","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001408-41/DE/",NA,"Germany","Berlin","2020-Apr",NA,"Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, Ferritin, IL-6, D-Dimer, Procalcitonin, Shock, Quality of Life, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","SOC, TCZ",NA
"NCT04356937","https://clinicaltrials.gov/show/NCT04356937",NA,"United States","Washington, Dc","2020-Apr",NA,"Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Renal Outcome (Unspecified)","SOC, TCZ",278
"2020-001160-28","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001160-28/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,NA,"Hospital","Hospitalization, Viral Load or Clearance, Pneumonia or ARDS, Non-invasive Ventilation, Cough, Fever, Dyspnea, Other Mild Symptoms, Organ Failure or Dysfunction (SOFA), Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Radiographic Findings","SOC, TCZ + mAb",NA
"NCT04358809","https://ClinicalTrials.gov/show/NCT04358809",NA,"India","Chandigarh","2020-Apr","2021-Feb","Not Recruiting","Randomised","Quadruple",2,NA,"Hospital","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Other Mild Symptoms, Adverse Events, Serious Adverse Events","Other, SOC",480
"IRCT20080901001165N46","http://en.irct.ir/trial/47087",NA,"Iran","Tehran","2020-Apr","2020-Aug","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Cough, Fever, Adverse Events, IL-1, IL-6, Tumor Necrosis Factor (Any)","SOC, Umifenovir",200
"EUCTR2020-001320-34-NL","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001320-34",NA,"Netherlands","Amsterdam","2020-Mar",NA,"Not Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO","ARBs, SOC",641
"IRCT20200402046923N1","http://en.irct.ir/trial/46879",NA,"Iran","East Azarbaijan","2020-Apr","2020-May","Completed","Randomised","Open-Label",2,NA,"Hospital","ICU Admission, Hospitalization, Cough, Fever, Dyspnea, Other Mild Symptoms, Adverse Events, Serious Adverse Events, ALT","Alternative therapy, SOC",110
"NCT04363216","https://ClinicalTrials.gov/show/NCT04363216",NA,"United States","Pennsylvania","2020-Apr","2021-May","Not Recruiting","Randomised","Open-Label",2,NA,"Hospital","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Fever","SOC, Vitamins",66
"IRCT20190917044805N2","http://en.irct.ir/trial/46804",NA,"Iran","Tehran","2020-Mar","2020-Oct","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Ferritin, Erythrocyte Sedimentation Rate","SOC, Vitamins",60
"IRCT20180923041093N5","http://en.irct.ir/trial/47018",NA,"Iran","Tehran","2020-Apr","2020-May","Completed","Randomised","Open-Label",2,NA,"Hospital","Mortality, Hospitalization, Cough, Fever, Other Mild Symptoms, C-Reactive Protein, Respiratory Rate, Radiographic Findings, Anxiety","Alternative therapy, SOC",60
"ACTRN12620000454976","https://anzctr.org.au/ACTRN12620000454976.aspx",NA,"Australia","Canberra","2020-Aug",NA,"Not Recruiting","Randomised","Unspecified",2,NA,"Hospital","Mortality, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2","SOC, Zinc",160
"IRCT20200328046882N1","http://en.irct.ir/trial/46784",NA,"Iran","Tehran","2020-Apr","2020-Jul","Completed","Randomised","Double",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","DAA",60
"NCT04359797","https://ClinicalTrials.gov/show/NCT04359797",NA,"United States","Tennessee","2020-Apr","2021-Apr","Recruiting","Randomised","Single",2,NA,"Hospital","Mortality, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2","Positioning",300
"NCT04358939","https://ClinicalTrials.gov/show/NCT04358939",NA,"France","Paris","2020-Apr","2020-Nov","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2, Patient Positioning","Positioning",248
"NCT04357782","https://ClinicalTrials.gov/show/NCT04357782",NA,"United States","Virginia","2020-Apr","2020-Jun","Recruiting","Single-Arm","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, Neutrophils, D-Dimer, LDH","Vitamins",20
"NCT04341584","https://ClinicalTrials.gov/show/NCT04341584",NA,"France","Paris","2020-Apr","2020-May","Not Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Anakinra",240
"IRCT20200411047030N1","http://en.irct.ir/trial/47099",NA,"Iran","Tehran","2020-Apr","2020-Jun","Completed","Unspecified","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Fever, Other Mild Symptoms, C-Reactive Protein","HCQ + AZT + Melatonin",82
"NCT04343261","https://ClinicalTrials.gov/show/NCT04343261",NA,"United States","Connecticut","2020-Apr","2020-Dec","Recruiting","Single-Arm","Open-Label",1,NA,"Hospital","Mortality, Viral Load or Clearance, Antibodies","Plasma based therapy",47
"NCT04355897","https://ClinicalTrials.gov/show/NCT04355897",NA,"United States","Ohio","2020-Apr","2020-Jul","Recruiting","Single-Arm","Open-Label",1,NA,"Hospital","Mortality, Invasive Mechanical Ventilation or ECMO, Adverse Events","Plasma based therapy",100
"NCT04360486","https://ClinicalTrials.gov/show/NCT04360486",NA,"United States","Virginia","2020-Apr",NA,"Recruiting","Unspecified","Unspecified",1,NA,"Hospital",NA,"Plasma based therapy",NA
"IRCT20200406046968N2","http://en.irct.ir/trial/47115",NA,"Iran","East Azarbaijan","2020-Apr","2020-Jul","Completed","Single-Arm","Open-Label",1,NA,"Hospital","Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","Plasma based therapy",30
"NCT04365439","https://clinicaltrials.gov/show/NCT04365439",NA,"Switzerland","Ticino","2020-Apr",NA,"Not Recruiting","Single-Arm","Open-Label",1,NA,"Hospital","Viral Load or Clearance, IL-6, Antibodies","Plasma based therapy",10
"NCT04356482","https://clinicaltrials.gov/show/NCT04356482",NA,"Mexico","Mexico","2020-Apr",NA,"Recruiting","Single-Arm","Open-Label",1,NA,"Hospital","ICU Admission, Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Adverse Events","Plasma based therapy",90
"ACTRN12620000472976","https://anzctr.org.au/ACTRN12620000472976.aspx",NA,"Australia","Canberra","2020-Apr",NA,"Not Recruiting","Non-Randomised","Open-Label",1,NA,"Hospital","Other Mild Symptoms","Other",100
"NCT04355494","https://ClinicalTrials.gov/show/NCT04355494",NA,"France","Paris","2020-Apr",NA,"Recruiting","Unspecified","Unspecified",1,NA,"Hospital",NA,"mAb",NA
"NCT04354155","https://clinicaltrials.gov/show/NCT04354155",NA,"United States","Washington, Dc","2020-Apr",NA,"Not Recruiting","Single-Arm","Open-Label",1,NA,"Hospital","Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, D-Dimer","Anticoagulants",38
"NCT04359615","https://ClinicalTrials.gov/show/NCT04359615",NA,"Iran","Tehran","2020-Apr","2020-May","Not Recruiting","Randomised","Triple",2,NA,"Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Serious Adverse Events","FPV + HCQ",40
"IRCT20200405046960N1","http://en.irct.ir/trial/46961",NA,"Iran","Tehran","2020-Apr","2020-Apr","Completed","Single-Arm","Open-Label",1,NA,"Hospital","C-Reactive Protein, White Blood Cell Count, Respiratory Rate","Alternative therapy",15
"2020-001659-42","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001659-42/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Dyspnea, Other Mild Symptoms, Serious or Seconday Infections, Adverse Events, Ferritin, IL-6, D-Dimer, LDH, Blood Pressure, PaO2-FiO2, SpO2, Radiographic Findings","Other",NA
"IRCT20200325046859N1","http://en.irct.ir/trial/46811",NA,"Iran","Tehran","2020-Apr","2020-May","Completed","Single-Arm","Open-Label",1,NA,"Hospital","Fever, White Blood Cell Count, Respiratory Rate, Radiographic Findings","Igs",50
"NCT04366791","https://ClinicalTrials.gov/show/NCT04366791",NA,"United States","Georgia","2020-Apr","2020-Oct","Recruiting","Single-Arm","Open-Label",1,NA,"Hospital","C-Reactive Protein, Ferritin, IL-6, Hemoglobin, D-Dimer, eGFR, Myoglobin, Troponin, Procalcitonin, Fibrinogen, Triglycerides, ALT, AST, Albumin, Bilirubin, LDH, Blood Gas, Blood Pressure, Heart Rate, Radiographic Findings, Blood pH","Radiation therapy",10
"NCT04352803","https://ClinicalTrials.gov/show/NCT04352803",NA,"United States","Massachusetts","2020-Apr","2024-Apr","Not Recruiting","Non-Randomised","Open-Label",2,NA,"Hospital","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Adverse Events","Stem cells",20
"IRCT20200325046860N2","http://en.irct.ir/trial/46789",NA,"Iran","Tehran","2020-Apr","2020-Apr","Completed","Non-Randomised","Open-Label",1,NA,"Hospital","Respiratory Rate","Stem cells",5
"NCT04352465","https://ClinicalTrials.gov/show/NCT04352465",NA,"Brazil","Brasilia","2020-Apr","2020-Jun","Not Recruiting","Non-Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospital Discharge, Respiratory Rate, Hypoxia","Other",42
"2020-001391-15","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001391-15/IE/",NA,"Ireland","Dublin","2020-Mar",NA,"Recruiting","Randomised","Double",3,NA,"Hospital","Mortality, ICU Admission, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, IL-1, IL-6, IL-8, IL-10, Tumor Necrosis Factor (Any), PaO2-FiO2, Shock, Renal Outcome (Unspecified)","Other",36
"2020-001459-42","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001459-42/DK/",NA,"Denmark","Copenhagen","2020-Apr",NA,"Recruiting","Unspecified","Open-Label",1,NA,"Hospital","Mortality","JAKi",NA
"NCT04359290","https://clinicaltrials.gov/show/NCT04359290",NA,"Germany","Berlin","2020-Apr",NA,"Recruiting","Single-Arm","Open-Label",1,NA,"Hospital","Mortality, ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Anti SARS-COV-2 Titers, C-Reactive Protein, Ferritin, IL-6, Radiographic Findings","JAKi",15
"2020-001255-40","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001255-40/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Unspecified","Open-Label",1,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Organ Failure or Dysfunction (SOFA), C-Reactive Protein, Ferritin, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Troponin, ALT, AST, LDH, Blood Urea Nitrogen, PaO2-FiO2, SpO2, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Sarilumab",NA
"ACTRN12620000478910","https://anzctr.org.au/ACTRN12620000478910.aspx",NA,"Australia","Canberra","2020-Apr",NA,"Not Recruiting","Randomised","Unspecified",1,NA,"Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Secondary CoViD-19 Re-infection, Invasive Mechanical Ventilation or ECMO, Other Mild Symptoms, Adverse Events, Anti SARS-COV-2 Titers","Stem cells",24
"2020-001375-32","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001375-32/NL/",NA,"Netherlands","Amsterdam","2020-Apr",NA,"Recruiting","Randomised","Open-Label",1,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, Anti SARS-COV-2 Titers, C-Reactive Protein, IL-2, IL-6, IL-8, LDH, Radiographic Findings","TCZ",NA
"NL8504","https://trialregister.nl/trial/8504",NA,"Netherlands","Amsterdam","2020-Mar",NA,"Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Anti SARS-COV-2 Titers, C-Reactive Protein, Ferritin, IL-6, IL-8, Radiographic Findings","TCZ",354
"NCT04368156","https://ClinicalTrials.gov/show/NCT04368156",NA,"Spain","Valencia","2020-Apr","2020-Jul","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Device",90
"NCT04370236","https://ClinicalTrials.gov/show/NCT04370236",NA,"United States","California","2020-Apr","2021-Feb","Not Recruiting","Randomised","Quadruple",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Deep Vein Thrombosis or Pulmonary Embolism, Renal Outcome (Unspecified)","Other",366
"2020-001321-31","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001321-31/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Open-Label",4,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Dyspnea, Other Mild Symptoms, Serious or Seconday Infections, Anti SARS-COV-2 Titers, Peak RC-Reactive Protein, Ferritin, IL-6, White Blood Cell Count, Lymphocyte Count, Neutrophils, Platelet Count, Hemoglobin, Erythrocyte Sedimentation Rate, D-Dimer, Creatinine Phosphokinase, Troponin, Procalcitonin, Fibrinogen, Coagulation Test, ALT, AST, Albumin, Bilirubin, LDH, PaO2-FiO2, SpO2, Respiratory Rate, Radiographic Findings, Shock","HCQ, Imatinib, JAKi, LPV/r",NA
"NCT04347031","https://ClinicalTrials.gov/show/NCT04347031",NA,"Russia","Moscow","2020-Apr","2020-Aug","Recruiting","Randomised","Open-Label",4,NA,"Hospital","Mortality, ICU Admission, Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Other Mild Symptoms, Adverse Events, Serious Adverse Events, C-Reactive Protein","HCQ, Other, TCZ + AZT + HCQ",320
"NCT04362332","https://ClinicalTrials.gov/show/NCT04362332",NA,"Netherlands","Utrecht","2020-Apr","2020-Jun","Status Unclear","Randomised","Open-Label",3,NA,"Hospital","Mortality, ICU Admission, Clinical Improvement Score (Any), Treatment-emergent Adverse Events","HCQ, SOC",25
"NCT04359277","https://ClinicalTrials.gov/show/NCT04359277",NA,"United States","New York","2020-Apr","2021-Apr","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Deep Vein Thrombosis or Pulmonary Embolism, D-Dimer, Troponin, Fibrinogen, Lung Inflamation, Hypoxemia, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)","Anticoagulants",1000
"NCT04345445","https://ClinicalTrials.gov/show/NCT04345445",NA,"Malaysia","Kuala Lumpur","2020-Apr","2020-Oct","Not Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation","Corticosteroids, TCZ",310
"PACTR202004801273802","https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10928",NA,"Nigeria","Niger","2020-Feb",NA,"Not Recruiting","Randomised","Double",2,NA,"Hospital","Clinical Improvement Score (Any), Viral Load or Clearance","HCQ, SOC",600
"NCT04344288","https://ClinicalTrials.gov/show/NCT04344288",NA,"France","Paris","2020-Apr","2020-Nov","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events","Corticosteroids, SOC",304
"NCT04344288","https://ClinicalTrials.gov/show/NCT04344288",NA,"France","Nord","2020-Apr","2020-Nov","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events","Corticosteroids, SOC",304
"NCT04344288","https://ClinicalTrials.gov/show/NCT04344288",NA,"France","Vienne","2020-Apr","2020-Nov","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events","Corticosteroids, SOC",304
"NCT04344431","https://ClinicalTrials.gov/show/NCT04344431",NA,"France","Paris","2020-Apr","2021-Apr","Recruiting","Randomised","Single",2,NA,"Hospital","Mortality, Hospitalization, Non-invasive Ventilation","Non-invasive respiratory support, SOC",100
"NCT04346693","https://ClinicalTrials.gov/show/NCT04346693",NA,"Russia","Moscow","2020-Apr","2020-Dec","Not Recruiting","Randomised","Open-Label",4,NA,"Hospital","Mortality, Hospitalization, Hospital Discharge, Viral Load or Clearance, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO","Other, SOC",320
"NCT04356534","https://ClinicalTrials.gov/show/NCT04356534",NA,"Bahrain","Manama","2020-Apr","2020-Jun","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Ferritin, White Blood Cell Count, D-Dimer, Troponin, Procalcitonin, LDH, Radiographic Findings","Plasma based therapy, SOC",40
"NCT04345523","https://ClinicalTrials.gov/show/NCT04345523",NA,"Spain","Zaragoza","2020-Apr","2020-Jul","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, C-Reactive Protein, IL-6, MCP-1, Dendritic Cell Count, D-Dimer, Coagulation Test, ALT, Glucose, LDH","Plasma based therapy, SOC",278
"NCT04345523","https://ClinicalTrials.gov/show/NCT04345523",NA,"Spain","Madrid","2020-Apr","2020-Jul","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, C-Reactive Protein, IL-6, MCP-1, Dendritic Cell Count, D-Dimer, Coagulation Test, ALT, Glucose, LDH","Plasma based therapy, SOC",278
"NCT04345523","https://ClinicalTrials.gov/show/NCT04345523",NA,"Spain","Asturias","2020-Apr","2020-Jul","Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, C-Reactive Protein, IL-6, MCP-1, Dendritic Cell Count, D-Dimer, Coagulation Test, ALT, Glucose, LDH","Plasma based therapy, SOC",278
"NCT04344184","https://ClinicalTrials.gov/show/NCT04344184",NA,"United States","Virginia","2020-Apr","2021-May","Not Recruiting","Randomised","Quadruple",2,NA,"Hospital","Clinical Improvement Score (Any), Fever","SOC, Vitamins",200
"NCT04355247","https://ClinicalTrials.gov/show/NCT04355247",NA,"Puerto Rico","Puerto Rico","2020-Apr","2020-Jul","Recruiting","Single-Arm","Open-Label",1,NA,"Hospital","Mortality, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Ferritin, IL-6, D-Dimer, LDH, Radiographic Findings","Corticosteroids",20
"NCT04343976","https://ClinicalTrials.gov/show/NCT04343976",NA,"United States","Massachusetts","2020-Apr","2021-Mar","Recruiting","Randomised","Single",2,NA,"Hospital","Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Respiratory Rate","IFN",20
"NCT04342897","https://ClinicalTrials.gov/show/NCT04342897",NA,"United States","Colorado","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Serious Adverse Events","mAb",210
"NCT04342897","https://ClinicalTrials.gov/show/NCT04342897",NA,"United States","Connecticut","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Serious Adverse Events","mAb",210
"NCT04342897","https://ClinicalTrials.gov/show/NCT04342897",NA,"United States","Illinois","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Serious Adverse Events","mAb",210
"NCT04342897","https://ClinicalTrials.gov/show/NCT04342897",NA,"United States","Indiana","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Serious Adverse Events","mAb",210
"NCT04342897","https://ClinicalTrials.gov/show/NCT04342897",NA,"United States","Louisiana","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Serious Adverse Events","mAb",210
"NCT04342897","https://ClinicalTrials.gov/show/NCT04342897",NA,"United States","Massachusetts","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Serious Adverse Events","mAb",210
"NCT04342897","https://ClinicalTrials.gov/show/NCT04342897",NA,"United States","Michigan","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Serious Adverse Events","mAb",210
"NCT04342897","https://ClinicalTrials.gov/show/NCT04342897",NA,"United States","Minnesota","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Serious Adverse Events","mAb",210
"NCT04342897","https://ClinicalTrials.gov/show/NCT04342897",NA,"United States","New York","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Serious Adverse Events","mAb",210
"NCT04342897","https://ClinicalTrials.gov/show/NCT04342897",NA,"United States","North Carolina","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,NA,"Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Serious Adverse Events","mAb",210
"NCT04345679","https://ClinicalTrials.gov/show/NCT04345679",NA,"Hungary","Budapest","2020-Apr","2020-Jun","Not Recruiting","Single-Arm","Open-Label",1,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Other Mild Symptoms, Bilirubin","Plasma based therapy",20
"NCT04360837","https://ClinicalTrials.gov/show/NCT04360837",NA,"Hungary","Szeged","2020-Apr","2021-Jun","Recruiting","Single-Arm","Open-Label",1,NA,"Hospital","Clinical Improvement Score (Any), PaO2-FiO2","Respiratory support",10
"2020-001442-19","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001442-19/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Creatinine Phosphokinase, CK-MB, Troponin, Fibrinogen, ALT, AST, Bilirubin, Glucose, LDH","TCZ",NA
"NCT04342221","https://ClinicalTrials.gov/show/NCT04342221",NA,"Germany","Berlin","2020-Apr","2021-Mar","Recruiting","Randomised","Quadruple",2,NA,"Hospital","Mortality, Invasive Mechanical Ventilation or ECMO",NA,220
"NCT04342221","https://ClinicalTrials.gov/show/NCT04342221",NA,"Germany","Hamburg","2020-Apr","2021-Mar","Recruiting","Randomised","Quadruple",2,NA,"Hospital","Mortality, Invasive Mechanical Ventilation or ECMO",NA,220
"NCT04341727","https://ClinicalTrials.gov/show/NCT04341727",NA,"United States","Missouri","2020-Apr","2021-Apr","Suspended","Randomised","Open-Label",3,NA,"Hospital",NA,NA,500
"NCT04345276","https://ClinicalTrials.gov/show/NCT04345276",NA,"China","Hubei","2020-Apr","2020-Apr","Completed","Single-Arm","Open-Label",1,NA,"Hospital","ICU Admission, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Serious Adverse Events",NA,10
"NCT04340557","https://ClinicalTrials.gov/show/NCT04340557",NA,"United States","California","2020-Apr","2020-Oct","Recruiting","Randomised","Open-Label",2,NA,"Hospital","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6",NA,200
"NCT04345289","https://ClinicalTrials.gov/show/NCT04345289",NA,"Denmark","Copenhagen","2020-Apr","2021-Jun","Recruiting","Randomised","Quadruple",6,NA,"Hospital","Mortality, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO",NA,1500
"NCT04340050","https://ClinicalTrials.gov/show/NCT04340050",NA,"United States","Illinois","2020-Apr","2020-Dec","Not Recruiting","Single-Arm","Open-Label",1,NA,"Hospital","Mortality, Invasive Mechanical Ventilation or ECMO",NA,10
"NCT04340232","https://ClinicalTrials.gov/show/NCT04340232",NA,"United States","Colorado","2020-Apr","2020-Aug","Not Recruiting","Single-Arm","Open-Label",1,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose, Renal Outcome (Unspecified)",NA,80
"NCT04343183","https://ClinicalTrials.gov/show/NCT04343183",NA,"United States","Louisiana","2020-Apr","2020-Jun","Not Recruiting","Randomised","Single",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation",NA,48
"2020-001156-18","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001156-18/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Open-Label",3,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO",NA,NA
"2020-001307-16","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001307-16/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO",NA,NA
"IRCT20200321046828N1","http://en.irct.ir/trial/46624",NA,"Iran","Tehran","2020-Mar","2020-Mar","Completed","Non-Randomised","Open-Label",6,NA,"Hospital","Fever, Radiographic Findings",NA,30
"NCT04343144","https://clinicaltrials.gov/show/NCT04343144",NA,"France","Paris","2020-Sep",NA,"Not Recruiting","Randomised","Open-Label",2,NA,"Hospital","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events, Serious Adverse Events",NA,92
"NCT04340414","https://clinicaltrials.gov/show/NCT04340414",NA,"China","Beijing","2020-Mar",NA,"Recruiting","Single-Arm","Open-Label",1,NA,"Hospital","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6",NA,10
"NCT04344561","https://clinicaltrials.gov/show/NCT04344561",NA,"United States","Washington, Dc","2020-Oct",NA,"Recruiting","Randomised","Open-Label",2,NA,"Hospital","Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance",NA,70
"NCT04308668","https://ClinicalTrials.gov/show/NCT04308668",NA,"United States","Minnesota","2020-Mar","2020-May","Completed","Randomised","Quadruple",2,"Mixed","Healthy Exposed, Healthcare Workers, Outpatient","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, PaO2-FiO2, Blood pH","HCQ, SOC",1309
"NCT04308668","https://ClinicalTrials.gov/show/NCT04308668",NA,"Canada","Alberta","2020-Mar","2020-May","Completed","Randomised","Quadruple",2,"Mixed","Healthy Exposed, Healthcare Workers, Outpatient","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, PaO2-FiO2, Blood pH","HCQ, SOC",1309
"NCT04308668","https://ClinicalTrials.gov/show/NCT04308668",NA,"Canada","Manitoba","2020-Mar","2020-May","Completed","Randomised","Quadruple",2,"Mixed","Healthy Exposed, Healthcare Workers, Outpatient","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, PaO2-FiO2, Blood pH","HCQ, SOC",1309
"NCT04308668","https://ClinicalTrials.gov/show/NCT04308668",NA,"Canada","Quebec","2020-Mar","2020-May","Completed","Randomised","Quadruple",2,"Mixed","Healthy Exposed, Healthcare Workers, Outpatient","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, PaO2-FiO2, Blood pH","HCQ, SOC",1309
"NCT04337541","https://ClinicalTrials.gov/show/NCT04337541",NA,"Denmark","Copenhagen","2020-Apr","2020-Jul","Recruiting","Randomised","Open-Label",2,"Healthy","Healthcare Workers, Outpatient","Viral Load or Clearance, Antibodies",NA,6000
"NCT04406246","https://ClinicalTrials.gov/show/NCT04406246",NA,"Mexico","Mexico","2020-May","2020-Dec","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Healthcare Workers, Outpatient","Hospitalization","Antivirals",150
"NCT04353037","https://ClinicalTrials.gov/show/NCT04353037",NA,"United States","New York","2020-Apr","2021-Apr","Recruiting","Randomised","Double",2,NA,"Healthcare Workers, Outpatient","Hospitalization, Viral Load or Clearance, Household Members with CoViD-19, Labor Absenteeism, Adverse Events","HCQ, SOC",850
"NCT04390503","https://ClinicalTrials.gov/show/NCT04390503",NA,"United States","New York","2020-May","2021-Apr","Recruiting","Randomised","Double",2,"Confirmed Or Suspected","Healthy Exposed, Outpatient",NA,"Plasma based therapy, SOC",200
"2020-001994-66","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001994-66/ES/",NA,"Spain","Madrid","2020-May",NA,"Recruiting","Randomised","Double",2,"Confirmed, Healthy","Healthy Exposed, Outpatient","Mortality, Viral Load or Clearance, Household Members with CoViD-19, Anti SARS-COV-2 Titers","Ivermectin, SOC",NA
"NCT04363827","https://ClinicalTrials.gov/show/NCT04363827",NA,"Italy","Rome","2020-Apr","2020-Sep","Recruiting","Randomised","Open-Label",4,NA,"Healthy Exposed, Outpatient","Serious Adverse Events, Quality of Life","HCQ, SOC",2300
"NCT04337918","https://ClinicalTrials.gov/show/NCT04337918",NA,"Canada","British Columbia","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,"Confirmed","Healthy Unexposed, Outpatient","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","Non-invasive respiratory support",200
"NCT04337918","https://ClinicalTrials.gov/show/NCT04337918",NA,"Canada","Quebec","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,"Confirmed","Healthy Unexposed, Outpatient","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","Non-invasive respiratory support",200
"IRCT20200516047462N1","http://en.irct.ir/trial/48141",NA,"Iran","Tehran","2020-May","2020-Jun","Completed","Randomised","Double",2,"Suspected","Outpatient","Cough, Dyspnea","Alternative therapy + Other, SOC",50
"CTRI/2020/05/025167","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43378",NA,"India","New Delhi","2020-May",NA,"Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Outpatient",NA,"Other, SOC",64
"ISRCTN13311119","http://isrctn.com/ISRCTN13311119",NA,"India","New Delhi","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient",NA,"Alternative therapy, SOC",116
"CTRI/2020/04/024857","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43212",NA,"India","New Delhi","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",1,"Confirmed","Outpatient","ICU Admission","Alternative therapy",100
"NCT04425629","https://ClinicalTrials.gov/show/NCT04425629",NA,"United States","Colorado","2020-Jun","2020-Nov","Recruiting","Randomised","Quadruple",3,"Confirmed","Outpatient","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies","mAB, SOC",1054
"NCT04425629","https://ClinicalTrials.gov/show/NCT04425629",NA,"United States","District Of Columbia","2020-Jun","2020-Nov","Recruiting","Randomised","Quadruple",3,"Confirmed","Outpatient","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies","mAB, SOC",1054
"NCT04425629","https://ClinicalTrials.gov/show/NCT04425629",NA,"United States","Florida","2020-Jun","2020-Nov","Recruiting","Randomised","Quadruple",3,"Confirmed","Outpatient","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies","mAB, SOC",1054
"NCT04425629","https://ClinicalTrials.gov/show/NCT04425629",NA,"United States","New York","2020-Jun","2020-Nov","Recruiting","Randomised","Quadruple",3,"Confirmed","Outpatient","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies","mAB, SOC",1054
"NCT04425629","https://ClinicalTrials.gov/show/NCT04425629",NA,"United States","Pennsylvania","2020-Jun","2020-Nov","Recruiting","Randomised","Quadruple",3,"Confirmed","Outpatient","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies","mAB, SOC",1054
"NCT04425629","https://ClinicalTrials.gov/show/NCT04425629",NA,"United States","Texas","2020-Jun","2020-Nov","Recruiting","Randomised","Quadruple",3,"Confirmed","Outpatient","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies","mAB, SOC",1054
"CHICTR2000033057","http://www.chictr.org.cn/showproj.aspx?proj=53529",NA,"China","Liaoning","2020-May","2020-Sep","Recruiting","Randomised","Unspecified",2,"Confirmed","Outpatient","Depression, Anxiety","Rehabilitation",160
"CTRI/2020/04/024949","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43400",NA,"India","New Delhi","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient",NA,"Other, SOC",48
"NCT04418505","https://ClinicalTrials.gov/show/NCT04418505",NA,"Canada","Ontario","2020-Jun","2021-Jan","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Mortality, Hospitalization, SpO2","Alternative therapy, SOC",280
"NCT04307693","https://ClinicalTrials.gov/show/NCT04307693",NA,"South Korea","Seoul","2020-Mar","2020-Apr","Status Unclear","Randomised","Open-Label",3,"Confirmed","Outpatient","Mortality, ICU Admission, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Other Mild Symptoms, Adverse Events, Respiratory Rate","HCQ, LPV/r, SOC",65
"NCT04351516","https://clinicaltrials.gov/show/NCT04351516",NA,"Germany","Berlin","2020-Apr",NA,"Recruiting","Randomised","Quadruple",2,"Yes","Outpatient","Mortality, Hospitalization","HCQ, SOC",350
"NCT04334967","https://ClinicalTrials.gov/show/NCT04334967",NA,"United States","Oregon","2020-Apr","2020-May","Suspended","Randomised","Single",2,"Confirmed","Outpatient","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea",NA,13
"NCT04334382","https://ClinicalTrials.gov/show/NCT04334382",NA,"United States","Utah","2020-Apr","2020-Dec","Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6",NA,1550
"NCT04363203","https://ClinicalTrials.gov/show/NCT04363203",NA,"United States","California","2020-Apr","2021-Mar","Suspended","Single-Arm","Quadruple",3,"Confirmed","Outpatient","Mortality, Hospitalization, Cough, Fever, Dyspnea","AZT, HCQ, SOC",300
"NCT04338074","https://ClinicalTrials.gov/show/NCT04338074",NA,"United States","Alabama","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",2,"Confirmed","Outpatient","Viral Load or Clearance, Treatment-emergent Adverse Events",NA,100
"NCT04342728","https://ClinicalTrials.gov/show/NCT04342728",NA,"United States","Florida","2020-Apr","2020-Dec","Recruiting","Single-Arm","Open-Label",4,"Yes","Outpatient","Hospitalization, Cough, Fever, Dyspnea, Other Mild Symptoms","SOC, Vitamins, Vitamins + Zinc, Zinc",520
"NCT04342728","https://ClinicalTrials.gov/show/NCT04342728",NA,"United States","Ohio","2020-Apr","2020-Dec","Recruiting","Single-Arm","Open-Label",4,"Yes","Outpatient","Hospitalization, Cough, Fever, Dyspnea, Other Mild Symptoms","SOC, Vitamins, Vitamins + Zinc, Zinc",520
"NCT04344457","https://ClinicalTrials.gov/show/NCT04344457",NA,"United States","Arizona","2020-Apr","2020-Jun","Recruiting","Single-Arm","Open-Label",3,"Yes","Outpatient","Clinical Improvement Score (Any), Cough, Fever, Treatment-emergent Adverse Events","AZT, HCQ, NSAIDs",80
"NCT04344457","https://ClinicalTrials.gov/show/NCT04344457",NA,"United States","Louisiana","2020-Apr","2020-Jun","Recruiting","Single-Arm","Open-Label",3,"Yes","Outpatient","Clinical Improvement Score (Any), Cough, Fever, Treatment-emergent Adverse Events","AZT, HCQ, NSAIDs",80
"NCT04342169","https://ClinicalTrials.gov/show/NCT04342169",NA,"United States","Utah","2020-Apr","2022-Apr","Recruiting","Randomised","Open-Label",2,"Yes","Outpatient","ICU Admission, Depression, Anxiety","HCQ, SOC",400
"NCT04348474","https://ClinicalTrials.gov/show/NCT04348474",NA,"Brazil","Brasilia","2020-Apr","2020-Jun","Suspended","Single-Arm","Open-Label",1,"Yes","Outpatient","Mortality, Hospitalization, Clinical Improvement Score (Any)","HCQ + AZT",200
"NCT04349241","https://ClinicalTrials.gov/show/NCT04349241",NA,"Egypt","Cairo","2020-Apr","2020-Jun","Completed","Randomised","Open-Label",2,"Yes","Outpatient","Viral Load or Clearance, Fever, Radiographic Findings","FPV, SOC",100
"NCT04342689","https://ClinicalTrials.gov/show/NCT04342689",NA,"United States","Connecticut","2020-Apr","2021-Jun","Recruiting","Randomised","Quadruple",2,"Yes","Outpatient","Mortality, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","Nutrition, SOC",1500
"NCT04342689","https://ClinicalTrials.gov/show/NCT04342689",NA,"United States","Michigan","2020-Apr","2021-Jun","Recruiting","Randomised","Quadruple",2,"Yes","Outpatient","Mortality, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","Nutrition, SOC",1500
"NCT04438057","https://ClinicalTrials.gov/show/NCT04438057",NA,"United States","Illinois","2020-Jun","2021-Jul","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Hospitalization","Plasma based therapy, SOC",150
"NCT04441398","https://ClinicalTrials.gov/show/NCT04441398",NA,"Brazil","Brasilia","2020-Jun","2020-Sep","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Outpatient","Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events","Antivirals, SOC",300
"NCT04377711","https://ClinicalTrials.gov/show/NCT04377711",NA,"United States","New York","2020-May","2020-Sep","Recruiting","Randomised","Double",2,"Confirmed","Outpatient","Mortality, Hospitalization, Visits or Returns to Emergency Department, Viral Load or Clearance, Cough, Fever, Dyspnea, Other Mild Symptoms, Adverse Events, SpO2","Corticosteroids, SOC",400
"NCT04416334","https://ClinicalTrials.gov/show/NCT04416334",NA,"Spain","Cantabria","2020-Jun","2020-Sep","Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Hospitalization","Colchicine, SOC",1028
"NCT04428073","https://ClinicalTrials.gov/show/NCT04428073",NA,"United States","Georgia","2020-Jun","2021-Jul","Not Recruiting","Non-Randomised","Open-Label",2,"Confirmed","Outpatient","Adverse Events, CD8","Vaccine",32
"CHICTR2000030054","http://www.chictr.org.cn/showproj.aspx?proj=49869",NA,"China","Fujian","2020-Feb","2020-May","Not Recruiting","Randomised","Unspecified",3,"Confirmed","Outpatient","Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Serious Adverse Events, Heart Rate, Respiratory Rate","HCQ, SOC",100
"NCT04400799","https://ClinicalTrials.gov/show/NCT04400799",NA,"Switzerland","Zurich","2020-May","2021-Mar","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Mortality, Hospitalization, Coagulation Test","Anticoagulants, SOC",1000
"NCT04442230","https://ClinicalTrials.gov/show/NCT04442230",NA,"United States","Maryland","2020-Jun","2020-Nov","Not Recruiting","Randomised","Double",2,"Confirmed Or Suspected","Outpatient","Mortality","SOC, Vaccine",96
"NCT04351191","https://ClinicalTrials.gov/show/NCT04351191",NA,"Pakistan","Punjab","2020-Apr","2020-May","Recruiting","Randomised","Quadruple",4,"Yes","Outpatient","Mortality, Clinical Improvement Score (Any), Viral Load or Clearance","HCQ, SOC",400
"NCT04421664","https://ClinicalTrials.gov/show/NCT04421664",NA,"United States","Minnesota","2020-Jun","2020-Jul","Recruiting","Randomised","Quadruple",2,"Confirmed","Outpatient","Mortality, Hospitalization","HCQ, SOC",1500
"NCT04421664","https://ClinicalTrials.gov/show/NCT04421664",NA,"Canada","Alberta","2020-Jun","2020-Jul","Recruiting","Randomised","Quadruple",2,"Confirmed","Outpatient","Mortality, Hospitalization","HCQ, SOC",1500
"NCT04421664","https://ClinicalTrials.gov/show/NCT04421664",NA,"Canada","British Columbia","2020-Jun","2020-Jul","Recruiting","Randomised","Quadruple",2,"Confirmed","Outpatient","Mortality, Hospitalization","HCQ, SOC",1500
"NCT04421664","https://ClinicalTrials.gov/show/NCT04421664",NA,"Canada","Manitoba","2020-Jun","2020-Jul","Recruiting","Randomised","Quadruple",2,"Confirmed","Outpatient","Mortality, Hospitalization","HCQ, SOC",1500
"NCT04421664","https://ClinicalTrials.gov/show/NCT04421664",NA,"Canada","Newfoundland And Labrador","2020-Jun","2020-Jul","Recruiting","Randomised","Quadruple",2,"Confirmed","Outpatient","Mortality, Hospitalization","HCQ, SOC",1500
"NCT04421664","https://ClinicalTrials.gov/show/NCT04421664",NA,"Canada","Ontario","2020-Jun","2020-Jul","Recruiting","Randomised","Quadruple",2,"Confirmed","Outpatient","Mortality, Hospitalization","HCQ, SOC",1500
"NCT04421664","https://ClinicalTrials.gov/show/NCT04421664",NA,"Canada","Quebec","2020-Jun","2020-Jul","Recruiting","Randomised","Quadruple",2,"Confirmed","Outpatient","Mortality, Hospitalization","HCQ, SOC",1500
"2020-001752-17","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001752-17/FR/",NA,"France","Paris","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Hospitalization, Viral Load or Clearance, Antibodies","AZT, SOC",NA
"IRCT20081019001369N5","http://en.irct.ir/trial/47141",NA,"Iran","Tehran","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,"Confirmed","Outpatient","Clinical Improvement Score (Any), Cough, Fever, Other Mild Symptoms, C-Reactive Protein","Lithium, SOC",40
"2020-001723-13","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001723-13/FR/",NA,"France","Paris","2020-Apr",NA,"Recruiting","Randomised","Open-Label",4,"Confirmed","Outpatient","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Other Mild Symptoms, Adverse Events, Serious Adverse Events","AZT",NA
"IRCT20180923041093N3","http://en.irct.ir/trial/46721",NA,"Iran","Tehran","2020-Mar","2020-May","Completed","Randomised","Open-Label",2,"Confirmed","Outpatient","Mortality, Hospitalization, Cough, Fever, Other Mild Symptoms, Respiratory Rate",NA,70
"JPRN-JRCTS031190269","https://jrct.niph.go.jp/latest-detail/jRCTs031190269",NA,"Japan","Toyama","2020-Mar",NA,"Recruiting","Randomised","Open-Label",NA,"Yes","Outpatient","Viral Load or Clearance, Pneumonia or ARDS, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events",NA,90
"NCT04351620","https://ClinicalTrials.gov/show/NCT04351620",NA,"United States","Illinois","2020-Apr","2020-Jun","Recruiting","Single-Arm","Open-Label",1,"Confirmed","Outpatient","Hospitalization, Fever, Other Mild Symptoms, Adverse Events","HCQ",20
"NCT04303299","https://ClinicalTrials.gov/show/NCT04303299",NA,"Thailand","Nan","2020-Mar","2020-Dec","Not Recruiting","Randomised","Open-Label",7,"Confirmed","Outpatient","ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","DRV/r + FPV + HCQ, DRV/r + Oseltamivir, DRV/r + Oseltamivir + HCQ, HCQ + Oseltamivir, LPV/r + FPV, LPV/r + Oseltamivir, SOC",320
"PACTR202006899597082","https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11103",NA,"Madagascar","Antananarivo","2020-May",NA,"Not Recruiting","Randomised","Unspecified",3,"Confirmed","Outpatient",NA,"Other, Other + Vitamins, SOC",60
"CHICTR2000029600","http://www.chictr.org.cn/showproj.aspx?proj=49042","https://reader.elsevier.com/reader/sd/pii/S2095809920300631?token=A28CA1B43E646EFBA54D61F15A05C13723D1BFA784EAC81E632C0FB769F1BD4BA964D4E304CB8D9EAA24DF528709668A","China","Guangdong","2020-Feb","2020-Apr","Completed w. Results","Non-Randomised","Unspecified",3,"Confirmed","Outpatient","Viral Load or Clearance, Radiographic Findings, Renal Outcome (Unspecified)","FPV + IFN, IFN, LPV/r + IFN",90
"CHICTR2000029387","http://www.chictr.org.cn/showproj.aspx?proj=48782",NA,"China","Chongqing","2020-Jan",NA,"Recruiting","Randomised","Unspecified",3,"Confirmed","Outpatient","Mortality, Viral Load or Clearance, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","Antivirals + IFN, Antivirals + LPV/r + IFN, LPV/r + IFN",108
"NCT04372628","https://ClinicalTrials.gov/show/NCT04372628",NA,"United States","Colorado","2020-May","2020-Dec","Recruiting","Randomised","Triple",3,"Confirmed","Outpatient","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Other Mild Symptoms, Quality of Life","HCQ, LPV/r, SOC",900
"NCT04372628","https://ClinicalTrials.gov/show/NCT04372628",NA,"United States","Massachusetts","2020-May","2020-Dec","Recruiting","Randomised","Triple",3,"Confirmed","Outpatient","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Other Mild Symptoms, Quality of Life","HCQ, LPV/r, SOC",900
"NCT04372628","https://ClinicalTrials.gov/show/NCT04372628",NA,"United States","Tennessee","2020-May","2020-Dec","Recruiting","Randomised","Triple",3,"Confirmed","Outpatient","Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Other Mild Symptoms, Quality of Life","HCQ, LPV/r, SOC",900
"NCT04425720","https://clinicaltrials.gov/show/NCT04425720",NA,"United States","Washington, Dc","2020-Feb",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Visits or Returns to Emergency Department, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events","Monitoring, SOC",300
"CHICTR2000029741","http://www.chictr.org.cn/showproj.aspx?proj=49263",NA,"China","Guangdong","2020-Feb","2020-Dec","Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Mortality, C-Reactive Protein, IL-6, IL-10, Tumor Necrosis Factor (Any), Lymphocyte Count, Neutrophils, Platelet Count, D-Dimer, Myoglobin, Procalcitonin, Prothrombin, Fibrinogen, Coagulation Test, Renal Outcome (Unspecified)","HCQ, LPV/r",112
"CHICTR2000030539","http://www.chictr.org.cn/showproj.aspx?proj=50660",NA,"China","Guangdong","2020-Mar","2021-Mar","Not Recruiting","Non-Randomised","Unspecified",2,"Confirmed","Outpatient","Viral Load or Clearance","Hygiene, SOC",40
"CHICTR2000029899","http://www.chictr.org.cn/showproj.aspx?proj=49536",NA,"China","Beijing","2020-Feb","2020-Apr","Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, IgG, IgM or IgA","HCQ",100
"NCT04404218","https://clinicaltrials.gov/show/NCT04404218",NA,"Canada","Ontario","2020-May",NA,"Not Recruiting","Randomised","Quadruple",2,"Confirmed","Outpatient",NA,"Other, SOC",480
"NCT04332107","https://ClinicalTrials.gov/show/NCT04332107",NA,"United States","California","2020-Apr","2020-Sep","Recruiting","Randomised","Quadruple",2,"Confirmed","Outpatient","Mortality, Hospitalization, Visits or Returns to Emergency Department, Clinical Improvement Score (Any), Viral Load or Clearance, Household Members with CoViD-19, Cough, Fever, Dyspnea, Other Mild Symptoms, Adverse Events","AZT, SOC",2271
"NCT04331600","https://ClinicalTrials.gov/show/NCT04331600",NA,"Poland","Warsaw","2020-Apr","2020-Sep","Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Mortality, Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS, Serious or Seconday Infections","HCQ, SOC",400
"NCT04435795","https://ClinicalTrials.gov/show/NCT04435795",NA,"Canada","Quebec","2020-Jun","2021-Feb","Not Recruiting","Randomised","Triple",2,"Confirmed","Outpatient","Mortality, Hospitalization, Dyspnea, Anxiety","Corticosteroids, SOC",454
"NCT04322682","https://ClinicalTrials.gov/show/NCT04322682",NA,"United States","California","2020-Mar","2020-Sep","Recruiting","Randomised","Single",2,"Confirmed","Outpatient","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2, Blood pH","Colchicine, SOC",6000
"NCT04322682","https://ClinicalTrials.gov/show/NCT04322682",NA,"United States","New York","2020-Mar","2020-Sep","Recruiting","Randomised","Single",2,"Confirmed","Outpatient","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2, Blood pH","Colchicine, SOC",6000
"NCT04322682","https://ClinicalTrials.gov/show/NCT04322682",NA,"Canada","Quebec","2020-Mar","2020-Sep","Recruiting","Randomised","Single",2,"Confirmed","Outpatient","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2, Blood pH","Colchicine, SOC",6000
"NCT04322682","https://ClinicalTrials.gov/show/NCT04322682",NA,"Spain","Madrid","2020-Mar","2020-Sep","Recruiting","Randomised","Single",2,"Confirmed","Outpatient","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2, Blood pH","Colchicine, SOC",6000
"2020-001603-16","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001603-16/ES/",NA,"Spain","Madrid","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Hospitalization, Invasive Mechanical Ventilation or ECMO, Adverse Events","Colchicine, SOC",NA
"NCT04405570","https://clinicaltrials.gov/show/NCT04405570",NA,"United States","Washington, Dc","2020-May",NA,"Recruiting","Randomised","Double",2,"Confirmed","Outpatient","Adverse Events","Antivirals, SOC",44
"CHICTR2000030804","http://www.chictr.org.cn/showproj.aspx?proj=51018",NA,"China","Guangdong","2020-Mar","2021-Mar","Recruiting","Randomised","Unspecified",2,"Confirmed","Outpatient","Hospitalization, Cough, C-Reactive Protein","SOC, TCM",128
"NCT04291053","https://ClinicalTrials.gov/show/NCT04291053",NA,"China","Beijing","2020-Mar","2020-Aug","Not Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, PaO2-FiO2, Respiratory Rate","SOC, TCM",550
"NCT04329611","https://ClinicalTrials.gov/show/NCT04329611",NA,"Canada","Alberta","2020-Apr","2020-Aug","Suspended","Single-Arm","Triple",2,"Confirmed","Outpatient","Mortality, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",1660
"NCT04333654","https://ClinicalTrials.gov/show/NCT04333654",NA,"United States","Massachusetts","2020-Apr","2020-Aug","Suspended","Randomised","Quadruple",2,"Confirmed","Outpatient","Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, IL-6, Tumor Necrosis Factor (Any), D-Dimer, Antibodies, PaO2-FiO2","HCQ, SOC",210
"NCT04333654","https://ClinicalTrials.gov/show/NCT04333654",NA,"Belgium","Brussels","2020-Apr","2020-Aug","Suspended","Randomised","Quadruple",2,"Confirmed","Outpatient","Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, IL-6, Tumor Necrosis Factor (Any), D-Dimer, Antibodies, PaO2-FiO2","HCQ, SOC",210
"NCT04333654","https://ClinicalTrials.gov/show/NCT04333654",NA,"France","Paris","2020-Apr","2020-Aug","Suspended","Randomised","Quadruple",2,"Confirmed","Outpatient","Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, IL-6, Tumor Necrosis Factor (Any), D-Dimer, Antibodies, PaO2-FiO2","HCQ, SOC",210
"NCT04333654","https://ClinicalTrials.gov/show/NCT04333654",NA,"Netherlands","Groningen","2020-Apr","2020-Aug","Suspended","Randomised","Quadruple",2,"Confirmed","Outpatient","Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, IL-6, Tumor Necrosis Factor (Any), D-Dimer, Antibodies, PaO2-FiO2","HCQ, SOC",210
"NCT04333654","https://ClinicalTrials.gov/show/NCT04333654",NA,"Netherlands","Amsterdam","2020-Apr","2020-Aug","Suspended","Randomised","Quadruple",2,"Confirmed","Outpatient","Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, IL-6, Tumor Necrosis Factor (Any), D-Dimer, Antibodies, PaO2-FiO2","HCQ, SOC",210
"NCT04385264","https://ClinicalTrials.gov/show/NCT04385264",NA,"Switzerland","Vaud","2020-May","2020-Aug","Not Recruiting","Randomised","Quadruple",2,"Confirmed","Outpatient","Pneumonia or ARDS, Adverse Events","HCQ, SOC",800
"NCT04304053","https://ClinicalTrials.gov/show/NCT04304053",NA,"Spain","Barcelona","2020-Mar","2020-Jun","Completed","Randomised","Open-Label",2,"Confirmed","Outpatient","Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Treatment-emergent Adverse Events, CD4, PaO2-FiO2, Radiographic Findings","HCQ + Antivirals, SOC",2300
"NCT04412018","https://ClinicalTrials.gov/show/NCT04412018",NA,"Canada","Ontario","2020-Jun","2020-Dec","Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","C-Reactive Protein, Lymphocyte Count, Platelet Count, Erythrocyte Sedimentation Rate, D-Dimer, Albumin","Other, SOC",100
"NCT04407507","https://ClinicalTrials.gov/show/NCT04407507",NA,"Mexico","Jalisco","2020-May","2020-Aug","Not Recruiting","Randomised","Single",2,"Confirmed","Outpatient",NA,"Ivermectin, SOC",66
"NCT04390022","https://ClinicalTrials.gov/show/NCT04390022",NA,"Spain","Navarra","2020-May","2020-Aug","Recruiting","Randomised","Double",2,"Confirmed","Outpatient","Viral Load or Clearance, Cough, Fever, Adverse Events, IgG, IgM or IgA, CD4, CD8","Ivermectin, SOC",24
"2020-001474-29","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001474-29/ES/",NA,"Spain","Madrid","2020-May",NA,"Recruiting","Randomised","Double",2,"Confirmed","Outpatient","Mortality, Viral Load or Clearance, Cough, Fever, Adverse Events, IgG, IgM or IgA","Ivermectin, SOC",NA
"NCT04414124","https://ClinicalTrials.gov/show/NCT04414124",NA,"United States","California","2020-Jun","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Hospitalization, Fever, Treatment-emergent Adverse Events, SpO2","Other, SOC",400
"NCT04414124","https://ClinicalTrials.gov/show/NCT04414124",NA,"United States","Georgia","2020-Jun","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Hospitalization, Fever, Treatment-emergent Adverse Events, SpO2","Other, SOC",400
"NCT04414124","https://ClinicalTrials.gov/show/NCT04414124",NA,"United States","Massachusetts","2020-Jun","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Hospitalization, Fever, Treatment-emergent Adverse Events, SpO2","Other, SOC",400
"NCT04414124","https://ClinicalTrials.gov/show/NCT04414124",NA,"United States","Nevada","2020-Jun","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Hospitalization, Fever, Treatment-emergent Adverse Events, SpO2","Other, SOC",400
"NCT04414124","https://ClinicalTrials.gov/show/NCT04414124",NA,"United States","North Carolina","2020-Jun","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Hospitalization, Fever, Treatment-emergent Adverse Events, SpO2","Other, SOC",400
"NCT04414124","https://ClinicalTrials.gov/show/NCT04414124",NA,"United States","Tennessee","2020-Jun","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Hospitalization, Fever, Treatment-emergent Adverse Events, SpO2","Other, SOC",400
"NCT04414124","https://ClinicalTrials.gov/show/NCT04414124",NA,"United States","Texas","2020-Jun","2020-Oct","Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Hospitalization, Fever, Treatment-emergent Adverse Events, SpO2","Other, SOC",400
"CHICTR2000029539","http://www.chictr.org.cn/showproj.aspx?proj=48991",NA,"China","Hubei","2020-Feb","2021-Feb","Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","ICU Admission, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Cough, Fever, Dyspnea, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Respiratory Rate","LPV/r, SOC",328
"NCT04399356","https://ClinicalTrials.gov/show/NCT04399356",NA,"United States","Massachusetts","2020-May","2020-Oct","Not Recruiting","Randomised","Triple",3,"Confirmed","Outpatient","Viral Load or Clearance","Other, SOC",100
"NCT04385901","https://clinicaltrials.gov/show/NCT04385901",NA,"United States","Washington, Dc","2020-Jun",NA,"Recruiting","Non-Randomised","Double",2,"Confirmed","Outpatient","6-Minute Walking Distance","Rehabilitation, SOC",72
"CHICTR2000029589","http://www.chictr.org.cn/showproj.aspx?proj=49104",NA,"China","Beijing","2020-Feb","2021-Dec","Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Viral Load or Clearance, Cough, Fever, Dyspnea","SOC, TCM",120
"CHICTR2000029439","http://www.chictr.org.cn/showproj.aspx?proj=48904",NA,"China","Beijing","2020-Feb","2021-Dec","Not Recruiting","Randomised","Unspecified",2,"Confirmed","Outpatient","Viral Load or Clearance, Pneumonia or ARDS, Fever, Adverse Events, Serious Adverse Events, PaO2-FiO2, Respiratory Rate","SOC, TCM",120
"NCT04334005","https://ClinicalTrials.gov/show/NCT04334005",NA,"Spain","Granada","2020-Apr","2020-Jun","Not Recruiting","Randomised","Double",2,"Confirmed","Outpatient","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms","SOC, Vitamins",200
"NCT04373460","https://ClinicalTrials.gov/show/NCT04373460",NA,"United States","Alabama","2020-May","2022-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient","Mortality, Hospitalization, Serious Adverse Events, Antibodies","Plasma based therapy, SOC",1344
"NCT04373460","https://ClinicalTrials.gov/show/NCT04373460",NA,"United States","California","2020-May","2022-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient","Mortality, Hospitalization, Serious Adverse Events, Antibodies","Plasma based therapy, SOC",1344
"NCT04373460","https://ClinicalTrials.gov/show/NCT04373460",NA,"United States","Illinois","2020-May","2022-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient","Mortality, Hospitalization, Serious Adverse Events, Antibodies","Plasma based therapy, SOC",1344
"NCT04373460","https://ClinicalTrials.gov/show/NCT04373460",NA,"United States","Maryland","2020-May","2022-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient","Mortality, Hospitalization, Serious Adverse Events, Antibodies","Plasma based therapy, SOC",1344
"NCT04373460","https://ClinicalTrials.gov/show/NCT04373460",NA,"United States","Washington","2020-May","2022-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient","Mortality, Hospitalization, Serious Adverse Events, Antibodies","Plasma based therapy, SOC",1344
"NCT04373460","https://ClinicalTrials.gov/show/NCT04373460",NA,"United States","Massachusetts","2020-May","2022-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient","Mortality, Hospitalization, Serious Adverse Events, Antibodies","Plasma based therapy, SOC",1344
"NCT04373460","https://ClinicalTrials.gov/show/NCT04373460",NA,"United States","New York","2020-May","2022-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient","Mortality, Hospitalization, Serious Adverse Events, Antibodies","Plasma based therapy, SOC",1344
"NCT04373460","https://ClinicalTrials.gov/show/NCT04373460",NA,"United States","Ohio","2020-May","2022-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient","Mortality, Hospitalization, Serious Adverse Events, Antibodies","Plasma based therapy, SOC",1344
"NCT04373460","https://ClinicalTrials.gov/show/NCT04373460",NA,"United States","Rhode Island","2020-May","2022-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient","Mortality, Hospitalization, Serious Adverse Events, Antibodies","Plasma based therapy, SOC",1344
"NCT04373460","https://ClinicalTrials.gov/show/NCT04373460",NA,"United States","Texas","2020-May","2022-Dec","Recruiting","Randomised","Triple",2,"Confirmed","Outpatient","Mortality, Hospitalization, Serious Adverse Events, Antibodies","Plasma based therapy, SOC",1344
"CHICTR2000032635","http://www.chictr.org.cn/showproj.aspx?proj=52671",NA,"China","Hubei","2020-May","2021-Mar","Not Recruiting","Randomised","Double",2,"Confirmed","Outpatient","Clinical Improvement Score (Any), Viral Load or Clearance, White Blood Cell Count, Lymphocyte Count, Neutrophils, Antibodies, Radiographic Findings","TCM",60
"CHICTR2000030922","http://www.chictr.org.cn/showproj.aspx?proj=51141",NA,"China","Guangdong","2020-Mar","2020-Aug","Recruiting","Randomised","Open-Label",2,"Confirmed","Outpatient","Mortality, Viral Load or Clearance, Pneumonia or ARDS, ALT","IFN + Other, Umifenovir + IFN",30
"CHICTR2000030849","http://www.chictr.org.cn/showproj.aspx?proj=51086",NA,"China","Henan","2020-Mar","2021-Mar","Not Recruiting","Single-Arm","Unspecified",1,"Confirmed","Outpatient","Depression, Anxiety","Psychological therapy",81
"NCT04330586","https://ClinicalTrials.gov/show/NCT04330586",NA,"South Korea","Seoul","2020-Apr","2020-Jun","Not Recruiting","Randomised","Open-Label",3,"Confirmed Or Suspected","Outpatient","ICU Admission, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","Corticosteroids, HCQ + Corticosteroids, SOC",141
"CHICTR2000029601","http://www.chictr.org.cn/showproj.aspx?proj=48988",NA,"China","Hubei","2020-Feb","2020-Aug","Recruiting","Randomised","Unspecified",2,"Confirmed Or Suspected","Outpatient","Clinical Improvement Score (Any), Viral Load or Clearance, Fever","Education, Education + TCM",400
"NCT04273763","https://ClinicalTrials.gov/show/NCT04273763",NA,"China","Zhejiang","2020-Feb","2020-May","Not Recruiting","Randomised","Open-Label",3,"Confirmed Or Suspected","Outpatient","Mortality, ICU Admission, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms, PaO2-FiO2, Respiratory Rate","IFN + Umifenovir, IFN + Umifenovir + Other",18
"NCT04381962","https://ClinicalTrials.gov/show/NCT04381962",NA,"United Kingdom","Oxfordshire","2020-May","2020-Sep","Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Outpatient","Mortality, Pneumonia or ARDS","AZT, SOC",800
"NCT04381962","https://ClinicalTrials.gov/show/NCT04381962",NA,"United Kingdom","Dundee","2020-May","2020-Sep","Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Outpatient","Mortality, Pneumonia or ARDS","AZT, SOC",800
"NCT04381962","https://ClinicalTrials.gov/show/NCT04381962",NA,"United Kingdom","Birmingham","2020-May","2020-Sep","Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Outpatient","Mortality, Pneumonia or ARDS","AZT, SOC",800
"NCT04381962","https://ClinicalTrials.gov/show/NCT04381962",NA,"United Kingdom","London","2020-May","2020-Sep","Recruiting","Randomised","Open-Label",2,"Confirmed Or Suspected","Outpatient","Mortality, Pneumonia or ARDS","AZT, SOC",800
"NCT04433078","https://clinicaltrials.gov/show/NCT04433078",NA,"United States","Washington, Dc","2020-Oct",NA,"Recruiting","Randomised","Triple",2,"Confirmed Or Suspected","Outpatient","Mortality, ICU Admission, Hospitalization, Hypoxemia","Antibiotics, SOC",20
"NCT04311177","https://ClinicalTrials.gov/show/NCT04311177",NA,"United States","Minnesota","2020-Mar","2021-Apr","Recruiting","Randomised","Quadruple",2,"Confirmed Or Suspected Or Exposed","Outpatient","Visits or Returns to Emergency Department","ARBs, SOC",580
"NCT04382131","https://clinicaltrials.gov/show/NCT04382131",NA,"United Kingdom","London","2020-Aug",NA,"Not Recruiting","Randomised","Open-Label",2,"Confirmed, Suspected","Outpatient","Hospitalization, Clinical Improvement Score (Any), Other Mild Symptoms, Adverse Events","Hygiene, SOC",405
"CHICTR2000029435","http://www.chictr.org.cn/showproj.aspx?proj=48827",NA,"China","Hubei","2020-Feb","2020-Mar","Not Recruiting","Randomised","Unspecified",8,"Healthy (Exposed) Or Suspected","Outpatient","Viral Load or Clearance, Fever, Weight, Height or BMI, Creatinine Phosphokinase, CK-MB, eGFR, ALT, Albumin, Bilirubin, Blood Pressure, Heart Rate, Radiographic Findings","SOC, TCM",160
"EUCTR2020-001740-26-GB","https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001740-26",NA,"United Kingdom","London","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",2,"Suspected","Outpatient","Mortality, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Adverse Events","AZT, SOC",800
"NCT04416399","https://ClinicalTrials.gov/show/NCT04416399",NA,"United Kingdom","Oxfordshire","2020-Jun","2020-Nov","Not Recruiting","Randomised","Open-Label",2,"Suspected","Outpatient","Visits or Returns to Emergency Department, Viral Load or Clearance, Fever, SpO2","Corticosteroids, SOC",478
"2020-001889-10","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001889-10/GB/",NA,"United Kingdom","London","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Suspected","Outpatient","Visits or Returns to Emergency Department, Viral Load or Clearance, Fever, SpO2","Corticosteroids, SOC",478
"NCT04365582","https://clinicaltrials.gov/show/NCT04365582",NA,"France","Paris","2020-Apr",NA,"Recruiting","Randomised","Open-Label",4,NA,"Outpatient",NA,"AZT, HCQ, LPV/r, SOC",640
"2020-001435-27","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001435-27/FR/",NA,"France","Paris","2020-Apr",NA,"Recruiting","Randomised","Open-Label",5,NA,"Outpatient","Mortality, Hospitalization, Treatment-emergent Adverse Events","ARBs, FPV, HCQ, Imatinib",NA
"NCT04357990","https://ClinicalTrials.gov/show/NCT04357990",NA,"Iceland","Reykjavik","2020-Apr","2020-Jul","Recruiting","Randomised","Triple",3,NA,"Outpatient","Hospitalization, Cough, Fever, Dyspnea, Other Mild Symptoms, Adverse Events","Alternative therapy, SOC",81
"NCT04365738","https://ClinicalTrials.gov/show/NCT04365738",NA,"Turkey","Istanbul","2020-Apr","2020-Apr","Completed","Randomised","Single",2,NA,"Outpatient","Dyspnea, Other Mild Symptoms, Depression, Anxiety","Education, Non-invasive respiratory support",270
"IRCT20200403046926N1","http://en.irct.ir/trial/46926",NA,"Iran","Tehran","2020-Apr","2020-May","Completed","Randomised","Open-Label",2,NA,"Outpatient","Hospitalization, C-Reactive Protein","HCQ, HCQ + LPV/r",60
"NCT04370782","https://ClinicalTrials.gov/show/NCT04370782",NA,"United States","New York","2020-May","2020-Sep","Recruiting","Randomised","Open-Label",4,NA,"Outpatient","ICU Admission, Hospitalization, Adverse Events","HCQ + AZT + Zinc, HCQ + Zinc + Antibiotics",750
"IRCT20200413047053N1","http://en.irct.ir/trial/47139",NA,"Iran","Tehran","2020-Apr","2020-Jul","Recruiting","Randomised","Double",3,NA,"Outpatient","C-Reactive Protein","Alternative therapy, SOC",60
"NCT04371107","https://ClinicalTrials.gov/show/NCT04371107",NA,"France","Paris","2020-May","2020-Jun","Not Recruiting","Randomised","Open-Label",2,NA,"Outpatient",NA,"AZT, SOC",64
"IRCT20081019001369N2","http://en.irct.ir/trial/46868",NA,"Iran","Tehran","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,NA,"Outpatient","Clinical Improvement Score (Any), Fever, C-Reactive Protein","Alternative therapy, SOC",40
"NCT04353284","https://ClinicalTrials.gov/show/NCT04353284",NA,"United States","Connecticut","2020-Apr","2021-May","Recruiting","Randomised","Quadruple",2,NA,"Outpatient","Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Other Mild Symptoms","Other, SOC",114
"IRCT20081019001369N3","http://en.irct.ir/trial/46978",NA,"Iran","Tehran","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,NA,"Outpatient","Clinical Improvement Score (Any), Fever, C-Reactive Protein","Alternative therapy, SOC",40
"NCT04371952","https://ClinicalTrials.gov/show/NCT04371952",NA,"France","Paris","2020-May","2020-Dec","Not Recruiting","Randomised","Double",2,NA,"Outpatient","Mortality, ICU Admission, Hospitalization","Antibiotics, SOC",330
"IRCT20200415047089N1","http://en.irct.ir/trial/47234",NA,"Iran","Markazi","2020-Apr","2020-May","Completed","Randomised","Single",2,NA,"Outpatient","Hospitalization, Other Mild Symptoms","Alternative therapy, SOC",100
"IRCT20200406046965N1","http://en.irct.ir/trial/46958",NA,"Iran","Tehran","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,NA,"Outpatient","Cough, Fever, Dyspnea, Other Mild Symptoms, C-Reactive Protein","Alternative therapy, SOC",40
"NCT04359329","https://clinicaltrials.gov/show/NCT04359329",NA,"United States","Washington, Dc","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,NA,"Outpatient","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","Estrogen steroid hormone, SOC",110
"NCT04346628","https://ClinicalTrials.gov/show/NCT04346628",NA,"United States","California","2020-Apr","2021-Jul","Not Recruiting","Randomised","Double",3,NA,"Outpatient","Clinical Improvement Score (Any), Viral Load or Clearance, Other Mild Symptoms, Anti SARS-COV-2 Titers","FPV, SOC",120
"NCT04342663","https://ClinicalTrials.gov/show/NCT04342663",NA,"United States","Illinois","2020-Apr","2020-Aug","Recruiting","Randomised","Triple",2,NA,"Outpatient","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Troponin","SOC, SSRIs",152
"NCT04342663","https://ClinicalTrials.gov/show/NCT04342663",NA,"United States","Missouri","2020-Apr","2020-Aug","Recruiting","Randomised","Triple",2,NA,"Outpatient","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Troponin","SOC, SSRIs",152
"NCT04353271","https://ClinicalTrials.gov/show/NCT04353271",NA,"United States","Alabama","2020-Apr","2020-Jul","Not Recruiting","Randomised","Quadruple",2,NA,"Outpatient","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Anti SARS-COV-2 Titers, Antibodies","HCQ, SOC",58
"NCT04358068","https://ClinicalTrials.gov/show/NCT04358068",NA,"United States","Alabama","2020-Apr","2020-Jul","Not Recruiting","Randomised","Double",4,NA,"Outpatient","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Other Mild Symptoms, Treatment-emergent Adverse Events, Cardiac Outcome (Unspecified)","HCQ + AZT, SOC",20
"NCT04358068","https://ClinicalTrials.gov/show/NCT04358068",NA,"United States","California","2020-Apr","2020-Jul","Not Recruiting","Randomised","Double",4,NA,"Outpatient","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Other Mild Symptoms, Treatment-emergent Adverse Events, Cardiac Outcome (Unspecified)","HCQ + AZT, SOC",20
"NCT04358068","https://ClinicalTrials.gov/show/NCT04358068",NA,"United States","District Of Columbia","2020-Apr","2020-Jul","Not Recruiting","Randomised","Double",4,NA,"Outpatient","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Other Mild Symptoms, Treatment-emergent Adverse Events, Cardiac Outcome (Unspecified)","HCQ + AZT, SOC",20
"NCT04358068","https://ClinicalTrials.gov/show/NCT04358068",NA,"United States","Illinois","2020-Apr","2020-Jul","Not Recruiting","Randomised","Double",4,NA,"Outpatient","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Other Mild Symptoms, Treatment-emergent Adverse Events, Cardiac Outcome (Unspecified)","HCQ + AZT, SOC",20
"NCT04358068","https://ClinicalTrials.gov/show/NCT04358068",NA,"United States","North Carolina","2020-Apr","2020-Jul","Not Recruiting","Randomised","Double",4,NA,"Outpatient","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Other Mild Symptoms, Treatment-emergent Adverse Events, Cardiac Outcome (Unspecified)","HCQ + AZT, SOC",20
"NCT04358068","https://ClinicalTrials.gov/show/NCT04358068",NA,"United States","Ohio","2020-Apr","2020-Jul","Not Recruiting","Randomised","Double",4,NA,"Outpatient","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Other Mild Symptoms, Treatment-emergent Adverse Events, Cardiac Outcome (Unspecified)","HCQ + AZT, SOC",20
"NCT04358068","https://ClinicalTrials.gov/show/NCT04358068",NA,"United States","Pennsylvania","2020-Apr","2020-Jul","Not Recruiting","Randomised","Double",4,NA,"Outpatient","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Other Mild Symptoms, Treatment-emergent Adverse Events, Cardiac Outcome (Unspecified)","HCQ + AZT, SOC",20
"NCT04358068","https://ClinicalTrials.gov/show/NCT04358068",NA,"United States","Texas","2020-Apr","2020-Jul","Not Recruiting","Randomised","Double",4,NA,"Outpatient","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Other Mild Symptoms, Treatment-emergent Adverse Events, Cardiac Outcome (Unspecified)","HCQ + AZT, SOC",20
"NCT04358068","https://ClinicalTrials.gov/show/NCT04358068",NA,"United States","Washington","2020-Apr","2020-Jul","Not Recruiting","Randomised","Double",4,NA,"Outpatient","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Other Mild Symptoms, Treatment-emergent Adverse Events, Cardiac Outcome (Unspecified)","HCQ + AZT, SOC",20
"NCT04365231","https://ClinicalTrials.gov/show/NCT04365231",NA,"France","Paris","2020-Apr","2020-Jun","Not Recruiting","Randomised","Open-Label",2,NA,"Outpatient","ICU Admission, Hospitalization","HCQ + AZT, SOC",50
"IRCT20200404046933N1","http://en.irct.ir/trial/46893",NA,"Iran","Tehran","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,NA,"Outpatient","Clinical Improvement Score (Any), C-Reactive Protein","Alternative therapy, SOC",40
"IRCT20081019001369N4","http://en.irct.ir/trial/46977",NA,"Iran","Tehran","2020-Apr","2020-Jul","Recruiting","Randomised","Double",2,NA,"Outpatient","Clinical Improvement Score (Any), Fever, C-Reactive Protein","Antibiotics, SOC",40
"NCT04368923","https://ClinicalTrials.gov/show/NCT04368923",NA,"Egypt","Cairo","2020-Apr","2020-Jun","Not Recruiting","Randomised","Single",2,NA,"Outpatient","Blood Gas, Blood Pressure, Heart Rate, SpO2, Respiratory Rate, Blood pH","Non-invasive respiratory support, SOC",60
"2020-001622-64","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001622-64/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,NA,"Outpatient","ICU Admission, Hospitalization, Blood Gas, ECG, SpO2, Radiographic Findings","Corticosteroids, SOC",NA
"NCT04355767","https://ClinicalTrials.gov/show/NCT04355767",NA,"United States","California","2020-Apr","2022-Dec","Not Recruiting","Randomised","Double",2,NA,"Outpatient","ICU Admission, Hospitalization, Clinical Improvement Score (Any), Fever, Dyspnea, Other Mild Symptoms","Plasma based therapy, SOC",600
"NCT04355767","https://ClinicalTrials.gov/show/NCT04355767",NA,"United States","Michigan","2020-Apr","2022-Dec","Not Recruiting","Randomised","Double",2,NA,"Outpatient","ICU Admission, Hospitalization, Clinical Improvement Score (Any), Fever, Dyspnea, Other Mild Symptoms","Plasma based therapy, SOC",600
"NCT04355767","https://ClinicalTrials.gov/show/NCT04355767",NA,"United States","Pennsylvania","2020-Apr","2022-Dec","Not Recruiting","Randomised","Double",2,NA,"Outpatient","ICU Admission, Hospitalization, Clinical Improvement Score (Any), Fever, Dyspnea, Other Mild Symptoms","Plasma based therapy, SOC",600
"NCT04355767","https://ClinicalTrials.gov/show/NCT04355767",NA,"United States","South Carolina","2020-Apr","2022-Dec","Not Recruiting","Randomised","Double",2,NA,"Outpatient","ICU Admission, Hospitalization, Clinical Improvement Score (Any), Fever, Dyspnea, Other Mild Symptoms","Plasma based therapy, SOC",600
"NCT04361214","https://ClinicalTrials.gov/show/NCT04361214",NA,"United States","Illinois","2020-Apr","2020-Jul","Recruiting","Single-Arm","Open-Label",1,NA,"Outpatient","Hospitalization, Clinical Improvement Score (Any), Fever, Other Mild Symptoms, Adverse Events","DMARD",20
"IRCT20200408046990N1","http://en.irct.ir/trial/47061",NA,"Iran","Tehran","2020-Apr","2020-Sep","Recruiting","Non-Randomised","Open-Label",2,NA,"Outpatient","Hospitalization, Cough, Fever, Other Mild Symptoms, Adverse Events, Radiographic Findings","Alternative therapy",60
"NCT04356495","https://ClinicalTrials.gov/show/NCT04356495",NA,"France","Paris","2020-Apr","2020-Dec","Recruiting","Randomised","Open-Label",5,NA,"Outpatient","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, Creatinine Phosphokinase, Procalcitonin, Prothrombin, ALT, LDH, Bicarbonates, Quality of Life","Antihypertensive, FPV, HCQ, Other, SOC",845
"NCT04354428","https://ClinicalTrials.gov/show/NCT04354428",NA,"United States","Illinois","2020-Apr","2020-Jul","Recruiting","Randomised","Double",4,NA,"Outpatient","Mortality, Hospitalization, Viral Load or Clearance, Serious or Seconday Infections, Adverse Events, Serious Adverse Events","HCQ, HCQ + AZT, SOC",630
"NCT04354428","https://ClinicalTrials.gov/show/NCT04354428",NA,"United States","Louisiana","2020-Apr","2020-Jul","Recruiting","Randomised","Double",4,NA,"Outpatient","Mortality, Hospitalization, Viral Load or Clearance, Serious or Seconday Infections, Adverse Events, Serious Adverse Events","HCQ, HCQ + AZT, SOC",630
"NCT04354428","https://ClinicalTrials.gov/show/NCT04354428",NA,"United States","Massachusetts","2020-Apr","2020-Jul","Recruiting","Randomised","Double",4,NA,"Outpatient","Mortality, Hospitalization, Viral Load or Clearance, Serious or Seconday Infections, Adverse Events, Serious Adverse Events","HCQ, HCQ + AZT, SOC",630
"NCT04354428","https://ClinicalTrials.gov/show/NCT04354428",NA,"United States","New York","2020-Apr","2020-Jul","Recruiting","Randomised","Double",4,NA,"Outpatient","Mortality, Hospitalization, Viral Load or Clearance, Serious or Seconday Infections, Adverse Events, Serious Adverse Events","HCQ, HCQ + AZT, SOC",630
"NCT04354428","https://ClinicalTrials.gov/show/NCT04354428",NA,"United States","Washington","2020-Apr","2020-Jul","Recruiting","Randomised","Double",4,NA,"Outpatient","Mortality, Hospitalization, Viral Load or Clearance, Serious or Seconday Infections, Adverse Events, Serious Adverse Events","HCQ, HCQ + AZT, SOC",630
"NCT04360759","https://clinicaltrials.gov/show/NCT04360759",NA,"South Africa","Pretoria","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",2,NA,"Outpatient",NA,"HCQ, SOC",560
"NCT04345991","https://ClinicalTrials.gov/show/NCT04345991",NA,"France","Paris","2020-Apr","2020-May","Recruiting","Randomised","Open-Label",2,NA,"Outpatient","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Ferritin, IL-6, D-Dimer, Creatinine Phosphokinase, Myoglobin, Troponin, Procalcitonin, Fibrinogen, Coagulation Test, Triglycerides, Electrolytes, Albumin, LDH, Urine Sample, PaO2-FiO2, Respiratory Rate","Plasma based therapy, SOC",120
"NCT04340544","https://ClinicalTrials.gov/show/NCT04340544",NA,"Germany","Berlin","2020-Apr","2021-Nov","Recruiting","Randomised","Quadruple",2,NA,"Outpatient","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6",NA,2700
"NCT04344548","https://clinicaltrials.gov/show/NCT04344548",NA,"Colombia","Bogota","2020-Oct",NA,"Not Recruiting","Single-Arm","Open-Label",1,NA,"Outpatient","ICU Admission, Hospitalization, Hospital Discharge, Viral Load or Clearance, Household Members with CoViD-19, Labor Absenteeism, Adverse Events, Treatment-emergent Adverse Events",NA,10
"2020-001678-31","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001678-31/FR/",NA,"France","Paris","2020-Apr",NA,"Recruiting","Randomised","Single",2,"Negative","Healthy Unexposed, Healthy Exposed, Healthcare Workers","ICU Admission, Hospitalization, Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Anti SARS-COV-2 Titers","SOC, Vaccine",NA
"NCT04438837","https://ClinicalTrials.gov/show/NCT04438837",NA,"Israel","Haifa","2020-Jun","2022-Jun","Not Recruiting","Randomised","Open-Label",2,"Healthy","Healthy Exposed, Healthcare Workers","Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Adverse Events","HCQ, SOC",582
"NCT04384549","https://clinicaltrials.gov/show/NCT04384549",NA,"France","Paris","2020-Jun",NA,"Not Recruiting","Randomised","Single",2,"Healthy","Healthy Exposed, Healthcare Workers",NA,"SOC, Vaccine",1120
"NCT04387409","https://clinicaltrials.gov/show/NCT04387409",NA,"Germany","Berlin","2020-Nov",NA,"Recruiting","Randomised","Triple",2,"Healthy","Healthy Exposed, Healthcare Workers",NA,"SOC, Vaccine",1200
"NCT04437693","https://ClinicalTrials.gov/show/NCT04437693",NA,"Qatar","Doha","2020-Jun","2021-Jun","Not Recruiting","Randomised","Double",2,"Healthy","Healthy Exposed, Healthcare Workers",NA,"HCQ, SOC",500
"NCT04435808","https://ClinicalTrials.gov/show/NCT04435808",NA,"United States","New Mexico","2020-Jun","2021-Apr","Recruiting","Non-Randomised","Open-Label",2,"Healthy","Healthy Exposed, Healthcare Workers","ICU Admission, Hospitalization","HCQ, SOC",350
"NCT04372017","https://ClinicalTrials.gov/show/NCT04372017",NA,"United States","South Dakota","2020-May","2022-Apr","Recruiting","Randomised","Double",4,NA,"Healthy Exposed, Healthcare Workers",NA,"HCQ, Vitamins",1739
"IRCT20130306012728N8","http://en.irct.ir/trial/46932",NA,"Iran","East Azarbaijan","2020-Apr",NA,"Recruiting","Randomised","Double",2,NA,"Healthy Exposed, Healthcare Workers","Mortality, Hospitalization, Viral Load or Clearance","HCQ, SOC",500
"IRCT20200401046909N2","http://en.irct.ir/trial/47010",NA,"Iran","Tehran","2020-Apr","2020-Oct","Recruiting","Randomised","Double",2,NA,"Healthy Exposed, Healthcare Workers","Cough, Fever, Dyspnea, Radiographic Findings","SOC, Vitamins",540
"NCT04334928","https://ClinicalTrials.gov/show/NCT04334928",NA,"Spain","Madrid","2020-Apr","2020-Jun","Recruiting","Randomised","Double",4,"Healthy","Healthcare Workers","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","HCQ, HCQ + NRTIs, NRTIs, SOC",4000
"NCT04334928","https://ClinicalTrials.gov/show/NCT04334928",NA,"Spain","Alicante","2020-Apr","2020-Jun","Recruiting","Randomised","Double",4,"Healthy","Healthcare Workers","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","HCQ, HCQ + NRTIs, NRTIs, SOC",4000
"NCT04334928","https://ClinicalTrials.gov/show/NCT04334928",NA,"Spain","Asturias","2020-Apr","2020-Jun","Recruiting","Randomised","Double",4,"Healthy","Healthcare Workers","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","HCQ, HCQ + NRTIs, NRTIs, SOC",4000
"NCT04334928","https://ClinicalTrials.gov/show/NCT04334928",NA,"Spain","Barcelona","2020-Apr","2020-Jun","Recruiting","Randomised","Double",4,"Healthy","Healthcare Workers","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","HCQ, HCQ + NRTIs, NRTIs, SOC",4000
"NCT04334928","https://ClinicalTrials.gov/show/NCT04334928",NA,"Spain","Las Palmas","2020-Apr","2020-Jun","Recruiting","Randomised","Double",4,"Healthy","Healthcare Workers","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","HCQ, HCQ + NRTIs, NRTIs, SOC",4000
"NCT04334928","https://ClinicalTrials.gov/show/NCT04334928",NA,"Spain","La Rioja","2020-Apr","2020-Jun","Recruiting","Randomised","Double",4,"Healthy","Healthcare Workers","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","HCQ, HCQ + NRTIs, NRTIs, SOC",4000
"NCT04334928","https://ClinicalTrials.gov/show/NCT04334928",NA,"Spain","Murcia","2020-Apr","2020-Jun","Recruiting","Randomised","Double",4,"Healthy","Healthcare Workers","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","HCQ, HCQ + NRTIs, NRTIs, SOC",4000
"NCT04334928","https://ClinicalTrials.gov/show/NCT04334928",NA,"Spain","Navarra","2020-Apr","2020-Jun","Recruiting","Randomised","Double",4,"Healthy","Healthcare Workers","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","HCQ, HCQ + NRTIs, NRTIs, SOC",4000
"NCT04334928","https://ClinicalTrials.gov/show/NCT04334928",NA,"Spain","Valencia","2020-Apr","2020-Jun","Recruiting","Randomised","Double",4,"Healthy","Healthcare Workers","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","HCQ, HCQ + NRTIs, NRTIs, SOC",4000
"NCT04334928","https://ClinicalTrials.gov/show/NCT04334928",NA,"Spain","Alava","2020-Apr","2020-Jun","Recruiting","Randomised","Double",4,"Healthy","Healthcare Workers","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","HCQ, HCQ + NRTIs, NRTIs, SOC",4000
"NCT04334928","https://ClinicalTrials.gov/show/NCT04334928",NA,"Spain","Albacete","2020-Apr","2020-Jun","Recruiting","Randomised","Double",4,"Healthy","Healthcare Workers","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","HCQ, HCQ + NRTIs, NRTIs, SOC",4000
"NCT04334928","https://ClinicalTrials.gov/show/NCT04334928",NA,"Spain","Burgos","2020-Apr","2020-Jun","Recruiting","Randomised","Double",4,"Healthy","Healthcare Workers","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","HCQ, HCQ + NRTIs, NRTIs, SOC",4000
"NCT04334928","https://ClinicalTrials.gov/show/NCT04334928",NA,"Spain","Cuenca","2020-Apr","2020-Jun","Recruiting","Randomised","Double",4,"Healthy","Healthcare Workers","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","HCQ, HCQ + NRTIs, NRTIs, SOC",4000
"NCT04334928","https://ClinicalTrials.gov/show/NCT04334928",NA,"Spain","Granada","2020-Apr","2020-Jun","Recruiting","Randomised","Double",4,"Healthy","Healthcare Workers","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","HCQ, HCQ + NRTIs, NRTIs, SOC",4000
"NCT04334928","https://ClinicalTrials.gov/show/NCT04334928",NA,"Spain","Palencia","2020-Apr","2020-Jun","Recruiting","Randomised","Double",4,"Healthy","Healthcare Workers","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","HCQ, HCQ + NRTIs, NRTIs, SOC",4000
"NCT04334928","https://ClinicalTrials.gov/show/NCT04334928",NA,"Spain","Salamanca","2020-Apr","2020-Jun","Recruiting","Randomised","Double",4,"Healthy","Healthcare Workers","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","HCQ, HCQ + NRTIs, NRTIs, SOC",4000
"NCT04334928","https://ClinicalTrials.gov/show/NCT04334928",NA,"Spain","Segovia","2020-Apr","2020-Jun","Recruiting","Randomised","Double",4,"Healthy","Healthcare Workers","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","HCQ, HCQ + NRTIs, NRTIs, SOC",4000
"NCT04334928","https://ClinicalTrials.gov/show/NCT04334928",NA,"Spain","Sevilla","2020-Apr","2020-Jun","Recruiting","Randomised","Double",4,"Healthy","Healthcare Workers","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","HCQ, HCQ + NRTIs, NRTIs, SOC",4000
"NCT04334928","https://ClinicalTrials.gov/show/NCT04334928",NA,"Spain","Valladolid","2020-Apr","2020-Jun","Recruiting","Randomised","Double",4,"Healthy","Healthcare Workers","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","HCQ, HCQ + NRTIs, NRTIs, SOC",4000
"NCT04334928","https://ClinicalTrials.gov/show/NCT04334928",NA,"Spain","Zaragoza","2020-Apr","2020-Jun","Recruiting","Randomised","Double",4,"Healthy","Healthcare Workers","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","HCQ, HCQ + NRTIs, NRTIs, SOC",4000
"NCT04336748","https://ClinicalTrials.gov/show/NCT04336748",NA,"Austria","Vienna","2020-Apr","2020-Jul","Not Recruiting","Randomised","Triple",2,"Healthy","Healthcare Workers","Viral Load or Clearance, Labor Absenteeism",NA,440
"NCT04344379","https://ClinicalTrials.gov/show/NCT04344379",NA,"France","Paris","2020-Apr","2020-Jul","Recruiting","Randomised","Double",3,"No","Healthcare Workers","Viral Load or Clearance","AZT, HCQ, SOC",900
"NCT04349371","https://ClinicalTrials.gov/show/NCT04349371",NA,"United States","New York","2020-Apr","2021-Apr","Recruiting","Randomised","Quadruple",2,"No","Healthcare Workers","Viral Load or Clearance, Serious Adverse Events","HCQ, SOC",350
"NCT04348370","https://ClinicalTrials.gov/show/NCT04348370",NA,"United States","California","2020-Apr","2021-May","Recruiting","Randomised","Double",2,"No","Healthcare Workers","Clinical Improvement Score (Any), Viral Load or Clearance","SOC, Vaccine",1800
"NCT04348370","https://ClinicalTrials.gov/show/NCT04348370",NA,"United States","Texas","2020-Apr","2021-May","Recruiting","Randomised","Double",2,"No","Healthcare Workers","Clinical Improvement Score (Any), Viral Load or Clearance","SOC, Vaccine",1800
"NCT04350931","https://ClinicalTrials.gov/show/NCT04350931",NA,"Egypt","Cairo","2020-Apr","2020-Oct","Not Recruiting","Randomised","Single",2,"No","Healthcare Workers","Viral Load or Clearance","SOC, Vaccine",900
"NCT04345653","https://ClinicalTrials.gov/show/NCT04345653",NA,"United States","New Jersey","2020-Apr","2020-Jun","Not Recruiting","Single-Arm","Open-Label",1,"No","Healthcare Workers","Viral Load or Clearance, Adverse Events, Serious Adverse Events","HCQ",44
"NCT04349631","https://ClinicalTrials.gov/show/NCT04349631",NA,"United States","Texas","2020-Apr","2020-Dec","Recruiting","Single-Arm","Open-Label",1,"No","Healthcare Workers","Hospitalization, Cough, Fever, Dyspnea, Serious or Seconday Infections, C-Reactive Protein, IL-6, IL-10, Tumor Necrosis Factor (Any), White Blood Cell Count, Monocyte Count, Lymphocyte Count, Neutrophils, Platelet Count, Hemoglobin, Prothrombin, Electrolytes, INR, ALT, AST, Albumin, Bilirubin, Glucose, Blood Urea Nitrogen, Blood Gas, Quality of Life, Depression, Renal Outcome (Unspecified)","Stem cells",56
"NCT04348435","https://ClinicalTrials.gov/show/NCT04348435",NA,"United States","Texas","2020-Apr","2020-Dec","Recruiting","Randomised","Quadruple",4,"No","Healthcare Workers","Hospitalization, Labor Absenteeism, IL-6, IL-10, Tumor Necrosis Factor (Any), Monocyte Count, Neutrophils, Platelet Count, Hemoglobin, Prothrombin, INR, Albumin, Bilirubin, Glucose, Blood Urea Nitrogen","SOC, Stem cells",100
"NCT04349228","https://ClinicalTrials.gov/show/NCT04349228",NA,"Tunisia","Tunis","2020-Apr","2020-Jul","Recruiting","Randomised","Single",2,"No","Healthcare Workers","Viral Load or Clearance, Cough, Fever, Dyspnea, Other Mild Symptoms, Renal Outcome (Unspecified)","HCQ, SOC",530
"NCT04334148","https://ClinicalTrials.gov/show/NCT04334148",NA,"United States","Florida","2020-Apr","2020-Jul","Recruiting","Randomised","Triple",2,"Healthy","Healthcare Workers","Viral Load or Clearance, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","HCQ, SOC",15000
"NCT04334148","https://ClinicalTrials.gov/show/NCT04334148",NA,"United States","Kansas","2020-Apr","2020-Jul","Recruiting","Randomised","Triple",2,"Healthy","Healthcare Workers","Viral Load or Clearance, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","HCQ, SOC",15000
"NCT04334148","https://ClinicalTrials.gov/show/NCT04334148",NA,"United States","Louisiana","2020-Apr","2020-Jul","Recruiting","Randomised","Triple",2,"Healthy","Healthcare Workers","Viral Load or Clearance, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","HCQ, SOC",15000
"NCT04334148","https://ClinicalTrials.gov/show/NCT04334148",NA,"United States","Maryland","2020-Apr","2020-Jul","Recruiting","Randomised","Triple",2,"Healthy","Healthcare Workers","Viral Load or Clearance, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","HCQ, SOC",15000
"NCT04334148","https://ClinicalTrials.gov/show/NCT04334148",NA,"United States","Minnesota","2020-Apr","2020-Jul","Recruiting","Randomised","Triple",2,"Healthy","Healthcare Workers","Viral Load or Clearance, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","HCQ, SOC",15000
"NCT04334148","https://ClinicalTrials.gov/show/NCT04334148",NA,"United States","Missouri","2020-Apr","2020-Jul","Recruiting","Randomised","Triple",2,"Healthy","Healthcare Workers","Viral Load or Clearance, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","HCQ, SOC",15000
"NCT04334148","https://ClinicalTrials.gov/show/NCT04334148",NA,"United States","New York","2020-Apr","2020-Jul","Recruiting","Randomised","Triple",2,"Healthy","Healthcare Workers","Viral Load or Clearance, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","HCQ, SOC",15000
"NCT04334148","https://ClinicalTrials.gov/show/NCT04334148",NA,"United States","North Carolina","2020-Apr","2020-Jul","Recruiting","Randomised","Triple",2,"Healthy","Healthcare Workers","Viral Load or Clearance, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","HCQ, SOC",15000
"NCT04334148","https://ClinicalTrials.gov/show/NCT04334148",NA,"United States","Tennessee","2020-Apr","2020-Jul","Recruiting","Randomised","Triple",2,"Healthy","Healthcare Workers","Viral Load or Clearance, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","HCQ, SOC",15000
"NCT04334148","https://ClinicalTrials.gov/show/NCT04334148",NA,"United States","Texas","2020-Apr","2020-Jul","Recruiting","Randomised","Triple",2,"Healthy","Healthcare Workers","Viral Load or Clearance, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","HCQ, SOC",15000
"NCT04334148","https://ClinicalTrials.gov/show/NCT04334148",NA,"United States","Washington","2020-Apr","2020-Jul","Recruiting","Randomised","Triple",2,"Healthy","Healthcare Workers","Viral Load or Clearance, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","HCQ, SOC",15000
"NCT04334148","https://ClinicalTrials.gov/show/NCT04334148",NA,"United States","Wisconsin","2020-Apr","2020-Jul","Recruiting","Randomised","Triple",2,"Healthy","Healthcare Workers","Viral Load or Clearance, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events","HCQ, SOC",15000
"NCT04335084","https://ClinicalTrials.gov/show/NCT04335084",NA,"United States","California","2020-Apr","2021-Jun","Recruiting","Single-Arm","Double",2,"Healthy","Healthcare Workers","Viral Load or Clearance, Cough, Fever, Dyspnea, Other Mild Symptoms, Adverse Events, Serious Adverse Events","HCQ + Vitamins + Zinc, SOC",600
"2020-001441-39","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001441-39/GB/",NA,"United Kingdom","London","2020-Apr",NA,"Recruiting","Randomised","Double",2,"Healthy","Healthcare Workers",NA,"HCQ, SOC",40000
"2020-001704-42","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001704-42/ES/",NA,"Spain","Madrid","2020-May",NA,"Recruiting","Randomised","Double",2,"Healthy","Healthcare Workers",NA,"HCQ, SOC",NA
"CHICTR2000030432","http://www.chictr.org.cn/showproj.aspx?proj=50268",NA,"China","Fujian","2020-Mar","2020-Aug","Not Recruiting","Randomised","Open-Label",2,"Healthy (Exposed)","Healthcare Workers","Quality of Life","Respiratory support, SOC",80
"NCT04347889","https://ClinicalTrials.gov/show/NCT04347889",NA,"United States","New York","2020-Apr","2020-Dec","Not Recruiting","Randomised","Single",2,"Negative","Healthcare Workers","Hospitalization, Anti SARS-COV-2 Titers","HCQ, Vitamins",1212
"NCT04333225","https://ClinicalTrials.gov/show/NCT04333225",NA,"United States","Texas","2020-Apr","2020-Jul","Not Recruiting","Non-Randomised","Open-Label",2,"Exposed","Healthcare Workers","Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Dyspnea, C-Reactive Protein, IL-6, Tumor Necrosis Factor (Any), Radiographic Findings","HCQ, SOC",228
"NCT04333732","https://ClinicalTrials.gov/show/NCT04333732",NA,"United States","Missouri","2020-Apr","2021-Feb","Not Recruiting","Randomised","Double",4,"Healthy (Exposed)","Healthcare Workers",NA,"HCQ, SOC",55000
"NCT04333732","https://ClinicalTrials.gov/show/NCT04333732",NA,"Canada","Ontario","2020-Apr","2021-Feb","Not Recruiting","Randomised","Double",4,"Healthy (Exposed)","Healthcare Workers",NA,"HCQ, SOC",55000
"NCT04333732","https://ClinicalTrials.gov/show/NCT04333732",NA,"Ireland","Dublin","2020-Apr","2021-Feb","Not Recruiting","Randomised","Double",4,"Healthy (Exposed)","Healthcare Workers",NA,"HCQ, SOC",55000
"NCT04333732","https://ClinicalTrials.gov/show/NCT04333732",NA,"South Africa","Pretoria","2020-Apr","2021-Feb","Not Recruiting","Randomised","Double",4,"Healthy (Exposed)","Healthcare Workers",NA,"HCQ, SOC",55000
"NCT04333732","https://ClinicalTrials.gov/show/NCT04333732",NA,"South Africa","Gauteng","2020-Apr","2021-Feb","Not Recruiting","Randomised","Double",4,"Healthy (Exposed)","Healthcare Workers",NA,"HCQ, SOC",55000
"NCT04333732","https://ClinicalTrials.gov/show/NCT04333732",NA,"South Africa","Western Cape","2020-Apr","2021-Feb","Not Recruiting","Randomised","Double",4,"Healthy (Exposed)","Healthcare Workers",NA,"HCQ, SOC",55000
"NCT04333732","https://ClinicalTrials.gov/show/NCT04333732",NA,"United Kingdom","London","2020-Apr","2021-Feb","Not Recruiting","Randomised","Double",4,"Healthy (Exposed)","Healthcare Workers",NA,"HCQ, SOC",55000
"NCT04333732","https://ClinicalTrials.gov/show/NCT04333732",NA,"Zambia","Lusaka","2020-Apr","2021-Feb","Not Recruiting","Randomised","Double",4,"Healthy (Exposed)","Healthcare Workers",NA,"HCQ, SOC",55000
"NCT04328467","https://ClinicalTrials.gov/show/NCT04328467",NA,"United States","Minnesota","2020-Mar","2020-Aug","Not Recruiting","Randomised","Quadruple",3,"Healthy (Exposed)","Healthcare Workers",NA,"HCQ, SOC",1500
"NCT04320238","https://ClinicalTrials.gov/show/NCT04320238",NA,"China","Hubei","2020-Mar","2020-May","Recruiting","Non-Randomised","Open-Label",2,"Healthy (Exposed)","Healthcare Workers","Viral Load or Clearance, Cough, Fever, Dyspnea, Other Mild Symptoms, Adverse Events, Treatment-emergent Adverse Events","IFN, IFN + Other",2944
"2020-000919-69","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000919-69/NL/",NA,"Netherlands","Amsterdam","2020-Mar",NA,"Recruiting","Randomised","Double",2,"Healthy (Exposed)","Healthcare Workers","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS","SOC, Vaccine",NA
"NCT04318015","https://ClinicalTrials.gov/show/NCT04318015",NA,"Mexico","Mexico","2020-Mar","2020-Dec","Recruiting","Randomised","Quadruple",2,"Healthy (Exposed)","Healthcare Workers","Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Cough, Fever, Dyspnea, Other Mild Symptoms","HCQ, SOC",400
"NCT04312243","https://ClinicalTrials.gov/show/NCT04312243",NA,"United States","Massachusetts","2020-Mar","2021-Apr","Recruiting","Randomised","Open-Label",2,"Healthy (Exposed)","Healthcare Workers","Viral Load or Clearance, Labor Absenteeism","Non-invasive respiratory support, SOC",470
"CHICTR2000030013","http://www.chictr.org.cn/showproj.aspx?proj=49796",NA,"China","Beijing","2020-Feb","2020-Jun","Not Recruiting","Non-Randomised","Unspecified",2,"Healthy (Exposed)","Healthcare Workers","Pneumonia or ARDS, Cough, Fever, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Radiographic Findings","IFN, SOC",450
"NCT04327206","https://ClinicalTrials.gov/show/NCT04327206",NA,"Australia","New South Wales","2020-Mar","2020-Oct","Recruiting","Randomised","Double",2,"Healthy (Exposed)","Healthcare Workers","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Adverse Events","Vaccine",10078
"NCT04327206","https://ClinicalTrials.gov/show/NCT04327206",NA,"Australia","South Australia","2020-Mar","2020-Oct","Recruiting","Randomised","Double",2,"Healthy (Exposed)","Healthcare Workers","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Adverse Events","Vaccine",10078
"NCT04327206","https://ClinicalTrials.gov/show/NCT04327206",NA,"Australia","Victoria","2020-Mar","2020-Oct","Recruiting","Randomised","Double",2,"Healthy (Exposed)","Healthcare Workers","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Adverse Events","Vaccine",10078
"NCT04327206","https://ClinicalTrials.gov/show/NCT04327206",NA,"Australia","Western Australia","2020-Mar","2020-Oct","Recruiting","Randomised","Double",2,"Healthy (Exposed)","Healthcare Workers","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Adverse Events","Vaccine",10078
"ACTRN12620000417987","https://anzctr.org.au/ACTRN12620000417987.aspx",NA,"Australia","Canberra","2020-Mar",NA,"Recruiting","Randomised","Open-Label",1,"Healthy (Exposed)","Healthcare Workers","Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Cough, Fever, Dyspnea, Other Mild Symptoms","HCQ",680
"NCT04331834","https://ClinicalTrials.gov/show/NCT04331834",NA,"Spain","Barcelona","2020-Apr","2020-Oct","Recruiting","Randomised","Quadruple",2,"Negative","Healthcare Workers","Viral Load or Clearance, Treatment-emergent Adverse Events, Serious Adverse Events","HCQ, SOC",440
"NCT04406532","https://ClinicalTrials.gov/show/NCT04406532",NA,"United States","New York","2020-May","2021-Jan","Not Recruiting","Randomised","Single",2,"Confirmed Or Suspected","Healthcare Workers","Hospitalization, Visits or Returns to Emergency Department, Depression, Anxiety","Other",100
"NCT04386252","https://ClinicalTrials.gov/show/NCT04386252",NA,"United States","California","2020-May","2020-Dec","Not Recruiting","Randomised","Quadruple",6,"Healthy","Healthcare Workers","IgG, IgM or IgA","Vaccine",180
"NCT04328285","https://ClinicalTrials.gov/show/NCT04328285",NA,"France","Paris","2020-Mar","2020-Nov","Not Recruiting","Randomised","Triple",4,"Healthy","Healthcare Workers","Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Treatment-emergent Adverse Events","HCQ, LPV/r, SOC",1200
"NCT04379336","https://ClinicalTrials.gov/show/NCT04379336",NA,"South Africa","Western Cape","2020-May","2021-Apr","Recruiting","Randomised","Quadruple",2,"Healthy","Healthcare Workers","Mortality, ICU Admission, Hospitalization, Labor Absenteeism, Adverse Events","SOC, Vaccine",500
"NCT04328441","https://ClinicalTrials.gov/show/NCT04328441",NA,"Netherlands","Amsterdam","2020-Mar","2020-Oct","Recruiting","Randomised","Quadruple",2,"Healthy","Healthcare Workers","Mortality, ICU Admission, Hospitalization, Labor Absenteeism, Fever, Other Mild Symptoms, Anti SARS-COV-2 Titers, IgG, IgM or IgA, Antibodies","SOC, Vaccine",1500
"NCT04328441","https://ClinicalTrials.gov/show/NCT04328441",NA,"Netherlands","Gelderland","2020-Mar","2020-Oct","Recruiting","Randomised","Quadruple",2,"Healthy","Healthcare Workers","Mortality, ICU Admission, Hospitalization, Labor Absenteeism, Fever, Other Mild Symptoms, Anti SARS-COV-2 Titers, IgG, IgM or IgA, Antibodies","SOC, Vaccine",1500
"NCT04328441","https://ClinicalTrials.gov/show/NCT04328441",NA,"Netherlands","Zuid-Holland","2020-Mar","2020-Oct","Recruiting","Randomised","Quadruple",2,"Healthy","Healthcare Workers","Mortality, ICU Admission, Hospitalization, Labor Absenteeism, Fever, Other Mild Symptoms, Anti SARS-COV-2 Titers, IgG, IgM or IgA, Antibodies","SOC, Vaccine",1500
"NCT04328441","https://ClinicalTrials.gov/show/NCT04328441",NA,"Netherlands","Utrecht","2020-Mar","2020-Oct","Recruiting","Randomised","Quadruple",2,"Healthy","Healthcare Workers","Mortality, ICU Admission, Hospitalization, Labor Absenteeism, Fever, Other Mild Symptoms, Anti SARS-COV-2 Titers, IgG, IgM or IgA, Antibodies","SOC, Vaccine",1500
"2020-001888-90","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001888-90/DK/",NA,"Denmark","Copenhagen","2020-Apr",NA,"Recruiting","Randomised","Single",2,"Healthy","Healthcare Workers","Mortality, ICU Admission, Labor Absenteeism, Fever","SOC, Vaccine",NA
"2020-001783-28","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001783-28/HU/",NA,"Hungary","Budapest","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Healthy","Healthcare Workers","Mortality, ICU Admission, Labor Absenteeism, Fever","SOC, Vaccine",NA
"NCT04373291","https://clinicaltrials.gov/show/NCT04373291",NA,"Denmark","Copenhagen","2020-Jan",NA,"Not Recruiting","Randomised","Double",3,"Healthy","Healthcare Workers","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Viral Load or Clearance, Labor Absenteeism, Fever, Other Mild Symptoms","SOC, Vaccine",1500
"NCT04405999","https://ClinicalTrials.gov/show/NCT04405999",NA,"Russia","Moscow","2020-May","2020-Jun","Recruiting","Randomised","Open-Label",2,"Healthy","Healthcare Workers",NA,"Other, SOC",140
"NCT04405271","https://ClinicalTrials.gov/show/NCT04405271",NA,"Argentina","Buenos Aires","2020-May","2020-Nov","Not Recruiting","Randomised","Quadruple",2,"Healthy","Healthcare Workers","IgG, IgM or IgA","NRTIs, SOC",1378
"NCT04408183","https://clinicaltrials.gov/show/NCT04408183",NA,"United States","Washington, Dc","2020-May",NA,"Recruiting","Randomised","Triple",2,"Healthy","Healthcare Workers","Adverse Events, Radiographic Findings","Other, SOC",225
"NCT04384458","https://ClinicalTrials.gov/show/NCT04384458",NA,"Brazil","Brasilia","2020-May","2020-Oct","Not Recruiting","Randomised","Open-Label",2,"Healthy","Healthcare Workers","Adverse Events, Heart Rate, ECG","HCQ, SOC",400
"2020-001697-30","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001697-30/ES/",NA,"Spain","Madrid","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Healthy","Healthcare Workers","ICU Admission, Pneumonia or ARDS, Cough, Fever, Other Mild Symptoms, ECG","HCQ, SOC",NA
"ACTRN12620000501943","https://anzctr.org.au/ACTRN12620000501943.aspx",NA,"Australia","Canberra","2020-Apr",NA,"Recruiting","Randomised","Unspecified",2,"Healthy","Healthcare Workers",NA,"HCQ, SOC",2250
"NCT04416919","https://ClinicalTrials.gov/show/NCT04416919",NA,"United States","Oklahoma","2020-Jun","2025-May","Recruiting","Single-Arm","Open-Label",1,"Healthy","Healthcare Workers",NA,"Device",20
"NCT04427865","https://ClinicalTrials.gov/show/NCT04427865",NA,"Egypt","Cairo","2020-Jun","2020-Sep","Not Recruiting","Randomised","Open-Label",2,"Healthy","Healthcare Workers",NA,"Other",200
"NCT04421391","https://ClinicalTrials.gov/show/NCT04421391",NA,"United States","California","2020-Jun","2020-Nov","Recruiting","Single-Arm","Open-Label",1,"Healthy","Healthcare Workers","Labor Absenteeism, Serious Adverse Events","Nutrition",500
"IRCT20200411047019N1","http://en.irct.ir/trial/47279",NA,"Iran","Alborz","2020-May","2021-Jun","Recruiting","Randomised","Double",2,"Healthy (Exposed)","Healthcare Workers","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Anti SARS-COV-2 Titers","SOC, Vaccine",500
"CHICTR2000030093","http://www.chictr.org.cn/showproj.aspx?proj=49932",NA,"China","Shanxi","2020-Feb","2021-Mar","Not Recruiting","Non-Randomised","Unspecified",2,"Healthy (Exposed)","Healthcare Workers","Anxiety","Psychological therapy",60
"NCT04360122","https://ClinicalTrials.gov/show/NCT04360122",NA,"Egypt","Cairo","2020-Apr","2020-Nov","Not Recruiting","Randomised","Open-Label",3,NA,"Healthcare Workers","Viral Load or Clearance","Other",100
"2020-001331-26","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001331-26/GB/",NA,"United Kingdom","London","2020-Apr",NA,"Recruiting","Randomised","Double",3,NA,"Healthcare Workers","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Other Mild Symptoms, Adverse Events","HCQ, SOC",NA
"NCT04362124","https://ClinicalTrials.gov/show/NCT04362124",NA,"Colombia","Antioquia","2020-Apr","2021-Jun","Not Recruiting","Randomised","Quadruple",2,NA,"Healthcare Workers","Mortality, Viral Load or Clearance, Adverse Events, Serious Adverse Events","SOC, Vaccine",1000
"NCT04374942","https://ClinicalTrials.gov/show/NCT04374942",NA,"Canada","Ontario","2020-May","2020-Aug","Recruiting","Randomised","Quadruple",2,NA,"Healthcare Workers","Mortality, Hospitalization, Viral Load or Clearance, Labor Absenteeism, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Other Mild Symptoms, Adverse Events, Quality of Life, Distress","HCQ, SOC",988
"NCT04364815","https://ClinicalTrials.gov/show/NCT04364815",NA,"Philippines","Quezon","2020-Apr","2021-May","Not Recruiting","Randomised","Double",2,NA,"Healthcare Workers",NA,"HCQ, SOC",960
"NCT04371523","https://ClinicalTrials.gov/show/NCT04371523",NA,"Canada","Ontario","2020-May","2020-Jul","Not Recruiting","Randomised","Quadruple",2,NA,"Healthcare Workers","Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Adverse Events","HCQ, SOC",1100
"NCT04363450","https://ClinicalTrials.gov/show/NCT04363450",NA,"United States","Louisiana","2020-Apr","2020-Jul","Recruiting","Randomised","Quadruple",2,NA,"Healthcare Workers","Labor Absenteeism","HCQ, SOC",1700
"NCT04354870","https://ClinicalTrials.gov/show/NCT04354870",NA,"United States","New York","2020-Apr","2020-Aug","Recruiting","Non-Randomised","Open-Label",2,NA,"Healthcare Workers","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Labor Absenteeism, Other Mild Symptoms, Adverse Events, Serious Adverse Events, Anti SARS-COV-2 Titers","HCQ, SOC",350
"2020-001440-26","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001440-26/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Double",2,NA,"Healthcare Workers","Adverse Events, Anti SARS-COV-2 Titers","HCQ, SOC",NA
"NCT04346329","https://clinicaltrials.gov/show/NCT04346329",NA,"Colombia","Bogota","2020-Oct",NA,"Not Recruiting","Randomised","Double",2,NA,"Healthcare Workers","Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events","HCQ, SOC",86
"NCT04352946","https://clinicaltrials.gov/show/NCT04352946",NA,"United States","Washington, Dc","2020-Apr",NA,"Not Recruiting","Randomised","Quadruple",2,NA,"Healthcare Workers","Mortality, Hospitalization, Viral Load or Clearance, Labor Absenteeism, Adverse Events, Anti SARS-COV-2 Titers","HCQ, SOC",374
"NCT04370015","https://clinicaltrials.gov/show/NCT04370015",NA,"Pakistan","Punjab","2020-Apr",NA,"Not Recruiting","Randomised","Quadruple",2,NA,"Healthcare Workers","Labor Absenteeism, Adverse Events","HCQ, SOC",374
"NCT04354597","https://ClinicalTrials.gov/show/NCT04354597",NA,"Jordan","Amman","2020-Apr","2020-Aug","Not Recruiting","Randomised","Open-Label",2,NA,"Healthcare Workers","Mortality, ICU Admission, Viral Load or Clearance, Non-invasive Ventilation, Adverse Events","HCQ + AZT, SOC",200
"NCT04353128","https://ClinicalTrials.gov/show/NCT04353128",NA,"Spain","Madrid","2020-Apr","2020-Oct","Recruiting","Randomised","Quadruple",2,NA,"Healthcare Workers","Viral Load or Clearance","Melatonin, SOC",450
"2020-001530-35","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001530-35/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Double",2,NA,"Healthcare Workers","Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms, IgG, IgM or IgA, Radiographic Findings, Distress","Melatonin, SOC",NA
"PACTR202004693933092","https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10953",NA,"Egypt","Cairo","2020-Dec",NA,"Not Recruiting","Randomised","Unspecified",2,NA,"Healthcare Workers","Hospitalization, Viral Load or Clearance, Cough, Fever, Dyspnea, Other Mild Symptoms","SOC, Vaccine",200
"ACTRN12620000473965","https://anzctr.org.au/ACTRN12620000473965.aspx",NA,"Australia","Canberra","2020-Apr",NA,"Not Recruiting","Randomised","Open-Label",2,NA,"Healthcare Workers","Viral Load or Clearance, Other Mild Symptoms, Serious or Seconday Infections, Anti SARS-COV-2 Titers","Other, SOC",1000
"NCT04366180","https://ClinicalTrials.gov/show/NCT04366180",NA,"Spain","Granada","2020-Apr","2020-Jun","Recruiting","Randomised","Quadruple",2,NA,"Healthcare Workers","ICU Admission, Pneumonia or ARDS, Cough, Other Mild Symptoms","Nutrition, SOC",314
"2020-001536-98","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001536-98/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Status Unclear","Non-Randomised","Unspecified",3,NA,"Healthcare Workers","Viral Load or Clearance, Other Mild Symptoms","HCQ",NA
"NCT04352933","https://ClinicalTrials.gov/show/NCT04352933",NA,"United Kingdom","London","2020-Apr","2020-Oct","Recruiting","Randomised","Quadruple",3,NA,"Healthcare Workers","Hospitalization, Viral Load or Clearance, Other Mild Symptoms","HCQ, SOC",1000
"NCT04359537","https://ClinicalTrials.gov/show/NCT04359537",NA,"Pakistan","Islamabad","2020-Apr","2020-Aug","Recruiting","Randomised","Single",2,NA,"Healthcare Workers","Mortality, ICU Admission, Hospitalization, Other Mild Symptoms, Treatment-emergent Adverse Events","HCQ, SOC",200
"NCT04359680","https://ClinicalTrials.gov/show/NCT04359680",NA,"United States","Florida","2020-Apr","2020-Aug","Recruiting","Randomised","Triple",3,NA,"Healthcare Workers","Viral Load or Clearance","Antivirals, SOC",800
"NCT04359680","https://ClinicalTrials.gov/show/NCT04359680",NA,"United States","New York","2020-Apr","2020-Aug","Recruiting","Randomised","Triple",3,NA,"Healthcare Workers","Viral Load or Clearance","Antivirals, SOC",800
"NCT04359680","https://ClinicalTrials.gov/show/NCT04359680",NA,"United States","Texas","2020-Apr","2020-Aug","Recruiting","Randomised","Triple",3,NA,"Healthcare Workers","Viral Load or Clearance","Antivirals, SOC",800
"NCT04341441","https://clinicaltrials.gov/show/NCT04341441",NA,"United States","Washington, Dc","2020-Jul",NA,"Recruiting","Randomised","Triple",6,NA,"Healthcare Workers","Hospitalization, Viral Load or Clearance, Other Mild Symptoms, Adverse Events, Serious Adverse Events, IgG, IgM or IgA","HCQ, SOC",3000
"NCT04340349","https://clinicaltrials.gov/show/NCT04340349",NA,"Mexico","Mexico","2020-Feb",NA,"Recruiting","Randomised","Triple",1,NA,"Healthcare Workers","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6",NA,140
"PACTR202006717277937","https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11088",NA,"Nigeria","Niger","2020-May",NA,"Not Recruiting","Randomised","Unspecified",7,"Healthy","Healthy Exposed",NA,"Other + Alternative therapy, Other + Alternative therapy + Corticosteroids",48
"SLCTR/2020/011","https://slctr.lk/trials/slctr-2020-011",NA,"Sri Lanka","Western Province","2020-May",NA,"Not Recruiting","Randomised","Unspecified",2,"Healthy","Healthy Exposed","Cough, Fever, Dyspnea, Other Mild Symptoms","HCQ, SOC",400
"2020-001194-69","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001194-69/ES/",NA,"Spain","Madrid","2020-Apr",NA,"Recruiting","Randomised","Double",2,"Healthy","Healthy Exposed","Mortality, Viral Load or Clearance",NA,NA
"CHICTR2000030386","http://www.chictr.org.cn/showproj.aspx?proj=50323",NA,"China","Hunan","2020-Feb","2020-Dec","Not Recruiting","Single-Arm","Unspecified",1,"Healthy (Exposed Or Unexposed)","Healthy Exposed","Quality of Life","TCM",1000
"CHICTR2000030033","http://www.chictr.org.cn/showproj.aspx?proj=49703",NA,"China","Guangdong","2020-Feb","2020-Jun","Not Recruiting","Randomised","Open-Label",3,"Healthy (Exposed)","Healthy Exposed","Household Members with CoViD-19","SOC, TCM",828
"NCT04328961","https://ClinicalTrials.gov/show/NCT04328961",NA,"United States","California","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,"Healthy (Exposed)","Healthy Exposed",NA,"HCQ, Vitamins",2000
"NCT04328961","https://ClinicalTrials.gov/show/NCT04328961",NA,"United States","Louisiana","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,"Healthy (Exposed)","Healthy Exposed",NA,"HCQ, Vitamins",2000
"NCT04328961","https://ClinicalTrials.gov/show/NCT04328961",NA,"United States","Maryland","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,"Healthy (Exposed)","Healthy Exposed",NA,"HCQ, Vitamins",2000
"NCT04328961","https://ClinicalTrials.gov/show/NCT04328961",NA,"United States","Massachusetts","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,"Healthy (Exposed)","Healthy Exposed",NA,"HCQ, Vitamins",2000
"NCT04328961","https://ClinicalTrials.gov/show/NCT04328961",NA,"United States","New York","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,"Healthy (Exposed)","Healthy Exposed",NA,"HCQ, Vitamins",2000
"NCT04328961","https://ClinicalTrials.gov/show/NCT04328961",NA,"United States","Washington","2020-Apr","2020-Sep","Recruiting","Randomised","Double",2,"Healthy (Exposed)","Healthy Exposed",NA,"HCQ, Vitamins",2000
"NCT04318444","https://ClinicalTrials.gov/show/NCT04318444",NA,"United States","New York","2020-Mar","2021-Mar","Recruiting","Randomised","Quadruple",2,"Healthy (Exposed)","Healthy Exposed","Viral Load or Clearance","HCQ, SOC",1600
"NCT04321174","https://ClinicalTrials.gov/show/NCT04321174",NA,"Canada","British Columbia","2020-Mar","2021-Mar","Recruiting","Randomised","Single",2,"Healthy (Exposed)","Healthy Exposed","Mortality, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Cough, Fever, Other Mild Symptoms, Adverse Events, Quality of Life, Distress","LPV/r, SOC",1220
"NCT04321174","https://ClinicalTrials.gov/show/NCT04321174",NA,"Canada","Ontario","2020-Mar","2021-Mar","Recruiting","Randomised","Single",2,"Healthy (Exposed)","Healthy Exposed","Mortality, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Cough, Fever, Other Mild Symptoms, Adverse Events, Quality of Life, Distress","LPV/r, SOC",1220
"NCT04395976","https://ClinicalTrials.gov/show/NCT04395976",NA,"United Kingdom","London","2020-May","2020-Sep","Not Recruiting","Randomised","Open-Label",2,"Suspected","Healthy Exposed","Viral Load or Clearance","Alternative therapy, SOC",120
"CTRI/2020/05/024967","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43338",NA,"India","New Delhi","2020-Jan",NA,"Not Recruiting","Single-Arm","Open-Label",2,"Suspected","Healthy Exposed","Cough, Fever, Dyspnea","Other, SOC",30
"CTRI/2020/04/024731","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42912",NA,"India","New Delhi","2020-Apr",NA,"Not Recruiting","Single-Arm","Open-Label",1,"Healthy (Exposed)","Healthy Exposed","Cough, Other Mild Symptoms","Alternative therapy",50
"CTRI/2020/05/024986","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43455",NA,"India","Delhi","2020-Apr",NA,"Not Recruiting","Single-Arm","Unspecified",1,"Suspected","Healthy Exposed",NA,"Alternative therapy",10000
"CHICTR2000032459","http://www.chictr.org.cn/showproj.aspx?proj=53003",NA,"China","Henan","2020-Apr",NA,"Recruiting","Randomised","Double",68,"Healthy","Healthy Exposed",NA,"SOC, Vaccine",288
"NCT04435314","https://ClinicalTrials.gov/show/NCT04435314",NA,"Brazil","Brasilia","2020-Jun","2020-Aug","Not Recruiting","Randomised","Quadruple",2,"Healthy","Healthy Exposed","Treatment-emergent Adverse Events","Antivirals, SOC",200
"NCT04409327","https://ClinicalTrials.gov/show/NCT04409327",NA,"United States","Rhode Island","2020-Jun","2020-Sep","Recruiting","Randomised","Quadruple",2,"Healthy","Healthy Exposed","Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO","Other, SOC",550
"CHICTR2000029803","http://www.chictr.org.cn/showproj.aspx?proj=49428",NA,"China","Hubei","2020-Feb","2021-Feb","Not Recruiting","Randomised","Open-Label",4,"Healthy (Exposed)","Healthy Exposed","Viral Load or Clearance, Cough, Fever, Serious Adverse Events, C-Reactive Protein, Radiographic Findings","HCQ, Umifenovir",320
"CHICTR2000029602","http://www.chictr.org.cn/showproj.aspx?proj=48985",NA,"China","Hubei","2020-Feb","2020-Aug","Recruiting","Randomised","Open-Label",2,"Healthy (Exposed)","Healthy Exposed","Clinical Improvement Score (Any), Viral Load or Clearance, Fever","Education + Monitoring + TCM, Psychological therapy",600
"NCT04330144","https://ClinicalTrials.gov/show/NCT04330144",NA,"South Korea","Seoul","2020-Apr","2021-Mar","Not Recruiting","Randomised","Single",2,"Healthy (Exposed)","Healthy Exposed","Viral Load or Clearance","HCQ",2486
"NCT04368988","https://ClinicalTrials.gov/show/NCT04368988",NA,"Australia","Queensland","2020-Apr","2020-Dec","Recruiting","Randomised","Triple",7,NA,"Healthy Exposed","IgG, IgM or IgA, Antibodies","SOC, Vaccine",131
"NCT04368988","https://ClinicalTrials.gov/show/NCT04368988",NA,"Australia","Victoria","2020-Apr","2020-Dec","Recruiting","Randomised","Triple",7,NA,"Healthy Exposed","IgG, IgM or IgA, Antibodies","SOC, Vaccine",131
"NCT04364022","https://ClinicalTrials.gov/show/NCT04364022",NA,"Switzerland","Bern","2020-Apr","2020-Oct","Recruiting","Randomised","Open-Label",2,NA,"Healthy Exposed",NA,"HCQ, LPV/r",420
"NCT04369794","https://clinicaltrials.gov/show/NCT04369794",NA,"Brazil","Brasilia","2020-Apr",NA,"Not Recruiting","Randomised","Quadruple",2,NA,"Healthy Exposed",NA,"SOC, Vaccine",1000
"CHICTR2000031944","http://www.chictr.org.cn/showproj.aspx?proj=52414",NA,"China","Beijing","2020-Apr","2020-Dec","Recruiting","Randomised","Unspecified",2,NA,"Healthy Exposed","Viral Load or Clearance, Fever, Other Mild Symptoms","SOC, TCM",2000
"IRCT20190122042450N4","http://en.irct.ir/trial/47090",NA,"Iran","Tehran","2020-Apr","2020-Jun","Completed","Randomised","Open-Label",2,NA,"Healthy Exposed","Viral Load or Clearance, Radiographic Findings","HCQ, SOC",1000
"CTRI/2020/04/024659","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42967",NA,"India","New Delhi","2020-Apr",NA,"Not Recruiting","Single-Arm","Open-Label",1,NA,"Healthy Exposed","Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea","Alternative therapy",30
"NCT04342156","https://ClinicalTrials.gov/show/NCT04342156",NA,"Singapore","Singapore","2020-Apr","2020-Aug","Not Recruiting","Randomised","Open-Label",2,NA,"Healthy Exposed","Mortality, Hospitalization, Visits or Returns to Emergency Department, Invasive Mechanical Ventilation or ECMO","HCQ, SOC",1200
"TCTR20200404004","http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5995",NA,"Thailand","Nan","2020-Mar",NA,"Not Recruiting","Randomised","Unspecified",2,NA,"Healthy Exposed","Hospitalization, Anti SARS-COV-2 Titers","HCQ, SOC",400
"NCT04344600","https://clinicaltrials.gov/show/NCT04344600",NA,"United States","Washington, Dc","2020-Oct",NA,"Recruiting","Randomised","Single",2,NA,"Healthy Exposed","Viral Load or Clearance","IFN, SOC",164
"NCT04336410","https://ClinicalTrials.gov/show/NCT04336410",NA,"United States","Kentucky","2020-Apr","2021-Jul","Recruiting","Non-Randomised","Open-Label",2,"Healthy","Healthy Unexposed","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","Vaccine",120
"NCT04336410","https://ClinicalTrials.gov/show/NCT04336410",NA,"United States","Missouri","2020-Apr","2021-Jul","Recruiting","Non-Randomised","Open-Label",2,"Healthy","Healthy Unexposed","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","Vaccine",120
"NCT04336410","https://ClinicalTrials.gov/show/NCT04336410",NA,"United States","Pennsylvania","2020-Apr","2021-Jul","Recruiting","Non-Randomised","Open-Label",2,"Healthy","Healthy Unexposed","ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6","Vaccine",120
"ISRCTN90906759","http://isrctn.com/ISRCTN90906759",NA,"United Kingdom","London","2020-Jul",NA,"Recruiting","Randomised","Single",5,"Healthy","Healthy Unexposed","Serious Adverse Events","Vaccine",10560
"NCT04398147","https://ClinicalTrials.gov/show/NCT04398147",NA,"Canada","Ottawa","2020-May","2021-Dec","Not Recruiting","Randomised","Quadruple",3,"Healthy","Healthy Unexposed","Adverse Events, Serious Adverse Events, Anti SARS-COV-2 Titers, IL-2, Tumor Necrosis Factor (Any), Interferon (Any), Lymphocyte Count, IgG, IgM or IgA, Antibodies","SOC, Vaccine",696
"CTRI/2020/05/024981","http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43374",NA,"India","New Delhi","2020-Feb",NA,"Recruiting","Randomised","Open-Label",2,"Healthy","Healthy Unexposed",NA,"Alternative therapy, SOC",600
"PACTR202005681895696","https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10988",NA,"Kenya","Nairobi","2020-Apr",NA,"Not Recruiting","Randomised","Single",2,"Healthy","Healthy Unexposed","Serious Adverse Events, IgG, IgM or IgA, Antibodies","Vaccine",400
"NCT04334980","https://ClinicalTrials.gov/show/NCT04334980",NA,"United States","California","2020-Apr","2021-Aug","Not Recruiting","Randomised","Triple",6,"Healthy","Healthy Unexposed","Adverse Events, Stool Sample, IgG, IgM or IgA, Antibodies","SOC, Vaccine",112
"NCT04334980","https://ClinicalTrials.gov/show/NCT04334980",NA,"Canada","British Columbia","2020-Apr","2021-Aug","Not Recruiting","Randomised","Triple",6,"Healthy","Healthy Unexposed","Adverse Events, Stool Sample, IgG, IgM or IgA, Antibodies","SOC, Vaccine",112
"NCT04334980","https://ClinicalTrials.gov/show/NCT04334980",NA,"Canada","Nova Scotia","2020-Apr","2021-Aug","Not Recruiting","Randomised","Triple",6,"Healthy","Healthy Unexposed","Adverse Events, Stool Sample, IgG, IgM or IgA, Antibodies","SOC, Vaccine",112
"NCT04324606","https://ClinicalTrials.gov/show/NCT04324606",NA,"United Kingdom","Southampton","2020-Mar","2021-May","Not Recruiting","Randomised","Single",6,"Healthy","Healthy Unexposed",NA,"SOC, Vaccine",1090
"NCT04324606","https://ClinicalTrials.gov/show/NCT04324606",NA,"United Kingdom","Bristol","2020-Mar","2021-May","Not Recruiting","Randomised","Single",6,"Healthy","Healthy Unexposed",NA,"SOC, Vaccine",1090
"NCT04324606","https://ClinicalTrials.gov/show/NCT04324606",NA,"United Kingdom","London","2020-Mar","2021-May","Not Recruiting","Randomised","Single",6,"Healthy","Healthy Unexposed",NA,"SOC, Vaccine",1090
"NCT04326114","https://clinicaltrials.gov/show/NCT04326114",NA,"Spain","Madrid","2020-Mar",NA,"Not Recruiting","Randomised","Single",3,"Healthy","Healthy Unexposed","Viral Load or Clearance, Cough, Fever, Dyspnea, Other Mild Symptoms, Adverse Events","Non-invasive respiratory support, SOC",240
"NCT04313127","https://ClinicalTrials.gov/show/NCT04313127",NA,"China","Hubei","2020-Mar","2020-Dec","Not Recruiting","Non-Randomised","Open-Label",3,"Healthy","Healthy Unexposed","Treatment-emergent Adverse Events, Serious Adverse Events, Antibodies","Vaccine",108
"NCT04321928","https://ClinicalTrials.gov/show/NCT04321928",NA,"Hungary","Budapest","2020-Mar","2021-Apr","Recruiting","Randomised","Double",2,"Healthy","Healthy Unexposed","ICU Admission, Hospitalization, Other Mild Symptoms","Education, Psychological therapy",7576
"CHICTR2000029479","http://www.chictr.org.cn/showproj.aspx?proj=48773",NA,"China","Sichuan","2020-Feb","2020-May","Completed","Randomised","Open-Label",2,"Healthy","Healthy Unexposed","Pneumonia or ARDS","SOC, TCM",20000
"NCT04283461","https://ClinicalTrials.gov/show/NCT04283461",NA,"United States","Georgia","2020-Feb","2021-Nov","Recruiting","Non-Randomised","Open-Label",3,"Healthy","Healthy Unexposed","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Anti SARS-COV-2 Titers, Ferritin, IL-6, D-Dimer, Glucose, Antibodies, PaO2-FiO2","Vaccine",155
"NCT04283461","https://ClinicalTrials.gov/show/NCT04283461",NA,"United States","Maryland","2020-Feb","2021-Nov","Recruiting","Non-Randomised","Open-Label",3,"Healthy","Healthy Unexposed","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Anti SARS-COV-2 Titers, Ferritin, IL-6, D-Dimer, Glucose, Antibodies, PaO2-FiO2","Vaccine",155
"NCT04283461","https://ClinicalTrials.gov/show/NCT04283461",NA,"United States","Washington","2020-Feb","2021-Nov","Recruiting","Non-Randomised","Open-Label",3,"Healthy","Healthy Unexposed","Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Anti SARS-COV-2 Titers, Ferritin, IL-6, D-Dimer, Glucose, Antibodies, PaO2-FiO2","Vaccine",155
"RPCEC00000308","https://rpcec.sld.cu/en/trials/RPCEC00000308-En",NA,"Cuba","Havana","2020-Mar",NA,"Not Recruiting","Randomised","Unspecified",6,"Healthy","Healthy Unexposed",NA,"IFN",30
"NCT04412538","https://ClinicalTrials.gov/show/NCT04412538",NA,"China","Sichuan","2020-Jun","2020-Sep","Recruiting","Randomised","Quadruple",8,"Healthy","Healthy Unexposed","Serious Adverse Events, IgG, IgM or IgA, Antibodies","SOC, Vaccine",942
"NCT04436276","https://clinicaltrials.gov/show/NCT04436276",NA,"United States","Washington, Dc","2020-Jun",NA,"Not Recruiting","Randomised","Double",5,"Healthy","Healthy Unexposed","Serious Adverse Events","SOC, Vaccine",1045
"NCT04436276","https://clinicaltrials.gov/show/NCT04436276",NA,"Belgium","Brussels","2020-Jun",NA,"Not Recruiting","Randomised","Double",5,"Healthy","Healthy Unexposed","Serious Adverse Events","SOC, Vaccine",1045
"ACTRN12620000674932","https://anzctr.org.au/ACTRN12620000674932.aspx",NA,"Australia","Canberra","2020-Dec",NA,"Not Recruiting","Randomised","Double",5,"Healthy","Healthy Unexposed","Fever, Other Mild Symptoms, Adverse Events, Antibodies","SOC, Vaccine",120
"NCT04383574","https://ClinicalTrials.gov/show/NCT04383574",NA,"China","Hebei","2020-May","2020-Jul","Not Recruiting","Randomised","Double",4,"Healthy","Healthy Unexposed","Serious Adverse Events, Antibodies","SOC, Vaccine",422
"2020-001228-32","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001228-32/GB/",NA,"United Kingdom","London","2020-Apr",NA,"Recruiting","Randomised","Single",5,"Healthy","Healthy Unexposed","Stool Sample","SOC, Vaccine",10560
"NCT04405908","https://ClinicalTrials.gov/show/NCT04405908",NA,"Australia","Western Australia","2020-May","2020-Oct","Recruiting","Randomised","Triple",3,"Healthy","Healthy Unexposed","Adverse Events, ACE, ACE-II, Antibodies","Vaccine",150
"NCT04377646","https://ClinicalTrials.gov/show/NCT04377646",NA,"Tunisia","Tunis","2020-May","2020-May","Not Recruiting","Randomised","Triple",4,"Healthy","Healthy Unexposed","Adverse Events","HCQ, HCQ + Zinc, SOC",660
"NCT04377789","https://ClinicalTrials.gov/show/NCT04377789",NA,"Turkey","Istanbul","2020-May","2020-Jul","Recruiting","Non-Randomised","Open-Label",3,"Healthy","Healthy Unexposed","Mortality","Alternative therapy, SOC",50
"NCT04436471","https://ClinicalTrials.gov/show/NCT04436471",NA,"Russia","Moscow","2020-Jun","2020-Aug","Not Recruiting","Non-Randomised","Open-Label",3,"Healthy","Healthy Unexposed","Adverse Events, Antibodies","Vaccine",38
"NCT04437875","https://ClinicalTrials.gov/show/NCT04437875",NA,"Russia","Moscow","2020-Jun","2020-Aug","Not Recruiting","Non-Randomised","Open-Label",3,"Healthy","Healthy Unexposed","Adverse Events, Antibodies","Vaccine",38
"NCT04330300","https://ClinicalTrials.gov/show/NCT04330300",NA,"Ireland","Galway","2020-Apr","2021-Jul","Suspended","Randomised","Open-Label",4,"Healthy","Healthy Unexposed","Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Troponin","Antihypertensive",2414
"RPCEC00000315","https://rpcec.sld.cu/en/trials/RPCEC00000315-En",NA,"Cuba","Havana","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Healthy","Healthy Unexposed","Monocyte Count, Lymphocyte Count, Dendritic Cell Count, CD4, CD8","Other",60
"ISRCTN89951424","http://isrctn.com/ISRCTN89951424",NA,"Brazil","Brasilia","2020-Nov",NA,"Recruiting","Randomised","Single",2,"Healthy","Healthy Unexposed",NA,"SOC, Vaccine",2000
"NCT04405076","https://ClinicalTrials.gov/show/NCT04405076",NA,"United States","Georgia","2020-May","2021-Mar","Not Recruiting","Randomised","Double",3,"Healthy","Healthy Unexposed","Serious Adverse Events, Antibodies, Blood Pressure, Respiratory Rate","Vaccine",600
"NCT04405076","https://ClinicalTrials.gov/show/NCT04405076",NA,"United States","Kansas","2020-May","2021-Mar","Not Recruiting","Randomised","Double",3,"Healthy","Healthy Unexposed","Serious Adverse Events, Antibodies, Blood Pressure, Respiratory Rate","Vaccine",600
"NCT04405076","https://ClinicalTrials.gov/show/NCT04405076",NA,"United States","Missouri","2020-May","2021-Mar","Not Recruiting","Randomised","Double",3,"Healthy","Healthy Unexposed","Serious Adverse Events, Antibodies, Blood Pressure, Respiratory Rate","Vaccine",600
"NCT04405076","https://ClinicalTrials.gov/show/NCT04405076",NA,"United States","Nebraska","2020-May","2021-Mar","Not Recruiting","Randomised","Double",3,"Healthy","Healthy Unexposed","Serious Adverse Events, Antibodies, Blood Pressure, Respiratory Rate","Vaccine",600
"NCT04405076","https://ClinicalTrials.gov/show/NCT04405076",NA,"United States","North Carolina","2020-May","2021-Mar","Not Recruiting","Randomised","Double",3,"Healthy","Healthy Unexposed","Serious Adverse Events, Antibodies, Blood Pressure, Respiratory Rate","Vaccine",600
"NCT04405076","https://ClinicalTrials.gov/show/NCT04405076",NA,"United States","South Dakota","2020-May","2021-Mar","Not Recruiting","Randomised","Double",3,"Healthy","Healthy Unexposed","Serious Adverse Events, Antibodies, Blood Pressure, Respiratory Rate","Vaccine",600
"NCT04405076","https://ClinicalTrials.gov/show/NCT04405076",NA,"United States","Texas","2020-May","2021-Mar","Not Recruiting","Randomised","Double",3,"Healthy","Healthy Unexposed","Serious Adverse Events, Antibodies, Blood Pressure, Respiratory Rate","Vaccine",600
"NCT04405076","https://ClinicalTrials.gov/show/NCT04405076",NA,"United States","Utah","2020-May","2021-Mar","Not Recruiting","Randomised","Double",3,"Healthy","Healthy Unexposed","Serious Adverse Events, Antibodies, Blood Pressure, Respiratory Rate","Vaccine",600
"NCT04414267","https://ClinicalTrials.gov/show/NCT04414267",NA,"Greece","Athens","2020-Jun","2021-May","Recruiting","Randomised","Quadruple",2,"Healthy","Healthy Unexposed","IgG, IgM or IgA","SOC, Vaccine",900
"NL8547","https://trialregister.nl/trial/8547",NA,"Netherlands","Amsterdam","2020-Apr",NA,"Recruiting","Randomised","Single",2,"Healthy","Healthy Unexposed",NA,"SOC, Vaccine",1600
"NCT04439045","https://clinicaltrials.gov/show/NCT04439045",NA,"Canada","Ontario","2020-Mar",NA,"Not Recruiting","Randomised","Double",2,"Healthy","Healthy Unexposed",NA,"SOC, Vaccine",3626
"NCT04435379","https://clinicaltrials.gov/show/NCT04435379",NA,"Germany","Berlin","2020-Jun",NA,"Recruiting","Randomised","Triple",2,"Healthy","Healthy Unexposed",NA,"SOC, Vaccine",2038
"NCT04392219","https://ClinicalTrials.gov/show/NCT04392219",NA,"United States","Florida","2020-May","2020-Aug","Recruiting","Randomised","Double",2,"Healthy","Healthy Unexposed","Adverse Events","Antivirals, SOC",130
"NCT04392219","https://ClinicalTrials.gov/show/NCT04392219",NA,"United States","Texas","2020-May","2020-Aug","Recruiting","Randomised","Double",2,"Healthy","Healthy Unexposed","Adverse Events","Antivirals, SOC",130
"NCT04392219","https://ClinicalTrials.gov/show/NCT04392219",NA,"United States","Wisconsin","2020-May","2020-Aug","Recruiting","Randomised","Double",2,"Healthy","Healthy Unexposed","Adverse Events","Antivirals, SOC",130
"NCT04392219","https://ClinicalTrials.gov/show/NCT04392219",NA,"United Kingdom","Leeds","2020-May","2020-Aug","Recruiting","Randomised","Double",2,"Healthy","Healthy Unexposed","Adverse Events","Antivirals, SOC",130
"NCT04408456","https://ClinicalTrials.gov/show/NCT04408456",NA,"India","Chandigarh","2020-May","2020-Jun","Recruiting","Non-Randomised","Open-Label",2,"Healthy","Healthy Unexposed",NA,"HCQ, SOC",200
"CHICTR2000031174","http://www.chictr.org.cn/showproj.aspx?proj=51437",NA,"China","Shanghai","2020-Mar","2020-Sep","Not Recruiting","Single-Arm","Unspecified",2,"Healthy","Healthy Unexposed",NA,"HCQ, SOC",1000
"2020-001357-52","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001357-52/ES/",NA,"Spain","Madrid","2020-May",NA,"Recruiting","Randomised","Double",2,"Healthy","Healthy Unexposed","Viral Load or Clearance, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, Distress","HCQ, SOC",NA
"NCT04442048","https://clinicaltrials.gov/show/NCT04442048",NA,"Canada","Ontario","2020-Jun",NA,"Not Recruiting","Randomised","Open-Label",2,"Healthy","Healthy Unexposed",NA,"SOC, Vaccine",1500
"NCT04441918","https://ClinicalTrials.gov/show/NCT04441918",NA,"China","Shanghai","2020-Jun","2020-Dec","Recruiting","Randomised","Quadruple",2,"Healthy","Healthy Unexposed","Adverse Events","mAb, SOC",40
"RPCEC00000314","https://rpcec.sld.cu/en/trials/RPCEC00000314-En",NA,"Cuba","Havana","2020-May",NA,"Recruiting","Unspecified","Open-Label",2,"Healthy","Healthy Unexposed",NA,"SOC, Vaccine",115000
"CHICTR2000033003","http://www.chictr.org.cn/showproj.aspx?proj=53790",NA,"China","Beijing","2020-May","2022-Apr","Not Recruiting","Single-Arm","Unspecified",1,"Healthy","Healthy Unexposed","Adverse Events","Other",25
"NCT04380532","https://ClinicalTrials.gov/show/NCT04380532",NA,"Canada","British Columbia","2020-May","2021-May","Not Recruiting","Single-Arm","Open-Label",1,"Healthy","Healthy Unexposed","Adverse Events, Platelet Count, Radiographic Findings","Vaccine",20
"NCT04380532","https://ClinicalTrials.gov/show/NCT04380532",NA,"Mongolia","Ulaanbaatar","2020-May","2021-May","Not Recruiting","Single-Arm","Open-Label",1,"Healthy","Healthy Unexposed","Adverse Events, Platelet Count, Radiographic Findings","Vaccine",20
"NCT04368728","https://ClinicalTrials.gov/show/NCT04368728",NA,"United States","California","2020-Apr","2021-Jun","Recruiting","Randomised","Triple",7,NA,"Healthy Unexposed","Serious Adverse Events, Antibodies","SOC, Vaccine",7600
"NCT04368728","https://ClinicalTrials.gov/show/NCT04368728",NA,"United States","Florida","2020-Apr","2021-Jun","Recruiting","Randomised","Triple",7,NA,"Healthy Unexposed","Serious Adverse Events, Antibodies","SOC, Vaccine",7600
"NCT04368728","https://ClinicalTrials.gov/show/NCT04368728",NA,"United States","Georgia","2020-Apr","2021-Jun","Recruiting","Randomised","Triple",7,NA,"Healthy Unexposed","Serious Adverse Events, Antibodies","SOC, Vaccine",7600
"NCT04368728","https://ClinicalTrials.gov/show/NCT04368728",NA,"United States","Kentucky","2020-Apr","2021-Jun","Recruiting","Randomised","Triple",7,NA,"Healthy Unexposed","Serious Adverse Events, Antibodies","SOC, Vaccine",7600
"NCT04368728","https://ClinicalTrials.gov/show/NCT04368728",NA,"United States","Maryland","2020-Apr","2021-Jun","Recruiting","Randomised","Triple",7,NA,"Healthy Unexposed","Serious Adverse Events, Antibodies","SOC, Vaccine",7600
"NCT04368728","https://ClinicalTrials.gov/show/NCT04368728",NA,"United States","Massachusetts","2020-Apr","2021-Jun","Recruiting","Randomised","Triple",7,NA,"Healthy Unexposed","Serious Adverse Events, Antibodies","SOC, Vaccine",7600
"NCT04368728","https://ClinicalTrials.gov/show/NCT04368728",NA,"United States","Missouri","2020-Apr","2021-Jun","Recruiting","Randomised","Triple",7,NA,"Healthy Unexposed","Serious Adverse Events, Antibodies","SOC, Vaccine",7600
"NCT04368728","https://ClinicalTrials.gov/show/NCT04368728",NA,"United States","Nebraska","2020-Apr","2021-Jun","Recruiting","Randomised","Triple",7,NA,"Healthy Unexposed","Serious Adverse Events, Antibodies","SOC, Vaccine",7600
"NCT04368728","https://ClinicalTrials.gov/show/NCT04368728",NA,"United States","New York","2020-Apr","2021-Jun","Recruiting","Randomised","Triple",7,NA,"Healthy Unexposed","Serious Adverse Events, Antibodies","SOC, Vaccine",7600
"NCT04368728","https://ClinicalTrials.gov/show/NCT04368728",NA,"United States","North Carolina","2020-Apr","2021-Jun","Recruiting","Randomised","Triple",7,NA,"Healthy Unexposed","Serious Adverse Events, Antibodies","SOC, Vaccine",7600
"NCT04368728","https://ClinicalTrials.gov/show/NCT04368728",NA,"United States","Ohio","2020-Apr","2021-Jun","Recruiting","Randomised","Triple",7,NA,"Healthy Unexposed","Serious Adverse Events, Antibodies","SOC, Vaccine",7600
"NCT04368728","https://ClinicalTrials.gov/show/NCT04368728",NA,"United States","Texas","2020-Apr","2021-Jun","Recruiting","Randomised","Triple",7,NA,"Healthy Unexposed","Serious Adverse Events, Antibodies","SOC, Vaccine",7600
"NCT04368728","https://ClinicalTrials.gov/show/NCT04368728",NA,"United States","Utah","2020-Apr","2021-Jun","Recruiting","Randomised","Triple",7,NA,"Healthy Unexposed","Serious Adverse Events, Antibodies","SOC, Vaccine",7600
"NCT04380701","https://ClinicalTrials.gov/show/NCT04380701",NA,"Germany","Berlin","2020-May","2020-Aug","Recruiting","Non-Randomised","Open-Label",4,NA,"Healthy Unexposed","Adverse Events, Treatment-emergent Adverse Events, Anti SARS-COV-2 Titers","Vaccine",200
"2020-001072-15","https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001072-15/GB/",NA,"United Kingdom","London","2020-Mar",NA,"Recruiting","Randomised","Single",4,NA,"Healthy Unexposed","Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Other Mild Symptoms, Serious or Seconday Infections, Adverse Events, Anti SARS-COV-2 Titers","Vaccine",1112
"NCT04417335","https://ClinicalTrials.gov/show/NCT04417335",NA,"Netherlands","Gelderland","2020-Jun","2021-May","Not Recruiting","Randomised","Single",2,NA,"Healthy Unexposed","Mortality, ICU Admission, Hospitalization, Secondary CoViD-19 Re-infection, Fever, Other Mild Symptoms","SOC, Vaccine",2014
"NCT04417335","https://ClinicalTrials.gov/show/NCT04417335",NA,"Netherlands","Utrecht","2020-Jun","2021-May","Not Recruiting","Randomised","Single",2,NA,"Healthy Unexposed","Mortality, ICU Admission, Hospitalization, Secondary CoViD-19 Re-infection, Fever, Other Mild Symptoms","SOC, Vaccine",2014
"CHICTR2000032487","http://www.chictr.org.cn/showproj.aspx?proj=52394",NA,"China","Shanghai","2020-Apr","2020-Sep","Not Recruiting","Randomised","Unspecified",2,NA,"Healthy Unexposed","Antibodies","HCQ, SOC",2000
"IRCT20200405046958N1","http://en.irct.ir/trial/46946",NA,"Iran","Tehran","2020-Apr","2020-Jun","Completed","Randomised","Triple",2,NA,"Healthy Unexposed","Viral Load or Clearance","HCQ, SOC",60
"NCT04357028","https://clinicaltrials.gov/show/NCT04357028",NA,"Egypt","Cairo","2020-Apr",NA,"Recruiting","Randomised","Single",2,NA,"Healthy Unexposed",NA,"SOC, Vaccine",200
"NCT04353518","https://ClinicalTrials.gov/show/NCT04353518",NA,"India","Chandigarh","2020-Apr","2021-Mar","Not Recruiting","Randomised","Quadruple",2,NA,"Healthy Unexposed","Serious or Seconday Infections, Adverse Events, Serious Adverse Events","Other",4000
"NCT04341389","https://ClinicalTrials.gov/show/NCT04341389",NA,"China","Hubei","2020-Apr","2021-Jan","Not Recruiting","Randomised","Double",3,NA,"Healthy Unexposed","Viral Load or Clearance, Adverse Events, Serious Adverse Events, Anti SARS-COV-2 Titers, Interferon (Any), IgG, IgM or IgA, Antibodies","SOC, Vaccine",508
"NCT04352608","https://ClinicalTrials.gov/show/NCT04352608",NA,"China","Jiangsu","2020-Apr","2020-Aug","Recruiting","Randomised","Quadruple",6,NA,"Healthy Unexposed","Visits or Returns to Emergency Department, Serious Adverse Events, Platelet Count, Hemoglobin, Creatinine Phosphokinase, ALT, AST, Bilirubin, Urine Sample, IgG, IgM or IgA, Antibodies","SOC, Vaccine",744
"NCT04364009","https://clinicaltrials.gov/show/NCT04364009",NA,"France","Paris","2020-Apr",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed",NA,"Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, White Blood Cell Count, D-Dimer, Fibrinogen, LDH, PaO2-FiO2, Respiratory Rate, Quality of Life","Anakinra, SOC",240
"NCT04392713","https://clinicaltrials.gov/show/NCT04392713",NA,"Pakistan","Islamabad","2020-May",NA,"Recruiting","Randomised","Open-Label",2,"Confirmed",NA,NA,"Ivermectin, SOC",100
"NCT04400890","https://ClinicalTrials.gov/show/NCT04400890",NA,"United States","Ohio","2020-May","2020-Sep","Not Recruiting","Randomised","Quadruple",2,NA,NA,"ICU Admission, Hospitalization","Vitamins, Vitamins + Polyphenols",200
